assays_assay_id,assays_assay_tissue,assays_curated_by,assays_description,assays_src_id,assays_variant_id,assays_assay_subcellular_fraction,assays_tid,assays_relationship_type,assays_confidence_score,assays_src_assay_id,assays_chembl_id,assays_cell_id,assays_bao_format,assays_tissue_id
7524,Kidney,Intermediate,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL618647,,BAO_0000218,2113.0
7525,Kidney,Intermediate,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,1,,,50597,N,1,,CHEMBL618648,,BAO_0000218,2113.0
7526,Kidney,Intermediate,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL618649,,BAO_0000218,2113.0
7527,Liver,Intermediate,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL618650,,BAO_0000218,2107.0
7528,Liver,Intermediate,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,1,,,50597,N,1,,CHEMBL618651,,BAO_0000218,2107.0
7529,Liver,Intermediate,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL876497,,BAO_0000218,2107.0
7530,Lung,Intermediate,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL618652,,BAO_0000218,2048.0
7531,Lung,Intermediate,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,1,,,50597,N,1,,CHEMBL618653,,BAO_0000218,2048.0
7532,Lung,Intermediate,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL618654,,BAO_0000218,2048.0
7533,,Intermediate,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,1,,,50597,N,1,,CHEMBL618655,,BAO_0000218,
7534,,Intermediate,Compound was tested for solubility in water,1,,,50597,N,1,,CHEMBL618656,,BAO_0000218,
7535,,Intermediate,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),1,,,22229,U,0,,CHEMBL618657,,BAO_0000100,
7536,,Intermediate,Solubility was determined,1,,,50597,N,1,,CHEMBL618658,,BAO_0000218,
7537,,Intermediate,solubility in water (ug/mL) at 37 degree C.,1,,,50597,N,1,,CHEMBL618659,,BAO_0000218,
7538,,Intermediate,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,1,,,50597,N,1,,CHEMBL618660,,BAO_0000218,
7539,,Intermediate,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,1,,,50597,N,1,,CHEMBL618661,,BAO_0000218,
7540,,Intermediate,Half life in rats,1,,,50597,N,1,,CHEMBL873807,,BAO_0000218,
7541,,Intermediate,Half life in Dawley rat,1,,,50597,N,1,,CHEMBL618662,,BAO_0000218,
7542,,Intermediate,Half life period after 3 mg/kg iv administration,1,,,50597,N,1,,CHEMBL618663,,BAO_0000218,
7543,,Intermediate,Half life period after 3 mg/kg iv administration in rat,1,,,50597,N,1,,CHEMBL618664,,BAO_0000218,
7544,,Intermediate,Half life period after 3 mg/kg iv administration in the rat,1,,,50597,N,1,,CHEMBL618665,,BAO_0000218,
7545,,Intermediate,Half life period in female Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL876498,,BAO_0000218,
7546,,Intermediate,Half life period in rat,1,,,50597,N,1,,CHEMBL618666,,BAO_0000218,
7547,,Intermediate,Half-life in rats was determined,1,,,50597,N,1,,CHEMBL620440,,BAO_0000218,
7548,,Intermediate,Half-life in rats with metabolic oxidation,1,,,50597,N,1,,CHEMBL620441,,BAO_0000218,
7549,,Intermediate,Half-life in rats,1,,,50597,N,1,,CHEMBL620442,,BAO_0000218,
7550,,Intermediate,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL620443,,BAO_0000218,
7551,,Intermediate,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL620444,,BAO_0000218,
7552,,Intermediate,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL620445,,BAO_0000218,
7553,,Intermediate,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL620446,,BAO_0000218,
7554,Plasma,Intermediate,Biological half-life measured in plasma of rat,1,,,50597,N,1,,CHEMBL620447,,BAO_0000218,1969.0
7555,Plasma,Intermediate,Biological half-life measured in plasma of rat; 22-25,1,,,50597,N,1,,CHEMBL621129,,BAO_0000218,1969.0
7556,Plasma,Intermediate,Biological half-life measured in plasma of rat; 9-16,1,,,50597,N,1,,CHEMBL621130,,BAO_0000218,1969.0
7557,,Intermediate,Compound was evaluated for its half life when administered intravenously in rat,1,,,50597,N,1,,CHEMBL873808,,BAO_0000218,
7558,,Intermediate,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,1,,,50597,N,1,,CHEMBL876598,,BAO_0000218,
7559,,Intermediate,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,1,,,50597,N,1,,CHEMBL621131,,BAO_0000218,
7560,,Intermediate,Half life (T1/2) after oral administration in rat,1,,,50597,N,1,,CHEMBL621132,,BAO_0000218,
7561,,Intermediate,Half life of compound after iv administration of 20 mg/kg dose in rat,1,,,50597,N,1,,CHEMBL621133,,BAO_0000218,
7562,,Expert,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL621312,,BAO_0000218,
7563,,Intermediate,Half life of compound was determined in rat,1,,,50597,N,1,,CHEMBL621313,,BAO_0000218,
7564,Blood,Intermediate,Half life of compound was determined in rat blood,1,,,50597,N,1,,CHEMBL621314,,BAO_0000218,178.0
7565,,Intermediate,Half life at 1 mg/kg was determined in rat,1,,,50597,N,1,,CHEMBL621315,,BAO_0000218,
7566,,Intermediate,Half life at 10 mg/kg was determined in rat,1,,,50597,N,1,,CHEMBL621316,,BAO_0000218,
7567,,Intermediate,Half life in rats,1,,,50597,N,1,,CHEMBL621317,,BAO_0000218,
7568,,Intermediate,Half life in rats in hours,1,,,50597,N,1,,CHEMBL621318,,BAO_0000218,
7569,,Intermediate,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,,50597,N,1,,CHEMBL621319,,BAO_0000218,
7570,,Intermediate,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,1,,,50597,N,1,,CHEMBL621377,,BAO_0000218,
7571,,Intermediate,Half life was determined,1,,,50597,N,1,,CHEMBL621378,,BAO_0000218,
7572,,Intermediate,Half life after i.v. administration,1,,,50597,N,1,,CHEMBL876599,,BAO_0000218,
7573,,Intermediate,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,1,,,50597,N,1,,CHEMBL621379,,BAO_0000218,
7574,Plasma,Intermediate,Half life in rat plasma,1,,,50597,N,1,,CHEMBL621380,,BAO_0000218,1969.0
7575,Plasma,Intermediate,Half life in rat plasma; Not detected,1,,,50597,N,1,,CHEMBL621381,,BAO_0000218,1969.0
7576,,Intermediate,Half life in rats,1,,,50597,N,1,,CHEMBL618515,,BAO_0000218,
7577,,Intermediate,Half life period of compound was determined after peroral administration,1,,,50597,N,1,,CHEMBL618516,,BAO_0000218,
7578,,Intermediate,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,1,,,50597,N,1,,CHEMBL618517,,BAO_0000218,
7579,,Intermediate,Half life period in rat,1,,,50597,N,1,,CHEMBL618518,,BAO_0000218,
7580,,Intermediate,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,,50597,N,1,,CHEMBL618519,,BAO_0000218,
7581,,Intermediate,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,,50597,N,1,,CHEMBL618698,,BAO_0000218,
7582,,Intermediate,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,1,,,50597,N,1,,CHEMBL618862,,BAO_0000218,
7583,,Intermediate,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL618863,,BAO_0000218,
7584,,Intermediate,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,1,,,50597,N,1,,CHEMBL618864,,BAO_0000218,
7585,,Intermediate,Half life time in rat the dose of 2 mg/kg,1,,,50597,N,1,,CHEMBL618865,,BAO_0000218,
7586,,Intermediate,Half-life 24 hr after 10 mg/kg iv administration in rats,1,,,50597,N,1,,CHEMBL618866,,BAO_0000218,
7587,,Intermediate,Half-life 24 hr after 2 mg/kg iv administration in rats,1,,,50597,N,1,,CHEMBL618867,,BAO_0000218,
7588,,Intermediate,Half-life consistent with the observed metabolic steady state in rats,1,,,50597,N,1,,CHEMBL875828,,BAO_0000218,
7589,,Intermediate,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,,50597,N,1,,CHEMBL618868,,BAO_0000218,
7590,,Intermediate,Half-life for oxidative metabolic stability was determined using male human,1,,,50597,N,1,,CHEMBL618869,,BAO_0000218,
7591,,Intermediate,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",1,,,50597,N,1,,CHEMBL618870,,BAO_0000218,
7592,Plasma,Intermediate,Half-life in rat plasma,1,,,50597,N,1,,CHEMBL618871,,BAO_0000218,1969.0
7593,Plasma,Intermediate,Half-life in rat plasma was determined,1,,,50597,N,1,,CHEMBL618872,,BAO_0000218,1969.0
7594,,Intermediate,Half-life in rats was determined,1,,,50597,N,1,,CHEMBL873816,,BAO_0000218,
7595,,Autocuration,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,1,,,22224,U,0,,CHEMBL618873,,BAO_0000218,
7596,,Autocuration,Area under curve after oral dose of 0.1 mg//kg,1,,,22224,U,0,,CHEMBL621602,,BAO_0000019,
7597,,Autocuration,Area under curve after oral dose of 0.3 mg/kg,1,,,22224,U,0,,CHEMBL621603,,BAO_0000218,
7598,,Autocuration,Area under curve after oral dose of 1 mg/kg,1,,,22224,U,0,,CHEMBL621604,,BAO_0000218,
7599,,Autocuration,Area under curve after oral dose of 10 mg/kg,1,,,22224,U,0,,CHEMBL621605,,BAO_0000218,
7600,,Autocuration,Area under curve after oral dose of 23.4 mg/kg,1,,,22224,U,0,,CHEMBL621606,,BAO_0000218,
7601,,Autocuration,Area under curve after oral dose of 3 mg/kg,1,,,22224,U,0,,CHEMBL621607,,BAO_0000218,
7602,,Autocuration,Area under curve after oral dose of 3.87 mg/kg,1,,,22224,U,0,,CHEMBL621608,,BAO_0000218,
7603,,Autocuration,Area under curve was determined,1,,,22224,U,0,,CHEMBL621609,,BAO_0000019,
7604,,Autocuration,Area under curve at a dose of 10 mg/kg,1,,,22224,U,0,,CHEMBL621610,,BAO_0000218,
7605,,Intermediate,Area under curve was determined; ND=No data,1,,,50597,N,1,,CHEMBL621611,,BAO_0000218,
7606,,Intermediate,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL621612,,BAO_0000218,
7607,,Intermediate,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,,,50597,N,1,,CHEMBL622308,,BAO_0000218,
7608,,Intermediate,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL622309,,BAO_0000218,
7609,,Intermediate,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,1,,,50597,N,1,,CHEMBL622310,,BAO_0000218,
7610,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL622311,,BAO_0000218,
7611,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,1,,,50597,N,1,,CHEMBL622312,,BAO_0000218,
7612,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL622931,,BAO_0000218,
7613,,Intermediate,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,1,,,50597,N,1,,CHEMBL622932,,BAO_0000218,
7614,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL622736,,BAO_0000218,1969.0
7615,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,,,50597,N,1,,CHEMBL622737,,BAO_0000218,1969.0
7616,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL622738,,BAO_0000218,1969.0
7617,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,1,,,50597,N,1,,CHEMBL622739,,BAO_0000218,1969.0
7618,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL622740,,BAO_0000218,1969.0
7619,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,1,,,50597,N,1,,CHEMBL622741,,BAO_0000218,1969.0
7620,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,,,50597,N,1,,CHEMBL622742,,BAO_0000218,1969.0
7621,Plasma,Intermediate,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,1,,,50597,N,1,,CHEMBL622743,,BAO_0000218,1969.0
7622,Plasma,Intermediate,AUC in mice,1,,,50594,N,1,,CHEMBL622744,,BAO_0000218,1969.0
7623,,Autocuration,Area under curve was measured from the graph obtained from concentration Vs time,1,,,22224,U,0,,CHEMBL624134,,BAO_0000019,
7624,,Autocuration,Area under curve value of compound per hour after oral administration,1,,,22224,U,0,,CHEMBL624135,,BAO_0000019,
7625,,Intermediate,Area under curve was determined after oral administration in rats,1,,,50597,N,1,,CHEMBL624136,,BAO_0000218,
7626,,Intermediate,Area under curve was determined after oral administration in rats; No data,1,,,50597,N,1,,CHEMBL624137,,BAO_0000218,
7627,,Intermediate,Area under curve was determined after oral administration in rats;No data,1,,,50597,N,1,,CHEMBL624320,,BAO_0000218,
7628,,Intermediate,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,,,50588,N,1,,CHEMBL624321,,BAO_0000218,
7629,,Intermediate,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,1,,,50597,N,1,,CHEMBL624322,,BAO_0000218,
7630,,Intermediate,Area under curve was determined for the compound after iv dose of 5.06 in rats,1,,,50597,N,1,,CHEMBL624323,,BAO_0000218,
7631,,Intermediate,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,1,,,50597,N,1,,CHEMBL624324,,BAO_0000218,
7632,,Intermediate,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,1,,,50597,N,1,,CHEMBL624325,,BAO_0000218,
7633,,Intermediate,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,1,,,50597,N,1,,CHEMBL624326,,BAO_0000218,
7634,,Intermediate,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,1,,,50597,N,1,,CHEMBL624327,,BAO_0000218,
7635,,Intermediate,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,1,,,50597,N,1,,CHEMBL624328,,BAO_0000218,
7636,,Intermediate,Area under curve was determined in Dogs after peroral administration,1,,,50588,N,1,,CHEMBL627848,,BAO_0000218,
7637,,Intermediate,Area under curve was determined in Rats after peroral administration,1,,,50597,N,1,,CHEMBL627849,,BAO_0000218,
7638,,Intermediate,Area under curve was determined in carotid blood of rat when administered intradermally,1,,,50597,N,1,,CHEMBL627850,,BAO_0000218,
7639,,Intermediate,Area under curve was determined in portal blood of rat when administered intradermally,1,,,50597,N,1,,CHEMBL627851,,BAO_0000218,
7640,,Intermediate,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL627852,,BAO_0000218,
7641,,Intermediate,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL627853,,BAO_0000218,
7642,,Intermediate,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,,,50594,N,1,,CHEMBL627854,,BAO_0000218,
7643,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL627855,,BAO_0000218,
7644,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),1,,,50594,N,1,,CHEMBL627856,,BAO_0000218,
7645,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL875339,,BAO_0000218,
7646,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),1,,,50594,N,1,,CHEMBL627857,,BAO_0000218,
7647,Spleen,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL627858,,BAO_0000218,2106.0
7648,Blood,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627859,,BAO_0000218,178.0
7649,Brain,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627860,,BAO_0000218,955.0
7650,Heart,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627019,,BAO_0000218,948.0
7651,Liver,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627020,,BAO_0000218,2107.0
7652,Lung,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627021,,BAO_0000218,2048.0
7653,Muscle tissue,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627022,,BAO_0000218,2385.0
7654,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627023,,BAO_0000218,
7655,Spleen,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627024,,BAO_0000218,2106.0
7656,Thyroid gland,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627025,,BAO_0000218,2046.0
7657,Kidney,Intermediate,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627026,,BAO_0000218,2113.0
7658,Blood,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627027,,BAO_0000218,178.0
7659,Brain,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627028,,BAO_0000218,955.0
7660,Heart,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627029,,BAO_0000218,948.0
7661,Kidney,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627030,,BAO_0000218,2113.0
7662,Liver,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627031,,BAO_0000218,2107.0
7663,Lung,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627032,,BAO_0000218,2048.0
7664,Muscle tissue,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627033,,BAO_0000218,2385.0
7665,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627034,,BAO_0000218,
7666,Spleen,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627035,,BAO_0000218,2106.0
7667,Thyroid gland,Intermediate,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627036,,BAO_0000218,2046.0
7668,Blood,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL875340,,BAO_0000218,178.0
7669,Heart,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627037,,BAO_0000218,948.0
7670,Kidney,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627038,,BAO_0000218,2113.0
7671,Liver,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627039,,BAO_0000218,2107.0
7672,Muscle tissue,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL627040,,BAO_0000218,2385.0
7673,Spleen,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL624663,,BAO_0000218,2106.0
7674,Thyroid gland,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL625963,,BAO_0000218,2046.0
7675,Brain,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL876799,,BAO_0000218,955.0
7676,Lung,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL626133,,BAO_0000218,2048.0
7677,,Intermediate,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,1,,,50597,N,1,,CHEMBL626134,,BAO_0000218,
7678,,Intermediate,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL626135,,BAO_0000218,
7679,,Intermediate,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL626136,,BAO_0000218,
7680,,Intermediate,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,1,,,50597,N,1,,CHEMBL626137,,BAO_0000218,
7681,,Intermediate,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL626138,,BAO_0000218,
7682,,Intermediate,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL626139,,BAO_0000218,
7683,,Intermediate,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL626140,,BAO_0000218,
7684,,Intermediate,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL626141,,BAO_0000218,
7685,,Intermediate,C24h in rat p.o. at 20 mg/kg concentration,1,,,50597,N,1,,CHEMBL626142,,BAO_0000218,
7686,Muscle tissue,Intermediate,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL627930,,BAO_0000218,2385.0
7687,Muscle tissue,Intermediate,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,1,,,50597,N,1,,CHEMBL627931,,BAO_0000218,2385.0
7688,Muscle tissue,Intermediate,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL627932,,BAO_0000218,2385.0
7689,Spleen,Intermediate,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL627933,,BAO_0000218,2106.0
7690,Spleen,Intermediate,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,1,,,50597,N,1,,CHEMBL627934,,BAO_0000218,2106.0
7691,Spleen,Intermediate,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,1,,,50597,N,1,,CHEMBL627935,,BAO_0000218,2106.0
7692,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL627936,,BAO_0000218,178.0
7693,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL627937,,BAO_0000218,178.0
7694,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL627938,,BAO_0000218,178.0
7695,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,1,,,50597,N,1,,CHEMBL627939,,BAO_0000218,178.0
7696,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL627940,,BAO_0000218,178.0
7697,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL627941,,BAO_0000218,178.0
7698,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL876800,,BAO_0000218,178.0
7699,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL627942,,BAO_0000218,178.0
7700,Blood,Intermediate,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL627943,,BAO_0000218,178.0
7701,Blood,Intermediate,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,1,,,50597,N,1,,CHEMBL627944,,BAO_0000218,178.0
7702,Blood,Intermediate,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,1,,,50597,N,1,,CHEMBL627945,,BAO_0000218,178.0
7703,Blood,Intermediate,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,1,,,50597,N,1,,CHEMBL628584,,BAO_0000218,178.0
7704,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 15 min,1,,,50597,N,1,,CHEMBL628585,,BAO_0000218,178.0
7705,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,1,,,50597,N,1,,CHEMBL628586,,BAO_0000218,178.0
7706,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 30 min,1,,,50597,N,1,,CHEMBL628587,,BAO_0000218,178.0
7707,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,1,,,50597,N,1,,CHEMBL628588,,BAO_0000218,178.0
7708,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,1,,,50597,N,1,,CHEMBL628589,,BAO_0000218,178.0
7709,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,1,,,50597,N,1,,CHEMBL625304,,BAO_0000218,178.0
7710,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,1,,,50597,N,1,,CHEMBL625305,,BAO_0000218,178.0
7711,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,1,,,50597,N,1,,CHEMBL625306,,BAO_0000218,178.0
7712,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,1,,,50597,N,1,,CHEMBL625307,,BAO_0000218,178.0
7713,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,1,,,50597,N,1,,CHEMBL625308,,BAO_0000218,178.0
7714,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,1,,,50597,N,1,,CHEMBL627740,,BAO_0000218,178.0
7715,Blood,Intermediate,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,1,,,50597,N,1,,CHEMBL627741,,BAO_0000218,178.0
7716,Blood,Intermediate,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL627742,,BAO_0000218,178.0
7717,Blood,Intermediate,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,1,,,50597,N,1,,CHEMBL627743,,BAO_0000218,178.0
7718,Blood,Intermediate,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,1,,,50597,N,1,,CHEMBL627744,,BAO_0000218,178.0
7719,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL627745,,BAO_0000218,10000001.0
7720,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL627746,,BAO_0000218,10000001.0
7721,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL627747,,BAO_0000218,10000001.0
7722,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,1,,,50597,N,1,,CHEMBL876810,,BAO_0000218,10000001.0
7723,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL627748,,BAO_0000218,10000001.0
7724,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL627749,,BAO_0000218,10000001.0
7725,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL627750,,BAO_0000218,10000001.0
7726,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL618728,,BAO_0000218,10000001.0
7727,Bone,Intermediate,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL618729,,BAO_0000218,10000001.0
7728,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 15 min,1,,,50597,N,1,,CHEMBL618730,,BAO_0000218,10000001.0
7729,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,1,,,50597,N,1,,CHEMBL618731,,BAO_0000218,10000001.0
7730,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 30 min,1,,,50597,N,1,,CHEMBL618732,,BAO_0000218,10000001.0
7731,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,1,,,50597,N,1,,CHEMBL618733,,BAO_0000218,10000001.0
7732,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,1,,,50597,N,1,,CHEMBL618734,,BAO_0000218,10000001.0
7733,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,1,,,50597,N,1,,CHEMBL618735,,BAO_0000218,10000001.0
7734,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,1,,,50597,N,1,,CHEMBL876602,,BAO_0000218,10000001.0
7735,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,1,,,50597,N,1,,CHEMBL618736,,BAO_0000218,10000001.0
7736,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,1,,,50597,N,1,,CHEMBL618737,,BAO_0000218,10000001.0
7737,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,1,,,50597,N,1,,CHEMBL618738,,BAO_0000218,10000001.0
7738,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,1,,,50597,N,1,,CHEMBL618739,,BAO_0000218,10000001.0
7739,Bone,Intermediate,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,1,,,50597,N,1,,CHEMBL618740,,BAO_0000218,10000001.0
7740,Bone,Intermediate,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL618741,,BAO_0000218,10000001.0
7741,Bone,Intermediate,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,1,,,50597,N,1,,CHEMBL618742,,BAO_0000218,10000001.0
7742,Bone,Intermediate,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,1,,,50597,N,1,,CHEMBL618743,,BAO_0000218,10000001.0
7743,Plasma,Intermediate,Half-life from rat plasma at a single oral dose of 25 mg/kg,1,,,50597,N,1,,CHEMBL618744,,BAO_0000218,1969.0
7744,,Intermediate,Half-life in male rat,1,,,50597,N,1,,CHEMBL618745,,BAO_0000218,
7745,,Intermediate,Half-life in rat after peroral administration at 10 mg/kg concentration,1,,,50597,N,1,,CHEMBL620479,,BAO_0000218,
7746,,Intermediate,Half-life in rat after peroral administration at 5 mg/kg concentration,1,,,50597,N,1,,CHEMBL620480,,BAO_0000218,
7747,,Intermediate,Half-life in rat at a dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL620481,,BAO_0000218,
7748,,Intermediate,Half-life was evaluated in rats,1,,,50597,N,1,,CHEMBL620482,,BAO_0000218,
7749,,Intermediate,Half-life was measured in rat,1,,,50597,N,1,,CHEMBL876603,,BAO_0000218,
7750,,Intermediate,Half-life period for the compound was determined in rats at 50 mg/kg dose,1,,,50597,N,1,,CHEMBL620483,,BAO_0000218,
7751,,Intermediate,Half-life period in rats after intravenous administration at 5 mg/kg,1,,,50597,N,1,,CHEMBL620484,,BAO_0000218,
7752,,Intermediate,Half-life period in rat at 10 mg/kg,1,,,50597,N,1,,CHEMBL620485,,BAO_0000218,
7753,,Intermediate,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL620486,,BAO_0000218,
7754,,Intermediate,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",1,,,50597,N,1,,CHEMBL620487,,BAO_0000218,
7755,,Intermediate,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",1,,,50597,N,1,,CHEMBL620488,,BAO_0000218,
7756,,Intermediate,Half-life time in rat the dose of 2 mg/kg,1,,,50597,N,1,,CHEMBL620489,,BAO_0000218,
7757,,Intermediate,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,1,,,50597,N,1,,CHEMBL620490,,BAO_0000218,
7758,,Intermediate,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,1,,,50597,N,1,,CHEMBL620491,,BAO_0000218,
7759,Plasma,Intermediate,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,,,50597,N,1,,CHEMBL876604,,BAO_0000218,1969.0
7760,,Intermediate,Oral half life was determined,1,,,50597,N,1,,CHEMBL620492,,BAO_0000218,
7761,,Intermediate,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",1,,,50597,N,1,,CHEMBL620493,,BAO_0000218,
7762,,Intermediate,Pharmacokinetic property (t1/2) in rat,1,,,50597,N,1,,CHEMBL620494,,BAO_0000218,
7763,Plasma,Intermediate,Plasma elimination half-life was determined,1,,,50597,N,1,,CHEMBL620495,,BAO_0000218,1969.0
7764,Plasma,Intermediate,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,,50597,N,1,,CHEMBL620496,,BAO_0000218,1969.0
7765,Plasma,Intermediate,Plasma half life was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL620497,,BAO_0000218,1969.0
7766,Plasma,Intermediate,Plasma half-life was determined,1,,,50597,N,1,,CHEMBL620498,,BAO_0000218,1969.0
7767,Plasma,Intermediate,Plasma half-life following oral administration in Fisher rats,1,,,50597,N,1,,CHEMBL620499,,BAO_0000218,1969.0
7768,Plasma,Intermediate,Plasma half-life in rat,1,,,50597,N,1,,CHEMBL620500,,BAO_0000218,1969.0
7769,Plasma,Intermediate,Plasmatic Half-life after intravenous administration to rat,1,,,50597,N,1,,CHEMBL873809,,BAO_0000218,1969.0
7770,,Intermediate,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,,,50597,N,1,,CHEMBL620501,,BAO_0000218,
7771,,Intermediate,Terminal half life after intravenous administration (1 mg/kg) in rat,1,,,50597,N,1,,CHEMBL620502,,BAO_0000218,
7772,,Intermediate,Terminal half life in Rat at a oral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL620503,,BAO_0000218,
7773,,Intermediate,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,,,50597,N,1,,CHEMBL620504,,BAO_0000218,
7774,,Intermediate,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,1,,,50597,N,1,,CHEMBL876605,,BAO_0000218,
7775,,Intermediate,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,1,,,50597,N,1,,CHEMBL620505,,BAO_0000218,
7776,Plasma,Intermediate,plasma half life was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL873811,,BAO_0000218,1969.0
7777,,Expert,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL624016,,BAO_0000218,
7778,,Intermediate,Half life of compound determined in rat,1,,,50597,N,1,,CHEMBL624017,,BAO_0000218,
7779,,Intermediate,Mean residence time determined in rat,1,,,50597,N,1,,CHEMBL624018,,BAO_0000218,
7780,,Intermediate,Plasma half life determined in rat,1,,,50597,N,1,,CHEMBL624019,,BAO_0000218,
7781,Brain,Intermediate,Compound was evaluated for Tmax in brain after intravenous administration in male rats,1,,,50597,N,1,,CHEMBL624020,,BAO_0000218,955.0
7782,,Intermediate,Compound was evaluated for pharmacokinetic parameter maximum time period,1,,,50597,N,1,,CHEMBL624201,,BAO_0000218,
7783,,Intermediate,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,,,50597,N,1,,CHEMBL872528,,BAO_0000218,
7784,,Intermediate,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624202,,BAO_0000218,
7785,,Intermediate,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624203,,BAO_0000218,
7786,,Intermediate,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624350,,BAO_0000218,
7787,,Intermediate,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL621320,,BAO_0000218,
7788,,Intermediate,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,,50597,N,1,,CHEMBL621321,,BAO_0000218,
7789,,Intermediate,Maximum time (Tmax) required to reach Cmax in rats,1,,,50597,N,1,,CHEMBL621322,,BAO_0000218,
7790,,Intermediate,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL621323,,BAO_0000218,
7791,,Intermediate,Maximum time of clearance of compound in rats after peroral administration,1,,,50597,N,1,,CHEMBL621324,,BAO_0000218,
7792,,Intermediate,Maximum time at the dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL621325,,BAO_0000218,
7793,Plasma,Intermediate,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,1,,,50597,N,1,,CHEMBL875837,,BAO_0000218,1969.0
7794,Plasma,Intermediate,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,1,,,50597,N,1,,CHEMBL621326,,BAO_0000218,1969.0
7795,,Intermediate,Tmax in Guinea pig (PO dose),1,,,50597,N,1,,CHEMBL621327,,BAO_0000218,
7796,,Intermediate,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",1,,,50597,N,1,,CHEMBL621328,,BAO_0000218,
7797,,Intermediate,Pharmacokinetic parameter (Tmax) in rat,1,,,50597,N,1,,CHEMBL621329,,BAO_0000218,
7798,,Intermediate,Pharmacokinetic parameter (Tmax) was estimated,1,,,50597,N,1,,CHEMBL621330,,BAO_0000218,
7799,,Intermediate,Pharmacokinetic property (Tmax) in rat,1,,,50597,N,1,,CHEMBL621331,,BAO_0000218,
7800,,Intermediate,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,,50597,N,1,,CHEMBL621332,,BAO_0000218,
7801,,Intermediate,T max in Rat at a oral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL621333,,BAO_0000218,
7802,,Intermediate,T max was determined at 10 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL621334,,BAO_0000218,
7803,,Intermediate,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),1,,,50594,N,1,,CHEMBL621335,,BAO_0000218,
7804,,Intermediate,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,1,,,50588,N,1,,CHEMBL621336,,BAO_0000218,
7805,,Intermediate,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,1,,,50597,N,1,,CHEMBL621337,,BAO_0000218,
7806,,Intermediate,Area under curve was measured after i.v. administration into Beagle dog.,1,,,50588,N,1,,CHEMBL621338,,BAO_0000218,
7807,,Intermediate,Area under curve was measured after iv administration into Beagle dog,1,,,50588,N,1,,CHEMBL875838,,BAO_0000218,
7808,,Intermediate,Area under curve was measured after po administration into Beagle dog,1,,,50588,N,1,,CHEMBL621339,,BAO_0000218,
7809,,Intermediate,Area under curve was measured after po administration into Beagle dog.,1,,,50588,N,1,,CHEMBL621340,,BAO_0000218,
7810,,Autocuration,Area under curve was measured at peroral dose of 3 mg/kg,1,,,22224,U,0,,CHEMBL621341,,BAO_0000218,
7811,,Autocuration,Area under curve was measured by using concentration Vs time,1,,,22224,U,0,,CHEMBL621342,,BAO_0000019,
7812,,Autocuration,Area under curve was measured by using concentration Vs time; not tested,1,,,22224,U,0,,CHEMBL621343,,BAO_0000019,
7813,,Intermediate,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),1,,,50594,N,1,,CHEMBL621344,,BAO_0000218,
7814,,Intermediate,Area under curve(AUC) was measured in mice after oral administration.,1,,,50594,N,1,,CHEMBL621345,,BAO_0000218,
7815,,Autocuration,Area under curve(AUC) value of the compound,1,,,22224,U,0,,CHEMBL621346,,BAO_0000019,
7816,,Autocuration,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,1,,,22224,U,0,,CHEMBL621347,,BAO_0000218,
7817,,Intermediate,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,1,,,50588,N,1,,CHEMBL621348,,BAO_0000218,
7818,Blood,Autocuration,Area under curve(carotid artery) was determined by the availability in blood,1,,,22224,U,0,,CHEMBL621349,,BAO_0000019,178.0
7819,Blood,Autocuration,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,1,,,22224,U,0,,CHEMBL621350,,BAO_0000019,178.0
7820,Blood,Autocuration,Area under curve(carotid artery) was determined by the availability in blood; No data,1,,,22224,U,0,,CHEMBL875839,,BAO_0000019,178.0
7821,Blood,Autocuration,Area under curve(portal vein) was determined by the availability in blood,1,,,22224,U,0,,CHEMBL620211,,BAO_0000019,178.0
7822,Blood,Autocuration,Area under curve(portal vein) was determined by the availability in blood; ND means no data,1,,,22224,U,0,,CHEMBL620212,,BAO_0000019,178.0
7823,Blood,Autocuration,Area under curve(portal vein) was determined by the availability in blood; No data,1,,,22224,U,0,,CHEMBL620213,,BAO_0000019,178.0
7824,Plasma,Intermediate,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,,,50797,N,1,,CHEMBL620214,,BAO_0000218,1969.0
7825,Plasma,Intermediate,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,,,50797,N,1,,CHEMBL620215,,BAO_0000218,1969.0
7826,Plasma,Intermediate,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,1,,,50797,N,1,,CHEMBL620216,,BAO_0000218,1969.0
7827,Plasma,Intermediate,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",1,,,50588,N,1,,CHEMBL620888,,BAO_0000218,1969.0
7828,Plasma,Intermediate,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",1,,,50588,N,1,,CHEMBL620889,,BAO_0000218,1969.0
7829,Plasma,Autocuration,Area under plasma concentration vs time curve observed in rats for 0-3 h,1,,,22224,U,0,,CHEMBL620890,,BAO_0000019,1969.0
7830,Plasma,Intermediate,Area under plasma time curve determined in male rat,1,,,50597,N,1,,CHEMBL620891,,BAO_0000218,1969.0
7831,,Autocuration,Area under the MAP curve measured over 5 min.,1,,,22224,U,0,,CHEMBL620892,,BAO_0000019,
7832,,Intermediate,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,1,,,50594,N,1,,CHEMBL621079,,BAO_0000218,
7833,,Intermediate,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,1,,,50594,N,1,,CHEMBL621080,,BAO_0000218,
7834,,Intermediate,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,1,,,50588,N,1,,CHEMBL621081,,BAO_0000218,
7835,,Intermediate,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,1,,,100712,N,1,,CHEMBL621082,,BAO_0000218,
7836,,Intermediate,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,1,,,50597,N,1,,CHEMBL621083,,BAO_0000218,
7837,,Intermediate,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,1,,,50588,N,1,,CHEMBL621084,,BAO_0000218,
7838,,Intermediate,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,1,,,50588,N,1,,CHEMBL621085,,BAO_0000218,
7839,,Intermediate,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,1,,,50588,N,1,,CHEMBL621086,,BAO_0000218,
7840,,Intermediate,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,,,50588,N,1,,CHEMBL621087,,BAO_0000218,
7841,,Intermediate,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),1,,,50588,N,1,,CHEMBL622607,,BAO_0000218,
7842,,Intermediate,Serum AUC in marmosets (IV dose),1,,,50588,N,1,,CHEMBL622608,,BAO_0000218,
7843,,Autocuration,Area under the curve after intravenous administration at a dose of 10 umol/kg,1,,,22224,U,0,,CHEMBL624481,,BAO_0000019,
7844,,Autocuration,Area under the curve after intravenous administration at a dose of 2 umol/kg,1,,,22224,U,0,,CHEMBL624482,,BAO_0000019,
7845,,Autocuration,Area under the curve after intravenous administration at a dose of 4 umol/kg,1,,,22224,U,0,,CHEMBL624483,,BAO_0000019,
7846,,Autocuration,Area under the curve after intravenous administration at a dose of 40 umol/kg,1,,,22224,U,0,,CHEMBL624484,,BAO_0000019,
7847,,Autocuration,Area under the curve after intravenous administration at a dose of 5 umol/kg,1,,,22224,U,0,,CHEMBL624485,,BAO_0000019,
7848,,Intermediate,Area under the curve for fumarate salt was evaluated in F344 Rats.,1,,,50597,N,1,,CHEMBL624486,,BAO_0000218,
7849,,Autocuration,Area under the curve for the compound was calculated.,1,,,22224,U,0,,CHEMBL624487,,BAO_0000019,
7850,,Autocuration,Area under the curve in concentration/ time,1,,,22224,U,0,,CHEMBL624488,,BAO_0000019,
7851,,Intermediate,Area under the curve administered intraintestinal in rats.,1,,,50597,N,1,,CHEMBL624489,,BAO_0000218,
7852,,Intermediate,Area under the curve administered intravenously in rats.,1,,,50597,N,1,,CHEMBL625184,,BAO_0000218,
7853,,Autocuration,Area under the curve during intravenous administration,1,,,22224,U,0,,CHEMBL625185,,BAO_0000019,
7854,,Autocuration,Area under the curve during intravenous administration; Not determined,1,,,22224,U,0,,CHEMBL875954,,BAO_0000019,
7855,,Autocuration,Area under the curve during systemic administration,1,,,22224,U,0,,CHEMBL625186,,BAO_0000019,
7856,,Autocuration,Area under the curve during systemic administration; Not determined,1,,,22224,U,0,,CHEMBL625187,,BAO_0000019,
7857,,Autocuration,Area under the curve was calculated for the compound.,1,,,22224,U,0,,CHEMBL625188,,BAO_0000019,
7858,,Intermediate,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,1,,,50588,N,1,,CHEMBL625189,,BAO_0000218,
7859,,Intermediate,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,1,,,50588,N,1,,CHEMBL625190,,BAO_0000218,
7860,,Intermediate,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL621733,,BAO_0000218,
7861,,Intermediate,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL621734,,BAO_0000218,
7862,,Intermediate,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,1,,,50597,N,1,,CHEMBL621735,,BAO_0000218,
7863,Plasma,Intermediate,Clearance of the drug was measured in the plasma of rat; No data,1,,,50597,N,1,,CHEMBL621736,,BAO_0000218,1969.0
7864,Plasma,Intermediate,The pharmacokinetic parameter plasma clearance in vivo in rats,1,,,50597,N,1,,CHEMBL621737,,BAO_0000218,1969.0
7865,,Intermediate,Plasma clearance at the dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL621738,,BAO_0000218,
7866,,Intermediate,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL622806,,BAO_0000218,
7867,,Intermediate,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL623519,,BAO_0000218,
7868,,Intermediate,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL623520,,BAO_0000218,
7869,,Intermediate,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,50597,N,1,,CHEMBL623521,,BAO_0000218,
7870,,Intermediate,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,50597,N,1,,CHEMBL623522,,BAO_0000218,
7871,,Intermediate,Clearance rate in rat,1,,,50597,N,1,,CHEMBL623523,,BAO_0000218,
7872,,Intermediate,Clearance rate in rat,1,,,50597,N,1,,CHEMBL623690,,BAO_0000218,
7873,,Intermediate,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623691,,BAO_0000218,
7874,,Intermediate,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623692,,BAO_0000218,
7875,,Intermediate,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623693,,BAO_0000218,
7876,,Intermediate,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623694,,BAO_0000218,
7877,,Intermediate,Clearance of compound after iv administration of 20 mg/kg dose in rat,1,,,50597,N,1,,CHEMBL623695,,BAO_0000218,
7878,,Intermediate,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL623696,,BAO_0000218,
7879,,Intermediate,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL623697,,BAO_0000218,
7880,Plasma,Intermediate,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,1,,,22224,U,0,,CHEMBL623698,,BAO_0000218,1969.0
7881,Plasma,Intermediate,Compound was tested for its plasma clearance rate in Sprague Dawley rats,1,,,22224,U,0,,CHEMBL623699,,BAO_0000218,1969.0
7882,,Intermediate,Mean (%CV) PK parameters for CL(mL/min/kg).,1,,,50597,N,1,,CHEMBL623700,,BAO_0000218,
7883,,Intermediate,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,1,,,50597,N,1,,CHEMBL623701,,BAO_0000218,
7884,Plasma,Intermediate,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,1,,,50597,N,1,,CHEMBL623702,,BAO_0000218,1969.0
7885,,Intermediate,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,1,,,50597,N,1,,CHEMBL623703,,BAO_0000218,
7886,,Intermediate,Plasma clearance in rat was determined,1,,,50597,N,1,,CHEMBL623704,,BAO_0000218,
7887,,Intermediate,Plasma clearance in rat after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL623705,,BAO_0000218,
7888,,Intermediate,Plasma clearance in rat after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL623706,,BAO_0000218,
7889,,Intermediate,Plasma clearance was determined,1,,,50597,N,1,,CHEMBL623707,,BAO_0000218,
7890,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL623708,,BAO_0000218,
7891,,Intermediate,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,1,,,50597,N,1,,CHEMBL623709,,BAO_0000218,
7892,,Intermediate,Plasma clearance in rat by iv administration,1,,,50597,N,1,,CHEMBL623710,,BAO_0000218,
7893,,Intermediate,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL623711,,BAO_0000218,
7894,,Intermediate,Plasma clearance in rat p.o.,1,,,50597,N,1,,CHEMBL623712,,BAO_0000218,
7895,,Intermediate,Plasma clearance in rats,1,,,50597,N,1,,CHEMBL623713,,BAO_0000218,
7896,,Intermediate,Plasma clearance was determined; ND denotes no data,1,,,50597,N,1,,CHEMBL623714,,BAO_0000218,
7897,,Intermediate,Plasma clearance was determined; ND denotes not determined,1,,,50597,N,1,,CHEMBL623715,,BAO_0000218,
7898,,Intermediate,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,,50597,N,1,,CHEMBL623716,,BAO_0000218,
7899,,Intermediate,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,,50597,N,1,,CHEMBL622980,,BAO_0000218,
7900,,Intermediate,Plasma administration to rats,1,,,50597,N,1,,CHEMBL622981,,BAO_0000218,
7901,,Intermediate,Plasma clearance of the compound in female Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL622982,,BAO_0000218,
7902,,Intermediate,Plasma clearance was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL622983,,BAO_0000218,
7903,,Intermediate,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,1,,,50597,N,1,,CHEMBL622984,,BAO_0000218,
7904,,Intermediate,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,1,,,50597,N,1,,CHEMBL622985,,BAO_0000218,
7905,Plasma,Intermediate,plasma clearance was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL623631,,BAO_0000218,1969.0
7906,,Intermediate,In vivo CL/F determined,1,,,50597,N,1,,CHEMBL623632,,BAO_0000218,
7907,Plasma,Intermediate,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL623633,,BAO_0000218,1969.0
7908,Plasma,Intermediate,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL623634,,BAO_0000218,1969.0
7909,,Intermediate,Compound was tested for the lower blood clearance in rat,1,,,50597,N,1,,CHEMBL623635,,BAO_0000218,
7910,,Intermediate,Evaluated for the low clearance in rat (in vivo),1,,,50597,N,1,,CHEMBL621195,,BAO_0000218,
7911,,Intermediate,Pharmacokinetic property (CLb)of the compound was determined in rat,1,,,50597,N,1,,CHEMBL621196,,BAO_0000218,
7912,,Intermediate,Rapid clearance after intravenous administration in rat was determined,1,,,50597,N,1,,CHEMBL875287,,BAO_0000218,
7913,,Intermediate,Clearance measured in rat,1,,,50597,N,1,,CHEMBL621197,,BAO_0000218,
7914,Plasma,Intermediate,Compound was evaluated for plasma clearance in rat,1,,,50597,N,1,,CHEMBL621198,,BAO_0000218,1969.0
7915,Plasma,Intermediate,Low plasma clearance was calculated in rat,1,,,50597,N,1,,CHEMBL621199,,BAO_0000218,1969.0
7916,,Intermediate,Pharmacokinetic property (Clp) in rat,1,,,50597,N,1,,CHEMBL621200,,BAO_0000218,
7917,,Intermediate,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL621201,,BAO_0000218,
7918,,Intermediate,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL621202,,BAO_0000218,
7919,,Intermediate,Plasma clearance after IV dosing at 0.5 mg/kg in rat,1,,,50597,N,1,,CHEMBL621203,,BAO_0000218,
7920,,Intermediate,Plasma clearance after IV dosing at 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL621204,,BAO_0000218,
7921,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL621205,,BAO_0000218,948.0
7922,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621206,,BAO_0000218,948.0
7923,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL621207,,BAO_0000218,948.0
7924,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL621208,,BAO_0000218,948.0
7925,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,1,,,50597,N,1,,CHEMBL621209,,BAO_0000218,948.0
7926,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL876484,,BAO_0000218,948.0
7927,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL621210,,BAO_0000218,948.0
7928,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621211,,BAO_0000218,948.0
7929,Heart,Intermediate,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL621212,,BAO_0000218,948.0
7930,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 15 min,1,,,50597,N,1,,CHEMBL621213,,BAO_0000218,948.0
7931,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,1,,,50597,N,1,,CHEMBL621214,,BAO_0000218,948.0
7932,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 30 min,1,,,50597,N,1,,CHEMBL621215,,BAO_0000218,948.0
7933,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,1,,,50597,N,1,,CHEMBL621216,,BAO_0000218,948.0
7934,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,1,,,50597,N,1,,CHEMBL621217,,BAO_0000218,948.0
7935,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,1,,,50597,N,1,,CHEMBL621218,,BAO_0000218,948.0
7936,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,1,,,50597,N,1,,CHEMBL621219,,BAO_0000218,948.0
7937,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,1,,,50597,N,1,,CHEMBL621220,,BAO_0000218,948.0
7938,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,1,,,50597,N,1,,CHEMBL621221,,BAO_0000218,948.0
7939,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,1,,,50597,N,1,,CHEMBL621222,,BAO_0000218,948.0
7940,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,1,,,50597,N,1,,CHEMBL621223,,BAO_0000218,948.0
7941,Heart,Intermediate,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,1,,,50597,N,1,,CHEMBL876485,,BAO_0000218,948.0
7942,Heart,Intermediate,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL621224,,BAO_0000218,948.0
7943,Heart,Intermediate,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,1,,,50597,N,1,,CHEMBL621225,,BAO_0000218,948.0
7944,Heart,Intermediate,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,1,,,50597,N,1,,CHEMBL621226,,BAO_0000218,948.0
7945,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621227,,BAO_0000218,2113.0
7946,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL621228,,BAO_0000218,2113.0
7947,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL621229,,BAO_0000218,2113.0
7948,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,1,,,50597,N,1,,CHEMBL621230,,BAO_0000218,2113.0
7949,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,,,50597,N,1,,CHEMBL621231,,BAO_0000218,2113.0
7950,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL621232,,BAO_0000218,2113.0
7951,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL621233,,BAO_0000218,2113.0
7952,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621234,,BAO_0000218,2113.0
7953,Kidney,Intermediate,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,,,50597,N,1,,CHEMBL621235,,BAO_0000218,2113.0
7954,Kidney,Intermediate,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL621236,,BAO_0000218,2113.0
7955,Kidney,Intermediate,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,1,,,50597,N,1,,CHEMBL621237,,BAO_0000218,2113.0
7956,Kidney,Intermediate,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,1,,,50597,N,1,,CHEMBL876486,,BAO_0000218,2113.0
7957,Intestine,Intermediate,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,1,,,50597,N,1,,CHEMBL622436,,BAO_0000218,160.0
7958,Intestine,Intermediate,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,1,,,50597,N,1,,CHEMBL622437,,BAO_0000218,160.0
7959,Intestine,Intermediate,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,1,,,50597,N,1,,CHEMBL622438,,BAO_0000218,160.0
7960,Liver,Intermediate,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,1,,,50597,N,1,,CHEMBL622439,,BAO_0000218,2107.0
7961,Liver,Intermediate,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,1,,,50597,N,1,,CHEMBL622440,,BAO_0000218,2107.0
7962,Liver,Intermediate,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,1,,,50597,N,1,,CHEMBL622441,,BAO_0000218,2107.0
7963,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL622442,,BAO_0000218,2107.0
7964,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL622443,,BAO_0000218,2107.0
7965,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL622444,,BAO_0000218,2107.0
7966,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL622445,,BAO_0000218,2107.0
7967,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,,50597,N,1,,CHEMBL622446,,BAO_0000218,2107.0
7968,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL622447,,BAO_0000218,2107.0
7969,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL622448,,BAO_0000218,2107.0
7970,Liver,Intermediate,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,,,50597,N,1,,CHEMBL622449,,BAO_0000218,2107.0
7971,Liver,Intermediate,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,1,,,50597,N,1,,CHEMBL622450,,BAO_0000218,2107.0
7972,Liver,Intermediate,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,1,,,50597,N,1,,CHEMBL622451,,BAO_0000218,2107.0
7973,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 15 min,1,,,50597,N,1,,CHEMBL622452,,BAO_0000218,2107.0
7974,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,1,,,50597,N,1,,CHEMBL622453,,BAO_0000218,2107.0
7975,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 30 min,1,,,50597,N,1,,CHEMBL622454,,BAO_0000218,2107.0
7976,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,1,,,50597,N,1,,CHEMBL622455,,BAO_0000218,2107.0
7977,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,1,,,50597,N,1,,CHEMBL876024,,BAO_0000218,2107.0
7978,,Intermediate,T max was determined at 3 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL622456,,BAO_0000218,
7979,,Intermediate,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL622457,,BAO_0000218,
7980,,Intermediate,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL622458,,BAO_0000218,
7981,,Intermediate,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,1,,,50597,N,1,,CHEMBL622459,,BAO_0000218,
7982,,Intermediate,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,1,,,50597,N,1,,CHEMBL873343,,BAO_0000218,
7983,,Intermediate,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,1,,,50597,N,1,,CHEMBL622460,,BAO_0000218,
7984,Plasma,Intermediate,Time for maximum plasma concentration determined in rat,1,,,50597,N,1,,CHEMBL622461,,BAO_0000218,1969.0
7985,Plasma,Intermediate,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,,,50597,N,1,,CHEMBL622462,,BAO_0000218,1969.0
7986,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL622463,,BAO_0000218,
7987,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL622464,,BAO_0000218,
7988,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL622465,,BAO_0000218,
7989,,Intermediate,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL622466,,BAO_0000218,
7990,,Intermediate,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL622467,,BAO_0000218,
7991,Plasma,Intermediate,Time of maximum plasma concentration in rat,1,,,50597,N,1,,CHEMBL622468,,BAO_0000218,1969.0
7992,Plasma,Intermediate,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL876025,,BAO_0000218,1969.0
7993,Plasma,Intermediate,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,,,50597,N,1,,CHEMBL622469,,BAO_0000218,1969.0
7994,Plasma,Intermediate,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL622470,,BAO_0000218,1969.0
7995,,Intermediate,Time required to reach maximum concentration (Cmax) after oral administration in rat,1,,,50597,N,1,,CHEMBL622471,,BAO_0000218,
7996,Plasma,Intermediate,Time required to reach maximum concentration in rat plasma,1,,,50597,N,1,,CHEMBL622472,,BAO_0000218,1969.0
7997,Plasma,Intermediate,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,,,50597,N,1,,CHEMBL622473,,BAO_0000218,1969.0
7998,Plasma,Intermediate,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL624282,,BAO_0000218,1969.0
7999,Plasma,Intermediate,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL624283,,BAO_0000218,1969.0
8000,Plasma,Intermediate,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL624284,,BAO_0000218,1969.0
8001,Plasma,Intermediate,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,,50597,N,1,,CHEMBL624285,,BAO_0000218,1969.0
8002,,Intermediate,Time to reach Cmax after oral administration to rats,1,,,50597,N,1,,CHEMBL624286,,BAO_0000218,
8003,,Intermediate,Time to reach Cmax when a dose of 1 mg/kg is administered orally,1,,,50597,N,1,,CHEMBL624287,,BAO_0000218,
8004,,Intermediate,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,1,,,50597,N,1,,CHEMBL624288,,BAO_0000218,
8005,Plasma,Intermediate,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,1,,,50597,N,1,,CHEMBL624289,,BAO_0000218,1969.0
8006,Plasma,Intermediate,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL873344,,BAO_0000218,1969.0
8007,,Intermediate,Tmax after peroral administration (10 mg/kg) was determined in rat,1,,,50597,N,1,,CHEMBL619623,,BAO_0000218,
8008,,Expert,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL621399,,BAO_0000218,
8009,,Intermediate,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL621400,,BAO_0000218,
8010,,Intermediate,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",1,,,50597,N,1,,CHEMBL621401,,BAO_0000218,
8011,,Intermediate,Tmax was determined,1,,,50597,N,1,,CHEMBL621402,,BAO_0000218,
8012,,Intermediate,Tmax was determined,1,,,50597,N,1,,CHEMBL621403,,BAO_0000218,
8013,,Intermediate,Tmax after oral administration in rat,1,,,50597,N,1,,CHEMBL621121,,BAO_0000218,
8014,,Intermediate,Tmax after peroral administration in rats at 2.4 uM/kg,1,,,50597,N,1,,CHEMBL872525,,BAO_0000218,
8015,,Intermediate,Tmax in male rat,1,,,50597,N,1,,CHEMBL621122,,BAO_0000218,
8016,,Intermediate,Tmax in rat at 10 mg/kg,1,,,50597,N,1,,CHEMBL621123,,BAO_0000218,
8017,,Intermediate,Tmax in rat by po administration at a dose of 40 mg/kg,1,,,50597,N,1,,CHEMBL621124,,BAO_0000218,
8018,,Intermediate,Tmax in rats,1,,,50597,N,1,,CHEMBL621125,,BAO_0000218,
8019,,Intermediate,Tmax was measured in rats after peroral administration at 5 mg/kg,1,,,50597,N,1,,CHEMBL621126,,BAO_0000218,
8020,,Intermediate,Tmax value after oral dose at a dose of 10 mg/kg in rats.,1,,,50597,N,1,,CHEMBL621127,,BAO_0000218,
8021,,Intermediate,Tmax value after administration of 20 mg/Kg oral dose in rat,1,,,50597,N,1,,CHEMBL621128,,BAO_0000218,
8022,,Intermediate,Tmax value at a dose of 10 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL618263,,BAO_0000218,
8023,,Intermediate,Tmax value at a dose of 100 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL618264,,BAO_0000218,
8024,,Intermediate,Tmax value at a dose of 50 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL618265,,BAO_0000218,
8025,Plasma,Intermediate,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,,50597,N,1,,CHEMBL618266,,BAO_0000218,1969.0
8026,,Intermediate,time required to reach maximum concentration (Cmax) after oral administration in rat,1,,,50597,N,1,,CHEMBL618267,,BAO_0000218,
8027,Urine,Intermediate,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),1,,,50597,N,1,,CHEMBL618450,,BAO_0000218,1088.0
8028,Urine,Intermediate,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),1,,,50597,N,1,,CHEMBL618451,,BAO_0000218,1088.0
8029,,Intermediate,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,,50597,N,1,,CHEMBL618452,,BAO_0000218,
8030,Urine,Intermediate,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,1,,,50597,N,1,,CHEMBL618453,,BAO_0000218,1088.0
8031,Urine,Intermediate,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,1,,,50597,N,1,,CHEMBL618454,,BAO_0000218,1088.0
8032,Urine,Intermediate,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,1,,,50597,N,1,,CHEMBL618455,,BAO_0000218,1088.0
8033,,Intermediate,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,1,,,50597,N,1,,CHEMBL618456,,BAO_0000218,
8034,,Intermediate,Compound distribution in rat tissues was determined,1,,,50597,N,1,,CHEMBL618457,,BAO_0000218,
8035,,Intermediate,Volume of distribution was evaluated in rat,1,,,50597,N,1,,CHEMBL618458,,BAO_0000218,
8036,,Intermediate,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL618459,,BAO_0000218,
8037,,Intermediate,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL876733,,BAO_0000218,
8038,,Intermediate,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,1,,,50588,N,1,,CHEMBL618460,,BAO_0000218,
8039,,Intermediate,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL618461,,BAO_0000218,
8040,,Autocuration,Area under the curve was determined after oral administration (300 uM/Kg),1,,,22224,U,0,,CHEMBL618462,,BAO_0000019,
8041,,Intermediate,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL618463,,BAO_0000218,
8042,,Intermediate,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,1,,,50597,N,1,,CHEMBL618464,,BAO_0000218,
8043,,Intermediate,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL618465,,BAO_0000218,
8044,,Intermediate,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,1,,,50597,N,1,,CHEMBL618466,,BAO_0000218,
8045,,Intermediate,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,1,,,50597,N,1,,CHEMBL618467,,BAO_0000218,
8046,,Intermediate,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,1,,,50597,N,1,,CHEMBL618468,,BAO_0000218,
8047,Plasma,Intermediate,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,1,,,50588,N,1,,CHEMBL618469,,BAO_0000218,1969.0
8048,Plasma,Intermediate,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,1,,,50588,N,1,,CHEMBL618470,,BAO_0000218,1969.0
8049,,Autocuration,Plasma drug AUC in rat (PO dose),1,,,22224,U,0,,CHEMBL618471,,BAO_0000218,
8050,,Intermediate,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,1,,,50594,N,1,,CHEMBL618472,,BAO_0000218,
8051,,Autocuration,Area under was determined at a dose of 30 mg/kg,1,,,22224,U,0,,CHEMBL618473,,BAO_0000218,
8052,,Intermediate,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,1,,,50506,N,1,,CHEMBL621699,,BAO_0000218,
8053,,Intermediate,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,1,,,50597,N,1,,CHEMBL621700,,BAO_0000218,
8054,,Intermediate,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,1,,,50597,N,1,,CHEMBL621701,,BAO_0000218,
8055,,Intermediate,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,1,,,50506,N,1,,CHEMBL621702,,BAO_0000218,
8056,,Intermediate,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,1,,,50588,N,1,,CHEMBL621703,,BAO_0000218,
8057,,Intermediate,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,1,,,50588,N,1,,CHEMBL621704,,BAO_0000218,
8058,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624259,,BAO_0000218,
8059,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624260,,BAO_0000218,
8060,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624430,,BAO_0000218,
8061,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624431,,BAO_0000218,
8062,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624432,,BAO_0000218,
8063,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624433,,BAO_0000218,
8064,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624434,,BAO_0000218,
8065,,Intermediate,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",1,,,50597,N,1,,CHEMBL624435,,BAO_0000218,
8066,,Intermediate,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,1,,,50594,N,1,,CHEMBL618570,,BAO_0000218,
8067,,Intermediate,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,50594,N,1,,CHEMBL618571,,BAO_0000218,
8068,,Intermediate,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,1,,,50594,N,1,,CHEMBL618572,,BAO_0000218,
8069,,Intermediate,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,50594,N,1,,CHEMBL618573,,BAO_0000218,
8070,,Intermediate,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,1,,,50594,N,1,,CHEMBL619267,,BAO_0000218,
8071,,Intermediate,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,50594,N,1,,CHEMBL619431,,BAO_0000218,
8072,,Intermediate,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,1,,,50594,N,1,,CHEMBL619432,,BAO_0000218,
8073,,Intermediate,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,50594,N,1,,CHEMBL619433,,BAO_0000218,
8074,Plasma,Autocuration,AUC in mice after oral dose (50 mg/kg),1,,,22224,U,0,,CHEMBL619434,,BAO_0000218,1969.0
8075,Serum,Intermediate,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,1,,,50594,N,1,,CHEMBL619435,,BAO_0000218,1977.0
8076,Plasma,Autocuration,AUC (0-4 hr) ug/ml/h,1,,,22224,U,0,,CHEMBL619436,,BAO_0000019,1969.0
8077,,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,1,,,50597,N,1,,CHEMBL619437,,BAO_0000218,
8078,,Autocuration,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,1,,,22224,U,0,,CHEMBL619438,,BAO_0000218,
8079,,Intermediate,Compound was evaluated for Area under curve in mice,1,,,50594,N,1,,CHEMBL619439,,BAO_0000218,
8080,,Intermediate,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,,50597,N,1,,CHEMBL619440,,BAO_0000218,
8081,,Autocuration,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,,22224,U,0,,CHEMBL619441,,BAO_0000218,
8082,,Intermediate,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,,,50597,N,1,,CHEMBL619442,,BAO_0000218,
8083,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,1,,,22224,U,0,,CHEMBL875156,,BAO_0000019,
8084,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,1,,,22224,U,0,,CHEMBL619443,,BAO_0000019,
8085,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,1,,,22224,U,0,,CHEMBL619444,,BAO_0000019,
8086,,Autocuration,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,1,,,22224,U,0,,CHEMBL623464,,BAO_0000019,
8087,,Intermediate,Compound was evaluated for area under curve when administered through oral route in mouse,1,,,50594,N,1,,CHEMBL623465,,BAO_0000218,
8088,,Intermediate,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,1,,,50597,N,1,,CHEMBL623466,,BAO_0000218,
8089,,Intermediate,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,1,,,50597,N,1,,CHEMBL623467,,BAO_0000218,
8090,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL623468,,BAO_0000218,
8091,,Intermediate,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,,,50597,N,1,,CHEMBL622660,,BAO_0000218,
8092,,Intermediate,Plasma clearance rate in Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL622661,,BAO_0000218,
8093,,Intermediate,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL622662,,BAO_0000218,
8094,,Intermediate,Pharmacokinetic property (total body clearance) in rat,1,,,50597,N,1,,CHEMBL622663,,BAO_0000218,
8095,,Intermediate,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,1,,,50597,N,1,,CHEMBL622664,,BAO_0000218,
8096,,Intermediate,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL622665,,BAO_0000218,
8097,,Intermediate,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL622666,,BAO_0000218,
8098,,Intermediate,Cl in rat i.v. at 2 mg/kg concentration,1,,,50597,N,1,,CHEMBL621615,,BAO_0000218,
8099,,Intermediate,Clearance of compound after intravenous administration in rats at 24 uM/kg,1,,,50597,N,1,,CHEMBL621616,,BAO_0000218,
8100,,Intermediate,Clearance was determined,1,,,50597,N,1,,CHEMBL621617,,BAO_0000218,
8101,,Intermediate,Clearance by intravenous administration of 3.4 mg/kg in rat,1,,,50597,N,1,,CHEMBL621618,,BAO_0000218,
8102,,Intermediate,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL621619,,BAO_0000218,
8103,,Intermediate,Clearance rate after i.v. administration in rats,1,,,50597,N,1,,CHEMBL621620,,BAO_0000218,
8104,,Intermediate,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL621786,,BAO_0000218,
8105,,Intermediate,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,,50597,N,1,,CHEMBL621787,,BAO_0000218,
8106,,Intermediate,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,1,,,50597,N,1,,CHEMBL621788,,BAO_0000218,
8107,,Intermediate,Clearance (Cl) after oral administration in rat,1,,,50597,N,1,,CHEMBL621789,,BAO_0000218,
8108,,Intermediate,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,1,,,50597,N,1,,CHEMBL621790,,BAO_0000218,
8109,Plasma,Intermediate,Compound was tested for plasma clearance in rat,1,,,50597,N,1,,CHEMBL621791,,BAO_0000218,1969.0
8110,,Intermediate,In vitro microsome metabolism clearance in rat was determined,1,,Microsomes,50597,N,1,,CHEMBL621792,,BAO_0000218,
8111,,Intermediate,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,1,,Microsomes,50597,N,1,,CHEMBL621793,,BAO_0000218,
8112,,Intermediate,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL621794,,BAO_0000218,
8113,Plasma,Intermediate,In vivo plasma clearance was determined,1,,,50597,N,1,,CHEMBL621795,,BAO_0000218,1969.0
8114,,Intermediate,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,1,,,50597,N,1,,CHEMBL621796,,BAO_0000218,
8115,Liver,Intermediate,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,1,,,50597,N,1,,CHEMBL621797,401.0,BAO_0000218,2107.0
8116,,Intermediate,Pharmacokinetic property (Plasma clearance) was measured in rat,1,,,50597,N,1,,CHEMBL621798,,BAO_0000218,
8117,,Intermediate,Pharmacokinetic property (clearance) in rat i.v.,1,,,50597,N,1,,CHEMBL621799,,BAO_0000218,
8118,,Intermediate,"Plasma Clearance was evaluated in rats, iv",1,,,50597,N,1,,CHEMBL621800,,BAO_0000218,
8119,,Intermediate,Plasma clearance (in vivo) in rats was determined,1,,,50597,N,1,,CHEMBL621801,,BAO_0000218,
8120,,Intermediate,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,1,,,50597,N,1,,CHEMBL621802,,BAO_0000218,
8121,,Intermediate,Plasma clearance was determined,1,,,50597,N,1,,CHEMBL618596,,BAO_0000218,
8122,,Intermediate,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,1,,,50597,N,1,,CHEMBL618597,,BAO_0000218,
8123,,Intermediate,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,1,,,50597,N,1,,CHEMBL618598,,BAO_0000218,
8124,,Intermediate,Plasma clearance in rats,1,,,50597,N,1,,CHEMBL618599,,BAO_0000218,
8125,,Intermediate,Plasma clearance rate determined in rat,1,,,50597,N,1,,CHEMBL618600,,BAO_0000218,
8126,,Intermediate,Plasma clearance was determined in rat,1,,,50597,N,1,,CHEMBL618601,,BAO_0000218,
8127,,Intermediate,Plasma clearance was determined,1,,,50597,N,1,,CHEMBL618602,,BAO_0000218,
8128,,Intermediate,Plasma clearance value in rat,1,,,50597,N,1,,CHEMBL618603,,BAO_0000218,
8129,Liver,Intermediate,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,,,50597,N,1,,CHEMBL618604,,BAO_0000218,2107.0
8130,,Intermediate,Clearance in rat,1,,,50597,N,1,,CHEMBL618605,,BAO_0000218,
8131,,Intermediate,Total body clearance in rat i.v. at 2 mg/kg concentration,1,,,50597,N,1,,CHEMBL618606,,BAO_0000218,
8132,,Intermediate,Clearance of compound in rats after intravenous administration,1,,,50597,N,1,,CHEMBL618607,,BAO_0000218,
8133,,Intermediate,Clearance after iv administration to rats,1,,,50597,N,1,,CHEMBL618608,,BAO_0000218,
8134,,Intermediate,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,,,50597,N,1,,CHEMBL618609,,BAO_0000218,
8135,,Intermediate,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,,,50597,N,1,,CHEMBL618610,,BAO_0000218,
8136,,Intermediate,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,1,,,50597,N,1,,CHEMBL618611,,BAO_0000218,
8137,,Intermediate,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,,,50597,N,1,,CHEMBL618612,,BAO_0000218,
8138,,Intermediate,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,,,50597,N,1,,CHEMBL618613,,BAO_0000218,
8139,,Intermediate,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,,,50597,N,1,,CHEMBL621076,,BAO_0000218,
8140,,Intermediate,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,,,50597,N,1,,CHEMBL621077,,BAO_0000218,
8141,,Intermediate,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",1,,,50597,N,1,,CHEMBL621078,,BAO_0000218,
8142,,Intermediate,Clearance in rat,1,,,50597,N,1,,CHEMBL621251,,BAO_0000218,
8143,,Intermediate,Clearance in rat after oral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL621252,,BAO_0000218,
8144,,Intermediate,Clearance in rat.,1,,,50597,N,1,,CHEMBL621253,,BAO_0000218,
8145,,Intermediate,Clearance rate following an oral dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL621254,,BAO_0000218,
8146,,Intermediate,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,1,,,50597,N,1,,CHEMBL621255,,BAO_0000218,
8147,Plasma,Intermediate,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,1,,,50597,N,1,,CHEMBL621256,,BAO_0000218,1969.0
8148,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,1,,,50597,N,1,,CHEMBL621257,,BAO_0000218,2107.0
8149,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,1,,,50597,N,1,,CHEMBL621258,,BAO_0000218,2107.0
8150,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,1,,,50597,N,1,,CHEMBL621259,,BAO_0000218,2107.0
8151,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,1,,,50597,N,1,,CHEMBL621260,,BAO_0000218,2107.0
8152,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,1,,,50597,N,1,,CHEMBL876494,,BAO_0000218,2107.0
8153,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,1,,,50597,N,1,,CHEMBL621261,,BAO_0000218,2107.0
8154,Liver,Intermediate,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,1,,,50597,N,1,,CHEMBL621262,,BAO_0000218,2107.0
8155,Liver,Intermediate,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,,50597,N,1,,CHEMBL621263,,BAO_0000218,2107.0
8156,Liver,Intermediate,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,1,,,50597,N,1,,CHEMBL621264,,BAO_0000218,2107.0
8157,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621265,,BAO_0000218,2385.0
8158,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,1,,,50597,N,1,,CHEMBL621266,,BAO_0000218,2385.0
8159,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621267,,BAO_0000218,2385.0
8160,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621268,,BAO_0000218,2385.0
8161,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,1,,,50597,N,1,,CHEMBL621269,,BAO_0000218,2385.0
8162,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,1,,,50597,N,1,,CHEMBL621270,,BAO_0000218,2385.0
8163,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,1,,,50597,N,1,,CHEMBL621271,,BAO_0000218,2385.0
8164,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,1,,,50597,N,1,,CHEMBL621272,,BAO_0000218,2385.0
8165,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,1,,,50597,N,1,,CHEMBL621273,,BAO_0000218,2385.0
8166,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,1,,,50597,N,1,,CHEMBL621274,,BAO_0000218,2385.0
8167,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,1,,,50597,N,1,,CHEMBL876495,,BAO_0000218,2385.0
8168,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,1,,,50597,N,1,,CHEMBL621275,,BAO_0000218,2385.0
8169,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,1,,,50597,N,1,,CHEMBL621276,,BAO_0000218,2385.0
8170,Muscle tissue,Intermediate,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,1,,,50597,N,1,,CHEMBL621277,,BAO_0000218,2385.0
8171,Intestine,Intermediate,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,1,,,50597,N,1,,CHEMBL621278,,BAO_0000218,160.0
8172,Intestine,Intermediate,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,1,,,50597,N,1,,CHEMBL621279,,BAO_0000218,160.0
8173,Intestine,Intermediate,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),1,,,50597,N,1,,CHEMBL621280,,BAO_0000218,160.0
8174,Spleen,Intermediate,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621281,,BAO_0000218,2106.0
8175,Spleen,Intermediate,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,1,,,50597,N,1,,CHEMBL621282,,BAO_0000218,2106.0
8176,Spleen,Intermediate,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,,,50597,N,1,,CHEMBL621283,,BAO_0000218,2106.0
8177,Spleen,Intermediate,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,1,,,50597,N,1,,CHEMBL621284,,BAO_0000218,2106.0
8178,Spleen,Intermediate,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,1,,,50597,N,1,,CHEMBL621285,,BAO_0000218,2106.0
8179,Spleen,Intermediate,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,1,,,50597,N,1,,CHEMBL621286,,BAO_0000218,2106.0
8180,Spleen,Intermediate,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,1,,,50597,N,1,,CHEMBL623220,,BAO_0000218,2106.0
8181,Spleen,Intermediate,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,1,,,50597,N,1,,CHEMBL623221,,BAO_0000218,2106.0
8182,Spleen,Intermediate,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,1,,,50597,N,1,,CHEMBL876029,,BAO_0000218,2106.0
8183,Stomach,Intermediate,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,1,,,50597,N,1,,CHEMBL623222,,BAO_0000218,945.0
8184,Stomach,Intermediate,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,1,,,50597,N,1,,CHEMBL623223,,BAO_0000218,945.0
8185,Stomach,Intermediate,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,1,,,50597,N,1,,CHEMBL621445,,BAO_0000218,945.0
8186,Blood,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621446,,BAO_0000218,178.0
8187,Blood,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621447,,BAO_0000218,178.0
8188,Blood,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619681,,BAO_0000218,178.0
8189,Blood,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619682,,BAO_0000218,178.0
8190,Blood,Intermediate,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619683,,BAO_0000218,178.0
8191,Brain,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619684,,BAO_0000218,955.0
8192,Brain,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619685,,BAO_0000218,955.0
8193,Brain,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619686,,BAO_0000218,955.0
8194,Brain,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619687,,BAO_0000218,955.0
8195,Brain,Intermediate,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619688,,BAO_0000218,955.0
8196,Heart,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619689,,BAO_0000218,948.0
8197,Heart,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619690,,BAO_0000218,948.0
8198,Heart,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619691,,BAO_0000218,948.0
8199,,Intermediate,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL619692,,BAO_0000218,
8200,,Expert,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL619693,,BAO_0000218,
8201,,Intermediate,Vc value after IV dose at a dose of 5 mg/kg in rats.,1,,,50597,N,1,,CHEMBL619694,,BAO_0000218,
8202,,Intermediate,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,1,,,50597,N,1,,CHEMBL619695,,BAO_0000218,
8203,,Intermediate,Compound was evaluated for pharmacokinetic parameter volume of distribution,1,,,50597,N,1,,CHEMBL619696,,BAO_0000218,
8204,,Intermediate,Compound was evaluated for volume of distribution in rat,1,,,50597,N,1,,CHEMBL619697,,BAO_0000218,
8205,,Intermediate,Steady state volume distribution was determined; steady state(ss),1,,,50597,N,1,,CHEMBL619698,,BAO_0000218,
8206,,Intermediate,Steady state volume of distribution after iv administration to rats,1,,,50597,N,1,,CHEMBL619699,,BAO_0000218,
8207,,Intermediate,Steady state volume of distribution dosing at 3 mg/kg iv,1,,,50597,N,1,,CHEMBL619700,,BAO_0000218,
8208,,Intermediate,The compound was evaluated for volume of distribution in rat,1,,,50597,N,1,,CHEMBL619701,,BAO_0000218,
8209,,Intermediate,The compound was tested for volume of distribution in rat,1,,,50597,N,1,,CHEMBL619702,,BAO_0000218,
8210,,Intermediate,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,1,,,50597,N,1,,CHEMBL620335,,BAO_0000218,
8211,,Intermediate,Volume distribution (VD) after oral administration in rat,1,,,50597,N,1,,CHEMBL620336,,BAO_0000218,
8212,,Intermediate,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,50597,N,1,,CHEMBL620337,,BAO_0000218,
8213,,Intermediate,Volume distribution in rat,1,,,50597,N,1,,CHEMBL620520,,BAO_0000218,
8214,,Intermediate,Volume distribution in rat,1,,,50597,N,1,,CHEMBL620521,,BAO_0000218,
8215,,Intermediate,Volume distribution in rat after peroral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL875825,,BAO_0000218,
8216,,Intermediate,Volume distribution in rat after peroral administration at 5 mg/kg,1,,,50597,N,1,,CHEMBL620522,,BAO_0000218,
8217,,Intermediate,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL620523,,BAO_0000218,
8218,,Intermediate,Volume of distribution in rat.,1,,,50597,N,1,,CHEMBL620524,,BAO_0000218,
8219,,Intermediate,Volume of distribution in rat,1,,,50597,N,1,,CHEMBL620525,,BAO_0000218,
8220,,Intermediate,Volume of distribution in rat,1,,,50597,N,1,,CHEMBL620526,,BAO_0000218,
8221,,Intermediate,Volume of distribution in rat by iv administration,1,,,50597,N,1,,CHEMBL620527,,BAO_0000218,
8222,,Intermediate,Volume of distribution in rats,1,,,50597,N,1,,CHEMBL620528,,BAO_0000218,
8223,,Intermediate,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,,50597,N,1,,CHEMBL620529,,BAO_0000218,
8224,,Intermediate,Volume distribution at the dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL620530,,BAO_0000218,
8225,,Intermediate,Steady state volume of distribution was determined,1,,,50597,N,1,,CHEMBL620531,,BAO_0000218,
8226,,Intermediate,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,1,,,22224,U,0,,CHEMBL620532,,BAO_0000218,
8227,,Intermediate,Compound was tested for its plasma volume distribution in Sprague Dawley rats,1,,,22224,U,0,,CHEMBL620533,,BAO_0000218,
8228,,Intermediate,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,1,,,22224,U,0,,CHEMBL620534,,BAO_0000218,
8229,,Intermediate,Mean (%CV) PK parameters for Vdss(mL/kg).,1,,,50597,N,1,,CHEMBL620535,,BAO_0000218,
8230,,Intermediate,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL875826,,BAO_0000218,
8231,,Intermediate,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL620536,,BAO_0000218,
8232,,Intermediate,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL620537,,BAO_0000218,
8233,,Intermediate,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,1,,,50597,N,1,,CHEMBL618526,,BAO_0000218,
8234,,Intermediate,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,1,,,50597,N,1,,CHEMBL618527,,BAO_0000218,
8235,,Intermediate,Pharmacokinetic property (Vdss) in rat,1,,,50597,N,1,,CHEMBL618528,,BAO_0000218,
8236,,Intermediate,Pharmacokinetic property (vdss) was measured in rat,1,,,50597,N,1,,CHEMBL618529,,BAO_0000218,
8237,,Intermediate,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL618530,,BAO_0000218,
8238,,Intermediate,Volume of distribution in rat,1,,,50597,N,1,,CHEMBL618531,,BAO_0000218,
8239,,Intermediate,The pharmacokinetic parameter volume of distribution in vivo in rats,1,,,50597,N,1,,CHEMBL618532,,BAO_0000218,
8240,,Intermediate,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL618533,,BAO_0000218,
8241,,Intermediate,Vdss in rat i.v. at 2 mg/kg concentration,1,,,50597,N,1,,CHEMBL618534,,BAO_0000218,
8242,,Intermediate,Volume distribution after intravenous administration (1 mg/kg) in rat,1,,,50597,N,1,,CHEMBL618535,,BAO_0000218,
8243,,Intermediate,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL618536,,BAO_0000218,
8244,,Intermediate,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL618537,,BAO_0000218,
8245,,Intermediate,Volume distribution at a dose of 10 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL618538,,BAO_0000218,
8246,,Intermediate,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,50597,N,1,,CHEMBL618539,,BAO_0000218,
8247,,Intermediate,Volume distribution was calculated in rat,1,,,50597,N,1,,CHEMBL618540,,BAO_0000218,
8248,,Intermediate,Volume distribution was determined,1,,,50597,N,1,,CHEMBL618541,,BAO_0000218,
8249,,Intermediate,Volume of distribution after intravenous administration was evaluated in rat,1,,,50597,N,1,,CHEMBL618542,,BAO_0000218,
8250,,Intermediate,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,50597,N,1,,CHEMBL622544,,BAO_0000218,
8251,,Intermediate,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL622545,,BAO_0000218,
8252,,Intermediate,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL622546,,BAO_0000218,
8253,,Intermediate,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",1,,,50597,N,1,,CHEMBL622547,,BAO_0000218,
8254,,Intermediate,Volume of distribution in steady state was determined in rat,1,,,50597,N,1,,CHEMBL622548,,BAO_0000218,
8255,,Intermediate,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,1,,,50597,N,1,,CHEMBL622549,,BAO_0000218,
8256,,Intermediate,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,,50597,N,1,,CHEMBL622550,,BAO_0000218,
8257,,Intermediate,Compound was evaluated for area under curve when administered through oral route to mouse,1,,,50594,N,1,,CHEMBL622551,,BAO_0000218,
8258,,Intermediate,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,,50597,N,1,,CHEMBL622552,,BAO_0000218,
8259,,Intermediate,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,,,50597,N,1,,CHEMBL622553,,BAO_0000218,
8260,,Autocuration,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,1,,,22224,U,0,,CHEMBL622554,,BAO_0000218,
8261,,Intermediate,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,1,,,50588,N,1,,CHEMBL622555,,BAO_0000218,
8262,,Intermediate,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,1,,,50594,N,1,,CHEMBL622556,,BAO_0000218,
8263,,Intermediate,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,1,,,50594,N,1,,CHEMBL622557,,BAO_0000218,
8264,Blood,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,1,,,50594,N,1,,CHEMBL622558,,BAO_0000218,178.0
8265,Blood,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,1,,,50594,N,1,,CHEMBL622559,,BAO_0000218,178.0
8266,,Intermediate,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,1,,,50588,N,1,,CHEMBL622560,,BAO_0000218,
8267,,Intermediate,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,,50597,N,1,,CHEMBL622561,,BAO_0000218,
8268,,Intermediate,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,1,,,50597,N,1,,CHEMBL622562,,BAO_0000218,
8269,,Intermediate,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,,50597,N,1,,CHEMBL622563,,BAO_0000218,
8270,,Autocuration,Concentration of compound in Central nervous system,1,,,22224,U,0,,CHEMBL622564,,BAO_0000019,
8271,,Autocuration,Concentration of compound in Central nervous system; Not detectable,1,,,22224,U,0,,CHEMBL622565,,BAO_0000019,
8272,,Intermediate,"Concentration of diester in the blood, following oral administration in mice",1,,,50594,N,1,,CHEMBL622566,,BAO_0000218,
8273,,Intermediate,"Concentration of monoester in the blood, following oral administration in mice",1,,,50594,N,1,,CHEMBL624515,,BAO_0000218,
8274,,Intermediate,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,1,,,50594,N,1,,CHEMBL624516,,BAO_0000218,
8275,,Autocuration,Evaluated for Pharmacokinetic property: Area under the curve,1,,,22224,U,0,,CHEMBL624517,,BAO_0000019,
8276,,Intermediate,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,1,,,50594,N,1,,CHEMBL624518,,BAO_0000218,
8277,,Intermediate,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,1,,,100710,N,1,,CHEMBL624519,,BAO_0000218,
8278,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,1,,,100710,N,1,,CHEMBL624520,,BAO_0000218,
8279,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,1,,,100710,N,1,,CHEMBL624521,,BAO_0000218,
8280,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,1,,,100710,N,1,,CHEMBL624522,,BAO_0000218,
8281,,Intermediate,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,1,,,100710,N,1,,CHEMBL624523,,BAO_0000218,
8282,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,,100710,N,1,,CHEMBL624409,,BAO_0000218,
8283,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",1,,,100710,N,1,,CHEMBL624410,,BAO_0000218,
8284,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,,100710,N,1,,CHEMBL624411,,BAO_0000218,
8285,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",1,,,100710,N,1,,CHEMBL623531,,BAO_0000218,
8286,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",1,,,100710,N,1,,CHEMBL623532,,BAO_0000218,
8287,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",1,,,100710,N,1,,CHEMBL623533,,BAO_0000218,
8288,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,,100710,N,1,,CHEMBL623534,,BAO_0000218,
8289,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,1,,,50594,N,1,,CHEMBL623535,,BAO_0000218,
8290,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,1,,,50594,N,1,,CHEMBL623536,,BAO_0000218,
8291,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,1,,,50594,N,1,,CHEMBL623537,,BAO_0000218,
8292,,Intermediate,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,1,,,50594,N,1,,CHEMBL623538,,BAO_0000218,
8293,,Intermediate,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,1,,,50594,N,1,,CHEMBL623539,,BAO_0000218,
8294,,Intermediate,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,1,,,50594,N,1,,CHEMBL623540,,BAO_0000218,
8295,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",1,,,50594,N,1,,CHEMBL623541,,BAO_0000218,
8296,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",1,,,50594,N,1,,CHEMBL623542,,BAO_0000218,
8297,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",1,,,50594,N,1,,CHEMBL623543,,BAO_0000218,
8298,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",1,,,50594,N,1,,CHEMBL623544,,BAO_0000218,
8299,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",1,,,50594,N,1,,CHEMBL623545,,BAO_0000218,
8300,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",1,,,50594,N,1,,CHEMBL623546,,BAO_0000218,
8301,Plasma,Intermediate,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL623547,,BAO_0000218,1969.0
8302,,Intermediate,High i.v. clearance in Dawley rats,1,,,50597,N,1,,CHEMBL623548,,BAO_0000218,
8303,Liver,Intermediate,In vitro clearance in rat liver microsomes,1,,Microsomes,50597,N,1,,CHEMBL623549,,BAO_0000218,2107.0
8304,Liver,Intermediate,Intrinsic clearance in rat liver microsomes was determined,1,,Microsomes,50597,N,1,,CHEMBL623550,,BAO_0000218,2107.0
8305,Liver,Intermediate,Intrinsic clearance in rat hepatocytes was determined,1,,,50597,N,1,,CHEMBL875276,401.0,BAO_0000218,2107.0
8306,,Intermediate,Plasma Clearance was determined,1,,,50597,N,1,,CHEMBL621872,,BAO_0000218,
8307,,Intermediate,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,1,,,50597,N,1,,CHEMBL621873,,BAO_0000218,
8308,,Intermediate,Plasma clearance in rat.,1,,,50597,N,1,,CHEMBL621874,,BAO_0000218,
8309,,Intermediate,Plasma clearance in rats,1,,,50597,N,1,,CHEMBL621875,,BAO_0000218,
8310,,Intermediate,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,1,,,50597,N,1,,CHEMBL621876,,BAO_0000218,
8311,,Intermediate,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,1,,,50597,N,1,,CHEMBL621877,,BAO_0000218,
8312,,Intermediate,Plasma clearance was measured in rat,1,,,50597,N,1,,CHEMBL621878,,BAO_0000218,
8313,,Intermediate,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,,50597,N,1,,CHEMBL621879,,BAO_0000218,
8314,Plasma,Intermediate,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",1,,,50597,N,1,,CHEMBL621880,,BAO_0000218,1969.0
8315,,Intermediate,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL621881,,BAO_0000218,
8316,,Intermediate,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,50597,N,1,,CHEMBL621882,,BAO_0000218,
8317,,Intermediate,Total clearance at 1 mg/kg was determined in rat,1,,,50597,N,1,,CHEMBL875283,,BAO_0000218,
8318,,Intermediate,Total clearance at 10 mg/kg was determined in rat,1,,,50597,N,1,,CHEMBL621883,,BAO_0000218,
8319,,Intermediate,Clearance in rat,1,,,50597,N,1,,CHEMBL621884,,BAO_0000218,
8320,,Intermediate,Plasma clearance rate determined in rats,1,,,50597,N,1,,CHEMBL621885,,BAO_0000218,
8321,,Intermediate,Clearance of compound in rat was evaluated,1,,,50597,N,1,,CHEMBL621886,,BAO_0000218,
8322,Plasma,Intermediate,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,,,50597,N,1,,CHEMBL621887,,BAO_0000218,1969.0
8323,,Intermediate,Pharmacokinetic property (blood clearance) in rat,1,,,50597,N,1,,CHEMBL621888,,BAO_0000218,
8324,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL621889,,BAO_0000218,
8325,,Intermediate,Plasma clearance in rats,1,,,50597,N,1,,CHEMBL621890,,BAO_0000218,
8326,Liver,Intermediate,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,1,,Microsomes,50597,N,1,,CHEMBL621891,,BAO_0000218,2107.0
8327,,Intermediate,Clearance in Dawley rat,1,,,50597,N,1,,CHEMBL621892,,BAO_0000218,
8328,,Intermediate,Clearance rat,1,,,50597,N,1,,CHEMBL621893,,BAO_0000218,
8329,,Intermediate,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),1,,,50597,N,1,,CHEMBL621894,,BAO_0000218,
8330,,Intermediate,Clearance rat; Not determined,1,,,50597,N,1,,CHEMBL621895,,BAO_0000218,
8331,,Intermediate,Clearance rate was determined in rat at a dose of 1 mpk i.v.,1,,,50597,N,1,,CHEMBL875284,,BAO_0000218,
8332,,Intermediate,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,,50597,N,1,,CHEMBL618699,,BAO_0000218,
8333,,Intermediate,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,,50597,N,1,,CHEMBL618700,,BAO_0000218,
8334,,Intermediate,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL618701,,BAO_0000218,
8335,Plasma,Intermediate,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,,,50597,N,1,,CHEMBL876600,,BAO_0000218,1969.0
8336,,Intermediate,Clearance of compound in rat after 1 mg/kg i.v. administration,1,,,50597,N,1,,CHEMBL618702,,BAO_0000218,
8337,,Intermediate,Compound was evaluated for Hepatic clearance in rat,1,,,50597,N,1,,CHEMBL618703,,BAO_0000218,
8338,,Intermediate,In vivo clearance after 5 mg/kg dose,1,,,50597,N,1,,CHEMBL618704,,BAO_0000218,
8339,Plasma,Intermediate,Compound was tested for plasma clearance in rats,1,,,50597,N,1,,CHEMBL618705,,BAO_0000218,1969.0
8340,,Intermediate,Hepatic clearance after intravenous administration was evaluated in rat,1,,,50597,N,1,,CHEMBL618706,,BAO_0000218,
8341,,Intermediate,Lower clearance in rat (i.v.) at 0.5 mpk,1,,,50597,N,1,,CHEMBL618707,,BAO_0000218,
8342,Plasma,Intermediate,Pharmacokinetic parameter expressed as plasma clearance in rat,1,,,50597,N,1,,CHEMBL618708,,BAO_0000218,1969.0
8343,,Intermediate,Pharmacokinetic property (Clp) in rat,1,,,50597,N,1,,CHEMBL618709,,BAO_0000218,
8344,,Intermediate,Plasma clearance in Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL618710,,BAO_0000218,
8345,,Intermediate,Plasma clearance (Clp) in rat,1,,,50597,N,1,,CHEMBL618711,,BAO_0000218,
8346,,Intermediate,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL618712,,BAO_0000218,
8347,,Intermediate,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,1,,,50597,N,1,,CHEMBL618713,,BAO_0000218,
8348,,Intermediate,Plasma clearance after intravenous administration of 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL618714,,BAO_0000218,
8349,,Intermediate,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,50597,N,1,,CHEMBL618715,,BAO_0000218,
8350,,Intermediate,Plasma clearance in rat was determined,1,,,50597,N,1,,CHEMBL618716,,BAO_0000218,
8351,,Intermediate,Plasma clearance measured in rat,1,,,50597,N,1,,CHEMBL876601,,BAO_0000218,
8352,,Intermediate,Plasma clearance was calculated in rat,1,,,50597,N,1,,CHEMBL618717,,BAO_0000218,
8353,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL618718,,BAO_0000218,
8354,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL618719,,BAO_0000218,
8355,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL618720,,BAO_0000218,
8356,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL618721,,BAO_0000218,
8357,,Intermediate,Plasma clearance in rats,1,,,50597,N,1,,CHEMBL621477,,BAO_0000218,
8358,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL621478,,BAO_0000218,
8359,,Intermediate,Plasma clearance was evaluated in rat,1,,,50597,N,1,,CHEMBL621479,,BAO_0000218,
8360,,Intermediate,Plasma clearance was evaluated in rat; Not tested,1,,,50597,N,1,,CHEMBL621480,,BAO_0000218,
8361,,Intermediate,Plasma clearance rate was determined for the compound in rat,1,,,50597,N,1,,CHEMBL621481,,BAO_0000218,
8362,,Intermediate,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL621482,,BAO_0000218,
8363,,Intermediate,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL621483,,BAO_0000218,
8364,,Intermediate,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",1,,,50597,N,1,,CHEMBL621484,,BAO_0000218,
8365,Heart,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621485,,BAO_0000218,948.0
8366,Heart,Intermediate,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621486,,BAO_0000218,948.0
8367,Intestine,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621487,,BAO_0000218,160.0
8368,Intestine,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621488,,BAO_0000218,160.0
8369,Intestine,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621489,,BAO_0000218,160.0
8370,Intestine,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621490,,BAO_0000218,160.0
8371,Intestine,Intermediate,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621491,,BAO_0000218,160.0
8372,Kidney,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621492,,BAO_0000218,2113.0
8373,Kidney,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621493,,BAO_0000218,2113.0
8374,Kidney,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621494,,BAO_0000218,2113.0
8375,Kidney,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621495,,BAO_0000218,2113.0
8376,Kidney,Intermediate,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621496,,BAO_0000218,2113.0
8377,Liver,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621497,,BAO_0000218,2107.0
8378,Liver,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621498,,BAO_0000218,2107.0
8379,Liver,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL621499,,BAO_0000218,2107.0
8380,Liver,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL618634,,BAO_0000218,2107.0
8381,Liver,Intermediate,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL618635,,BAO_0000218,2107.0
8382,Lung,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL618636,,BAO_0000218,2048.0
8383,Lung,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619737,,BAO_0000218,2048.0
8384,Lung,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL619738,,BAO_0000218,2048.0
8385,Lung,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL624329,,BAO_0000218,2048.0
8386,Lung,Intermediate,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL624330,,BAO_0000218,2048.0
8387,Muscle tissue,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL624331,,BAO_0000218,2385.0
8388,Muscle tissue,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL624332,,BAO_0000218,2385.0
8389,Muscle tissue,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL624333,,BAO_0000218,2385.0
8390,Muscle tissue,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL624334,,BAO_0000218,2385.0
8391,Muscle tissue,Intermediate,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL624335,,BAO_0000218,2385.0
8392,Spleen,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620016,,BAO_0000218,2106.0
8393,Spleen,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620169,,BAO_0000218,2106.0
8394,Spleen,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620170,,BAO_0000218,2106.0
8395,Spleen,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620171,,BAO_0000218,2106.0
8396,Spleen,Intermediate,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620172,,BAO_0000218,2106.0
8397,Stomach,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620173,,BAO_0000218,945.0
8398,Stomach,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620174,,BAO_0000218,945.0
8399,Stomach,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620175,,BAO_0000218,945.0
8400,Stomach,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620176,,BAO_0000218,945.0
8401,Stomach,Intermediate,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620177,,BAO_0000218,945.0
8402,Cerebellum,Intermediate,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620178,,BAO_0000218,2037.0
8403,Cerebellum,Intermediate,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620179,,BAO_0000218,2037.0
8404,,Intermediate,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620180,,BAO_0000218,
8405,,Intermediate,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,1,,,50597,N,1,,CHEMBL620181,,BAO_0000218,
8406,,Intermediate,Volume of distribution of compound in rats after intravenous administration,1,,,50597,N,1,,CHEMBL620182,,BAO_0000218,
8407,,Intermediate,Volume of distribution in rat,1,,,50597,N,1,,CHEMBL620183,,BAO_0000218,
8408,,Intermediate,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,1,,,50597,N,1,,CHEMBL620184,,BAO_0000218,
8409,,Intermediate,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,,50597,N,1,,CHEMBL620185,,BAO_0000218,
8410,,Intermediate,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,,50597,N,1,,CHEMBL620186,,BAO_0000218,
8411,,Intermediate,Volume of distribution was determined in Dawley rat,1,,,50597,N,1,,CHEMBL620187,,BAO_0000218,
8412,,Intermediate,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL620188,,BAO_0000218,
8413,,Intermediate,Volume of distribution was reported in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL620189,,BAO_0000218,
8414,,Intermediate,Volumes of distribution in rat after peroral administration,1,,,50597,N,1,,CHEMBL620190,,BAO_0000218,
8415,,Intermediate,Volumes of distribution in rat after po administration,1,,,50597,N,1,,CHEMBL620191,,BAO_0000218,
8416,,Intermediate,Volumes of distribution in rat after po administration; Not determined,1,,,50597,N,1,,CHEMBL620192,,BAO_0000218,
8417,,Intermediate,Pharmacokinetic property (Volume) in rat i.v.,1,,,50597,N,1,,CHEMBL620193,,BAO_0000218,
8418,,Intermediate,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,1,,,50597,N,1,,CHEMBL620194,,BAO_0000218,
8419,,Intermediate,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",1,,,50597,N,1,,CHEMBL876730,,BAO_0000218,
8420,,Intermediate,Volume distribution in rat after oral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL620195,,BAO_0000218,
8421,,Intermediate,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL620196,,BAO_0000218,
8422,,Intermediate,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,,50597,N,1,,CHEMBL620197,,BAO_0000218,
8423,,Intermediate,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,1,,,50597,N,1,,CHEMBL620198,,BAO_0000218,
8424,,Intermediate,Volume of distribution in rats,1,,,50597,N,1,,CHEMBL620199,,BAO_0000218,
8425,,Intermediate,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL620200,,BAO_0000218,
8426,,Intermediate,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL620201,,BAO_0000218,
8427,,Intermediate,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL620202,,BAO_0000218,
8428,,Intermediate,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL620203,,BAO_0000218,
8429,,Intermediate,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,1,,,50597,N,1,,CHEMBL620204,,BAO_0000218,
8430,,Intermediate,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL620205,,BAO_0000218,
8431,,Intermediate,Pharmacokinetic parameter (Vss) in rat,1,,,50597,N,1,,CHEMBL624664,,BAO_0000218,
8432,,Intermediate,Pharmacokinetic property (Volume) in rat i.v.,1,,,50597,N,1,,CHEMBL624665,,BAO_0000218,
8433,,Intermediate,Pharmacokinetic property (Vss) in rat,1,,,50597,N,1,,CHEMBL624666,,BAO_0000218,
8434,,Intermediate,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,,,50597,N,1,,CHEMBL624667,,BAO_0000218,
8435,,Intermediate,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624668,,BAO_0000218,
8436,,Intermediate,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624669,,BAO_0000218,
8437,,Intermediate,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624670,,BAO_0000218,
8438,,Intermediate,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624671,,BAO_0000218,
8439,,Intermediate,Steady state volume distribution in rat,1,,,50597,N,1,,CHEMBL624672,,BAO_0000218,
8440,Plasma,Intermediate,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",1,,,50597,N,1,,CHEMBL624673,,BAO_0000218,1969.0
8441,,Intermediate,Steady state volume of distribution determined in rat,1,,,50597,N,1,,CHEMBL624674,,BAO_0000218,
8442,,Intermediate,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,50597,N,1,,CHEMBL624675,,BAO_0000218,
8443,,Intermediate,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,1,,,50597,N,1,,CHEMBL621728,,BAO_0000218,
8444,,Intermediate,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,1,,,50597,N,1,,CHEMBL621729,,BAO_0000218,
8445,,Intermediate,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,1,,,50597,N,1,,CHEMBL621730,,BAO_0000218,
8446,,Intermediate,Volume distribution in rat after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL621731,,BAO_0000218,
8447,,Intermediate,Volume distribution in rat after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL621732,,BAO_0000218,
8448,,Intermediate,Volume in steady state distribution value was determined,1,,,50597,N,1,,CHEMBL621908,,BAO_0000218,
8449,,Intermediate,Volume in steady state distribution value was determined; ND denotes no data,1,,,50597,N,1,,CHEMBL875347,,BAO_0000218,
8450,,Intermediate,Volume in steady state distribution value was determined; ND denotes not determined,1,,,50597,N,1,,CHEMBL621909,,BAO_0000218,
8451,,Intermediate,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,50597,N,1,,CHEMBL621910,,BAO_0000218,
8452,,Intermediate,Volume of distribution at steady state was evaluated in rats,1,,,50597,N,1,,CHEMBL621911,,BAO_0000218,
8453,,Intermediate,Volume of distribution at steady state was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL621912,,BAO_0000218,
8454,,Intermediate,Volume of distribution in steady state was determined in rat,1,,,50597,N,1,,CHEMBL621913,,BAO_0000218,
8455,,Intermediate,Volume of distribution in steady state was determined in rat,1,,,50597,N,1,,CHEMBL621914,,BAO_0000218,
8456,,Intermediate,Volume of distribution after i.v. administration,1,,,50597,N,1,,CHEMBL621915,,BAO_0000218,
8457,,Intermediate,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,,50597,N,1,,CHEMBL621916,,BAO_0000218,
8458,Liver,Intermediate,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,,,50594,N,1,,CHEMBL621917,,BAO_0000218,2107.0
8459,Liver,Intermediate,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,,,50594,N,1,,CHEMBL621918,,BAO_0000218,2107.0
8460,Spleen,Intermediate,Biodistribution of compound (oxidized form) in spleen tissue,1,,,50594,N,1,,CHEMBL621919,,BAO_0000218,2106.0
8461,Spleen,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",1,,,50594,N,1,,CHEMBL621920,,BAO_0000218,2106.0
8462,Spleen,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",1,,,50594,N,1,,CHEMBL621921,,BAO_0000218,2106.0
8463,Spleen,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL622401,,BAO_0000218,2106.0
8464,Spleen,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,,,50594,N,1,,CHEMBL875348,,BAO_0000218,2106.0
8465,Spleen,Intermediate,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,,,50594,N,1,,CHEMBL622402,,BAO_0000218,2106.0
8466,Blood,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,1,,,50594,N,1,,CHEMBL622403,,BAO_0000218,178.0
8467,Blood,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL622404,,BAO_0000218,178.0
8468,Brain,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,1,,,50594,N,1,,CHEMBL622405,,BAO_0000218,955.0
8469,Brain,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL622406,,BAO_0000218,955.0
8470,Brain,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL622407,,BAO_0000218,955.0
8471,Heart,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,1,,,50594,N,1,,CHEMBL622408,,BAO_0000218,948.0
8472,Heart,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL622409,,BAO_0000218,948.0
8473,Heart,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL622410,,BAO_0000218,948.0
8474,Kidney,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,1,,,50594,N,1,,CHEMBL622411,,BAO_0000218,2113.0
8475,Kidney,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,,,50594,N,1,,CHEMBL627864,,BAO_0000218,2113.0
8476,Kidney,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL627865,,BAO_0000218,2113.0
8477,Liver,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,1,,,50594,N,1,,CHEMBL627866,,BAO_0000218,2107.0
8478,Liver,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL627751,,BAO_0000218,2107.0
8479,Spleen,Intermediate,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,1,,,50594,N,1,,CHEMBL627752,,BAO_0000218,2106.0
8480,Spleen,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,,,50594,N,1,,CHEMBL627753,,BAO_0000218,2106.0
8481,Spleen,Intermediate,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,,50594,N,1,,CHEMBL627754,,BAO_0000218,2106.0
8482,,Intermediate,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,1,,,50594,N,1,,CHEMBL627755,,BAO_0000218,
8483,Brain,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627756,,BAO_0000218,955.0
8484,Brain,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627757,,BAO_0000218,955.0
8485,Brain,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627758,,BAO_0000218,955.0
8486,Brain,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627759,,BAO_0000218,955.0
8487,Brain,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627760,,BAO_0000218,955.0
8488,Brain,Intermediate,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627761,,BAO_0000218,955.0
8489,Heart,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL876811,,BAO_0000218,948.0
8490,Heart,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627762,,BAO_0000218,948.0
8491,Heart,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627763,,BAO_0000218,948.0
8492,Heart,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627764,,BAO_0000218,948.0
8493,Heart,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627765,,BAO_0000218,948.0
8494,Heart,Intermediate,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627766,,BAO_0000218,948.0
8495,Kidney,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627767,,BAO_0000218,2113.0
8496,Kidney,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627768,,BAO_0000218,2113.0
8497,Kidney,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL628422,,BAO_0000218,2113.0
8498,Kidney,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL628423,,BAO_0000218,2113.0
8499,,Intermediate,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,1,,,50597,N,1,,CHEMBL628424,,BAO_0000218,
8500,,Intermediate,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,1,,,50597,N,1,,CHEMBL628425,,BAO_0000218,
8501,,Intermediate,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,1,,,50597,N,1,,CHEMBL628426,,BAO_0000218,
8502,,Intermediate,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,50597,N,1,,CHEMBL628427,,BAO_0000218,
8503,,Intermediate,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,,50597,N,1,,CHEMBL626938,,BAO_0000218,
8504,,Intermediate,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL626939,,BAO_0000218,
8505,,Intermediate,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626940,,BAO_0000218,
8506,,Intermediate,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626941,,BAO_0000218,
8507,,Intermediate,Plasma clearance was reported in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626942,,BAO_0000218,
8508,,Intermediate,Plasma clearance after intravenous administration (1 mg/kg) in rat,1,,,50597,N,1,,CHEMBL876812,,BAO_0000218,
8509,,Intermediate,Plasma clearance of compound in rats was evaluated,1,,,50597,N,1,,CHEMBL626943,,BAO_0000218,
8510,,Intermediate,Plasma clearance of compound in rats was evaluated; ND indicates not determined,1,,,50597,N,1,,CHEMBL626944,,BAO_0000218,
8511,,Intermediate,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,1,,,50597,N,1,,CHEMBL626945,,BAO_0000218,
8512,,Intermediate,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,,50597,N,1,,CHEMBL626946,,BAO_0000218,
8513,,Intermediate,Plasma clearance rate in Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL626856,,BAO_0000218,
8514,,Intermediate,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),1,,,50597,N,1,,CHEMBL626857,,BAO_0000218,
8515,Plasma,Intermediate,The compound was evaluated for plasma clearance in rat,1,,,50597,N,1,,CHEMBL626858,,BAO_0000218,1969.0
8516,Plasma,Intermediate,Total plasma clearance in rat,1,,,50597,N,1,,CHEMBL627018,,BAO_0000218,1969.0
8517,Blood,Intermediate,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,1,,,50597,N,1,,CHEMBL625331,,BAO_0000218,178.0
8518,Blood,Intermediate,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,1,,,50597,N,1,,CHEMBL625332,,BAO_0000218,178.0
8519,,Intermediate,C max was determined at 10 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL877590,,BAO_0000218,
8520,,Intermediate,C max was determined at 3 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL625333,,BAO_0000218,
8521,,Intermediate,Cmax after repeated oral dose of compound at 1 mg/kg in rats,1,,,50597,N,1,,CHEMBL625334,,BAO_0000218,
8522,,Intermediate,Cmax after single intravenous bolus of 1 mg/kg in rats,1,,,50597,N,1,,CHEMBL625335,,BAO_0000218,
8523,,Intermediate,Cmax of compound at 5 mg/kg after po administration was determined in rat,1,,,50597,N,1,,CHEMBL625336,,BAO_0000218,
8524,,Intermediate,Cmax 24 hr after 10 mg/kg oral administration in rats,1,,,50597,N,1,,CHEMBL625337,,BAO_0000218,
8525,,Intermediate,Cmax 24 hr after 2 mg/kg oral administration in rats,1,,,50597,N,1,,CHEMBL625338,,BAO_0000218,
8526,Plasma,Intermediate,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,1,,,50597,N,1,,CHEMBL625339,,BAO_0000218,1969.0
8527,,Intermediate,Cmax in rat after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL625340,,BAO_0000218,
8528,,Intermediate,Cmax in rat after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL625341,,BAO_0000218,
8529,,Intermediate,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,1,,,50597,N,1,,CHEMBL622687,,BAO_0000218,
8530,Plasma,Intermediate,Cmax wa determined in rat plasma at 30 mg/kg after po administration,1,,,50597,N,1,,CHEMBL622688,,BAO_0000218,1969.0
8531,Blood,Intermediate,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,1,,,50597,N,1,,CHEMBL622689,,BAO_0000218,178.0
8532,Blood,Intermediate,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,1,,,50597,N,1,,CHEMBL620295,,BAO_0000218,178.0
8533,,Intermediate,Cmax after 10 mg/kg oral administration in rat,1,,,50597,N,1,,CHEMBL620296,,BAO_0000218,
8534,,Intermediate,Cmax after IV dosing at 0.5 mg/kg in rat; no data,1,,,50597,N,1,,CHEMBL620297,,BAO_0000218,
8535,,Intermediate,Cmax after IV dosing at 1 mg/kg in rat; no data,1,,,50597,N,1,,CHEMBL620298,,BAO_0000218,
8536,,Intermediate,Cmax after oral administration at 20 mpk in rats,1,,,50597,N,1,,CHEMBL620299,,BAO_0000218,
8537,,Intermediate,Cmax after oral administration at 20 mpk in rats; Not performed.,1,,,50597,N,1,,CHEMBL620300,,BAO_0000218,
8538,,Intermediate,Cmax after oral administration at 20 mpk in rats d; Not performed.,1,,,50597,N,1,,CHEMBL620301,,BAO_0000218,
8539,,Intermediate,Cmax after oral administration in rat,1,,,50597,N,1,,CHEMBL620302,,BAO_0000218,
8540,,Intermediate,Cmax after oral administration at a dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL620303,,BAO_0000218,
8541,,Intermediate,Cmax after oral administration at a dose of 4 mg/kg in rat,1,,,50597,N,1,,CHEMBL620304,,BAO_0000218,
8542,,Intermediate,Cmax in rats after 20 mg/kg oral dose,1,,,50597,N,1,,CHEMBL620305,,BAO_0000218,
8543,,Intermediate,Cmax after peroral administration in rats at 2.4 uM/kg,1,,,50597,N,1,,CHEMBL620306,,BAO_0000218,
8544,,Intermediate,Cmax at the dose of 2 mg/Kg administered perorally in rats,1,,,50597,N,1,,CHEMBL620307,,BAO_0000218,
8545,,Intermediate,Cmax at the dose of 5 mg/Kg administered perorally in rats,1,,,50597,N,1,,CHEMBL620308,,BAO_0000218,
8546,,Intermediate,Cmax by administering at 20 mg/kg p.o. in rats,1,,,50597,N,1,,CHEMBL620309,,BAO_0000218,
8547,,Intermediate,Cmax in male rat,1,,,50597,N,1,,CHEMBL620310,,BAO_0000218,
8548,,Intermediate,Cmax in rat,1,,,50597,N,1,,CHEMBL620311,,BAO_0000218,
8549,,Intermediate,Cmax in rat,1,,,50597,N,1,,CHEMBL620312,,BAO_0000218,
8550,,Intermediate,Cmax in rat,1,,,50597,N,1,,CHEMBL620313,,BAO_0000218,
8551,,Intermediate,Cmax in rat at 10 mg/kg,1,,,50597,N,1,,CHEMBL620314,,BAO_0000218,
8552,,Intermediate,Cmax in rat at the dose of 1 mg/kg i.v.,1,,,50597,N,1,,CHEMBL620315,,BAO_0000218,
8553,,Intermediate,Cmax in rat by po administration at a dose of 40 mg/kg,1,,,50597,N,1,,CHEMBL620316,,BAO_0000218,
8554,,Intermediate,Cmax in rat p.o. at 20 mg/kg concentration,1,,,50597,N,1,,CHEMBL620317,,BAO_0000218,
8555,,Intermediate,Cmax in rats,1,,,50597,N,1,,CHEMBL620318,,BAO_0000218,
8556,,Intermediate,Cmax in rats,1,,,50597,N,1,,CHEMBL620319,,BAO_0000218,
8557,,Intermediate,Cmax was evaluated after 20 uM/kg of peroral administration,1,,,50597,N,1,,CHEMBL620320,,BAO_0000218,
8558,,Intermediate,Cmax was measured in rats after peroral administration at 3 mg/kg,1,,,50597,N,1,,CHEMBL620321,,BAO_0000218,
8559,,Intermediate,Cmax value after oral dose at a dose of 10 mg/kg in rats.,1,,,50597,N,1,,CHEMBL620322,,BAO_0000218,
8560,,Intermediate,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620323,,BAO_0000218,
8561,Frontal cortex,Intermediate,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620324,,BAO_0000218,1870.0
8562,Frontal cortex,Intermediate,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620325,,BAO_0000218,1870.0
8563,Hippocampus,Intermediate,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620326,,BAO_0000218,10000000.0
8564,Hippocampus,Intermediate,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620327,,BAO_0000218,10000000.0
8565,,Intermediate,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620328,,BAO_0000218,
8566,,Intermediate,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620329,,BAO_0000218,
8567,Midbrain,Intermediate,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620330,,BAO_0000218,1891.0
8568,Midbrain,Intermediate,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL875286,,BAO_0000218,1891.0
8569,,Intermediate,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620331,,BAO_0000218,
8570,,Intermediate,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620332,,BAO_0000218,
8571,Striatum,Intermediate,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620333,,BAO_0000218,2435.0
8572,Striatum,Intermediate,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,50597,N,1,,CHEMBL620334,,BAO_0000218,2435.0
8573,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL621015,,BAO_0000218,178.0
8574,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL621016,,BAO_0000218,178.0
8575,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL621191,,BAO_0000218,178.0
8576,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL621192,,BAO_0000218,178.0
8577,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL621193,,BAO_0000218,178.0
8578,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL621194,,BAO_0000218,178.0
8579,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL624204,,BAO_0000218,178.0
8580,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL624205,,BAO_0000218,178.0
8581,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL624206,,BAO_0000218,178.0
8582,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL624207,,BAO_0000218,178.0
8583,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL624208,,BAO_0000218,178.0
8584,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL624209,,BAO_0000218,178.0
8585,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL624210,,BAO_0000218,178.0
8586,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL624211,,BAO_0000218,178.0
8587,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL624212,,BAO_0000218,178.0
8588,Blood,Intermediate,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL624213,,BAO_0000218,178.0
8589,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL876611,,BAO_0000218,178.0
8590,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL624214,,BAO_0000218,178.0
8591,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL624215,,BAO_0000218,178.0
8592,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL624216,,BAO_0000218,178.0
8593,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL624217,,BAO_0000218,178.0
8594,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL624218,,BAO_0000218,178.0
8595,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL624219,,BAO_0000218,178.0
8596,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL624220,,BAO_0000218,178.0
8597,Blood,Intermediate,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL624221,,BAO_0000218,178.0
8598,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL624222,,BAO_0000218,
8599,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL624223,,BAO_0000218,
8600,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL624224,,BAO_0000218,
8601,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL624225,,BAO_0000218,
8602,,Intermediate,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,1,,,50597,N,1,,CHEMBL622420,,BAO_0000218,
8603,,Intermediate,Volume of steady state distribution after i.v. administration in rats,1,,,50597,N,1,,CHEMBL622421,,BAO_0000218,
8604,,Intermediate,Vss after intravenous administration (5.0 mg/kg) was determined in rat,1,,,50597,N,1,,CHEMBL622422,,BAO_0000218,
8605,,Intermediate,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,50597,N,1,,CHEMBL622423,,BAO_0000218,
8606,,Intermediate,Vss was determined,1,,,50597,N,1,,CHEMBL622424,,BAO_0000218,
8607,,Intermediate,Vss in rat,1,,,50597,N,1,,CHEMBL622425,,BAO_0000218,
8608,,Intermediate,Vss was evaluated after 10 uM/kg of intra arterial administration,1,,,50597,N,1,,CHEMBL876612,,BAO_0000218,
8609,,Intermediate,volume of distribution at steady state was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL622426,,BAO_0000218,
8610,,Intermediate,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL622427,,BAO_0000218,
8611,,Intermediate,Pharmacokinetic (PK) parameter Vz in rat,1,,,50597,N,1,,CHEMBL622428,,BAO_0000218,
8612,,Intermediate,Volume distribution in rats,1,,,50597,N,1,,CHEMBL622429,,BAO_0000218,
8613,,Intermediate,Volume of distribution in rat; No data,1,,,50597,N,1,,CHEMBL622430,,BAO_0000218,
8614,,Intermediate,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL622431,,BAO_0000218,
8615,Ileum,Intermediate,% absorption predicted from in vitro rat ileum transport studies,1,,,50597,N,1,,CHEMBL622432,,BAO_0000218,2116.0
8616,,Intermediate,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,,,50597,N,1,,CHEMBL622433,,BAO_0000218,
8617,,Intermediate,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,,,50597,N,1,,CHEMBL622434,,BAO_0000218,
8618,,Intermediate,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,1,,,50597,N,1,,CHEMBL622435,,BAO_0000218,
8619,,Intermediate,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),1,,,50597,N,1,,CHEMBL618748,,BAO_0000218,
8620,,Intermediate,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,,,50597,N,1,,CHEMBL618749,,BAO_0000218,
8621,,Intermediate,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,,,50597,N,1,,CHEMBL618750,,BAO_0000218,
8622,,Intermediate,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,,,50597,N,1,,CHEMBL618751,,BAO_0000218,
8623,,Intermediate,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,,,50597,N,1,,CHEMBL618752,,BAO_0000218,
8624,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL618753,,BAO_0000218,
8625,Plasma,Intermediate,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,1,,,50597,N,1,,CHEMBL618754,,BAO_0000218,1969.0
8626,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL618755,,BAO_0000218,
8627,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL618756,,BAO_0000218,
8628,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL618757,,BAO_0000218,
8629,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL618758,,BAO_0000218,
8630,,Intermediate,Oral bioavailability in rat (dose 30 mg/kg),1,,,50597,N,1,,CHEMBL621088,,BAO_0000218,
8631,,Intermediate,Pharmacokinetic property (cLogP) in rat,1,,,50597,N,1,,CHEMBL621089,,BAO_0000218,
8632,Blood,Intermediate,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,1,,,50597,N,1,,CHEMBL621090,,BAO_0000218,178.0
8633,Blood,Intermediate,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,1,,,50597,N,1,,CHEMBL621091,,BAO_0000218,178.0
8634,,Intermediate,Clearance in rat.,1,,,50597,N,1,,CHEMBL876731,,BAO_0000218,
8635,,Intermediate,Compound was evaluated for its clearance when administered intravenously in rat,1,,,50597,N,1,,CHEMBL621092,,BAO_0000218,
8636,,Intermediate,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL621093,,BAO_0000218,
8637,,Intermediate,Blood: Brain distribution ratio is determined in rat,1,,,50597,N,1,,CHEMBL621094,,BAO_0000218,
8638,,Intermediate,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,1,,,50597,N,1,,CHEMBL621095,,BAO_0000218,
8639,,Intermediate,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,1,,,50597,N,1,,CHEMBL621096,,BAO_0000218,
8640,Kidney,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL621097,,BAO_0000218,2113.0
8641,,Intermediate,Percent dose excreted in 0-48 hours administered ip to male rat,1,,,50597,N,1,,CHEMBL621098,,BAO_0000218,
8642,Cerebellum,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621099,,BAO_0000218,2037.0
8643,Cerebellum,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621100,,BAO_0000218,2037.0
8644,Cerebellum,Intermediate,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL621101,,BAO_0000218,2037.0
8645,Cerebellum,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621102,,BAO_0000218,2037.0
8646,Cerebellum,Intermediate,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL876732,,BAO_0000218,2037.0
8647,,Intermediate,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621103,,BAO_0000218,
8648,,Intermediate,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621104,,BAO_0000218,
8649,,Intermediate,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL621105,,BAO_0000218,
8650,,Intermediate,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621106,,BAO_0000218,
8651,,Intermediate,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621107,,BAO_0000218,
8652,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621108,,BAO_0000218,
8653,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621109,,BAO_0000218,
8654,Kidney,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL621110,,BAO_0000218,2113.0
8655,Kidney,Intermediate,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL621111,,BAO_0000218,2113.0
8656,Liver,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL622541,,BAO_0000218,2107.0
8657,Liver,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL622542,,BAO_0000218,2107.0
8658,Liver,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL622543,,BAO_0000218,2107.0
8659,Liver,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624412,,BAO_0000218,2107.0
8660,Liver,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624413,,BAO_0000218,2107.0
8661,Liver,Intermediate,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624414,,BAO_0000218,2107.0
8662,Lung,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624415,,BAO_0000218,2048.0
8663,Lung,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624416,,BAO_0000218,2048.0
8664,Lung,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624417,,BAO_0000218,2048.0
8665,Lung,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624418,,BAO_0000218,2048.0
8666,Lung,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624419,,BAO_0000218,2048.0
8667,Lung,Intermediate,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624420,,BAO_0000218,2048.0
8668,Muscle tissue,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624421,,BAO_0000218,2385.0
8669,Muscle tissue,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624422,,BAO_0000218,2385.0
8670,Muscle tissue,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL624423,,BAO_0000218,2385.0
8671,Muscle tissue,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL625123,,BAO_0000218,2385.0
8672,Muscle tissue,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL625124,,BAO_0000218,2385.0
8673,Muscle tissue,Intermediate,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL625125,,BAO_0000218,2385.0
8674,Zone of skin,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL625126,,BAO_0000218,14.0
8675,Zone of skin,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626947,,BAO_0000218,14.0
8676,Zone of skin,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626948,,BAO_0000218,14.0
8677,Zone of skin,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626949,,BAO_0000218,14.0
8678,Zone of skin,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626950,,BAO_0000218,14.0
8679,Zone of skin,Intermediate,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626951,,BAO_0000218,14.0
8680,Spleen,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626952,,BAO_0000218,2106.0
8681,Spleen,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626953,,BAO_0000218,2106.0
8682,Spleen,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626954,,BAO_0000218,2106.0
8683,Spleen,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626955,,BAO_0000218,2106.0
8684,Spleen,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626956,,BAO_0000218,2106.0
8685,Spleen,Intermediate,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626957,,BAO_0000218,2106.0
8686,Blood,Intermediate,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626958,,BAO_0000218,178.0
8687,Blood,Intermediate,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626959,,BAO_0000218,178.0
8688,Blood,Intermediate,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626960,,BAO_0000218,178.0
8689,Blood,Intermediate,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL626961,,BAO_0000218,178.0
8690,Blood,Intermediate,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627589,,BAO_0000218,178.0
8691,Blood,Intermediate,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),1,,,50594,N,1,,CHEMBL627590,,BAO_0000218,178.0
8692,,Intermediate,Time taken for EC90 was determined when tested in mouse,1,,,50594,N,1,,CHEMBL627591,,BAO_0000218,
8693,,Intermediate,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,1,,,50594,N,1,,CHEMBL627592,,BAO_0000218,
8694,,Intermediate,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),1,,,50594,N,1,,CHEMBL627593,,BAO_0000218,
8695,,Intermediate,Half life in mice,1,,,50594,N,1,,CHEMBL627594,,BAO_0000218,
8696,,Intermediate,Half life period in mouse after 10 mg/Kg dose,1,,,50594,N,1,,CHEMBL876813,,BAO_0000218,
8697,,Intermediate,Half life period in mouse after 10 mg/kg dose,1,,,50594,N,1,,CHEMBL627595,,BAO_0000218,
8698,,Intermediate,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,1,,,50594,N,1,,CHEMBL627596,,BAO_0000218,
8699,,Intermediate,Cmax value at 5 mg/kg po was determined in rat,1,,,50597,N,1,,CHEMBL627597,,BAO_0000218,
8700,,Intermediate,Cmax value evaluated in rat,1,,,50597,N,1,,CHEMBL627598,,BAO_0000218,
8701,Brain,Intermediate,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,1,,,50597,N,1,,CHEMBL627599,,BAO_0000218,955.0
8702,,Intermediate,Cmax value after administration of 20 mg/Kg oral dose in rat,1,,,50597,N,1,,CHEMBL627600,,BAO_0000218,
8703,,Intermediate,Cmax value at 1 mg/kg po in rat,1,,,50597,N,1,,CHEMBL627601,,BAO_0000218,
8704,,Intermediate,Cmax value at 5 mg/kg po in rat,1,,,50597,N,1,,CHEMBL627776,,BAO_0000218,
8705,,Intermediate,Cmax value at a dose of 10 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL627777,,BAO_0000218,
8706,,Intermediate,Cmax value at a dose of 100 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL627778,,BAO_0000218,
8707,,Intermediate,Cmax value at a dose of 50 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL627779,,BAO_0000218,
8708,,Intermediate,Cmax value in rats at 10 mg/kg,1,,,50597,N,1,,CHEMBL876814,,BAO_0000218,
8709,,Intermediate,Cmax value was evaluated in rats at a dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL627780,,BAO_0000218,
8710,,Intermediate,Cmax value was determined after peroral administration of 20 mg/kg in rat,1,,,50597,N,1,,CHEMBL627781,,BAO_0000218,
8711,,Intermediate,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,,,50597,N,1,,CHEMBL627782,,BAO_0000218,
8712,Plasma,Intermediate,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,1,,,50597,N,1,,CHEMBL627783,,BAO_0000218,1969.0
8713,Plasma,Intermediate,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,1,,,50597,N,1,,CHEMBL627784,,BAO_0000218,1969.0
8714,,Intermediate,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL627785,,BAO_0000218,
8715,,Intermediate,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL627786,,BAO_0000218,
8716,Plasma,Intermediate,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,1,,,50597,N,1,,CHEMBL627787,,BAO_0000218,1969.0
8717,Plasma,Intermediate,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,1,,,50597,N,1,,CHEMBL627788,,BAO_0000218,1969.0
8718,Plasma,Intermediate,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,1,,,50597,N,1,,CHEMBL626579,,BAO_0000218,1969.0
8719,Plasma,Intermediate,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,1,,,50597,N,1,,CHEMBL626580,,BAO_0000218,1969.0
8720,,Intermediate,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL876815,,BAO_0000218,
8721,Plasma,Intermediate,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,1,,,50597,N,1,,CHEMBL626581,,BAO_0000218,1969.0
8722,Plasma,Intermediate,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,1,,,50597,N,1,,CHEMBL626582,,BAO_0000218,1969.0
8723,,Intermediate,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,1,,,50597,N,1,,CHEMBL626583,,BAO_0000218,
8724,,Intermediate,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626205,,BAO_0000218,
8725,,Intermediate,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626206,,BAO_0000218,
8726,,Intermediate,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626207,,BAO_0000218,
8727,,Intermediate,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623882,,BAO_0000218,
8728,,Intermediate,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,1,,,50597,N,1,,CHEMBL623883,,BAO_0000218,
8729,,Intermediate,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,1,,,50597,N,1,,CHEMBL623884,,BAO_0000218,
8730,Plasma,Intermediate,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,,,50597,N,1,,CHEMBL623885,,BAO_0000218,1969.0
8731,Plasma,Intermediate,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL623886,,BAO_0000218,1969.0
8732,,Intermediate,Maximal concentration in rat was determined,1,,,50597,N,1,,CHEMBL623887,,BAO_0000218,
8733,,Intermediate,Maximal concentration after i.v. administration,1,,,50597,N,1,,CHEMBL623888,,BAO_0000218,
8734,Plasma,Intermediate,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL623889,,BAO_0000218,1969.0
8735,Plasma,Intermediate,Maximal plasma concentration in rat after oral administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL623890,,BAO_0000218,1969.0
8736,Plasma,Intermediate,Cmax in rat plasma after oral dose (50 mg/Kg),1,,,50597,N,1,,CHEMBL623891,,BAO_0000218,1969.0
8737,Plasma,Intermediate,Maximal plasma concentration was determined.,1,,,50597,N,1,,CHEMBL623892,,BAO_0000218,1969.0
8738,Plasma,Intermediate,Maximal plasma drug concentration was determined,1,,,50597,N,1,,CHEMBL623893,,BAO_0000218,1969.0
8739,,Intermediate,Maximal concentration in rats after peroral administration,1,,,50597,N,1,,CHEMBL877616,,BAO_0000218,
8740,,Intermediate,Maximum concentration in rat after 2 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL623894,,BAO_0000218,
8741,Plasma,Intermediate,Maximum concentration in rat plasma after 5 mg/kg oral gavage,1,,,50597,N,1,,CHEMBL623895,,BAO_0000218,1969.0
8742,,Intermediate,Maximum concentration of compound in rat was evaluated.,1,,,50597,N,1,,CHEMBL623896,,BAO_0000218,
8743,,Intermediate,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL623897,,BAO_0000218,
8744,,Intermediate,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL623898,,BAO_0000218,
8745,,Intermediate,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,1,,,50597,N,1,,CHEMBL623899,,BAO_0000218,
8746,,Intermediate,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL623900,,BAO_0000218,
8747,,Intermediate,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL623901,,BAO_0000218,
8748,,Intermediate,Maximum concentration was evaluated in rats,1,,,50597,N,1,,CHEMBL623902,,BAO_0000218,
8749,Cerebrospinal fluid,Intermediate,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,1,,,50597,N,1,,CHEMBL623903,,BAO_0000218,1359.0
8750,Plasma,Intermediate,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,1,,,50597,N,1,,CHEMBL623904,,BAO_0000218,1969.0
8751,Plasma,Intermediate,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,,50597,N,1,,CHEMBL877617,,BAO_0000218,1969.0
8752,,Intermediate,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,1,,,50597,N,1,,CHEMBL623905,,BAO_0000218,
8753,,Intermediate,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL623906,,BAO_0000218,
8754,Plasma,Intermediate,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,,50597,N,1,,CHEMBL623907,,BAO_0000218,1969.0
8755,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL623908,,BAO_0000218,
8756,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL623909,,BAO_0000218,
8757,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL623910,,BAO_0000218,
8758,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL623911,,BAO_0000218,
8759,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL623912,,BAO_0000218,
8760,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL624616,,BAO_0000218,
8761,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL624617,,BAO_0000218,
8762,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL624618,,BAO_0000218,
8763,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL624619,,BAO_0000218,
8764,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL624794,,BAO_0000218,
8765,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL624795,,BAO_0000218,
8766,,Intermediate,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL623921,,BAO_0000218,
8767,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL623922,,BAO_0000218,
8768,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL623923,,BAO_0000218,
8769,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL623924,,BAO_0000218,
8770,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL623925,,BAO_0000218,
8771,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL623926,,BAO_0000218,
8772,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL623927,,BAO_0000218,
8773,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL623928,,BAO_0000218,
8774,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL623929,,BAO_0000218,
8775,,Intermediate,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL623930,,BAO_0000218,
8776,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL623931,,BAO_0000218,955.0
8777,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL622165,,BAO_0000218,955.0
8778,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL621249,,BAO_0000218,955.0
8779,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL621250,,BAO_0000218,955.0
8780,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL621448,,BAO_0000218,955.0
8781,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL621449,,BAO_0000218,955.0
8782,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL621450,,BAO_0000218,955.0
8783,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL621451,,BAO_0000218,955.0
8784,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL621452,,BAO_0000218,955.0
8785,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL621453,,BAO_0000218,955.0
8786,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL621454,,BAO_0000218,955.0
8787,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL621455,,BAO_0000218,955.0
8788,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL621456,,BAO_0000218,955.0
8789,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL625145,,BAO_0000218,955.0
8790,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL875847,,BAO_0000218,955.0
8791,Brain,Intermediate,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL625146,,BAO_0000218,955.0
8792,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL625147,,BAO_0000218,955.0
8793,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL625148,,BAO_0000218,955.0
8794,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL625149,,BAO_0000218,955.0
8795,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL625150,,BAO_0000218,955.0
8796,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL625151,,BAO_0000218,955.0
8797,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL625152,,BAO_0000218,955.0
8798,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL625153,,BAO_0000218,955.0
8799,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL625154,,BAO_0000218,955.0
8800,Brain,Intermediate,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL625155,,BAO_0000218,955.0
8801,,Intermediate,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL625156,,BAO_0000218,
8802,,Intermediate,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624354,,BAO_0000218,
8803,Hippocampus,Intermediate,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624355,,BAO_0000218,10000000.0
8804,Hippocampus,Intermediate,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624356,,BAO_0000218,10000000.0
8805,Hippocampus,Intermediate,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624357,,BAO_0000218,10000000.0
8806,Hippocampus,Intermediate,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624358,,BAO_0000218,10000000.0
8807,Striatum,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624359,,BAO_0000218,2435.0
8808,Striatum,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624360,,BAO_0000218,2435.0
8809,Striatum,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL624361,,BAO_0000218,2435.0
8810,Striatum,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624362,,BAO_0000218,2435.0
8811,Striatum,Intermediate,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624363,,BAO_0000218,2435.0
8812,Blood,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624364,,BAO_0000218,178.0
8813,Blood,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624365,,BAO_0000218,178.0
8814,Blood,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624366,,BAO_0000218,178.0
8815,Blood,Intermediate,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624367,,BAO_0000218,178.0
8816,Brain,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624368,,BAO_0000218,955.0
8817,Brain,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL624369,,BAO_0000218,955.0
8818,Brain,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL624370,,BAO_0000218,955.0
8819,Brain,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625069,,BAO_0000218,955.0
8820,Brain,Intermediate,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625070,,BAO_0000218,955.0
8821,Heart,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626051,,BAO_0000218,948.0
8822,Heart,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626052,,BAO_0000218,948.0
8823,Heart,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL626053,,BAO_0000218,948.0
8824,Heart,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626054,,BAO_0000218,948.0
8825,Heart,Intermediate,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626055,,BAO_0000218,948.0
8826,Kidney,Intermediate,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626056,,BAO_0000218,2113.0
8827,Kidney,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626057,,BAO_0000218,2113.0
8828,Kidney,Intermediate,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625193,,BAO_0000218,2113.0
8829,Kidney,Intermediate,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625194,,BAO_0000218,2113.0
8830,Liver,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625195,,BAO_0000218,2107.0
8831,Liver,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625196,,BAO_0000218,2107.0
8832,Liver,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL625197,,BAO_0000218,2107.0
8833,Liver,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625198,,BAO_0000218,2107.0
8834,Liver,Intermediate,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL627929,,BAO_0000218,2107.0
8835,Lung,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL627074,,BAO_0000218,2048.0
8836,Lung,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL627075,,BAO_0000218,2048.0
8837,Lung,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL627076,,BAO_0000218,2048.0
8838,Lung,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL627077,,BAO_0000218,2048.0
8839,Lung,Intermediate,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL627078,,BAO_0000218,2048.0
8840,Muscle tissue,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL627079,,BAO_0000218,2385.0
8841,,Intermediate,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,1,,,50594,N,1,,CHEMBL873824,,BAO_0000218,
8842,Plasma,Intermediate,Half life in mouse plasma was determined at dose 25 mg/kg,1,,,50594,N,1,,CHEMBL627080,,BAO_0000218,1969.0
8843,,Intermediate,Half life was determined,1,,,50594,N,1,,CHEMBL627081,,BAO_0000218,
8844,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,,,50594,N,1,,CHEMBL627082,,BAO_0000218,
8845,,Intermediate,Half-life in male mice after 1 mg/kg intravenous dose,1,,,50594,N,1,,CHEMBL627083,,BAO_0000218,
8847,Plasma,Intermediate,Half life in mice plasma,1,,,50594,N,1,,CHEMBL627085,,BAO_0000218,1969.0
8848,,Intermediate,Half life in mouse,1,,,50594,N,1,,CHEMBL627086,,BAO_0000218,
8849,Plasma,Intermediate,Half life in mouse plasma at dose 25 mg/kg,1,,,50594,N,1,,CHEMBL627087,,BAO_0000218,1969.0
8850,,Intermediate,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,1,,,50594,N,1,,CHEMBL627088,,BAO_0000218,
8851,,Intermediate,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,1,,,50594,N,1,,CHEMBL627089,,BAO_0000218,
8852,,Intermediate,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,1,,,50594,N,1,,CHEMBL627090,,BAO_0000218,
8853,,Intermediate,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),1,,,50594,N,1,,CHEMBL627091,,BAO_0000218,
8854,,Intermediate,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",1,,,50594,N,1,,CHEMBL627092,,BAO_0000218,
8855,,Intermediate,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",1,,,50594,N,1,,CHEMBL876785,,BAO_0000218,
8856,,Intermediate,Half-life by iv administration in mouse,1,,,50594,N,1,,CHEMBL627093,,BAO_0000218,
8857,,Intermediate,Half-life by oral administration in mouse,1,,,50594,N,1,,CHEMBL627094,,BAO_0000218,
8858,,Intermediate,Half-life in mice,1,,,50594,N,1,,CHEMBL627095,,BAO_0000218,
8859,Brain,Intermediate,Half-life using mouse brain homogenate,1,,,50594,N,1,,CHEMBL627096,,BAO_0000218,955.0
8860,,Intermediate,Half-life was measured in mice,1,,,50594,N,1,,CHEMBL627097,,BAO_0000218,
8861,,Intermediate,Half-life was measured in mouse after an iv dose of 1 mg/kg,1,,,50594,N,1,,CHEMBL627098,,BAO_0000218,
8862,Blood,Intermediate,Half-life period was determined in mouse blood,1,,,50594,N,1,,CHEMBL627099,,BAO_0000218,178.0
8863,Brain,Intermediate,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",1,,,50594,N,1,,CHEMBL627100,,BAO_0000218,955.0
8864,Plasma,Intermediate,Plasma half life in mouse,1,,,50594,N,1,,CHEMBL627101,,BAO_0000218,1969.0
8865,,Intermediate,Stability of the peptide in the presence of mouse serum,1,,,50594,N,1,,CHEMBL627102,,BAO_0000218,
8866,,Intermediate,Terminal half life of compound was determined in mouse,1,,,50594,N,1,,CHEMBL627103,,BAO_0000218,
8867,,Intermediate,Terminal half life was evaluated in mice after intravenous administration,1,,,50594,N,1,,CHEMBL627104,,BAO_0000218,
8868,,Intermediate,Terminal half life was evaluated in mice after oral administration,1,,,50594,N,1,,CHEMBL627105,,BAO_0000218,
8869,,Intermediate,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,1,,,50594,N,1,,CHEMBL876786,,BAO_0000218,
8870,,Intermediate,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,1,,,50594,N,1,,CHEMBL873825,,BAO_0000218,
8871,,Intermediate,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,1,,,50594,N,1,,CHEMBL627106,,BAO_0000218,
8872,,Intermediate,half life period is evaluated by administering intravenously at 25 mg/kg in mice,1,,,50594,N,1,,CHEMBL626336,,BAO_0000218,
8873,,Intermediate,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",1,,,50594,N,1,,CHEMBL877462,,BAO_0000218,
8874,,Intermediate,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",1,,,50594,N,1,,CHEMBL626337,,BAO_0000218,
8875,,Intermediate,Half life after intraperitoneal administration of 100 mg/kg in mice,1,,,50594,N,1,,CHEMBL626338,,BAO_0000218,
8876,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,1,,,50594,N,1,,CHEMBL626339,,BAO_0000218,
8877,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,,,50594,N,1,,CHEMBL626340,,BAO_0000218,
8878,,Intermediate,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,1,,,50594,N,1,,CHEMBL625377,,BAO_0000218,
8879,,Intermediate,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,1,,,50594,N,1,,CHEMBL625378,,BAO_0000218,
8880,,Intermediate,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,1,,,50594,N,1,,CHEMBL625379,,BAO_0000218,
8881,,Autocuration,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),1,,Microsomes,22224,U,0,,CHEMBL625380,,BAO_0000251,
8882,,Autocuration,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),1,,Microsomes,22224,U,0,,CHEMBL625381,,BAO_0000251,
8883,,Autocuration,Stability to porcine renal DHP-I,1,,,22224,U,0,,CHEMBL625382,,BAO_0000019,
8884,,Autocuration,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,1,,,22224,U,0,,CHEMBL873828,,BAO_0000218,
8885,,Autocuration,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,1,,,22224,U,0,,CHEMBL625383,,BAO_0000218,
8886,,Autocuration,Half-life of the parent prodrug in porcine esterase solution,1,,,22224,U,0,,CHEMBL625384,,BAO_0000019,
8887,,Autocuration,"First order rate constant, k was determined in in pig liver Esterase",1,,,22224,U,0,,CHEMBL625385,,BAO_0000019,
8888,Liver,Autocuration,Half life of the in pig liver Esterase,1,,,22224,U,0,,CHEMBL625386,,BAO_0000221,2107.0
8889,Liver,Autocuration,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,1,,,22224,U,0,,CHEMBL623571,,BAO_0000221,2107.0
8890,Liver,Autocuration,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,1,,,22224,U,0,,CHEMBL623572,,BAO_0000221,2107.0
8891,Liver,Autocuration,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,1,,,22224,U,0,,CHEMBL623573,,BAO_0000221,2107.0
8892,Liver,Autocuration,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,1,,,22224,U,0,,CHEMBL623574,,BAO_0000221,2107.0
8893,Liver,Autocuration,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,1,,,22224,U,0,,CHEMBL623575,,BAO_0000221,2107.0
8894,Liver,Autocuration,Half-life in the presence of pig liver esterase(PLE) was evaluated.,1,,,22224,U,0,,CHEMBL623749,,BAO_0000221,2107.0
8895,Liver,Autocuration,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,1,,,22224,U,0,,CHEMBL623750,,BAO_0000221,2107.0
8896,Liver,Autocuration,Half-life in vitro in pig liver,1,,,22224,U,0,,CHEMBL623751,,BAO_0000221,2107.0
8897,Liver,Autocuration,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,1,,,22224,U,0,,CHEMBL623752,,BAO_0000221,2107.0
8898,Plasma,Intermediate,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,1,,,50597,N,1,,CHEMBL623753,,BAO_0000218,1969.0
8899,Plasma,Intermediate,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,,,50597,N,1,,CHEMBL623754,,BAO_0000218,1969.0
8900,Plasma,Intermediate,Maximum concentration in rat plasma was determined,1,,,50597,N,1,,CHEMBL623755,,BAO_0000218,1969.0
8901,,Intermediate,Maximum concentration in rats,1,,,50597,N,1,,CHEMBL623756,,BAO_0000218,
8902,,Intermediate,Maximum concentration in rats at 1-2 hours,1,,,50597,N,1,,CHEMBL623757,,BAO_0000218,
8903,,Intermediate,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,1,,,50597,N,1,,CHEMBL623758,,BAO_0000218,
8904,Brain,Intermediate,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,1,,,50597,N,1,,CHEMBL623759,,BAO_0000218,955.0
8905,,Intermediate,Maximum concentration at the dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL623760,,BAO_0000218,
8906,,Intermediate,Maximum concentration was evaluated in rats,1,,,50597,N,1,,CHEMBL623761,,BAO_0000218,
8907,Plasma,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL623762,,BAO_0000218,1969.0
8908,Plasma,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL877594,,BAO_0000218,1969.0
8909,Plasma,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL623763,,BAO_0000218,1969.0
8910,Plasma,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL623764,,BAO_0000218,1969.0
8911,Plasma,Intermediate,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL623765,,BAO_0000218,1969.0
8912,Blood,Intermediate,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,1,,,50597,N,1,,CHEMBL623766,,BAO_0000218,178.0
8913,Blood,Intermediate,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,1,,,50597,N,1,,CHEMBL623767,,BAO_0000218,178.0
8914,Blood,Intermediate,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,1,,,50597,N,1,,CHEMBL623768,,BAO_0000218,178.0
8915,Plasma,Intermediate,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623769,,BAO_0000218,1969.0
8916,Plasma,Intermediate,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623770,,BAO_0000218,1969.0
8917,Plasma,Intermediate,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623771,,BAO_0000218,1969.0
8918,Plasma,Intermediate,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623772,,BAO_0000218,1969.0
8919,Plasma,Intermediate,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623773,,BAO_0000218,1969.0
8920,Plasma,Intermediate,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623774,,BAO_0000218,1969.0
8921,Plasma,Intermediate,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL623775,,BAO_0000218,1969.0
8922,,Intermediate,Cmax in rat (PO dose),1,,,50597,N,1,,CHEMBL623776,,BAO_0000218,
8923,Plasma,Intermediate,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL622191,,BAO_0000218,1969.0
8924,Plasma,Intermediate,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL622192,,BAO_0000218,1969.0
8925,Plasma,Intermediate,Maximum plasma concentration determined in rat,1,,,50597,N,1,,CHEMBL622193,,BAO_0000218,1969.0
8926,Plasma,Intermediate,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL622194,,BAO_0000218,1969.0
8927,Plasma,Intermediate,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL622195,,BAO_0000218,1969.0
8928,Plasma,Intermediate,Maximum plasma concentration in rat,1,,,50597,N,1,,CHEMBL622196,,BAO_0000218,1969.0
8929,Plasma,Intermediate,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,50597,N,1,,CHEMBL622197,,BAO_0000218,1969.0
8930,Plasma,Intermediate,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,1,,,50597,N,1,,CHEMBL622198,,BAO_0000218,1969.0
8931,Plasma,Intermediate,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,1,,,50597,N,1,,CHEMBL622199,,BAO_0000218,1969.0
8932,Plasma,Intermediate,Maximum plasma concentration of compound was measured in rat,1,,,50597,N,1,,CHEMBL622200,,BAO_0000218,1969.0
8933,Plasma,Intermediate,Maximum plasma concentration after 20 mg/kg oral administration in rat,1,,,50597,N,1,,CHEMBL622201,,BAO_0000218,1969.0
8934,Plasma,Intermediate,Maximum plasma concentration after oral administration to rats,1,,,50597,N,1,,CHEMBL623990,,BAO_0000218,1969.0
8935,Plasma,Intermediate,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,50597,N,1,,CHEMBL623991,,BAO_0000218,1969.0
8936,Plasma,Intermediate,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",1,,,50597,N,1,,CHEMBL623992,,BAO_0000218,1969.0
8937,Plasma,Intermediate,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,50597,N,1,,CHEMBL623993,,BAO_0000218,1969.0
8938,Plasma,Intermediate,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,1,,,50597,N,1,,CHEMBL623994,,BAO_0000218,1969.0
8939,Plasma,Intermediate,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL623995,,BAO_0000218,1969.0
8940,Plasma,Intermediate,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL623996,,BAO_0000218,1969.0
8941,Plasma,Intermediate,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL623997,,BAO_0000218,1969.0
8942,Plasma,Intermediate,Maximum plasma concentration dosed orally in rats,1,,,50597,N,1,,CHEMBL623998,,BAO_0000218,1969.0
8943,Plasma,Intermediate,Maximum plasma concentration dosed orally in rats after 6 hours,1,,,50597,N,1,,CHEMBL623999,,BAO_0000218,1969.0
8944,Plasma,Intermediate,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,1,,,50597,N,1,,CHEMBL624000,,BAO_0000218,1969.0
8945,Plasma,Intermediate,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL624001,,BAO_0000218,1969.0
8946,Plasma,Intermediate,Maximum plasma concentration in rat after po administration,1,,,50597,N,1,,CHEMBL624002,,BAO_0000218,1969.0
8947,Plasma,Intermediate,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL624003,,BAO_0000218,1969.0
8948,Plasma,Intermediate,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",1,,,50597,N,1,,CHEMBL624004,,BAO_0000218,1969.0
8949,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL624005,,BAO_0000218,948.0
8950,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL624006,,BAO_0000218,948.0
8951,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL624007,,BAO_0000218,948.0
8952,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL624008,,BAO_0000218,948.0
8953,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL624009,,BAO_0000218,948.0
8954,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL874387,,BAO_0000218,948.0
8955,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL624010,,BAO_0000218,948.0
8956,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL624011,,BAO_0000218,948.0
8957,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL624012,,BAO_0000218,948.0
8958,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL624013,,BAO_0000218,948.0
8959,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL624736,,BAO_0000218,948.0
8960,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL624737,,BAO_0000218,948.0
8961,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL624738,,BAO_0000218,948.0
8962,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL624739,,BAO_0000218,948.0
8963,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL624740,,BAO_0000218,948.0
8964,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL624896,,BAO_0000218,948.0
8965,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL624897,,BAO_0000218,948.0
8966,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL624108,,BAO_0000218,948.0
8967,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL624109,,BAO_0000218,948.0
8968,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL624110,,BAO_0000218,948.0
8969,Heart,Intermediate,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL624111,,BAO_0000218,948.0
8970,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL624112,,BAO_0000218,948.0
8971,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL624113,,BAO_0000218,948.0
8972,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL619709,,BAO_0000218,948.0
8973,Heart,Intermediate,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL619710,,BAO_0000218,948.0
8974,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL619711,,BAO_0000218,2113.0
8975,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL619712,,BAO_0000218,2113.0
8976,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL619713,,BAO_0000218,2113.0
8977,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL619714,,BAO_0000218,2113.0
8978,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL619715,,BAO_0000218,2113.0
8979,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL619716,,BAO_0000218,2113.0
8980,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL619717,,BAO_0000218,2113.0
8981,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL619718,,BAO_0000218,2113.0
8982,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL619719,,BAO_0000218,2113.0
8983,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL875329,,BAO_0000218,2113.0
8984,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL619720,,BAO_0000218,2113.0
8985,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL619721,,BAO_0000218,2113.0
8986,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL619722,,BAO_0000218,2113.0
8987,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL619723,,BAO_0000218,2113.0
8988,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL619724,,BAO_0000218,2113.0
8989,Kidney,Intermediate,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL619725,,BAO_0000218,2113.0
8990,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL619726,,BAO_0000218,2113.0
8991,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL619727,,BAO_0000218,2113.0
8992,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL619728,,BAO_0000218,2113.0
8993,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL619729,,BAO_0000218,2113.0
8994,Muscle tissue,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL619730,,BAO_0000218,2385.0
8995,Muscle tissue,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL619731,,BAO_0000218,2385.0
8996,Muscle tissue,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL619732,,BAO_0000218,2385.0
8997,Muscle tissue,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL619733,,BAO_0000218,2385.0
8998,Muscle tissue,Intermediate,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL619734,,BAO_0000218,2385.0
8999,Zone of skin,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL619735,,BAO_0000218,14.0
9000,Zone of skin,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL875330,,BAO_0000218,14.0
9001,Zone of skin,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL628465,,BAO_0000218,14.0
9002,Zone of skin,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL628466,,BAO_0000218,14.0
9003,Zone of skin,Intermediate,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL628467,,BAO_0000218,14.0
9004,Spleen,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL628468,,BAO_0000218,2106.0
9005,Spleen,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL628469,,BAO_0000218,2106.0
9006,Spleen,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL628470,,BAO_0000218,2106.0
9007,Spleen,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL628471,,BAO_0000218,2106.0
9008,Spleen,Intermediate,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL628472,,BAO_0000218,2106.0
9009,Thyroid gland,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625191,,BAO_0000218,2046.0
9010,Thyroid gland,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL625192,,BAO_0000218,2046.0
9011,Thyroid gland,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,50597,N,1,,CHEMBL875337,,BAO_0000218,2046.0
9012,Thyroid gland,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626341,,BAO_0000218,2046.0
9013,Thyroid gland,Intermediate,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL626342,,BAO_0000218,2046.0
9014,Liver,Intermediate,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,50597,N,1,,CHEMBL621943,,BAO_0000218,2107.0
9015,,Intermediate,Half life in rats,1,,,50597,N,1,,CHEMBL621944,,BAO_0000218,
9016,,Intermediate,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,1,,,50597,N,1,,CHEMBL621945,,BAO_0000218,
9017,,Intermediate,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),1,,,50597,N,1,,CHEMBL621946,,BAO_0000218,
9018,,Intermediate,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,,,50597,N,1,,CHEMBL621947,,BAO_0000218,
9019,,Intermediate,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),1,,,50597,N,1,,CHEMBL621948,,BAO_0000218,
9020,,Intermediate,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,,,50597,N,1,,CHEMBL621949,,BAO_0000218,
9021,,Intermediate,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),1,,,50597,N,1,,CHEMBL621950,,BAO_0000218,
9022,,Intermediate,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,1,,,50597,N,1,,CHEMBL621951,,BAO_0000218,
9023,Blood,Intermediate,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,1,,,50597,N,1,,CHEMBL621952,,BAO_0000218,178.0
9024,Liver,Intermediate,Stability (%) in rat liver microsomes,1,,,50597,N,1,,CHEMBL621953,,BAO_0000218,2107.0
9025,,Intermediate,Area under curve was calculated after intravenous administration,1,,,50597,N,1,,CHEMBL621954,,BAO_0000218,
9026,,Intermediate,Area under the curve was calculated after iv administration in rat,1,,,50597,N,1,,CHEMBL621955,,BAO_0000218,
9027,,Intermediate,Area under the curve was calculated in rat after peroral administration,1,,,50597,N,1,,CHEMBL621956,,BAO_0000218,
9028,,Intermediate,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL621957,,BAO_0000218,
9029,,Intermediate,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,1,,,50597,N,1,,CHEMBL621958,,BAO_0000218,
9030,,Intermediate,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,1,,,50597,N,1,,CHEMBL621959,,BAO_0000218,
9031,,Intermediate,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,1,,,50597,N,1,,CHEMBL621960,,BAO_0000218,
9032,,Intermediate,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,1,,,50597,N,1,,CHEMBL621961,,BAO_0000218,
9033,,Intermediate,p value of the compound,1,,,50597,N,1,,CHEMBL621962,,BAO_0000218,
9034,,Intermediate,p value of the compound,1,,,50597,N,1,,CHEMBL876787,,BAO_0000218,
9035,,Intermediate,p value of the compound,1,,,50597,N,1,,CHEMBL621963,,BAO_0000218,
9036,Stomach,Intermediate,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,,50597,N,1,,CHEMBL622637,,BAO_0000218,945.0
9037,Stomach,Intermediate,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,,50597,N,1,,CHEMBL622638,,BAO_0000218,945.0
9038,Stomach,Intermediate,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,,50597,N,1,,CHEMBL626561,,BAO_0000218,945.0
9039,,Autocuration,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),1,,,22224,U,0,,CHEMBL626562,,BAO_0000019,
9040,,Autocuration,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),1,,,22224,U,0,,CHEMBL626563,,BAO_0000218,
9041,,Autocuration,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),1,,,22224,U,0,,CHEMBL626564,,BAO_0000218,
9042,,Autocuration,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,1,,,22224,U,0,,CHEMBL626565,,BAO_0000218,
9043,,Autocuration,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,1,,,22224,U,0,,CHEMBL626566,,BAO_0000218,
9044,,Autocuration,Clearance rate in rabbits,1,,,22224,U,0,,CHEMBL626567,,BAO_0000218,
9045,,Autocuration,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,1,,,22224,U,0,,CHEMBL626568,,BAO_0000218,
9046,,Autocuration,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,,,22224,U,0,,CHEMBL626569,,BAO_0000218,
9047,,Autocuration,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,,,22224,U,0,,CHEMBL626570,,BAO_0000218,
9048,,Autocuration,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,,,22224,U,0,,CHEMBL626571,,BAO_0000218,
9049,,Autocuration,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,1,,,22224,U,0,,CHEMBL626572,,BAO_0000218,
9050,Plasma,Autocuration,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,1,,,22224,U,0,,CHEMBL626573,,BAO_0000218,1969.0
9051,Liver,Autocuration,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,1,,Microsomes,22224,U,0,,CHEMBL626574,,BAO_0000251,2107.0
9052,Liver,Autocuration,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,1,,Microsomes,22224,U,0,,CHEMBL626575,,BAO_0000251,2107.0
9053,,Autocuration,Dose at which bioavailability of intravenously administered compound was tested in rabbit,1,,,22224,U,0,,CHEMBL626576,,BAO_0000218,
9054,,Autocuration,Dose at which bioavailability of perorally administered compound was tested in rabbit,1,,,22224,U,0,,CHEMBL626577,,BAO_0000218,
9055,,Autocuration,The compound was tested for its bioavailability in rabbit (by oral dosage).,1,,,22224,U,0,,CHEMBL626578,,BAO_0000218,
9056,,Autocuration,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,,,22224,U,0,,CHEMBL625263,,BAO_0000218,
9057,,Autocuration,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,,,22224,U,0,,CHEMBL625264,,BAO_0000218,
9058,,Autocuration,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,,,22224,U,0,,CHEMBL625265,,BAO_0000218,
9059,,Autocuration,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),1,,Microsomes,22224,U,0,,CHEMBL625266,,BAO_0000251,
9060,,Autocuration,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),1,,Microsomes,22224,U,0,,CHEMBL876796,,BAO_0000251,
9061,,Autocuration,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,1,,,22224,U,0,,CHEMBL625267,,BAO_0000218,
9062,Plasma,Autocuration,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,,,22224,U,0,,CHEMBL625268,,BAO_0000218,1969.0
9063,Plasma,Autocuration,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,,,22224,U,0,,CHEMBL625269,,BAO_0000218,1969.0
9064,Plasma,Autocuration,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,,,22224,U,0,,CHEMBL624689,,BAO_0000218,1969.0
9065,,Autocuration,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,1,,,22224,U,0,,CHEMBL624690,,BAO_0000218,
9066,Urine,Autocuration,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),1,,,22224,U,0,,CHEMBL624691,,BAO_0000218,1088.0
9067,Urine,Autocuration,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),1,,,22224,U,0,,CHEMBL624692,,BAO_0000218,1088.0
9068,,Autocuration,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,1,,,22224,U,0,,CHEMBL624693,,BAO_0000218,
9069,,Autocuration,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,1,,,22224,U,0,,CHEMBL624694,,BAO_0000218,
9070,,Autocuration,In vitro Biological half-life in crude homogenate of rabbit renal cortex,1,,,22224,U,0,,CHEMBL877596,,BAO_0000221,
9071,,Autocuration,Time within which only 10% of the drug was degraded,1,,,22224,U,0,,CHEMBL624695,,BAO_0000019,
9072,Liver,Autocuration,Half life period in rabbit liver homogenate,1,,,22224,U,0,,CHEMBL624696,,BAO_0000221,2107.0
9073,,Autocuration,Half life value in rabbits,1,,,22224,U,0,,CHEMBL624697,,BAO_0000019,
9074,Blood,Autocuration,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,1,,,22224,U,0,,CHEMBL624698,,BAO_0000218,178.0
9075,Blood,Autocuration,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,1,,,22224,U,0,,CHEMBL624699,,BAO_0000218,178.0
9076,,Autocuration,Half-life period in rabbits following intravenous administration at 2 mg/kg,1,,,22224,U,0,,CHEMBL624700,,BAO_0000218,
9077,Plasma,Intermediate,AUC 0-8 hr value in rats at 10 mg/kg,1,,,50597,N,1,,CHEMBL622903,,BAO_0000218,1969.0
9078,Plasma,Intermediate,AUC after administration at 2000 mg/kg/day in rats,1,,,50597,N,1,,CHEMBL622904,,BAO_0000218,1969.0
9079,Plasma,Intermediate,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,1,,,50597,N,1,,CHEMBL622905,,BAO_0000218,1969.0
9080,Plasma,Intermediate,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL622906,,BAO_0000218,1969.0
9081,Plasma,Intermediate,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL622907,,BAO_0000218,1969.0
9082,Plasma,Intermediate,AUC in rat after oral administration at 10.5 mg/kg dose,1,,,50597,N,1,,CHEMBL622908,,BAO_0000218,1969.0
9083,Plasma,Intermediate,AUC in rat after oral administration at 11.2 mg/kg dose,1,,,50597,N,1,,CHEMBL622909,,BAO_0000218,1969.0
9084,Plasma,Intermediate,AUC in rat after oral administration at 9.7 mg/kg dose,1,,,50597,N,1,,CHEMBL622910,,BAO_0000218,1969.0
9085,Brain,Intermediate,AUC in rat brain after oral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL622911,,BAO_0000218,955.0
9086,Plasma,Intermediate,AUC in rat p.o.,1,,,50597,N,1,,CHEMBL622912,,BAO_0000218,1969.0
9087,Plasma,Intermediate,AUC in rat p.o. at 20 mg/kg concentration,1,,,50597,N,1,,CHEMBL622913,,BAO_0000218,1969.0
9088,Plasma,Intermediate,AUC in rat plasma after oral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL622914,,BAO_0000218,1969.0
9089,Plasma,Intermediate,AUC in rats,1,,,50597,N,1,,CHEMBL622915,,BAO_0000218,1969.0
9090,Plasma,Intermediate,AUC value after IV dose at a dose of 5 mg/kg in rats.,1,,,50597,N,1,,CHEMBL622916,,BAO_0000218,1969.0
9091,Plasma,Intermediate,AUC value after oral dose at a dose of 10 mg/kg in rats.,1,,,50597,N,1,,CHEMBL622917,,BAO_0000218,1969.0
9092,Plasma,Intermediate,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL622918,,BAO_0000218,1969.0
9093,Plasma,Intermediate,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,1,,,50597,N,1,,CHEMBL622919,,BAO_0000218,1969.0
9094,Plasma,Intermediate,Maximum plasma concentration was evaluated in rat,1,,,50597,N,1,,CHEMBL622920,,BAO_0000218,1969.0
9095,Plasma,Intermediate,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,,,50597,N,1,,CHEMBL622921,,BAO_0000218,1969.0
9096,Plasma,Intermediate,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,1,,,50597,N,1,,CHEMBL622922,,BAO_0000218,1969.0
9097,Plasma,Intermediate,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,,,50597,N,1,,CHEMBL622923,,BAO_0000218,1969.0
9098,Plasma,Intermediate,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL877604,,BAO_0000218,1969.0
9099,Plasma,Intermediate,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL622924,,BAO_0000218,1969.0
9100,Plasma,Intermediate,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL622925,,BAO_0000218,1969.0
9101,Plasma,Intermediate,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,1,,,50597,N,1,,CHEMBL622926,,BAO_0000218,1969.0
9102,Plasma,Intermediate,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL623625,,BAO_0000218,1969.0
9103,Plasma,Expert,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL623626,,BAO_0000218,1969.0
9104,Plasma,Intermediate,Maximum plasma drug concentration was determined,1,,,50597,N,1,,CHEMBL623627,,BAO_0000218,1969.0
9105,,Intermediate,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,1,,,50597,N,1,,CHEMBL623628,,BAO_0000218,
9106,Plasma,Intermediate,Mean peak plasma concentration was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL623629,,BAO_0000218,1969.0
9107,Plasma,Intermediate,Mean peak plasma concentration was observed after oral administration in rat,1,,,50597,N,1,,CHEMBL623630,,BAO_0000218,1969.0
9108,,Intermediate,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,1,,,50597,N,1,,CHEMBL623804,,BAO_0000218,
9109,,Intermediate,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL623805,,BAO_0000218,
9110,Plasma,Intermediate,Peak oral plasma concentration was determined in rats by oral administration,1,,,50597,N,1,,CHEMBL623806,,BAO_0000218,1969.0
9111,Plasma,Intermediate,Peak plasma concentration (Cmax) was determined,1,,,50597,N,1,,CHEMBL623807,,BAO_0000218,1969.0
9112,Plasma,Intermediate,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL623808,,BAO_0000218,1969.0
9113,Plasma,Intermediate,Peak plasma concentration (Cmax) in rats,1,,,50597,N,1,,CHEMBL623809,,BAO_0000218,1969.0
9114,Plasma,Intermediate,Peak plasma concentration at 1 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL623810,,BAO_0000218,1969.0
9115,Plasma,Intermediate,Peak plasma concentration in rat,1,,,50597,N,1,,CHEMBL623811,,BAO_0000218,1969.0
9116,Plasma,Intermediate,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",1,,,50597,N,1,,CHEMBL623812,,BAO_0000218,1969.0
9117,,Intermediate,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,1,,,50597,N,1,,CHEMBL877605,,BAO_0000218,
9118,,Intermediate,Pharmacokinetic property (Cmax) in rat,1,,,50597,N,1,,CHEMBL623813,,BAO_0000218,
9119,,Intermediate,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,,50597,N,1,,CHEMBL623814,,BAO_0000218,
9120,,Intermediate,Cmax in rat after 3mg/kg oral dose,1,,,50597,N,1,,CHEMBL623815,,BAO_0000218,
9121,,Intermediate,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,1,,,50597,N,1,,CHEMBL623816,,BAO_0000218,
9122,,Intermediate,Cmax in rats after 20 mg/kg oral dose,1,,,50597,N,1,,CHEMBL623145,,BAO_0000218,
9123,Plasma,Intermediate,Cmax in rat plasma after 30mg/kg oral dose,1,,,50597,N,1,,CHEMBL623146,,BAO_0000218,1969.0
9124,Plasma,Intermediate,Plasma concentration after oral administration of 100 mg/kg to rats,1,,,50597,N,1,,CHEMBL623147,,BAO_0000218,1969.0
9125,Brain,Intermediate,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL623042,,BAO_0000218,955.0
9126,,Intermediate,Tested for the Cmax in rat at 10 mg/kg per orally,1,,,50597,N,1,,CHEMBL623043,,BAO_0000218,
9127,,Intermediate,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL623044,,BAO_0000218,
9128,,Intermediate,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL623045,,BAO_0000218,
9129,,Intermediate,Bioavailability as oral Cmax in rats at 30 mins,1,,,50597,N,1,,CHEMBL623046,,BAO_0000218,
9130,,Intermediate,Bioavailability as oral Cmax in rats at 6hr,1,,,50597,N,1,,CHEMBL623226,,BAO_0000218,
9131,,Intermediate,The maximum concentration of compound was measured at the dose of 100 umol/kg,1,,,50597,N,1,,CHEMBL623227,,BAO_0000218,
9132,,Intermediate,The maximum concentration of compound was measured at the dose of 300 umol/kg,1,,,50597,N,1,,CHEMBL623228,,BAO_0000218,
9133,,Intermediate,The maximum concentration of compound was measured at the dose of 30 umol/kg,1,,,50597,N,1,,CHEMBL623229,,BAO_0000218,
9134,Plasma,Intermediate,The maximum plasma levels for the compounds were determined by LC-MS.,1,,,50597,N,1,,CHEMBL623230,,BAO_0000218,1969.0
9135,Plasma,Intermediate,mean peak plasma concentration was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL623231,,BAO_0000218,1969.0
9136,Plasma,Intermediate,mean peak plasma concentration was observed after oral administration in rat,1,,,50597,N,1,,CHEMBL623232,,BAO_0000218,1969.0
9137,,Intermediate,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL623233,,BAO_0000218,
9138,,Intermediate,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,1,,,50597,N,1,,CHEMBL623234,,BAO_0000218,
9139,,Intermediate,Concentration in plasma (portal) following oral dose in rats at 1 hr,1,,,50597,N,1,,CHEMBL623235,,BAO_0000218,
9140,,Intermediate,Concentration in plasma (portal) following oral dose in rats at 2 hr,1,,,50597,N,1,,CHEMBL623236,,BAO_0000218,
9141,,Intermediate,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,1,,,50597,N,1,,CHEMBL623237,,BAO_0000218,
9142,,Intermediate,Concentration in plasma (systemic) following oral dose in rats at 1 hr,1,,,50597,N,1,,CHEMBL623238,,BAO_0000218,
9143,,Intermediate,Concentration in plasma (systemic) following oral dose in rats at 2 hr,1,,,50597,N,1,,CHEMBL623239,,BAO_0000218,
9144,Plasma,Intermediate,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,1,,,22224,U,0,,CHEMBL623240,,BAO_0000218,1969.0
9145,Hypothalamus,Intermediate,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",1,,,50597,N,1,,CHEMBL623241,,BAO_0000218,1898.0
9146,Hypothalamus,Intermediate,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",1,,,50597,N,1,,CHEMBL623242,,BAO_0000218,1898.0
9147,,Intermediate,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",1,,,50597,N,1,,CHEMBL874394,,BAO_0000218,
9148,,Intermediate,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",1,,,50597,N,1,,CHEMBL623243,,BAO_0000218,
9149,,Intermediate,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL623244,,BAO_0000218,
9150,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL623245,,BAO_0000218,2113.0
9151,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL623246,,BAO_0000218,2113.0
9152,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL623247,,BAO_0000218,2113.0
9153,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL623248,,BAO_0000218,2113.0
9154,Kidney,Intermediate,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL623249,,BAO_0000218,2113.0
9155,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL625072,,BAO_0000218,2107.0
9156,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL625073,,BAO_0000218,2107.0
9157,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL625074,,BAO_0000218,2107.0
9158,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL625075,,BAO_0000218,2107.0
9159,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL625076,,BAO_0000218,2107.0
9160,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL625077,,BAO_0000218,2107.0
9161,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL625078,,BAO_0000218,2107.0
9162,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL874395,,BAO_0000218,2107.0
9163,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL625079,,BAO_0000218,2107.0
9164,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL625080,,BAO_0000218,2107.0
9165,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL625081,,BAO_0000218,2107.0
9166,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL625082,,BAO_0000218,2107.0
9167,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL625083,,BAO_0000218,2107.0
9168,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL625084,,BAO_0000218,2107.0
9169,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL625085,,BAO_0000218,2107.0
9170,Liver,Intermediate,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL625086,,BAO_0000218,2107.0
9171,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL625087,,BAO_0000218,2107.0
9172,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL625088,,BAO_0000218,2107.0
9173,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL622205,,BAO_0000218,2107.0
9174,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL622206,,BAO_0000218,2107.0
9175,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL622207,,BAO_0000218,2107.0
9176,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL622366,,BAO_0000218,2107.0
9177,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL622367,,BAO_0000218,2107.0
9178,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL875331,,BAO_0000218,2107.0
9179,Liver,Intermediate,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL622368,,BAO_0000218,2107.0
9180,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL622369,,BAO_0000218,2048.0
9181,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL622370,,BAO_0000218,2048.0
9182,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL622371,,BAO_0000218,2048.0
9183,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL622372,,BAO_0000218,2048.0
9184,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL622373,,BAO_0000218,2048.0
9185,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL622374,,BAO_0000218,2048.0
9186,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL622375,,BAO_0000218,2048.0
9187,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL622376,,BAO_0000218,2048.0
9188,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL622377,,BAO_0000218,2048.0
9189,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL622378,,BAO_0000218,2048.0
9190,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL622379,,BAO_0000218,2048.0
9191,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL622380,,BAO_0000218,2048.0
9192,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL622381,,BAO_0000218,2048.0
9193,Lung,Intermediate,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL622382,,BAO_0000218,2048.0
9194,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL622383,,BAO_0000218,2048.0
9195,Stomach,Intermediate,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,,50597,N,1,,CHEMBL875332,,BAO_0000218,945.0
9196,Stomach,Intermediate,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,,50597,N,1,,CHEMBL622384,,BAO_0000218,945.0
9197,Stomach,Intermediate,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,,50597,N,1,,CHEMBL622385,,BAO_0000218,945.0
9198,Stomach,Intermediate,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,,50597,N,1,,CHEMBL622386,,BAO_0000218,945.0
9199,,Intermediate,The compound was tested for the plasma binding in rat,1,,,50597,N,1,,CHEMBL622387,,BAO_0000218,
9200,,Intermediate,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",1,,,50597,N,1,,CHEMBL622388,,BAO_0000218,
9201,,Intermediate,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",1,,,50597,N,1,,CHEMBL622389,,BAO_0000218,
9202,,Intermediate,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",1,,,50597,N,1,,CHEMBL622390,,BAO_0000218,
9203,,Intermediate,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),1,,,50597,N,1,,CHEMBL622391,,BAO_0000218,
9204,,Intermediate,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),1,,,50597,N,1,,CHEMBL622392,,BAO_0000218,
9205,,Intermediate,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),1,,,50597,N,1,,CHEMBL622393,,BAO_0000218,
9206,,Intermediate,Plasma level at 2 hr after administration of the compound,1,,,50597,N,1,,CHEMBL622394,,BAO_0000218,
9207,,Intermediate,plasma level at 2 hr after administration of the compound,1,,,50597,N,1,,CHEMBL622395,,BAO_0000218,
9208,Serum,Intermediate,Stability in rat serum measured as % recovery at 1 min,1,,,50597,N,1,,CHEMBL622396,,BAO_0000218,1977.0
9209,Serum,Intermediate,Stability in rat serum measured as % recovery at 10 min,1,,,50597,N,1,,CHEMBL624894,,BAO_0000218,1977.0
9210,Serum,Intermediate,Stability in rat serum measured as % recovery at 10 mins,1,,,50597,N,1,,CHEMBL624895,,BAO_0000218,1977.0
9211,Serum,Intermediate,Stability in rat serum measured as % recovery at 2 hr,1,,,50597,N,1,,CHEMBL624058,,BAO_0000218,1977.0
9212,Serum,Intermediate,Stability in rat serum measured as % recovery at 3 min,1,,,50597,N,1,,CHEMBL624059,,BAO_0000218,1977.0
9213,Serum,Intermediate,Stability in rat serum measured as % recovery at 3 mins,1,,,50597,N,1,,CHEMBL624060,,BAO_0000218,1977.0
9214,Serum,Intermediate,Stability in rat serum measured as % recovery at 5 min,1,,,50597,N,1,,CHEMBL624061,,BAO_0000218,1977.0
9215,Serum,Intermediate,Stability in rat serum measured as % recovery at 5 mins,1,,,50597,N,1,,CHEMBL624062,,BAO_0000218,1977.0
9216,,Intermediate,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL624063,,BAO_0000218,
9217,,Intermediate,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL624064,,BAO_0000218,
9218,Plasma,Intermediate,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,1,,,50597,N,1,,CHEMBL624065,,BAO_0000218,1969.0
9219,Plasma,Intermediate,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,1,,,50597,N,1,,CHEMBL624066,,BAO_0000218,1969.0
9220,,Intermediate,Half life tested in mature male rat at a dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL877490,,BAO_0000218,
9221,,Intermediate,Half life after intravenous administration of 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL874442,,BAO_0000218,
9222,,Intermediate,Half life period after administration (30 mg/kg) in rat,1,,,50597,N,1,,CHEMBL626890,,BAO_0000218,
9223,,Intermediate,Half life period in rat after 5 mg/Kg dose,1,,,50597,N,1,,CHEMBL626891,,BAO_0000218,
9224,,Intermediate,Half life period in rat after 5 mg/kg dose,1,,,50597,N,1,,CHEMBL626892,,BAO_0000218,
9225,,Intermediate,Half life period was determined,1,,,50597,N,1,,CHEMBL626893,,BAO_0000218,
9226,,Intermediate,Half life period was evaluated in rat,1,,,50597,N,1,,CHEMBL626894,,BAO_0000218,
9227,,Intermediate,Half life period was evaluated in rat; 0.5-1.0,1,,,50597,N,1,,CHEMBL626895,,BAO_0000218,
9228,,Intermediate,Half life period was evaluated in rat; 5.9-7.5,1,,,50597,N,1,,CHEMBL626896,,BAO_0000218,
9229,Plasma,Intermediate,Half-life in rat plasma,1,,,50597,N,1,,CHEMBL626897,,BAO_0000218,1969.0
9230,,Intermediate,Half-life time in rat was determined,1,,,50597,N,1,,CHEMBL626898,,BAO_0000218,
9231,,Intermediate,Terminal half-life after iv administration to rats,1,,,50597,N,1,,CHEMBL626899,,BAO_0000218,
9232,,Intermediate,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,1,,,50597,N,1,,CHEMBL626900,,BAO_0000218,
9233,,Intermediate,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,1,,,50597,N,1,,CHEMBL626901,,BAO_0000218,
9234,,Intermediate,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),1,,,50597,N,1,,CHEMBL626902,,BAO_0000218,
9235,,Intermediate,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),1,,,50597,N,1,,CHEMBL626903,,BAO_0000218,
9236,,Intermediate,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,1,,,50597,N,1,,CHEMBL874443,,BAO_0000218,
9237,,Intermediate,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL626904,,BAO_0000218,
9238,,Intermediate,Half life in rats,1,,,50597,N,1,,CHEMBL626905,,BAO_0000218,
9239,Plasma,Intermediate,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,,,50597,N,1,,CHEMBL873830,,BAO_0000218,1969.0
9240,,Intermediate,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,1,,,50597,N,1,,CHEMBL626906,,BAO_0000218,
9241,Plasma,Intermediate,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,,50597,N,1,,CHEMBL631076,,BAO_0000218,1969.0
9242,Plasma,Intermediate,Biological half-life was measured in plasma of rats,1,,,50597,N,1,,CHEMBL631077,,BAO_0000218,1969.0
9243,,Intermediate,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,50597,N,1,,CHEMBL631078,,BAO_0000218,
9244,,Intermediate,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,1,,,50597,N,1,,CHEMBL631079,,BAO_0000218,
9245,,Intermediate,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,1,,,50597,N,1,,CHEMBL631080,,BAO_0000218,
9246,,Intermediate,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL631081,,BAO_0000218,
9247,,Intermediate,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL631239,,BAO_0000218,
9248,Plasma,Intermediate,Compound was evaluated for plasma half life in rat,1,,,50597,N,1,,CHEMBL631240,,BAO_0000218,1969.0
9249,Plasma,Intermediate,AUC value at a dose of 5 mg/kg (p.o.) in rats,1,,,50597,N,1,,CHEMBL631241,,BAO_0000218,1969.0
9250,Plasma,Intermediate,AUC value after administration of 20 mg/Kg oral dose in rat,1,,,50597,N,1,,CHEMBL631242,,BAO_0000218,1969.0
9251,Plasma,Intermediate,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,1,,,50597,N,1,,CHEMBL631243,,BAO_0000218,1969.0
9252,Plasma,Intermediate,AUC0-96 after administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL874444,,BAO_0000218,1969.0
9253,Plasma,Intermediate,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,1,,,50597,N,1,,CHEMBL631244,,BAO_0000218,1969.0
9254,,Intermediate,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",1,,,50597,N,1,,CHEMBL631245,,BAO_0000218,
9255,,Intermediate,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL627162,,BAO_0000218,
9256,,Intermediate,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL627163,,BAO_0000218,
9257,,Intermediate,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,1,,,50597,N,1,,CHEMBL627164,,BAO_0000218,
9258,Kidney,Intermediate,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,1,,,50597,N,1,,CHEMBL627165,,BAO_0000218,2113.0
9259,,Intermediate,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,1,,,50597,N,1,,CHEMBL627166,,BAO_0000218,
9260,,Intermediate,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,1,,,50597,N,1,,CHEMBL627167,,BAO_0000218,
9261,,Intermediate,Area under curve (AUC) at a dose of 30 mg/kg in rats,1,,,50597,N,1,,CHEMBL627822,,BAO_0000218,
9262,,Intermediate,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL627823,,BAO_0000218,
9263,,Intermediate,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,1,,,50597,N,1,,CHEMBL627824,,BAO_0000218,
9264,,Intermediate,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL627825,,BAO_0000218,
9265,,Intermediate,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,1,,,50597,N,1,,CHEMBL627826,,BAO_0000218,
9266,,Intermediate,Area under curve (Pharmacokinetic property) was determined,1,,,50597,N,1,,CHEMBL627827,,BAO_0000218,
9267,,Intermediate,Area under curve (Pharmacokinetic property) of the compound; Not determined,1,,,50597,N,1,,CHEMBL627828,,BAO_0000218,
9268,,Intermediate,Area under curve after intravenous administration (1 mg/kg) in rat,1,,,50597,N,1,,CHEMBL627829,,BAO_0000218,
9269,,Intermediate,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL627830,,BAO_0000218,
9270,,Intermediate,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL627831,,BAO_0000218,
9271,,Intermediate,Area under curve in male SD rats was observed after oral administration in rat,1,,,50597,N,1,,CHEMBL627832,,BAO_0000218,
9272,,Intermediate,Area under curve of compound after iv administration of 20 mg/kg dose in rat,1,,,50597,N,1,,CHEMBL627833,,BAO_0000218,
9273,,Expert,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL627834,,BAO_0000218,
9274,,Expert,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL628004,,BAO_0000218,
9275,,Intermediate,Area under curve at 5 mg/kg po was determined in rat,1,,,50597,N,1,,CHEMBL628005,,BAO_0000218,
9276,,Intermediate,Area under curve in Rat at a oral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL628006,,BAO_0000218,
9277,,Intermediate,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,,50597,N,1,,CHEMBL628007,,BAO_0000218,
9278,,Intermediate,Area under curve was determined,1,,,50597,N,1,,CHEMBL625676,,BAO_0000218,
9279,,Intermediate,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,1,,,50597,N,1,,CHEMBL631309,,BAO_0000218,
9280,,Intermediate,Area under curve after intravenous administration at 3 mg/kg,1,,,50597,N,1,,CHEMBL631310,,BAO_0000218,
9281,,Intermediate,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,1,,,50597,N,1,,CHEMBL631311,,BAO_0000218,
9282,,Intermediate,Area under curve at 4 hr in rat,1,,,50597,N,1,,CHEMBL631312,,BAO_0000218,
9283,,Intermediate,Area under curve at a dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL631313,,BAO_0000218,
9284,,Intermediate,Area under curve at the dose of 2 mg/Kg administered perorally in rats,1,,,50597,N,1,,CHEMBL631314,,BAO_0000218,
9285,,Intermediate,Area under curve at the dose of 5 mg/Kg administered perorally in rats,1,,,50597,N,1,,CHEMBL631315,,BAO_0000218,
9286,,Intermediate,Area under curve for a 2-mpk po dose in SD rats,1,,,50597,N,1,,CHEMBL631316,,BAO_0000218,
9287,,Intermediate,Area under curve in SD rats,1,,,50597,N,1,,CHEMBL631317,,BAO_0000218,
9288,,Intermediate,Area under curve in rat after oral administration at 13 mg/kg dose,1,,,50597,N,1,,CHEMBL874471,,BAO_0000218,
9289,,Intermediate,Area under curve in rat by po administration at 0-24 hr,1,,,50597,N,1,,CHEMBL631318,,BAO_0000218,
9290,Plasma,Intermediate,Area under curve in rat plasma,1,,,50597,N,1,,CHEMBL631319,,BAO_0000218,1969.0
9291,,Intermediate,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL631320,,BAO_0000218,
9292,,Intermediate,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,1,,,50597,N,1,,CHEMBL631321,,BAO_0000218,
9293,,Intermediate,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,1,,,50597,N,1,,CHEMBL631322,,BAO_0000218,
9294,,Intermediate,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,1,,,50597,N,1,,CHEMBL631323,,BAO_0000218,
9295,,Intermediate,Area under curve value in rat at a dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL631324,,BAO_0000218,
9296,,Intermediate,Area under curve was determined after oral administration in rats,1,,,50597,N,1,,CHEMBL631325,,BAO_0000218,
9297,,Intermediate,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL631326,,BAO_0000218,
9298,,Intermediate,Area under curve was determined after peroral administration in rat,1,,,50597,N,1,,CHEMBL631327,,BAO_0000218,
9299,,Intermediate,Area under curve was determined at a dose 30 mpk administered orally.,1,,,50597,N,1,,CHEMBL631328,,BAO_0000218,
9300,,Intermediate,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,1,,,50597,N,1,,CHEMBL631329,,BAO_0000218,
9301,,Intermediate,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,1,,,50597,N,1,,CHEMBL627217,,BAO_0000218,
9302,,Intermediate,Area under curve was determined in male rat,1,,,50597,N,1,,CHEMBL626352,,BAO_0000218,
9303,,Intermediate,Area under curve was determined in rat after PO administration,1,,,50597,N,1,,CHEMBL626353,,BAO_0000218,
9304,,Intermediate,Area under curve was determined in rat after a 3 mg/kg of oral dose,1,,,50597,N,1,,CHEMBL626354,,BAO_0000218,
9305,,Intermediate,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,1,,,50597,N,1,,CHEMBL626355,,BAO_0000218,
9306,,Intermediate,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,1,,,50597,N,1,,CHEMBL626356,,BAO_0000218,
9307,,Intermediate,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,1,,,50597,N,1,,CHEMBL626357,,BAO_0000218,
9308,,Intermediate,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL626358,,BAO_0000218,
9309,,Intermediate,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL626359,,BAO_0000218,
9310,Plasma,Intermediate,Peak plasma concentration in rat at a dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL626360,,BAO_0000218,1969.0
9311,,Intermediate,Plasma concentration at 2 hr in rats was evaluated.,1,,,50597,N,1,,CHEMBL626361,,BAO_0000218,
9312,,Intermediate,Plasma concentration at 2 hr in rats was evaluated; Not available,1,,,50597,N,1,,CHEMBL626362,,BAO_0000218,
9313,,Intermediate,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL626363,,BAO_0000218,
9314,,Intermediate,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL626970,,BAO_0000218,
9315,,Intermediate,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL626971,,BAO_0000218,
9316,Plasma,Intermediate,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL626972,,BAO_0000218,1969.0
9317,Plasma,Intermediate,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL626973,,BAO_0000218,1969.0
9318,Plasma,Intermediate,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL626974,,BAO_0000218,1969.0
9319,Plasma,Intermediate,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL874592,,BAO_0000218,1969.0
9320,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,1,,,50597,N,1,,CHEMBL626975,,BAO_0000218,
9321,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,1,,,50597,N,1,,CHEMBL626976,,BAO_0000218,
9322,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,1,,,50597,N,1,,CHEMBL626977,,BAO_0000218,
9323,,Intermediate,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,1,,,50597,N,1,,CHEMBL626978,,BAO_0000218,
9324,,Intermediate,PK study was carried to determine the relative absorption ranking in rat.,1,,,50597,N,1,,CHEMBL626979,,BAO_0000218,
9325,Plasma,Intermediate,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL626980,,BAO_0000218,1969.0
9326,Blood,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",1,,,50597,N,1,,CHEMBL626981,,BAO_0000218,178.0
9327,Blood,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",1,,,50597,N,1,,CHEMBL626982,,BAO_0000218,178.0
9328,Blood,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",1,,,50597,N,1,,CHEMBL626983,,BAO_0000218,178.0
9329,Blood,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",1,,,50597,N,1,,CHEMBL622522,,BAO_0000218,178.0
9330,Blood,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",1,,,50597,N,1,,CHEMBL622523,,BAO_0000218,178.0
9331,Blood,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",1,,,50597,N,1,,CHEMBL622524,,BAO_0000218,178.0
9332,Brain,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",1,,,50597,N,1,,CHEMBL622525,,BAO_0000218,955.0
9333,Brain,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",1,,,50597,N,1,,CHEMBL622526,,BAO_0000218,955.0
9334,Brain,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",1,,,50597,N,1,,CHEMBL619849,,BAO_0000218,955.0
9335,Brain,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",1,,,50597,N,1,,CHEMBL619850,,BAO_0000218,955.0
9336,Brain,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",1,,,50597,N,1,,CHEMBL623864,,BAO_0000218,955.0
9337,Brain,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",1,,,50597,N,1,,CHEMBL623865,,BAO_0000218,955.0
9338,Heart,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",1,,,50597,N,1,,CHEMBL623866,,BAO_0000218,948.0
9339,Heart,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",1,,,50597,N,1,,CHEMBL623867,,BAO_0000218,948.0
9340,Heart,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",1,,,50597,N,1,,CHEMBL877615,,BAO_0000218,948.0
9341,Heart,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",1,,,50597,N,1,,CHEMBL623868,,BAO_0000218,948.0
9342,Heart,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",1,,,50597,N,1,,CHEMBL623869,,BAO_0000218,948.0
9343,Heart,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",1,,,50597,N,1,,CHEMBL623870,,BAO_0000218,948.0
9344,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL623871,,BAO_0000218,2048.0
9345,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL623872,,BAO_0000218,2048.0
9346,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL622129,,BAO_0000218,2048.0
9347,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL622130,,BAO_0000218,2048.0
9348,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL622131,,BAO_0000218,2048.0
9349,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL622132,,BAO_0000218,2048.0
9350,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL622133,,BAO_0000218,2048.0
9351,Lung,Intermediate,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL622134,,BAO_0000218,2048.0
9352,Lung,Intermediate,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL622135,,BAO_0000218,2048.0
9353,Lung,Intermediate,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL622136,,BAO_0000218,2048.0
9354,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL622137,,BAO_0000218,2385.0
9355,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL622138,,BAO_0000218,2385.0
9356,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL623017,,BAO_0000218,2385.0
9357,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL623018,,BAO_0000218,2385.0
9358,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL623019,,BAO_0000218,2385.0
9359,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL623020,,BAO_0000218,2385.0
9360,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL623021,,BAO_0000218,2385.0
9361,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL623022,,BAO_0000218,2385.0
9362,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL623023,,BAO_0000218,2385.0
9363,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL623024,,BAO_0000218,2385.0
9364,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL623025,,BAO_0000218,2385.0
9365,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL620545,,BAO_0000218,2385.0
9366,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL620546,,BAO_0000218,2385.0
9367,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL620547,,BAO_0000218,2385.0
9368,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL620548,,BAO_0000218,2385.0
9369,Muscle tissue,Intermediate,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL620549,,BAO_0000218,2385.0
9370,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL620550,,BAO_0000218,2385.0
9371,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL620551,,BAO_0000218,2385.0
9372,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL620552,,BAO_0000218,2385.0
9373,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL620553,,BAO_0000218,2385.0
9374,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL620554,,BAO_0000218,2385.0
9375,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL875845,,BAO_0000218,2385.0
9376,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL620555,,BAO_0000218,2385.0
9377,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL620556,,BAO_0000218,2385.0
9378,Muscle tissue,Intermediate,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL620557,,BAO_0000218,2385.0
9379,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL620558,,BAO_0000218,
9380,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL620559,,BAO_0000218,
9381,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL622939,,BAO_0000218,
9382,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL622940,,BAO_0000218,
9383,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL622941,,BAO_0000218,
9384,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL622942,,BAO_0000218,
9385,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL622943,,BAO_0000218,
9386,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL622944,,BAO_0000218,
9387,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL622945,,BAO_0000218,
9388,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL622946,,BAO_0000218,
9389,,Intermediate,Compound was evaluated for terminal half life in rat,1,,,50597,N,1,,CHEMBL622947,,BAO_0000218,
9390,Plasma,Intermediate,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,1,,,50597,N,1,,CHEMBL622948,,BAO_0000218,1969.0
9391,Plasma,Intermediate,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,1,,,50597,N,1,,CHEMBL622949,,BAO_0000218,1969.0
9392,,Intermediate,Compound was tested for its half life in rat,1,,,50597,N,1,,CHEMBL622950,,BAO_0000218,
9393,Plasma,Intermediate,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,1,,,22224,U,0,,CHEMBL622951,,BAO_0000218,1969.0
9394,Plasma,Intermediate,Compound was tested for its plasma half life in Sprague Dawley rats,1,,,22224,U,0,,CHEMBL622952,,BAO_0000366,1969.0
9395,Plasma,Intermediate,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,1,,,22224,U,0,,CHEMBL622953,,BAO_0000366,1969.0
9396,Plasma,Intermediate,Compound was tested for plasma half-life period in rat,1,,,50597,N,1,,CHEMBL873818,,BAO_0000218,1969.0
9397,,Intermediate,Elimination half life after i.v. administration of compound in rats,1,,,50597,N,1,,CHEMBL622954,,BAO_0000218,
9398,,Intermediate,Elimination half-life after IV dosing at 0.5 mg/kg in rat,1,,,50597,N,1,,CHEMBL622955,,BAO_0000218,
9399,,Intermediate,Elimination half-life after IV dosing at 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL875229,,BAO_0000218,
9400,,Intermediate,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL622956,,BAO_0000218,
9401,,Intermediate,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,1,,,50597,N,1,,CHEMBL622957,,BAO_0000218,
9402,Brain,Intermediate,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,,,50597,N,1,,CHEMBL622958,,BAO_0000218,955.0
9403,Plasma,Intermediate,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,,,50597,N,1,,CHEMBL622959,,BAO_0000218,1969.0
9404,Brain,Intermediate,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,,,50597,N,1,,CHEMBL622960,,BAO_0000218,955.0
9405,Plasma,Intermediate,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,,,50597,N,1,,CHEMBL622961,,BAO_0000218,1969.0
9406,,Intermediate,Evaluated for the half life in rat (in vivo),1,,,50597,N,1,,CHEMBL622962,,BAO_0000218,
9407,,Intermediate,Hafl life in rat,1,,,50597,N,1,,CHEMBL622963,,BAO_0000218,
9408,,Intermediate,Hafl life rat,1,,,50597,N,1,,CHEMBL622964,,BAO_0000218,
9409,,Intermediate,Hafl life rat,1,,,50597,N,1,,CHEMBL622965,,BAO_0000218,
9410,,Intermediate,Hafl life rat; Not determined,1,,,50597,N,1,,CHEMBL622966,,BAO_0000218,
9411,,Intermediate,Hafl life rat; Not determined,1,,,50597,N,1,,CHEMBL622967,,BAO_0000218,
9412,Kidney,Intermediate,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL622968,,BAO_0000218,2113.0
9413,Liver,Intermediate,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL622969,,BAO_0000218,2107.0
9414,Lung,Intermediate,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL875327,,BAO_0000218,2048.0
9415,,Intermediate,Half life in rat after 1 mg/kg i.v. administration,1,,,50597,N,1,,CHEMBL628638,,BAO_0000218,
9416,,Intermediate,Half life in rat after 2 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL628639,,BAO_0000218,
9417,,Intermediate,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL625840,,BAO_0000218,
9418,,Intermediate,Half life of 10 mg/kg oral dose determined in rats,1,,,50597,N,1,,CHEMBL625841,,BAO_0000218,
9419,,Intermediate,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625842,,BAO_0000218,
9420,,Intermediate,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625843,,BAO_0000218,
9421,,Intermediate,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625844,,BAO_0000218,
9422,,Intermediate,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL873822,,BAO_0000218,
9423,,Intermediate,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625845,,BAO_0000218,
9424,,Intermediate,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL627059,,BAO_0000218,
9425,,Intermediate,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL627060,,BAO_0000218,
9426,,Intermediate,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL627061,,BAO_0000218,
9427,,Intermediate,Half life of compound at 5 mg/kg after po administration was determined in rat,1,,,50597,N,1,,CHEMBL627709,,BAO_0000218,
9428,,Intermediate,Half life of compound determined after intravenous administration to rat,1,,,50597,N,1,,CHEMBL627710,,BAO_0000218,
9429,,Intermediate,Half life of compound was determined in rat,1,,,50597,N,1,,CHEMBL627711,,BAO_0000218,
9430,Plasma,Intermediate,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL627712,,BAO_0000218,1969.0
9431,,Intermediate,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL627713,,BAO_0000218,
9432,,Intermediate,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL627714,,BAO_0000218,
9433,,Intermediate,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,1,,,22224,U,0,,CHEMBL627889,,BAO_0000218,
9434,,Intermediate,Half life determined in rat by intravenous administration,1,,,22224,U,0,,CHEMBL627890,,BAO_0000218,
9435,,Intermediate,Half life determined in rats after iv administration,1,,,50597,N,1,,CHEMBL627891,,BAO_0000218,
9436,Plasma,Intermediate,Half life in rat plasma after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL627892,,BAO_0000218,1969.0
9437,Plasma,Intermediate,Half life in rat plasma after administration of 2 mg/kg iv,1,,,50597,N,1,,CHEMBL627893,,BAO_0000218,1969.0
9438,Plasma,Intermediate,Half life in rat plasma was determined,1,,,50597,N,1,,CHEMBL627894,,BAO_0000218,1969.0
9439,Plasma,Intermediate,Half life in rat plasma was determined; NA means not applicable,1,,,50597,N,1,,CHEMBL627895,,BAO_0000218,1969.0
9440,,Intermediate,Half life in rat was tested,1,,,50597,N,1,,CHEMBL627896,,BAO_0000218,
9441,Plasma,Intermediate,Half life measured in rat plasma,1,,,50597,N,1,,CHEMBL627897,,BAO_0000218,1969.0
9442,,Intermediate,Half life recorded in rats,1,,,50597,N,1,,CHEMBL627898,,BAO_0000218,
9443,,Intermediate,Half life was calculated,1,,,50597,N,1,,CHEMBL627899,,BAO_0000218,
9444,,Intermediate,Half life was calculated in rat,1,,,50597,N,1,,CHEMBL873823,,BAO_0000218,
9445,,Intermediate,Half life was determined,1,,,50597,N,1,,CHEMBL627900,,BAO_0000218,
9446,,Intermediate,Half life after 10 mg/kg oral administration in rat,1,,,50597,N,1,,CHEMBL627901,,BAO_0000218,
9447,,Intermediate,Half life after administering orally a dose of 10 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL627902,,BAO_0000218,
9448,,Intermediate,Half life after administering orally a dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL627903,,BAO_0000218,
9449,,Intermediate,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,1,,,50597,N,1,,CHEMBL627904,,BAO_0000218,
9450,,Intermediate,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,1,,,50597,N,1,,CHEMBL627905,,BAO_0000218,
9451,,Intermediate,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,1,,,50597,N,1,,CHEMBL627906,,BAO_0000218,
9452,,Intermediate,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,1,,,50597,N,1,,CHEMBL627907,,BAO_0000218,
9453,,Intermediate,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL876783,,BAO_0000218,
9454,,Intermediate,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,1,,,50597,N,1,,CHEMBL627908,,BAO_0000218,
9455,,Intermediate,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,50597,N,1,,CHEMBL627909,,BAO_0000218,
9456,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,1,,,50597,N,1,,CHEMBL627910,,BAO_0000218,
9457,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),1,,,50597,N,1,,CHEMBL627911,,BAO_0000218,
9458,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),1,,,50597,N,1,,CHEMBL627912,,BAO_0000218,
9459,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),1,,,50597,N,1,,CHEMBL627913,,BAO_0000218,
9460,,Intermediate,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),1,,,50597,N,1,,CHEMBL627914,,BAO_0000218,
9461,,Intermediate,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,1,,,50597,N,1,,CHEMBL627915,,BAO_0000218,
9462,,Intermediate,Area under the curve was evaluated after 20 uM/kg of peroral administration,1,,,50597,N,1,,CHEMBL627916,,BAO_0000218,
9463,,Intermediate,Area under the curve was measured in rat after an iv dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL627917,,BAO_0000218,
9464,,Intermediate,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,1,,,50597,N,1,,CHEMBL627918,,BAO_0000218,
9465,,Intermediate,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,1,,,50597,N,1,,CHEMBL627919,,BAO_0000218,
9466,,Intermediate,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL627920,,BAO_0000218,
9467,,Intermediate,Area under the curve was evaluated at an oral dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL627921,,BAO_0000218,
9468,,Intermediate,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL627922,,BAO_0000218,
9469,,Intermediate,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL876784,,BAO_0000218,
9470,,Intermediate,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL627923,,BAO_0000218,
9471,,Intermediate,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL626208,,BAO_0000218,
9472,,Intermediate,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL626209,,BAO_0000218,
9473,,Intermediate,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL626210,,BAO_0000218,
9474,Plasma,Intermediate,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,,,50597,N,1,,CHEMBL627994,,BAO_0000218,1969.0
9475,,Intermediate,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL627995,,BAO_0000218,
9476,,Intermediate,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,1,,,50597,N,1,,CHEMBL627996,,BAO_0000218,
9477,,Intermediate,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,1,,,50597,N,1,,CHEMBL627997,,BAO_0000218,
9478,,Intermediate,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL627998,,BAO_0000218,
9479,,Intermediate,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL628640,,BAO_0000218,
9480,,Intermediate,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL628641,,BAO_0000218,
9481,,Intermediate,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL628642,,BAO_0000218,
9482,,Intermediate,Compound was evaluated for area under the curve expressed as (h*ug/ml),1,,,50597,N,1,,CHEMBL628643,,BAO_0000218,
9483,,Intermediate,Compound was tested for area under curve in rat,1,,,50597,N,1,,CHEMBL628644,,BAO_0000218,
9484,,Intermediate,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,1,,,50597,N,1,,CHEMBL628645,,BAO_0000218,
9485,,Intermediate,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL628646,,BAO_0000218,
9486,,Intermediate,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),1,,,50597,N,1,,CHEMBL628647,,BAO_0000218,
9487,,Intermediate,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,,,50597,N,1,,CHEMBL628648,,BAO_0000218,
9488,,Intermediate,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,,,50597,N,1,,CHEMBL625358,,BAO_0000218,
9489,,Intermediate,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,,,50597,N,1,,CHEMBL625359,,BAO_0000218,
9490,,Intermediate,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,,,50597,N,1,,CHEMBL625360,,BAO_0000218,
9491,,Intermediate,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),1,,,50597,N,1,,CHEMBL625361,,BAO_0000218,
9492,,Intermediate,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),1,,,50597,N,1,,CHEMBL625362,,BAO_0000218,
9493,,Intermediate,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),1,,,50597,N,1,,CHEMBL625363,,BAO_0000218,
9494,,Intermediate,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,,,50597,N,1,,CHEMBL625364,,BAO_0000218,
9495,,Intermediate,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625365,,BAO_0000218,
9496,,Intermediate,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625366,,BAO_0000218,
9497,,Intermediate,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625367,,BAO_0000218,
9498,Kidney,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",1,,,50597,N,1,,CHEMBL625368,,BAO_0000218,2113.0
9499,Kidney,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",1,,,50597,N,1,,CHEMBL625369,,BAO_0000218,2113.0
9500,Kidney,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",1,,,50597,N,1,,CHEMBL625370,,BAO_0000218,2113.0
9501,Kidney,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",1,,,50597,N,1,,CHEMBL625371,,BAO_0000218,2113.0
9502,Kidney,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",1,,,50597,N,1,,CHEMBL625372,,BAO_0000218,2113.0
9503,Kidney,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",1,,,50597,N,1,,CHEMBL625373,,BAO_0000218,2113.0
9504,Liver,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",1,,,50597,N,1,,CHEMBL625374,,BAO_0000218,2107.0
9505,Liver,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",1,,,50597,N,1,,CHEMBL877593,,BAO_0000218,2107.0
9506,Liver,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",1,,,50597,N,1,,CHEMBL625375,,BAO_0000218,2107.0
9507,Liver,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",1,,,50597,N,1,,CHEMBL625376,,BAO_0000218,2107.0
9508,Liver,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",1,,,50597,N,1,,CHEMBL621973,,BAO_0000218,2107.0
9509,Liver,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",1,,,50597,N,1,,CHEMBL621974,,BAO_0000218,2107.0
9510,Lung,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",1,,,50597,N,1,,CHEMBL621975,,BAO_0000218,2048.0
9511,Lung,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",1,,,50597,N,1,,CHEMBL622166,,BAO_0000218,2048.0
9512,Lung,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",1,,,50597,N,1,,CHEMBL622167,,BAO_0000218,2048.0
9513,Lung,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",1,,,50597,N,1,,CHEMBL622168,,BAO_0000218,2048.0
9514,Lung,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",1,,,50597,N,1,,CHEMBL622169,,BAO_0000218,2048.0
9515,Lung,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",1,,,50597,N,1,,CHEMBL622170,,BAO_0000218,2048.0
9516,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",1,,,50597,N,1,,CHEMBL622171,,BAO_0000218,2046.0
9517,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",1,,,50597,N,1,,CHEMBL622172,,BAO_0000218,2046.0
9518,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",1,,,50597,N,1,,CHEMBL622173,,BAO_0000218,2046.0
9519,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",1,,,50597,N,1,,CHEMBL622174,,BAO_0000218,2046.0
9520,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",1,,,50597,N,1,,CHEMBL622175,,BAO_0000218,2046.0
9521,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",1,,,50597,N,1,,CHEMBL622176,,BAO_0000218,2046.0
9522,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",1,,,50597,N,1,,CHEMBL622177,,BAO_0000218,2046.0
9523,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",1,,,50597,N,1,,CHEMBL622178,,BAO_0000218,2046.0
9524,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",1,,,50597,N,1,,CHEMBL622179,,BAO_0000218,2046.0
9525,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",1,,,50597,N,1,,CHEMBL622180,,BAO_0000218,2046.0
9526,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL622181,,BAO_0000218,
9527,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL622182,,BAO_0000218,
9528,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL622183,,BAO_0000218,
9529,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL622184,,BAO_0000218,
9530,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL622185,,BAO_0000218,
9531,,Intermediate,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL622186,,BAO_0000218,
9532,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL622187,,BAO_0000218,
9533,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL625002,,BAO_0000218,
9534,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL622090,,BAO_0000218,
9535,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL622091,,BAO_0000218,
9536,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL622092,,BAO_0000218,
9537,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL622093,,BAO_0000218,
9538,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL622094,,BAO_0000218,
9539,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL622095,,BAO_0000218,
9540,,Intermediate,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL622264,,BAO_0000218,
9541,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL622265,,BAO_0000218,2106.0
9542,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL622266,,BAO_0000218,2106.0
9543,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL622267,,BAO_0000218,2106.0
9544,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL622268,,BAO_0000218,2106.0
9545,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL622269,,BAO_0000218,2106.0
9546,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL625071,,BAO_0000218,2106.0
9547,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL621621,,BAO_0000218,2106.0
9548,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL621622,,BAO_0000218,2106.0
9549,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL621623,,BAO_0000218,2106.0
9550,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL621624,,BAO_0000218,2106.0
9551,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL621625,,BAO_0000218,2106.0
9552,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL621626,,BAO_0000218,2106.0
9553,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL621627,,BAO_0000218,2106.0
9554,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL621628,,BAO_0000218,2106.0
9555,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL875328,,BAO_0000218,2106.0
9556,Spleen,Intermediate,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL621629,,BAO_0000218,2106.0
9557,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL621630,,BAO_0000218,2106.0
9558,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL621631,,BAO_0000218,2106.0
9559,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL621632,,BAO_0000218,2106.0
9560,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL621633,,BAO_0000218,2106.0
9561,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL621634,,BAO_0000218,2106.0
9562,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL621635,,BAO_0000218,2106.0
9563,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL621636,,BAO_0000218,2106.0
9564,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL621637,,BAO_0000218,2106.0
9565,Spleen,Intermediate,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL621638,,BAO_0000218,2106.0
9566,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL618883,,BAO_0000218,
9567,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL618884,,BAO_0000218,
9568,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL628627,,BAO_0000218,
9569,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL628628,,BAO_0000218,
9570,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL628629,,BAO_0000218,
9571,,Intermediate,Half life after administering orally a dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL628630,,BAO_0000218,
9572,,Intermediate,Half life after administering orally a dose of 3 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL628631,,BAO_0000218,
9573,,Intermediate,Half life after administering intravenously a dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL628632,,BAO_0000218,
9574,,Intermediate,Half life after oral dosing in rats,1,,,50597,N,1,,CHEMBL628633,,BAO_0000218,
9575,,Intermediate,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,1,,,50597,N,1,,CHEMBL628634,,BAO_0000218,
9576,,Intermediate,Half life by intravenous administration of 3.4 mg/kg in rat,1,,,50597,N,1,,CHEMBL627789,,BAO_0000218,
9577,,Intermediate,Half life in rat,1,,,50597,N,1,,CHEMBL627790,,BAO_0000218,
9578,,Intermediate,Half life in rat,1,,,50597,N,1,,CHEMBL627791,,BAO_0000218,
9579,,Intermediate,Half life in rat,1,,,50597,N,1,,CHEMBL627792,,BAO_0000218,
9580,,Intermediate,Half life in rat after intravenous administration of the compound,1,,,50597,N,1,,CHEMBL627793,,BAO_0000218,
9581,Plasma,Intermediate,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,1,,,50597,N,1,,CHEMBL627794,,BAO_0000218,1969.0
9582,,Intermediate,Half life in rat after po administration of the compound,1,,,50597,N,1,,CHEMBL627795,,BAO_0000218,
9583,,Intermediate,Half life in rat after po administration of the compound; ND means Not determined,1,,,50597,N,1,,CHEMBL627796,,BAO_0000218,
9584,Plasma,Intermediate,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,1,,,50597,N,1,,CHEMBL875335,,BAO_0000218,1969.0
9585,Plasma,Intermediate,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,1,,,50597,N,1,,CHEMBL627797,,BAO_0000218,1969.0
9586,,Intermediate,Half life in rat i.v.,1,,,50597,N,1,,CHEMBL627798,,BAO_0000218,
9587,,Intermediate,Half life in rat i.v. at 2 mg/kg concentration,1,,,50597,N,1,,CHEMBL627799,,BAO_0000218,
9588,,Intermediate,Half life in rats,1,,,50597,N,1,,CHEMBL627800,,BAO_0000218,
9589,,Intermediate,Half life in rats after intravenous administration,1,,,50597,N,1,,CHEMBL627801,,BAO_0000218,
9590,,Intermediate,Half life in rats at the dose of 1.0 mpk by i.v. administration,1,,,50597,N,1,,CHEMBL627802,,BAO_0000218,
9591,,Expert,Half life in rat,1,,,50597,N,1,,CHEMBL627803,,BAO_0000218,
9592,,Intermediate,Half life was evaluated after intravenous administration to rats,1,,,50597,N,1,,CHEMBL873820,,BAO_0000218,
9593,,Intermediate,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),1,,,50597,N,1,,CHEMBL627804,,BAO_0000218,
9594,,Intermediate,Half life was evaluated in rat,1,,,50597,N,1,,CHEMBL627805,,BAO_0000218,
9595,,Intermediate,Half life was evaluated in rat,1,,,50597,N,1,,CHEMBL627806,,BAO_0000218,
9596,,Intermediate,Half life was evaluated in rat; Not tested,1,,,50597,N,1,,CHEMBL627107,,BAO_0000218,
9597,,Intermediate,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,1,,,50597,N,1,,CHEMBL627108,,BAO_0000218,
9598,,Intermediate,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,1,,,50597,N,1,,CHEMBL627109,,BAO_0000218,
9599,Blood,Intermediate,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,1,,,50597,N,1,,CHEMBL627110,,BAO_0000218,178.0
9600,,Intermediate,Half life was measured in monkey at dose of 10 mg/kg by po administration,1,,,22224,U,0,,CHEMBL627111,,BAO_0000218,
9601,,Intermediate,Half life was measured in monkey at dose of 10 mg/kg by po administration,1,,,22224,U,0,,CHEMBL627112,,BAO_0000218,
9602,,Intermediate,Half life was measured in rat at dose of 30 mg/kg by iv administration,1,,,22224,U,0,,CHEMBL627113,,BAO_0000218,
9603,,Intermediate,Half life was measured in rat at dose of 30 mg/kg by po administration,1,,,22224,U,0,,CHEMBL627114,,BAO_0000218,
9604,,Intermediate,Half life (t1/2) was determined,1,,,50597,N,1,,CHEMBL627115,,BAO_0000218,
9605,,Intermediate,Half life period at a dose of 10 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL627116,,BAO_0000218,
9606,,Intermediate,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,1,,,50597,N,1,,CHEMBL627117,,BAO_0000218,
9607,,Intermediate,Half life period was determined,1,,,50597,N,1,,CHEMBL627118,,BAO_0000218,
9608,,Intermediate,Half life period after intravenous administration at 20 mpk in rats,1,,,50597,N,1,,CHEMBL627119,,BAO_0000218,
9609,,Intermediate,Half life period after intravenous administration at 20 mpk in rats; Not performed.,1,,,50597,N,1,,CHEMBL627120,,BAO_0000218,
9610,,Intermediate,Half life period after intravenous administration in rat,1,,,50597,N,1,,CHEMBL626922,,BAO_0000218,
9611,,Intermediate,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL626923,,BAO_0000218,
9612,,Intermediate,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL626924,,BAO_0000218,
9613,Plasma,Intermediate,Half life period in 80% rat plasma at 37 degree Centigrade,1,,,50597,N,1,,CHEMBL626925,,BAO_0000218,1969.0
9614,,Intermediate,Half life period in SD rats,1,,,50597,N,1,,CHEMBL626926,,BAO_0000218,
9615,Plasma,Intermediate,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),1,,,50597,N,1,,CHEMBL626927,,BAO_0000218,1969.0
9616,Plasma,Intermediate,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),1,,,50597,N,1,,CHEMBL626928,,BAO_0000218,1969.0
9617,Plasma,Intermediate,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,,50597,N,1,,CHEMBL626929,,BAO_0000218,1969.0
9618,Plasma,Intermediate,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,,50597,N,1,,CHEMBL626930,,BAO_0000218,1969.0
9619,,Intermediate,Half life period in rat,1,,,50597,N,1,,CHEMBL626931,,BAO_0000218,
9620,,Intermediate,Half life period in rat,1,,,50597,N,1,,CHEMBL626932,,BAO_0000218,
9621,,Intermediate,Half life period in rat,1,,,50597,N,1,,CHEMBL626933,,BAO_0000218,
9622,,Intermediate,Half life period in rat after oral administration at 10.5 mg/kg dose,1,,,50597,N,1,,CHEMBL873826,,BAO_0000218,
9623,,Intermediate,Half life period in rat after oral administration at 11.2 mg/kg dose,1,,,50597,N,1,,CHEMBL626934,,BAO_0000218,
9624,,Intermediate,Half life period in rat after oral administration at 13 mg/kg dose,1,,,50597,N,1,,CHEMBL626935,,BAO_0000218,
9625,,Intermediate,Half life period in rat after oral administration at 9.7 mg/kg dose,1,,,50597,N,1,,CHEMBL626936,,BAO_0000218,
9626,,Intermediate,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626937,,BAO_0000218,
9627,,Intermediate,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL625906,,BAO_0000218,
9628,,Intermediate,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,,,50597,N,1,,CHEMBL625907,,BAO_0000218,
9629,,Intermediate,PK study was carried to determine AUC (area under curve) value in rat,1,,,50597,N,1,,CHEMBL625908,,BAO_0000218,
9630,,Intermediate,Pharmacokinetic parameter AUC after intravenous administration to rats,1,,,50597,N,1,,CHEMBL625909,,BAO_0000218,
9631,,Intermediate,Pharmacokinetic parameter AUC after oral administration to rats,1,,,50597,N,1,,CHEMBL625910,,BAO_0000218,
9632,,Intermediate,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,1,,,50597,N,1,,CHEMBL625911,,BAO_0000218,
9633,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,1,,,50597,N,1,,CHEMBL625912,,BAO_0000218,
9634,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,1,,,50597,N,1,,CHEMBL626538,,BAO_0000218,
9635,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,1,,,50597,N,1,,CHEMBL876794,,BAO_0000218,
9636,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,1,,,50597,N,1,,CHEMBL626539,,BAO_0000218,
9637,,Intermediate,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,1,,,50597,N,1,,CHEMBL626540,,BAO_0000218,
9638,,Intermediate,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,1,,,50597,N,1,,CHEMBL626541,,BAO_0000218,
9639,,Intermediate,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,1,,,50597,N,1,,CHEMBL626542,,BAO_0000218,
9640,,Intermediate,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL626543,,BAO_0000218,
9641,,Intermediate,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL626544,,BAO_0000218,
9642,,Intermediate,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL626545,,BAO_0000218,
9643,,Intermediate,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL626546,,BAO_0000218,
9644,,Intermediate,Pharmacokinetic parameter area under curve was reported,1,,,50597,N,1,,CHEMBL626547,,BAO_0000218,
9645,,Intermediate,Pharmacokinetic property (AUC) in rat,1,,,50597,N,1,,CHEMBL626548,,BAO_0000218,
9646,,Intermediate,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,,50597,N,1,,CHEMBL626549,,BAO_0000218,
9647,,Intermediate,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,1,,,50597,N,1,,CHEMBL626550,,BAO_0000218,
9648,,Intermediate,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,1,,,50597,N,1,,CHEMBL626551,,BAO_0000218,
9649,,Intermediate,Pharmacokinetic property was determined,1,,,50597,N,1,,CHEMBL623777,,BAO_0000218,
9650,,Intermediate,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,1,,,50597,N,1,,CHEMBL623778,,BAO_0000218,
9651,,Intermediate,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,1,,,50597,N,1,,CHEMBL623779,,BAO_0000218,
9652,Plasma,Intermediate,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,,,50597,N,1,,CHEMBL623780,,BAO_0000218,1969.0
9653,Plasma,Intermediate,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,1,,,50597,N,1,,CHEMBL622015,,BAO_0000218,1969.0
9654,Plasma,Intermediate,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,1,,,50597,N,1,,CHEMBL622016,,BAO_0000218,1969.0
9655,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",1,,,50597,N,1,,CHEMBL622017,,BAO_0000218,
9656,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",1,,,50597,N,1,,CHEMBL622018,,BAO_0000218,
9657,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",1,,,50597,N,1,,CHEMBL622019,,BAO_0000218,
9658,,Intermediate,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",1,,,50597,N,1,,CHEMBL622020,,BAO_0000218,
9659,,Intermediate,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,1,,,50597,N,1,,CHEMBL622021,,BAO_0000218,
9660,,Intermediate,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,1,,,50597,N,1,,CHEMBL622022,,BAO_0000218,
9661,,Intermediate,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,1,,,50597,N,1,,CHEMBL622023,,BAO_0000218,
9662,,Intermediate,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,1,,,50597,N,1,,CHEMBL622024,,BAO_0000218,
9663,,Intermediate,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),1,,,50597,N,1,,CHEMBL622693,,BAO_0000218,
9664,,Intermediate,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),1,,,50597,N,1,,CHEMBL622694,,BAO_0000218,
9665,,Intermediate,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL622695,,BAO_0000218,
9666,,Intermediate,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,,,50597,N,1,,CHEMBL622696,,BAO_0000218,
9667,,Intermediate,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",1,,,50597,N,1,,CHEMBL622697,,BAO_0000218,
9668,,Intermediate,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",1,,,50597,N,1,,CHEMBL622874,,BAO_0000218,
9669,,Intermediate,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",1,,,50597,N,1,,CHEMBL622875,,BAO_0000218,
9670,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,,,50597,N,1,,CHEMBL622876,,BAO_0000218,
9671,,Intermediate,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,,,50597,N,1,,CHEMBL622877,,BAO_0000218,
9672,,Intermediate,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL622878,,BAO_0000218,
9673,Plasma,Intermediate,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL622879,,BAO_0000218,1969.0
9674,,Intermediate,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,1,,,50597,N,1,,CHEMBL877602,,BAO_0000218,
9675,,Intermediate,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL622880,,BAO_0000218,
9676,,Intermediate,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL622881,,BAO_0000218,
9677,,Intermediate,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL622882,,BAO_0000218,
9678,,Intermediate,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL622883,,BAO_0000218,
9679,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",1,,,50597,N,1,,CHEMBL622884,,BAO_0000218,2046.0
9680,Thyroid gland,Intermediate,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",1,,,50597,N,1,,CHEMBL622885,,BAO_0000218,2046.0
9681,,Intermediate,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,,50597,N,1,,CHEMBL622886,,BAO_0000218,
9682,,Intermediate,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,50597,N,1,,CHEMBL622887,,BAO_0000218,
9683,Urine,Intermediate,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,,50597,N,1,,CHEMBL622888,,BAO_0000218,1088.0
9684,Blood,Intermediate,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622889,,BAO_0000218,178.0
9685,Blood,Intermediate,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622890,,BAO_0000218,178.0
9686,Blood,Intermediate,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622891,,BAO_0000218,178.0
9687,Blood,Intermediate,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL877603,,BAO_0000218,178.0
9688,Brain,Intermediate,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622892,,BAO_0000218,955.0
9689,Brain,Intermediate,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622893,,BAO_0000218,955.0
9690,Brain,Intermediate,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622894,,BAO_0000218,955.0
9691,Brain,Intermediate,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622895,,BAO_0000218,955.0
9692,Brain,Intermediate,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,1,,,50597,N,1,,CHEMBL622896,,BAO_0000218,955.0
9693,Heart,Intermediate,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622897,,BAO_0000218,948.0
9694,Heart,Intermediate,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622898,,BAO_0000218,948.0
9695,Heart,Intermediate,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622899,,BAO_0000218,948.0
9696,Kidney,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622900,,BAO_0000218,2113.0
9697,Kidney,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624114,,BAO_0000218,2113.0
9698,Kidney,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624115,,BAO_0000218,2113.0
9699,Kidney,Intermediate,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624116,,BAO_0000218,2113.0
9700,Liver,Intermediate,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624117,,BAO_0000218,2107.0
9701,Liver,Intermediate,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624118,,BAO_0000218,2107.0
9702,Liver,Intermediate,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624119,,BAO_0000218,2107.0
9703,Liver,Intermediate,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624120,,BAO_0000218,2107.0
9704,Lung,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624121,,BAO_0000218,2048.0
9705,Lung,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624122,,BAO_0000218,2048.0
9706,Lung,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624123,,BAO_0000218,2048.0
9707,Lung,Intermediate,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624124,,BAO_0000218,2048.0
9708,Muscle tissue,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624125,,BAO_0000218,2385.0
9709,Muscle tissue,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624126,,BAO_0000218,2385.0
9710,Muscle tissue,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624127,,BAO_0000218,2385.0
9711,Muscle tissue,Intermediate,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624128,,BAO_0000218,2385.0
9712,Zone of skin,Intermediate,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL624129,,BAO_0000218,14.0
9713,Zone of skin,Intermediate,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL624130,,BAO_0000218,14.0
9714,Zone of skin,Intermediate,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622340,,BAO_0000218,14.0
9715,Zone of skin,Intermediate,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622341,,BAO_0000218,14.0
9716,Intestine,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622342,,BAO_0000218,160.0
9717,Intestine,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622343,,BAO_0000218,160.0
9718,Intestine,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622344,,BAO_0000218,160.0
9719,Intestine,Intermediate,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622345,,BAO_0000218,160.0
9720,Spleen,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622346,,BAO_0000218,2106.0
9721,Spleen,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622347,,BAO_0000218,2106.0
9722,Spleen,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622348,,BAO_0000218,2106.0
9723,Spleen,Intermediate,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622349,,BAO_0000218,2106.0
9724,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,50597,N,1,,CHEMBL622350,,BAO_0000218,
9725,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL622351,,BAO_0000218,
9726,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL622352,,BAO_0000218,
9727,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL622353,,BAO_0000218,
9728,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL622354,,BAO_0000218,
9729,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL622355,,BAO_0000218,
9730,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL622356,,BAO_0000218,
9731,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,50597,N,1,,CHEMBL622357,,BAO_0000218,
9732,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,50597,N,1,,CHEMBL622358,,BAO_0000218,
9733,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,50597,N,1,,CHEMBL622359,,BAO_0000218,
9734,,Intermediate,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,50597,N,1,,CHEMBL874393,,BAO_0000218,
9735,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL622872,,BAO_0000218,
9736,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL622873,,BAO_0000218,
9737,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL623047,,BAO_0000218,
9738,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL623048,,BAO_0000218,
9739,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL623049,,BAO_0000218,
9740,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL623050,,BAO_0000218,
9741,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL623051,,BAO_0000218,
9742,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL623052,,BAO_0000218,
9743,,Intermediate,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL626343,,BAO_0000218,
9744,,Intermediate,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,50597,N,1,,CHEMBL626344,,BAO_0000218,
9745,,Intermediate,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,50597,N,1,,CHEMBL626345,,BAO_0000218,
9746,,Intermediate,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,50597,N,1,,CHEMBL626346,,BAO_0000218,
9747,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,50597,N,1,,CHEMBL626347,,BAO_0000218,
9748,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,50597,N,1,,CHEMBL626348,,BAO_0000218,
9749,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,50597,N,1,,CHEMBL626349,,BAO_0000218,
9750,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,50597,N,1,,CHEMBL626350,,BAO_0000218,
9751,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,50597,N,1,,CHEMBL626351,,BAO_0000218,
9752,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,50597,N,1,,CHEMBL627650,,BAO_0000218,
9753,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,50597,N,1,,CHEMBL627651,,BAO_0000218,
9754,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,50597,N,1,,CHEMBL627652,,BAO_0000218,
9755,,Intermediate,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,50597,N,1,,CHEMBL627653,,BAO_0000218,
9756,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL627654,,BAO_0000218,
9757,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,1,,,50597,N,1,,CHEMBL627835,,BAO_0000218,
9758,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,1,,,50597,N,1,,CHEMBL627836,,BAO_0000218,
9759,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,1,,,50597,N,1,,CHEMBL627837,,BAO_0000218,
9760,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL627838,,BAO_0000218,
9761,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,1,,,50597,N,1,,CHEMBL875338,,BAO_0000218,
9762,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,1,,,50597,N,1,,CHEMBL627839,,BAO_0000218,
9763,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,1,,,50597,N,1,,CHEMBL627840,,BAO_0000218,
9764,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL627841,,BAO_0000218,
9765,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,1,,,50597,N,1,,CHEMBL627842,,BAO_0000218,
9766,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,1,,,50597,N,1,,CHEMBL627843,,BAO_0000218,
9767,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,1,,,50597,N,1,,CHEMBL627844,,BAO_0000218,
9768,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL627845,,BAO_0000218,
9769,,Intermediate,Half life period in rat by iv administration at a dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL627846,,BAO_0000218,
9770,Plasma,Intermediate,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),1,,,50597,N,1,,CHEMBL627847,,BAO_0000218,1969.0
9771,Plasma,Intermediate,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),1,,,50597,N,1,,CHEMBL873821,,BAO_0000218,1969.0
9772,Plasma,Intermediate,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,,50597,N,1,,CHEMBL626079,,BAO_0000218,1969.0
9773,Plasma,Intermediate,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,,50597,N,1,,CHEMBL626080,,BAO_0000218,1969.0
9774,Plasma,Intermediate,Half life period was evaluated in rat plasma,1,,,50597,N,1,,CHEMBL626081,,BAO_0000218,1969.0
9775,Plasma,Intermediate,Half life period was evaluated in rat plasma; Not tested,1,,,50597,N,1,,CHEMBL875344,,BAO_0000218,1969.0
9776,,Intermediate,Half life period was evaluated in rats,1,,,50597,N,1,,CHEMBL626082,,BAO_0000218,
9777,,Intermediate,"Half life period was evaluated in rats, iv",1,,,50597,N,1,,CHEMBL626250,,BAO_0000218,
9778,,Intermediate,Half life period after intravenous administration at 5 mg/kg in rat,1,,,50597,N,1,,CHEMBL626251,,BAO_0000218,
9779,,Intermediate,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,,50597,N,1,,CHEMBL626252,,BAO_0000218,
9780,,Intermediate,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL626253,,BAO_0000218,
9781,Plasma,Intermediate,Half life stability of compound was evaluated in rat plasma,1,,,50597,N,1,,CHEMBL626254,,BAO_0000218,1969.0
9782,,Intermediate,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,1,,,50597,N,1,,CHEMBL626255,,BAO_0000218,
9783,,Intermediate,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL626256,,BAO_0000218,
9784,,Intermediate,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,,50597,N,1,,CHEMBL626257,,BAO_0000218,
9785,,Intermediate,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,1,,,50597,N,1,,CHEMBL626258,,BAO_0000218,
9786,,Intermediate,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,1,,,50597,N,1,,CHEMBL626259,,BAO_0000218,
9787,,Intermediate,Half in rat i.v.,1,,,50597,N,1,,CHEMBL626260,,BAO_0000218,
9788,,Intermediate,Half period in rat after intravenous administration,1,,,50597,N,1,,CHEMBL875345,,BAO_0000218,
9789,,Intermediate,Half-life after repeated oral dose of compound at 1 mg/kg in rats,1,,,50597,N,1,,CHEMBL626261,,BAO_0000218,
9790,Liver,Intermediate,Half-life measured in in vitro Cathepsin B assay in rat liver,1,,,50597,N,1,,CHEMBL626262,,BAO_0000218,2107.0
9791,,Intermediate,Half-life of compound was determined in rats,1,,,50597,N,1,,CHEMBL626263,,BAO_0000218,
9792,,Intermediate,Half-life at 10 mg/kg in rat upon intravenous administration,1,,,50597,N,1,,CHEMBL625270,,BAO_0000218,
9793,,Intermediate,Half-life determined in rat,1,,,50597,N,1,,CHEMBL625271,,BAO_0000218,
9794,,Intermediate,Half-life determined in rat,1,,,50597,N,1,,CHEMBL625272,,BAO_0000218,
9795,Brain,Intermediate,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL625273,,BAO_0000218,955.0
9796,Plasma,Intermediate,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",1,,,50597,N,1,,CHEMBL625274,,BAO_0000218,1969.0
9797,,Intermediate,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,50597,N,1,,CHEMBL625275,,BAO_0000218,
9798,Plasma,Intermediate,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL625276,,BAO_0000218,1969.0
9799,Plasma,Intermediate,Half-life in rat plasma,1,,,50597,N,1,,CHEMBL625277,,BAO_0000218,1969.0
9800,Plasma,Intermediate,Half-life in rat plasma was determined,1,,,50597,N,1,,CHEMBL625278,,BAO_0000218,1969.0
9801,Plasma,Intermediate,Half-life in rat plasma; Not tested,1,,,50597,N,1,,CHEMBL625279,,BAO_0000218,1969.0
9802,Serum,Intermediate,Half-life in rat serum,1,,,50597,N,1,,CHEMBL625280,,BAO_0000218,1977.0
9803,Serum,Intermediate,Half-life in rat serum; na is not available,1,,,50597,N,1,,CHEMBL876797,,BAO_0000218,1977.0
9804,,Intermediate,Half-life was calculated in rat,1,,,50597,N,1,,CHEMBL625281,,BAO_0000218,
9805,Plasma,Intermediate,Half-life was calculated in rat plasma,1,,,50597,N,1,,CHEMBL873827,,BAO_0000218,1969.0
9806,,Intermediate,Half-life was determined,1,,,50597,N,1,,CHEMBL625282,,BAO_0000218,
9807,,Intermediate,Half-life was determined,1,,,50597,N,1,,CHEMBL625283,,BAO_0000218,
9808,,Intermediate,Half-life after administration of 20 mg/Kg oral dose in rat,1,,,50597,N,1,,CHEMBL625284,,BAO_0000218,
9809,,Intermediate,Half-life after administration of 3.2 mg/kg intravenously in male rat,1,,,50597,N,1,,CHEMBL625285,,BAO_0000218,
9810,,Intermediate,Half-life after intravenous administration in female rat,1,,,50597,N,1,,CHEMBL625286,,BAO_0000218,
9811,,Intermediate,Half-life after intravenous administration in male rat,1,,,50597,N,1,,CHEMBL625287,,BAO_0000218,
9812,,Intermediate,Half-life after intravenous dose in rat,1,,,50597,N,1,,CHEMBL625288,,BAO_0000218,
9813,Liver,Intermediate,Half-life in a rat liver homogenate preparation,1,,,50597,N,1,,CHEMBL625289,,BAO_0000218,2107.0
9814,Plasma,Intermediate,Half-life in plasma of rat,1,,,50597,N,1,,CHEMBL625290,,BAO_0000218,1969.0
9815,Plasma,Intermediate,Half-life in plasma of rat at dose of 3-10 mgkg,1,,,50597,N,1,,CHEMBL876798,,BAO_0000218,1969.0
9816,,Intermediate,Half-life in rat,1,,,50597,N,1,,CHEMBL625291,,BAO_0000218,
9817,,Intermediate,Half-life in rat,1,,,50597,N,1,,CHEMBL625292,,BAO_0000218,
9818,,Intermediate,Half-life in rat,1,,,50597,N,1,,CHEMBL625293,,BAO_0000218,
9819,,Intermediate,Half-life in rat,1,,,50597,N,1,,CHEMBL622832,,BAO_0000218,
9820,,Intermediate,Half-life in rat,1,,,50597,N,1,,CHEMBL622833,,BAO_0000218,
9821,,Intermediate,Half-life in rat,1,,,50597,N,1,,CHEMBL622834,,BAO_0000218,
9822,,Intermediate,Half-life in rat after oral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL622835,,BAO_0000218,
9823,,Intermediate,Half-life in rat after po administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL622836,,BAO_0000218,
9824,,Intermediate,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,,,50597,N,1,,CHEMBL622837,,BAO_0000218,
9825,,Intermediate,Half-life in rat at 3 mg/kg dose administered intravenously,1,,,50597,N,1,,CHEMBL622838,,BAO_0000218,
9826,Brain,Intermediate,Half-life in rat brain homogenate,1,,,50597,N,1,,CHEMBL622839,,BAO_0000218,955.0
9827,Plasma,Intermediate,Half-life in rat plasma,1,,,50597,N,1,,CHEMBL622840,,BAO_0000218,1969.0
9828,,Intermediate,Half-life in rats,1,,,50597,N,1,,CHEMBL622841,,BAO_0000218,
9829,,Intermediate,Half-life in Dawley rats,1,,,50597,N,1,,CHEMBL622842,,BAO_0000218,
9830,Plasma,Intermediate,Half-life in vitro in rat plasma,1,,,50597,N,1,,CHEMBL622843,,BAO_0000218,1969.0
9831,Plasma,Intermediate,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,1,,,50597,N,1,,CHEMBL622844,,BAO_0000218,1969.0
9832,,Intermediate,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",1,,,50597,N,1,,CHEMBL622845,,BAO_0000218,
9833,,Intermediate,The area under the curve of compound was measured at the dose of 100 umol/kg,1,,,50597,N,1,,CHEMBL622846,,BAO_0000218,
9834,,Intermediate,The area under the curve of compound was measured at the dose of 300 umol/kg,1,,,50597,N,1,,CHEMBL622847,,BAO_0000218,
9835,,Intermediate,The area under the curve of compound was measured at the dose of 30 umol/kg,1,,,50597,N,1,,CHEMBL622848,,BAO_0000218,
9836,,Intermediate,Bioavailability as oral AUC in rats,1,,,50597,N,1,,CHEMBL622849,,BAO_0000218,
9837,Plasma,Intermediate,The plasma concentration versus time curve (AUC) was determined,1,,,50597,N,1,,CHEMBL622850,,BAO_0000218,1969.0
9838,,Intermediate,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL876807,,BAO_0000218,
9839,,Intermediate,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL622851,,BAO_0000218,
9840,,Intermediate,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL622852,,BAO_0000218,
9841,,Intermediate,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,1,,,50597,N,1,,CHEMBL622853,,BAO_0000218,
9842,,Intermediate,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,1,,,50597,N,1,,CHEMBL622854,,BAO_0000218,
9843,,Intermediate,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,50597,N,1,,CHEMBL622855,,BAO_0000218,
9844,Plasma,Intermediate,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",1,,,50597,N,1,,CHEMBL622856,,BAO_0000218,1969.0
9845,Plasma,Intermediate,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",1,,,50597,N,1,,CHEMBL622857,,BAO_0000218,1969.0
9846,Plasma,Intermediate,AUC in rat after po administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL622858,,BAO_0000218,1969.0
9847,Plasma,Intermediate,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,1,,,50597,N,1,,CHEMBL622859,,BAO_0000218,1969.0
9848,,Intermediate,Area under curve value 24 hr after 10 mg/kg iv administration in rats,1,,,50597,N,1,,CHEMBL622860,,BAO_0000218,
9849,,Intermediate,Area under curve value 24 hr after 10 mg/kg oral administration in rats,1,,,50597,N,1,,CHEMBL622861,,BAO_0000218,
9850,,Intermediate,Area under curve value 24 hr after 2 mg/kg iv administration in rats,1,,,50597,N,1,,CHEMBL622862,,BAO_0000218,
9851,,Intermediate,Area under curve value 24 hr after 2 mg/kg oral administration in rats,1,,,50597,N,1,,CHEMBL622863,,BAO_0000218,
9852,,Intermediate,Area under curve value 6 hr after po administration in rat,1,,,50597,N,1,,CHEMBL623817,,BAO_0000218,
9853,,Intermediate,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,50597,N,1,,CHEMBL623818,,BAO_0000218,
9854,,Intermediate,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",1,,,50597,N,1,,CHEMBL623819,,BAO_0000218,
9855,,Intermediate,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,50597,N,1,,CHEMBL623820,,BAO_0000218,
9856,,Intermediate,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,1,,,50597,N,1,,CHEMBL623821,,BAO_0000218,
9857,Plasma,Intermediate,AUC normalized for dose (AUCN) in rat,1,,,50597,N,1,,CHEMBL623822,,BAO_0000218,1969.0
9858,,Intermediate,Area under curve in rat after p.o. administration,1,,,50597,N,1,,CHEMBL623823,,BAO_0000218,
9859,,Intermediate,Area under curve in rat after p.o. administration,1,,,50597,N,1,,CHEMBL623824,,BAO_0000218,
9860,,Intermediate,Area under curve in rat after p.o. administration; Not determined,1,,,50597,N,1,,CHEMBL623825,,BAO_0000218,
9861,,Intermediate,Area under curve in rat after peroral administration,1,,,50597,N,1,,CHEMBL622070,,BAO_0000218,
9862,,Intermediate,Area under curve (carotid artery) value of the compound,1,,,50597,N,1,,CHEMBL622071,,BAO_0000218,
9863,,Intermediate,Bioavailability expressed as the area under curve of rat carotid artery,1,,,50597,N,1,,CHEMBL622072,,BAO_0000218,
9864,,Intermediate,Area under curve in male SD rats was observed after intravenous administration in rat,1,,,50597,N,1,,CHEMBL622073,,BAO_0000218,
9865,,Intermediate,Area under curve of the compound was determined,1,,,50597,N,1,,CHEMBL622074,,BAO_0000218,
9866,,Intermediate,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,1,,,50597,N,1,,CHEMBL622075,,BAO_0000218,
9867,Plasma,Intermediate,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,1,,,50597,N,1,,CHEMBL622076,,BAO_0000218,1969.0
9868,Plasma,Intermediate,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,1,,,50597,N,1,,CHEMBL622077,,BAO_0000218,1969.0
9869,,Intermediate,Area under curve (portal vein) value of the compound,1,,,50597,N,1,,CHEMBL622078,,BAO_0000218,
9870,,Intermediate,Bioavailability expressed as the area under curve of rat portal vein,1,,,50597,N,1,,CHEMBL622079,,BAO_0000218,
9871,Plasma,Intermediate,Area Under plasma concentration time curve in rat upon peroral administration,1,,,50597,N,1,,CHEMBL622080,,BAO_0000218,1969.0
9872,,Intermediate,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,1,,,50597,N,1,,CHEMBL877612,,BAO_0000218,
9873,,Intermediate,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,1,,,50597,N,1,,CHEMBL622081,,BAO_0000218,
9874,,Intermediate,Compound was evaluated for oral bioavailability in rats,1,,,50597,N,1,,CHEMBL622082,,BAO_0000218,
9875,,Intermediate,Compound was evaluated for oral bioavailability in rats after iv administration,1,,,50597,N,1,,CHEMBL622083,,BAO_0000218,
9876,,Intermediate,Compound was evaluated for oral bioavailability in rats; 30-80,1,,,50597,N,1,,CHEMBL622084,,BAO_0000218,
9877,,Intermediate,Compound was evaluated for oral bioavailability in rats; 50-60,1,,,50597,N,1,,CHEMBL622085,,BAO_0000218,
9878,,Intermediate,Compound was evaluated for oral bioavailability in rats; no data,1,,,50597,N,1,,CHEMBL622086,,BAO_0000218,
9879,,Intermediate,Compound was evaluated for oral bioavailability in rats; peptide,1,,,50597,N,1,,CHEMBL622087,,BAO_0000218,
9880,Blood,Intermediate,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",1,,,50597,N,1,,CHEMBL622088,,BAO_0000218,178.0
9881,Blood,Intermediate,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",1,,,50597,N,1,,CHEMBL622089,,BAO_0000218,178.0
9882,Blood,Intermediate,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",1,,,50597,N,1,,CHEMBL623685,,BAO_0000218,178.0
9883,Blood,Intermediate,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",1,,,50597,N,1,,CHEMBL623686,,BAO_0000218,178.0
9884,Stomach,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL623687,,BAO_0000218,945.0
9885,Stomach,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL623688,,BAO_0000218,945.0
9886,Stomach,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL623689,,BAO_0000218,945.0
9887,Stomach,Intermediate,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622485,,BAO_0000218,945.0
9888,Thyroid gland,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622486,,BAO_0000218,2046.0
9889,Thyroid gland,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL877613,,BAO_0000218,2046.0
9890,Thyroid gland,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622487,,BAO_0000218,2046.0
9891,Thyroid gland,Intermediate,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622488,,BAO_0000218,2046.0
9892,Heart,Intermediate,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,,50597,N,1,,CHEMBL622489,,BAO_0000218,948.0
9893,Urine,Intermediate,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,,50597,N,1,,CHEMBL622490,,BAO_0000218,1088.0
9894,Urine,Intermediate,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,,,50597,N,1,,CHEMBL622491,,BAO_0000218,1088.0
9895,Liver,Intermediate,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,1,,,50597,N,1,,CHEMBL622492,,BAO_0000218,2107.0
9896,Urine,Intermediate,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,,50597,N,1,,CHEMBL622493,,BAO_0000218,1088.0
9897,Urine,Intermediate,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,,,50597,N,1,,CHEMBL622494,,BAO_0000218,1088.0
9898,Muscle tissue,Intermediate,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,,50597,N,1,,CHEMBL622495,,BAO_0000218,2385.0
9899,,Intermediate,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,1,,,50597,N,1,,CHEMBL622496,,BAO_0000218,
9900,Urine,Intermediate,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,,50597,N,1,,CHEMBL622497,,BAO_0000218,1088.0
9901,,Intermediate,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,1,,,50597,N,1,,CHEMBL622498,,BAO_0000218,
9902,Urine,Intermediate,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,1,,,50597,N,1,,CHEMBL624918,,BAO_0000218,1088.0
9903,Urine,Intermediate,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,1,,,50597,N,1,,CHEMBL624919,,BAO_0000218,1088.0
9904,Blood,Intermediate,Biodistribution of compound in rat blood after 5 min of administration,1,,,50597,N,1,,CHEMBL624920,,BAO_0000218,178.0
9905,Blood,Intermediate,Biodistribution of compound in rat blood after 5 min of administration.,1,,,50597,N,1,,CHEMBL624921,,BAO_0000218,178.0
9906,Brain,Intermediate,Biodistribution of compound in rat brain after 5 min of administration,1,,,50597,N,1,,CHEMBL624922,,BAO_0000218,955.0
9907,Heart,Intermediate,Biodistribution of compound in rat heart after 5 min of administration,1,,,50597,N,1,,CHEMBL624923,,BAO_0000218,948.0
9908,Heart,Intermediate,Biodistribution of compound in rat heart after 5 min of administration.,1,,,50597,N,1,,CHEMBL624924,,BAO_0000218,948.0
9909,Kidney,Intermediate,Biodistribution of compound in rat kidney after 5 min of administration,1,,,50597,N,1,,CHEMBL624925,,BAO_0000218,2113.0
9910,Kidney,Intermediate,Biodistribution of compound in rat kidney after 5 min of administration.,1,,,50597,N,1,,CHEMBL624926,,BAO_0000218,2113.0
9911,Liver,Intermediate,Biodistribution of compound in rat liver after 5 min of administration,1,,,50597,N,1,,CHEMBL624927,,BAO_0000218,2107.0
9912,Liver,Intermediate,Biodistribution of compound in rat liver after 5 min of administration.,1,,,50597,N,1,,CHEMBL874402,,BAO_0000218,2107.0
9913,Lung,Intermediate,Biodistribution of compound in rat lung after 5 min of administration,1,,,50597,N,1,,CHEMBL624928,,BAO_0000218,2048.0
9914,Lung,Intermediate,Biodistribution of compound in rat lung after 5 min of administration.,1,,,50597,N,1,,CHEMBL624929,,BAO_0000218,2048.0
9915,Muscle tissue,Intermediate,Biodistribution of compound in rat muscle after 5 min of administration,1,,,50597,N,1,,CHEMBL624930,,BAO_0000218,2385.0
9916,Muscle tissue,Intermediate,Biodistribution of compound in rat muscle after 5 min of administration.,1,,,50597,N,1,,CHEMBL624931,,BAO_0000218,2385.0
9917,Heart,Intermediate,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624932,,BAO_0000218,948.0
9918,Heart,Intermediate,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624933,,BAO_0000218,948.0
9919,Liver,Intermediate,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624934,,BAO_0000218,2107.0
9920,Liver,Intermediate,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624935,,BAO_0000218,2107.0
9921,,Intermediate,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624936,,BAO_0000218,
9922,,Intermediate,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624937,,BAO_0000218,
9923,Spleen,Intermediate,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624938,,BAO_0000218,2106.0
9924,Spleen,Intermediate,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624939,,BAO_0000218,2106.0
9925,,Intermediate,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL624940,,BAO_0000218,
9926,,Intermediate,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,50597,N,1,,CHEMBL874403,,BAO_0000218,
9927,,Intermediate,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,1,,,50597,N,1,,CHEMBL624941,,BAO_0000218,
9928,Urine,Intermediate,Dose required to lower urine osmolality to 300 mOsm/kg in rat,1,,,50597,N,1,,CHEMBL624942,,BAO_0000218,1088.0
9929,Urine,Intermediate,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,1,,,50597,N,1,,CHEMBL624943,,BAO_0000218,1088.0
9930,,Intermediate,% Bioavailability after 1 day of the drug administration in rats,1,,,50597,N,1,,CHEMBL624944,,BAO_0000218,
9931,,Intermediate,% Bioavailability after 4 day of the drug administration in rats,1,,,50597,N,1,,CHEMBL624945,,BAO_0000218,
9932,,Intermediate,Absolute bioavailability was evaluated in rat,1,,,50597,N,1,,CHEMBL624946,,BAO_0000218,
9933,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,1,,,50597,N,1,,CHEMBL624947,,BAO_0000218,
9934,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,1,,,50597,N,1,,CHEMBL624948,,BAO_0000218,
9935,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,1,,,50597,N,1,,CHEMBL624949,,BAO_0000218,
9936,Kidney,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL622025,,BAO_0000218,2113.0
9937,Kidney,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,1,,,50597,N,1,,CHEMBL622026,,BAO_0000218,2113.0
9938,Kidney,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,1,,,50597,N,1,,CHEMBL622027,,BAO_0000218,2113.0
9939,Kidney,Intermediate,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,1,,,50597,N,1,,CHEMBL622028,,BAO_0000218,2113.0
9940,Liver,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL622029,,BAO_0000218,2107.0
9941,Liver,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,1,,,50597,N,1,,CHEMBL622208,,BAO_0000218,2107.0
9942,Liver,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,1,,,50597,N,1,,CHEMBL622209,,BAO_0000218,2107.0
9943,Liver,Intermediate,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,1,,,50597,N,1,,CHEMBL622210,,BAO_0000218,2107.0
9944,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL622211,,BAO_0000218,
9945,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,1,,,50597,N,1,,CHEMBL622212,,BAO_0000218,
9946,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,1,,,50597,N,1,,CHEMBL622213,,BAO_0000218,
9947,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,1,,,50597,N,1,,CHEMBL874404,,BAO_0000218,
9948,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL620452,,BAO_0000218,2385.0
9949,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,1,,,50597,N,1,,CHEMBL620453,,BAO_0000218,2385.0
9950,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,1,,,50597,N,1,,CHEMBL620454,,BAO_0000218,2385.0
9951,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,1,,,50597,N,1,,CHEMBL624067,,BAO_0000218,2385.0
9952,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL624068,,BAO_0000218,
9953,Female gonad,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,1,,,50597,N,1,,CHEMBL624069,,BAO_0000218,992.0
9954,Female gonad,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,1,,,50597,N,1,,CHEMBL624070,,BAO_0000218,992.0
9955,Female gonad,Intermediate,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,1,,,50597,N,1,,CHEMBL624071,,BAO_0000218,992.0
9956,Uterus,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL624072,,BAO_0000218,995.0
9957,Uterus,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,1,,,50597,N,1,,CHEMBL624073,,BAO_0000218,995.0
9958,Uterus,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,1,,,50597,N,1,,CHEMBL624788,,BAO_0000218,995.0
9959,Uterus,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,1,,,50597,N,1,,CHEMBL624789,,BAO_0000218,995.0
9960,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL624790,,BAO_0000218,
9961,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,1,,,50597,N,1,,CHEMBL624791,,BAO_0000218,
9962,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,1,,,50597,N,1,,CHEMBL624792,,BAO_0000218,
9963,,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,1,,,50597,N,1,,CHEMBL624793,,BAO_0000218,
9964,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,1,,,50597,N,1,,CHEMBL877491,,BAO_0000218,2385.0
9965,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,1,,,50597,N,1,,CHEMBL624957,,BAO_0000218,2385.0
9966,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,1,,,50597,N,1,,CHEMBL624958,,BAO_0000218,2385.0
9967,Muscle tissue,Intermediate,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,1,,,50597,N,1,,CHEMBL624959,,BAO_0000218,2385.0
9968,,Intermediate,Dissociation constant was determined,1,,,50597,N,1,,CHEMBL624960,,BAO_0000218,
9969,,Intermediate,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",1,,,50597,N,1,,CHEMBL624961,,BAO_0000218,
9970,,Intermediate,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL624962,,BAO_0000218,
9971,,Intermediate,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL624963,,BAO_0000218,
9972,,Intermediate,Observed rate constant in 80% rat plasma at 37 degree Centigrade,1,,,50597,N,1,,CHEMBL624964,,BAO_0000218,
9973,,Intermediate,LogP value was evaluated in the in situ rat gut perfusion assay,1,,,50597,N,1,,CHEMBL624965,,BAO_0000218,
9974,,Intermediate,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,50597,N,1,,CHEMBL624966,,BAO_0000218,
9975,,Intermediate,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,1,,,50597,N,1,,CHEMBL624967,,BAO_0000218,
9976,,Intermediate,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,1,,,50597,N,1,,CHEMBL624968,,BAO_0000218,
9977,,Intermediate,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL624969,,BAO_0000218,
9978,,Expert,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,1,,,50597,N,1,,CHEMBL624970,,BAO_0000218,
9979,,Intermediate,Half-life was evaluated after 10 uM/kg of intra arterial administration,1,,,50597,N,1,,CHEMBL624971,,BAO_0000218,
9980,,Intermediate,Half-life was evaluated after 20 uM/kg of peroral administration,1,,,50597,N,1,,CHEMBL624972,,BAO_0000218,
9981,,Intermediate,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL624973,,BAO_0000218,
9982,Plasma,Intermediate,Half-life was evaluated in plasma of rat,1,,,50597,N,1,,CHEMBL624974,,BAO_0000218,1969.0
9983,,Intermediate,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL624975,,BAO_0000218,
9984,,Intermediate,Half-life was evaluated in rats at an oral dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL877492,,BAO_0000218,
9985,,Intermediate,Half-life was measured in rat after an iv dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL624976,,BAO_0000218,
9986,,Intermediate,Half-life period of compound in rats after peroral administration,1,,,50597,N,1,,CHEMBL624977,,BAO_0000218,
9987,Plasma,Intermediate,Half-life period of compound was measured in rat plasma.,1,,,50597,N,1,,CHEMBL626848,,BAO_0000218,1969.0
9988,Plasma,Intermediate,Half-life period of compound was measured in rat plasma; ND is not determined,1,,,50597,N,1,,CHEMBL626849,,BAO_0000218,1969.0
9989,Plasma,Intermediate,Half-life period of compound was measured in rat plasma; not determined,1,,,50597,N,1,,CHEMBL626850,,BAO_0000218,1969.0
9990,,Intermediate,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,50597,N,1,,CHEMBL626851,,BAO_0000218,
9991,,Intermediate,Half-life period in rat by iv administration,1,,,50597,N,1,,CHEMBL626852,,BAO_0000218,
9992,,Intermediate,Half-life period in rats following intravenous administration at 2 mg/kg,1,,,50597,N,1,,CHEMBL626853,,BAO_0000218,
9993,,Intermediate,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,50597,N,1,,CHEMBL626854,,BAO_0000218,
9994,,Intermediate,Half-life period was determined for the compound in rat,1,,,50597,N,1,,CHEMBL627486,,BAO_0000218,
9995,,Intermediate,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",1,,,50597,N,1,,CHEMBL627487,,BAO_0000218,
9996,,Intermediate,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",1,,,50597,N,1,,CHEMBL627488,,BAO_0000218,
9997,,Intermediate,Half-life value after IV dose at a dose of 5 mg/kg in rats.,1,,,50597,N,1,,CHEMBL627489,,BAO_0000218,
9998,,Intermediate,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL627490,,BAO_0000218,
9999,,Intermediate,Half-life was determined in rat after intravenous administration (0.5 mg/kg),1,,,50597,N,1,,CHEMBL873829,,BAO_0000218,
10000,,Intermediate,Half-life was determined in rat at a dose of 1 mpk i.v.,1,,,50597,N,1,,CHEMBL627655,,BAO_0000218,
10001,,Intermediate,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,,50597,N,1,,CHEMBL625994,,BAO_0000218,
10002,,Intermediate,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,,50597,N,1,,CHEMBL625995,,BAO_0000218,
10003,,Intermediate,Half-life in rat,1,,,50597,N,1,,CHEMBL625996,,BAO_0000218,
10004,Plasma,Intermediate,In vitro half life in rat plasma,1,,,50597,N,1,,CHEMBL625850,,BAO_0000218,1969.0
10005,Plasma,Intermediate,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",1,,,50597,N,1,,CHEMBL625851,,BAO_0000218,1969.0
10006,,Intermediate,In vitro half life in rat,1,,,50597,N,1,,CHEMBL625852,,BAO_0000218,
10007,,Intermediate,In vivo half life period after intravenous administration in rat,1,,,50597,N,1,,CHEMBL625853,,BAO_0000218,
10008,,Intermediate,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,50597,N,1,,CHEMBL625854,,BAO_0000218,
10009,,Intermediate,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,,50597,N,1,,CHEMBL874450,,BAO_0000218,
10010,,Intermediate,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625855,,BAO_0000218,
10011,,Intermediate,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625856,,BAO_0000218,
10012,,Intermediate,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625857,,BAO_0000218,
10013,,Intermediate,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL873831,,BAO_0000218,
10014,,Intermediate,Longer half-life in rat (i.v.) at 0.5 mpk,1,,,50597,N,1,,CHEMBL625858,,BAO_0000218,
10015,,Intermediate,Longer half-life in rat (p.o.) at 2.0 mpk,1,,,50597,N,1,,CHEMBL625859,,BAO_0000218,
10016,,Intermediate,Pharmacokinetic property (half life) in rat,1,,,50597,N,1,,CHEMBL625860,,BAO_0000218,
10017,,Intermediate,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL625861,,BAO_0000218,
10018,,Intermediate,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL625862,,BAO_0000218,
10019,,Intermediate,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL625863,,BAO_0000218,
10020,,Intermediate,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,1,,,50597,N,1,,CHEMBL625864,,BAO_0000218,
10021,,Intermediate,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,1,,,50597,N,1,,CHEMBL625865,,BAO_0000218,
10022,,Intermediate,Pharmacokinetic half time was determined intravenously in rats.,1,,,50597,N,1,,CHEMBL625866,,BAO_0000218,
10023,Plasma,Intermediate,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,1,,,50597,N,1,,CHEMBL625867,,BAO_0000218,1969.0
10024,Plasma,Intermediate,Plasma half life of hydrolysis of the compound,1,,,50597,N,1,,CHEMBL625868,,BAO_0000218,1969.0
10025,Plasma,Intermediate,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,1,,,50597,N,1,,CHEMBL625869,,BAO_0000218,1969.0
10026,Plasma,Intermediate,Plasma half life period was calculated in rat,1,,,50597,N,1,,CHEMBL874451,,BAO_0000218,1969.0
10027,Plasma,Intermediate,Plasma half-life in Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL625870,,BAO_0000218,1969.0
10028,Plasma,Intermediate,Plasma half-life in Sprague-Dawley rats; Not determined,1,,,50597,N,1,,CHEMBL625871,,BAO_0000218,1969.0
10029,Plasma,Intermediate,Plasma half-life in rats,1,,,50597,N,1,,CHEMBL625872,,BAO_0000218,1969.0
10030,Plasma,Intermediate,Plasma half-life in rats; <MQL,1,,,50597,N,1,,CHEMBL625873,,BAO_0000218,1969.0
10031,Plasma,Intermediate,Plasma half-life period (0-8 h) was determined,1,,,50597,N,1,,CHEMBL625874,,BAO_0000218,1969.0
10032,Plasma,Intermediate,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625875,,BAO_0000218,1969.0
10033,Plasma,Intermediate,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL625876,,BAO_0000218,1969.0
10034,Plasma,Intermediate,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL631258,,BAO_0000218,1969.0
10035,Plasma,Intermediate,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,1,,,50597,N,1,,CHEMBL631259,,BAO_0000218,1969.0
10036,Plasma,Intermediate,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,1,,,50597,N,1,,CHEMBL631260,,BAO_0000218,1969.0
10037,Blood,Intermediate,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",1,,,50597,N,1,,CHEMBL631261,,BAO_0000218,178.0
10038,Blood,Intermediate,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",1,,,50597,N,1,,CHEMBL631262,,BAO_0000218,178.0
10039,Blood,Intermediate,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",1,,,50597,N,1,,CHEMBL631263,,BAO_0000218,178.0
10040,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",1,,,50597,N,1,,CHEMBL631264,,BAO_0000218,
10041,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",1,,,50597,N,1,,CHEMBL631265,,BAO_0000218,
10042,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",1,,,50597,N,1,,CHEMBL631266,,BAO_0000218,
10043,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",1,,,50597,N,1,,CHEMBL631267,,BAO_0000218,
10044,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",1,,,50597,N,1,,CHEMBL631268,,BAO_0000218,
10045,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",1,,,50597,N,1,,CHEMBL631269,,BAO_0000218,
10046,,Intermediate,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",1,,,50597,N,1,,CHEMBL631270,,BAO_0000218,
10047,Heart,Intermediate,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,,,50597,N,1,,CHEMBL631271,,BAO_0000218,948.0
10048,Heart,Intermediate,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",1,,,50597,N,1,,CHEMBL631272,,BAO_0000218,948.0
10049,Heart,Intermediate,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",1,,,50597,N,1,,CHEMBL631273,,BAO_0000218,948.0
10050,Heart,Intermediate,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",1,,,50597,N,1,,CHEMBL631274,,BAO_0000218,948.0
10051,Heart,Intermediate,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",1,,,50597,N,1,,CHEMBL631275,,BAO_0000218,948.0
10052,Heart,Intermediate,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",1,,,50597,N,1,,CHEMBL626984,,BAO_0000218,948.0
10053,Heart,Intermediate,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",1,,,50597,N,1,,CHEMBL626985,,BAO_0000218,948.0
10054,Liver,Intermediate,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,,,50597,N,1,,CHEMBL626986,,BAO_0000218,2107.0
10055,Liver,Intermediate,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",1,,,50597,N,1,,CHEMBL626987,,BAO_0000218,2107.0
10056,Liver,Intermediate,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",1,,,50597,N,1,,CHEMBL626988,,BAO_0000218,2107.0
10057,Liver,Intermediate,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",1,,,50597,N,1,,CHEMBL626989,,BAO_0000218,2107.0
10058,Liver,Intermediate,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",1,,,50597,N,1,,CHEMBL626990,,BAO_0000218,2107.0
10059,Liver,Intermediate,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",1,,,50597,N,1,,CHEMBL626991,,BAO_0000218,2107.0
10060,Liver,Intermediate,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",1,,,50597,N,1,,CHEMBL626992,,BAO_0000218,2107.0
10061,Lung,Intermediate,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",1,,,50597,N,1,,CHEMBL626993,,BAO_0000218,2048.0
10062,Lung,Intermediate,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",1,,,50597,N,1,,CHEMBL874593,,BAO_0000218,2048.0
10063,Lung,Intermediate,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",1,,,50597,N,1,,CHEMBL626994,,BAO_0000218,2048.0
10064,Lung,Intermediate,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",1,,,50597,N,1,,CHEMBL626995,,BAO_0000218,2048.0
10065,Lung,Intermediate,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",1,,,50597,N,1,,CHEMBL626190,,BAO_0000218,2048.0
10066,Lung,Intermediate,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",1,,,50597,N,1,,CHEMBL626191,,BAO_0000218,2048.0
10067,Lung,Intermediate,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",1,,,50597,N,1,,CHEMBL626364,,BAO_0000218,2048.0
10068,Thyroid gland,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",1,,,50597,N,1,,CHEMBL626365,,BAO_0000218,2046.0
10069,Thyroid gland,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",1,,,50597,N,1,,CHEMBL626366,,BAO_0000218,2046.0
10070,Thyroid gland,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",1,,,50597,N,1,,CHEMBL626367,,BAO_0000218,2046.0
10071,Thyroid gland,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",1,,,50597,N,1,,CHEMBL626368,,BAO_0000218,2046.0
10072,Thyroid gland,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",1,,,50597,N,1,,CHEMBL626369,,BAO_0000218,2046.0
10073,Thyroid gland,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",1,,,50597,N,1,,CHEMBL626370,,BAO_0000218,2046.0
10074,,Intermediate,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",1,,,50597,N,1,,CHEMBL626371,,BAO_0000218,
10075,,Intermediate,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",1,,,50597,N,1,,CHEMBL626372,,BAO_0000218,
10076,,Intermediate,Bioavailability after a dose of 10 mg/kg p.o.,1,,,50597,N,1,,CHEMBL626373,,BAO_0000218,
10077,,Intermediate,Bioavailability after peroral administration (10 mg/kg) was determined in rat,1,,,50597,N,1,,CHEMBL626374,,BAO_0000218,
10078,,Intermediate,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,1,,,50597,N,1,,CHEMBL626375,,BAO_0000218,
10079,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL626376,,BAO_0000218,
10080,,Intermediate,Bioavailability in rat po was determined,1,,,50597,N,1,,CHEMBL626377,,BAO_0000218,
10081,,Intermediate,Bioavailability of compound at 10 mg/kg in rat after oral administration,1,,,50597,N,1,,CHEMBL626378,,BAO_0000218,
10082,,Intermediate,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,1,,,50597,N,1,,CHEMBL626379,,BAO_0000218,
10083,,Intermediate,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,50597,N,1,,CHEMBL626380,,BAO_0000218,
10084,,Intermediate,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,50597,N,1,,CHEMBL626381,,BAO_0000218,
10085,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL626382,,BAO_0000218,
10086,,Intermediate,Bioavailability in rat (Sprague-Dawley) (female),1,,,50597,N,1,,CHEMBL626383,,BAO_0000218,
10087,,Intermediate,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,50597,N,1,,CHEMBL874652,,BAO_0000218,
10088,,Intermediate,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),1,,,50597,N,1,,CHEMBL626384,,BAO_0000218,
10089,,Intermediate,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,1,,,50597,N,1,,CHEMBL626385,,BAO_0000218,
10090,,Intermediate,Bioavailability in rat at an oral dose of 2 mg/kg,1,,,50597,N,1,,CHEMBL626386,,BAO_0000218,
10091,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL626387,,BAO_0000218,
10092,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL626388,,BAO_0000218,
10093,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL626389,,BAO_0000218,
10094,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL626390,,BAO_0000218,
10095,,Intermediate,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,1,,,50597,N,1,,CHEMBL626391,,BAO_0000218,
10096,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL626392,,BAO_0000218,
10097,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL626393,,BAO_0000218,
10098,,Intermediate,Bioavailability was determined in rat,1,,,50597,N,1,,CHEMBL623026,,BAO_0000218,
10099,,Intermediate,Bioavailability,1,,,50597,N,1,,CHEMBL623027,,BAO_0000218,
10100,,Intermediate,Bioavailability,1,,,50597,N,1,,CHEMBL623028,,BAO_0000218,
10101,,Intermediate,Bioavailability in rat after 1 day dosing,1,,,50597,N,1,,CHEMBL623029,,BAO_0000218,
10102,,Intermediate,Bioavailability in rat after 4 day dosing,1,,,50597,N,1,,CHEMBL623030,,BAO_0000218,
10103,,Intermediate,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,1,,,50597,N,1,,CHEMBL623031,,BAO_0000218,
10104,,Intermediate,Bioavailability after IV dosing at 1 mg/kg in rat; no data,1,,,50597,N,1,,CHEMBL623032,,BAO_0000218,
10105,,Intermediate,Bioavailability after oral administration at a dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL623033,,BAO_0000218,
10106,,Intermediate,Bioavailability after oral administration at a dose of 4 mg/kg in rat,1,,,50597,N,1,,CHEMBL623034,,BAO_0000218,
10107,,Intermediate,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,1,,,50597,N,1,,CHEMBL623035,,BAO_0000218,
10108,,Intermediate,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,50597,N,1,,CHEMBL623036,,BAO_0000218,
10109,,Intermediate,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,50597,N,1,,CHEMBL623037,,BAO_0000218,
10110,,Intermediate,Bioavailability by intravenous administration of 3.4 mg/kg in rat,1,,,50597,N,1,,CHEMBL623038,,BAO_0000218,
10111,Plasma,Intermediate,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,1,,,50597,N,1,,CHEMBL874385,,BAO_0000218,1969.0
10112,,Intermediate,Bioavailability in rat (Fisher) (fasted),1,,,50597,N,1,,CHEMBL623039,,BAO_0000218,
10113,,Intermediate,Bioavailability in monkey after po administration of 10 mg/kg dose,1,,,22224,U,0,,CHEMBL623040,,BAO_0000218,
10114,,Intermediate,Oral bioavailability in monkey (dose 10 mg/kg),1,,,22224,U,0,,CHEMBL623041,,BAO_0000218,
10115,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL623741,,BAO_0000218,
10116,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL623742,,BAO_0000218,
10117,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL623743,,BAO_0000218,
10118,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL623744,,BAO_0000218,
10119,,Intermediate,Bioavailability in rat (dose 2.0 mg/kg p.o.),1,,,50597,N,1,,CHEMBL623745,,BAO_0000218,
10120,,Intermediate,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),1,,,50597,N,1,,CHEMBL623746,,BAO_0000218,
10121,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg p.o.),1,,,50597,N,1,,CHEMBL623747,,BAO_0000218,
10122,,Intermediate,Bioavailability in rat after po administration of 30 mg/kg dose,1,,,22224,U,0,,CHEMBL623748,,BAO_0000218,
10123,,Intermediate,Bioavailability in rat after po administration of 30 mg/kg dose,1,,,22224,U,0,,CHEMBL623916,,BAO_0000218,
10124,,Intermediate,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,50597,N,1,,CHEMBL623917,,BAO_0000218,
10125,,Intermediate,Bioavailability in rat (dose 2 mg/kg i.v.),1,,,50597,N,1,,CHEMBL623918,,BAO_0000218,
10126,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL874386,,BAO_0000218,
10127,Plasma,Intermediate,Bioavailability in rat; Only traces detected in rat plasma,1,,,50597,N,1,,CHEMBL623919,,BAO_0000218,1969.0
10128,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL623920,,BAO_0000218,
10129,,Intermediate,Bioavailability upon oral administration of compound,1,,,50597,N,1,,CHEMBL623148,,BAO_0000218,
10130,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),1,,,50597,N,1,,CHEMBL623149,,BAO_0000218,
10131,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL623150,,BAO_0000218,
10132,,Intermediate,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",1,,,50597,N,1,,CHEMBL623151,,BAO_0000218,
10133,,Intermediate,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",1,,,50597,N,1,,CHEMBL623152,,BAO_0000218,
10134,,Expert,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,1,,,50597,N,1,,CHEMBL623153,,BAO_0000218,
10135,,Expert,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,1,,,50597,N,1,,CHEMBL623154,,BAO_0000218,
10136,,Intermediate,In vitro and metabolic stability was determined,1,,,50597,N,1,,CHEMBL623155,,BAO_0000218,
10137,,Intermediate,In vitro metabolic stability in rat hepatocytes,1,,,50597,N,1,,CHEMBL623156,,BAO_0000218,
10138,,Intermediate,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,1,,,50597,N,1,,CHEMBL623157,,BAO_0000218,
10139,Liver,Intermediate,Metabolic rate for compound was observed in rat hepatocytes,1,,,50597,N,1,,CHEMBL623158,401.0,BAO_0000218,2107.0
10140,,Intermediate,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,1,,,50597,N,1,,CHEMBL623159,,BAO_0000218,
10141,,Intermediate,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),1,,,50597,N,1,,CHEMBL874390,,BAO_0000218,
10142,,Intermediate,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),1,,,50597,N,1,,CHEMBL623160,,BAO_0000218,
10143,,Intermediate,Metabolism of compound in rat S9 microsomes; Trace,1,,,50597,N,1,,CHEMBL623161,,BAO_0000218,
10144,,Intermediate,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,1,,,50597,N,1,,CHEMBL623162,,BAO_0000218,
10145,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,1,,,50597,N,1,,CHEMBL623163,,BAO_0000218,
10146,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,1,,,50597,N,1,,CHEMBL623164,,BAO_0000218,
10147,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,1,,,50597,N,1,,CHEMBL623165,,BAO_0000218,
10148,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,1,,,50597,N,1,,CHEMBL623166,,BAO_0000218,
10149,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,1,,,50597,N,1,,CHEMBL624983,,BAO_0000218,
10150,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,1,,,50597,N,1,,CHEMBL624984,,BAO_0000218,
10151,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,1,,,50597,N,1,,CHEMBL624985,,BAO_0000218,
10152,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,1,,,50597,N,1,,CHEMBL622970,,BAO_0000218,
10153,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,1,,,50597,N,1,,CHEMBL622971,,BAO_0000218,
10154,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,1,,,50597,N,1,,CHEMBL622972,,BAO_0000218,
10155,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,1,,,50597,N,1,,CHEMBL622973,,BAO_0000218,
10156,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,1,,,50597,N,1,,CHEMBL622974,,BAO_0000218,
10157,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,1,,,50597,N,1,,CHEMBL622975,,BAO_0000218,
10158,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,1,,,50597,N,1,,CHEMBL622976,,BAO_0000218,
10159,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,1,,,50597,N,1,,CHEMBL622977,,BAO_0000218,
10160,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,,,50597,N,1,,CHEMBL624351,,BAO_0000218,
10161,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,1,,,50597,N,1,,CHEMBL624352,,BAO_0000218,
10162,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,,,50597,N,1,,CHEMBL624353,,BAO_0000218,
10163,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,1,,,50597,N,1,,CHEMBL622397,,BAO_0000218,
10164,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,1,,,50597,N,1,,CHEMBL622398,,BAO_0000218,
10165,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,1,,,50597,N,1,,CHEMBL622399,,BAO_0000218,
10166,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,,,50597,N,1,,CHEMBL622400,,BAO_0000218,
10167,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,,,50597,N,1,,CHEMBL628428,,BAO_0000218,
10168,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,1,,,50597,N,1,,CHEMBL628590,,BAO_0000218,
10169,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,,,50597,N,1,,CHEMBL628591,,BAO_0000218,
10170,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,1,,,50597,N,1,,CHEMBL628592,,BAO_0000218,
10171,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,,,50597,N,1,,CHEMBL628593,,BAO_0000218,
10172,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,1,,,50597,N,1,,CHEMBL875333,,BAO_0000218,
10173,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,,,50597,N,1,,CHEMBL628594,,BAO_0000218,
10174,Plasma,Intermediate,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,1,,,50597,N,1,,CHEMBL628595,,BAO_0000218,1969.0
10175,Plasma,Intermediate,Stability in rat plasma was determined,1,,,50597,N,1,,CHEMBL628596,,BAO_0000218,1969.0
10176,Plasma,Intermediate,Stability in rat plasma was determined; ND= no data,1,,,50597,N,1,,CHEMBL628597,,BAO_0000218,1969.0
10177,Plasma,Intermediate,Tested for plasma half life period in rat (0-8 hr),1,,,50597,N,1,,CHEMBL628598,,BAO_0000218,1969.0
10178,Plasma,Intermediate,Tested for plasma half life period in rat (0-8 hr); Not determined,1,,,50597,N,1,,CHEMBL628599,,BAO_0000218,1969.0
10179,,Intermediate,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,1,,,50597,N,1,,CHEMBL628600,,BAO_0000218,
10180,,Intermediate,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,1,,,50597,N,1,,CHEMBL628601,,BAO_0000218,
10181,,Intermediate,Tested for the half life in rat,1,,,50597,N,1,,CHEMBL628602,,BAO_0000218,
10182,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,1,,,50597,N,1,,CHEMBL628603,,BAO_0000218,
10183,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,1,,,50597,N,1,,CHEMBL628604,,BAO_0000218,
10184,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,1,,,50597,N,1,,CHEMBL628605,,BAO_0000218,
10185,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,1,,,50597,N,1,,CHEMBL628606,,BAO_0000218,
10186,,Intermediate,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,1,,,50597,N,1,,CHEMBL628607,,BAO_0000218,
10187,,Intermediate,The biological half life the compound was measured at the dose of 100 umol/kg,1,,,50597,N,1,,CHEMBL628608,,BAO_0000218,
10188,,Intermediate,The biological half life the compound was measured at the dose of 30 umol/kg,1,,,50597,N,1,,CHEMBL628609,,BAO_0000218,
10189,Plasma,Intermediate,The compound was evaluated for plasma half life period in rat,1,,,50597,N,1,,CHEMBL628610,,BAO_0000218,1969.0
10190,,Intermediate,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL873819,,BAO_0000218,
10191,,Intermediate,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL628611,,BAO_0000218,
10192,,Intermediate,The pharmacokinetic parameter half-life period in vivo in rats,1,,,50597,N,1,,CHEMBL628612,,BAO_0000218,
10193,,Intermediate,"The pharmacokinetic property, Half-life was determined",1,,,50597,N,1,,CHEMBL628613,,BAO_0000218,
10194,,Intermediate,"The pharmacokinetic property, Half-life in rat in vivo",1,,,50597,N,1,,CHEMBL628614,,BAO_0000218,
10195,,Intermediate,"The pharmacokinetic property, Half-life was determined; ND denotes no data",1,,,50597,N,1,,CHEMBL628615,,BAO_0000218,
10196,,Intermediate,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",1,,,50597,N,1,,CHEMBL628616,,BAO_0000218,
10197,Plasma,Intermediate,The plasma half life period in rats,1,,,50597,N,1,,CHEMBL627924,,BAO_0000218,1969.0
10198,Liver,Intermediate,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,1,,,50597,N,1,,CHEMBL627925,,BAO_0000218,2107.0
10199,,Intermediate,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,,50597,N,1,,CHEMBL627926,,BAO_0000218,
10200,,Intermediate,t1/2 (apparent elimination)of the compound was determined,1,,,50597,N,1,,CHEMBL627927,,BAO_0000218,
10201,,Intermediate,t1/2 value in rat,1,,,50597,N,1,,CHEMBL627928,,BAO_0000218,
10202,,Intermediate,Half life in rat,1,,,50597,N,1,,CHEMBL627539,,BAO_0000218,
10203,Plasma,Intermediate,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,,,50597,N,1,,CHEMBL876790,,BAO_0000218,1969.0
10204,,Intermediate,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,1,,,50597,N,1,,CHEMBL858186,,BAO_0000218,
10205,,Intermediate,Half-life period in fasted rats,1,,,50597,N,1,,CHEMBL627540,,BAO_0000218,
10206,,Intermediate,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL627541,,BAO_0000218,
10207,,Intermediate,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL627715,,BAO_0000218,
10208,,Intermediate,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,,,50597,N,1,,CHEMBL627716,,BAO_0000218,
10209,,Intermediate,Maximum time required to achieve Cmax was determined in rat,1,,,50597,N,1,,CHEMBL627717,,BAO_0000218,
10210,,Intermediate,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,50597,N,1,,CHEMBL627718,,BAO_0000218,
10211,,Intermediate,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,50597,N,1,,CHEMBL627719,,BAO_0000218,
10212,,Intermediate,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,1,,,50597,N,1,,CHEMBL627720,,BAO_0000218,
10213,,Intermediate,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL627721,,BAO_0000218,
10214,,Intermediate,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,1,,,50597,N,1,,CHEMBL627722,,BAO_0000218,
10215,,Intermediate,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL627723,,BAO_0000218,
10216,,Intermediate,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626058,,BAO_0000218,
10217,,Intermediate,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626059,,BAO_0000218,
10218,,Intermediate,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL626060,,BAO_0000218,
10219,Plasma,Intermediate,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL626061,,BAO_0000218,1969.0
10220,,Intermediate,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL876791,,BAO_0000218,
10221,,Intermediate,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,50597,N,1,,CHEMBL626062,,BAO_0000218,
10222,,Intermediate,Tmax at the dose of 2 mg/Kg administered perorally in rats,1,,,50597,N,1,,CHEMBL626063,,BAO_0000218,
10223,,Intermediate,Tmax at the dose of 5 mg/Kg administered perorally in rats,1,,,50597,N,1,,CHEMBL626064,,BAO_0000218,
10224,Plasma,Intermediate,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL626065,,BAO_0000218,1969.0
10225,Plasma,Intermediate,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,1,,,50597,N,1,,CHEMBL626066,,BAO_0000218,1969.0
10226,,Intermediate,tmax upon peroral administration of 10.0 mg/Kg dose in rat,1,,,50597,N,1,,CHEMBL626067,,BAO_0000218,
10227,,Intermediate,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,1,,,50597,N,1,,CHEMBL626068,,BAO_0000218,
10228,,Intermediate,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,1,,,50597,N,1,,CHEMBL626069,,BAO_0000218,
10229,,Intermediate,Percent total excretion of 3-methoxyacetaminophen glucuronide,1,,,50597,N,1,,CHEMBL626070,,BAO_0000218,
10230,,Intermediate,Percent total excretion of N-methoxyacetaminophen glucuronide,1,,,50597,N,1,,CHEMBL626071,,BAO_0000218,
10231,,Intermediate,Percent total excretion of N-methoxyacetaminophen sulfate,1,,,50597,N,1,,CHEMBL626072,,BAO_0000218,
10232,,Intermediate,Percent total excretion of acetaminophen,1,,,50597,N,1,,CHEMBL626073,,BAO_0000218,
10233,Thyroid gland,Intermediate,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",1,,,50597,N,1,,CHEMBL626741,,BAO_0000218,2046.0
10234,,Intermediate,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",1,,,50597,N,1,,CHEMBL626742,,BAO_0000218,
10235,,Intermediate,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,1,,,50597,N,1,,CHEMBL626743,,BAO_0000218,
10236,,Intermediate,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,1,,,50597,N,1,,CHEMBL876792,,BAO_0000218,
10237,,Intermediate,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,,50597,N,1,,CHEMBL626744,,BAO_0000218,
10238,,Intermediate,Compound was tested for antidiuretic activity in rats,1,,,50597,N,1,,CHEMBL626745,,BAO_0000218,
10239,Plasma,Intermediate,AUC in rat after 3mg/kg oral dose,1,,,50597,N,1,,CHEMBL626746,,BAO_0000218,1969.0
10240,,Intermediate,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL626747,,BAO_0000218,
10241,,Intermediate,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,1,,,50597,N,1,,CHEMBL626748,,BAO_0000218,
10242,,Intermediate,Bioavailability administered orally at a dose of 10 mg/kg to rats,1,,,50597,N,1,,CHEMBL626749,,BAO_0000218,
10243,,Intermediate,Oral Bioavailability was determined,1,,,50597,N,1,,CHEMBL626750,,BAO_0000218,
10244,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL626751,,BAO_0000218,
10245,,Intermediate,Oral bioavailability in rat; Not performed.,1,,,50597,N,1,,CHEMBL626913,,BAO_0000218,
10246,,Intermediate,Bioavailability,1,,,50597,N,1,,CHEMBL626914,,BAO_0000218,
10247,,Intermediate,Bioavailability was determined; ND denotes no data,1,,,50597,N,1,,CHEMBL626915,,BAO_0000218,
10248,,Intermediate,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,1,,,50597,N,1,,CHEMBL626916,,BAO_0000218,
10249,,Intermediate,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,1,,,50597,N,1,,CHEMBL626917,,BAO_0000218,
10250,,Intermediate,Binding towards rat plasma protein at 10 uM,1,,,50597,N,1,,CHEMBL626918,,BAO_0000218,
10251,,Intermediate,Binding towards rat plasma protein at 100 uM,1,,,50597,N,1,,CHEMBL626919,,BAO_0000218,
10252,,Intermediate,Bioavailability in rat (dose 20 mg/kg p.o.),1,,,50597,N,1,,CHEMBL626920,,BAO_0000218,
10253,,Intermediate,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,,,50597,N,1,,CHEMBL621976,,BAO_0000218,
10254,,Intermediate,Bioavailability in rat after 5 mg/kg oral gavage,1,,,50597,N,1,,CHEMBL877599,,BAO_0000218,
10255,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL621977,,BAO_0000218,
10256,,Intermediate,Bioavailability in rat (dose 1 mg/kg i.v.),1,,,50597,N,1,,CHEMBL621978,,BAO_0000218,
10257,,Intermediate,Bioavailability in rat (dose 3 mg/kg p.o.),1,,,50597,N,1,,CHEMBL621979,,BAO_0000218,
10258,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL621980,,BAO_0000218,
10259,,Intermediate,Bioavailability of the compound in rats after administration of 30 mg/kg,1,,,50597,N,1,,CHEMBL621981,,BAO_0000218,
10260,,Intermediate,Bioavailability after administration of 10 mg/kg in rats,1,,,50597,N,1,,CHEMBL621982,,BAO_0000218,
10261,,Intermediate,Bioavailability after administration of 2 mg/kg in rats,1,,,50597,N,1,,CHEMBL882953,,BAO_0000218,
10262,,Intermediate,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,1,,,50597,N,1,,CHEMBL621983,,BAO_0000218,
10263,,Intermediate,Bioavailability in dogs was determined; high,1,,,50597,N,1,,CHEMBL621984,,BAO_0000218,
10264,,Intermediate,Bioavailability in monkey after intravenous administration at 1 mpk,1,,,50597,N,1,,CHEMBL621985,,BAO_0000218,
10265,,Intermediate,Bioavailability in monkey after peroral administration at 10 mpk,1,,,50597,N,1,,CHEMBL621986,,BAO_0000218,
10266,,Intermediate,Bioavailability in rat after intravenous administration at 1 mpk,1,,,50597,N,1,,CHEMBL621987,,BAO_0000218,
10267,,Intermediate,Bioavailability in rat after intravenous administration at 2 mpk,1,,,50597,N,1,,CHEMBL877600,,BAO_0000218,
10268,,Intermediate,Bioavailability in rat after peroral administration at 30 mpk,1,,,50597,N,1,,CHEMBL621988,,BAO_0000218,
10269,,Intermediate,Bioavailability in rat after peroral administration at at 100 mpk,1,,,50597,N,1,,CHEMBL621989,,BAO_0000218,
10270,,Intermediate,Bioavailability in rats was evaluated,1,,,50597,N,1,,CHEMBL621990,,BAO_0000218,
10271,,Intermediate,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,1,,,50597,N,1,,CHEMBL621991,,BAO_0000218,
10272,,Intermediate,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,1,,,50597,N,1,,CHEMBL621992,,BAO_0000218,
10273,,Intermediate,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,1,,,50597,N,1,,CHEMBL621993,,BAO_0000218,
10274,,Intermediate,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,1,,,50597,N,1,,CHEMBL621994,,BAO_0000218,
10275,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL621995,,BAO_0000218,
10276,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL621996,,BAO_0000218,
10277,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg),1,,,50597,N,1,,CHEMBL621997,,BAO_0000218,
10278,,Intermediate,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,,,50597,N,1,,CHEMBL621998,,BAO_0000218,
10279,,Intermediate,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,1,,,50597,N,1,,CHEMBL621999,,BAO_0000218,
10280,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622000,,BAO_0000218,
10281,,Intermediate,Bioavailability was measured in rat after oral administration; 2-4,1,,,50597,N,1,,CHEMBL622001,,BAO_0000218,
10282,,Intermediate,Bioavailability was measured in rat after oral administration; 3-7,1,,,50597,N,1,,CHEMBL622002,,BAO_0000218,
10283,,Intermediate,Bioavailability in rat (intraduodenal administration),1,,,50597,N,1,,CHEMBL622003,,BAO_0000218,
10284,,Intermediate,Bioavailability in rat (intraduodenal administration),1,,,50597,N,1,,CHEMBL877601,,BAO_0000218,
10285,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL624871,,BAO_0000218,
10286,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622004,,BAO_0000218,
10287,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),1,,,50597,N,1,,CHEMBL882954,,BAO_0000218,
10288,,Intermediate,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,1,,,50597,N,1,,CHEMBL622005,,BAO_0000218,
10289,,Intermediate,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,1,,,50597,N,1,,CHEMBL622006,,BAO_0000218,
10290,,Intermediate,Bioavailability was measured in rat,1,,,50597,N,1,,CHEMBL622007,,BAO_0000218,
10291,,Intermediate,Bioavailability was reported,1,,,50597,N,1,,CHEMBL622008,,BAO_0000218,
10292,,Intermediate,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,50597,N,1,,CHEMBL622009,,BAO_0000218,
10293,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL622010,,BAO_0000218,
10294,,Intermediate,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,,,50597,N,1,,CHEMBL622011,,BAO_0000218,
10295,,Intermediate,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),1,,,50597,N,1,,CHEMBL622012,,BAO_0000218,
10296,,Intermediate,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),1,,,50597,N,1,,CHEMBL622013,,BAO_0000218,
10297,,Intermediate,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL622014,,BAO_0000218,
10298,,Intermediate,Bioavailability was determined at 3 mg/kg po dose in rats,1,,,50597,N,1,,CHEMBL624749,,BAO_0000218,
10299,,Intermediate,Oral bioavailability in rat (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL624750,,BAO_0000218,
10300,,Intermediate,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL624751,,BAO_0000218,
10301,,Intermediate,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL624752,,BAO_0000218,
10302,,Intermediate,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,,50597,N,1,,CHEMBL624753,,BAO_0000218,
10303,,Intermediate,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL624754,,BAO_0000218,
10304,,Intermediate,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,,,50597,N,1,,CHEMBL624755,,BAO_0000218,
10305,,Intermediate,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL624756,,BAO_0000218,
10306,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL624757,,BAO_0000218,
10307,,Intermediate,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,,,50597,N,1,,CHEMBL624758,,BAO_0000218,
10308,,Intermediate,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL622270,,BAO_0000218,
10309,,Intermediate,Bioavailability in rat (Sprague-Dawley),1,,,50597,N,1,,CHEMBL622271,,BAO_0000218,
10310,,Intermediate,Bioavailability in rat at the dose of 2 mg/kg,1,,,50597,N,1,,CHEMBL622272,,BAO_0000218,
10311,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622273,,BAO_0000218,
10312,,Intermediate,Bioavailability in rat (cannulated) (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL622274,,BAO_0000218,
10313,,Intermediate,Bioavailability value of compound in rats was determined after peroral administration,1,,,50597,N,1,,CHEMBL622275,,BAO_0000218,
10314,,Intermediate,Oral bioavailability in rat (dose 20 mg/kg),1,,,50597,N,1,,CHEMBL622276,,BAO_0000218,
10315,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622277,,BAO_0000218,
10316,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg),1,,,50597,N,1,,CHEMBL622278,,BAO_0000218,
10317,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622279,,BAO_0000218,
10318,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622280,,BAO_0000218,
10319,,Intermediate,Compound was evaluated for oral bioavailability in rats; 15-27 %,1,,,50597,N,1,,CHEMBL624083,,BAO_0000218,
10320,,Intermediate,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,1,,,50597,N,1,,CHEMBL624084,,BAO_0000218,
10321,,Intermediate,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),1,,,50597,N,1,,CHEMBL624085,,BAO_0000218,
10322,,Intermediate,Compound was tested for bioavailability in rats,1,,,50597,N,1,,CHEMBL624086,,BAO_0000218,
10323,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL624087,,BAO_0000218,
10324,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL624088,,BAO_0000218,
10325,,Intermediate,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,1,,,22224,U,0,,CHEMBL624089,,BAO_0000218,
10326,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,22224,U,0,,CHEMBL624090,,BAO_0000218,
10327,,Intermediate,Evaluated for the bioavailability in rat (in vivo),1,,,50597,N,1,,CHEMBL624091,,BAO_0000218,
10328,,Intermediate,F value of compound in rats was determined after peroral administration,1,,,50597,N,1,,CHEMBL624092,,BAO_0000218,
10329,,Intermediate,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624093,,BAO_0000218,
10330,,Intermediate,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624094,,BAO_0000218,
10331,,Intermediate,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624095,,BAO_0000218,
10332,,Intermediate,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL624096,,BAO_0000218,
10333,,Intermediate,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",1,,,50597,N,1,,CHEMBL624097,,BAO_0000218,
10334,,Intermediate,Maximum fall in carotid flow in rat,1,,,50597,N,1,,CHEMBL624098,,BAO_0000218,
10335,,Intermediate,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,1,,,50597,N,1,,CHEMBL874392,,BAO_0000218,
10336,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg),1,,,50597,N,1,,CHEMBL624099,,BAO_0000218,
10337,,Intermediate,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL624100,,BAO_0000218,
10338,,Intermediate,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,50597,N,1,,CHEMBL624101,,BAO_0000218,
10339,,Intermediate,Oral bioavailability in rat (male Wistar),1,,,50597,N,1,,CHEMBL624102,,BAO_0000218,
10340,,Intermediate,Oral bioavailability after administration (30 mg/kg) in rat; good,1,,,50597,N,1,,CHEMBL624103,,BAO_0000218,
10341,,Intermediate,Oral bioavailability at the dose of 2 mg/kg in rat,1,,,50597,N,1,,CHEMBL624104,,BAO_0000218,
10342,,Intermediate,Oral bioavailability determined in rats,1,,,50597,N,1,,CHEMBL624105,,BAO_0000218,
10343,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),1,,,50597,N,1,,CHEMBL624106,,BAO_0000218,
10344,,Intermediate,Oral bioavailability in rat (dose single 10 mg/kg),1,,,50597,N,1,,CHEMBL624107,,BAO_0000218,
10345,,Intermediate,Oral bioavailability in rat (dose single 10 mg/kg),1,,,50597,N,1,,CHEMBL623943,,BAO_0000218,
10346,,Intermediate,Oral bioavailability in rat (dose 5 mg/kg,1,,,50597,N,1,,CHEMBL623944,,BAO_0000218,
10347,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,1,,,50597,N,1,,CHEMBL623945,,BAO_0000218,
10348,,Intermediate,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,1,,,50597,N,1,,CHEMBL623946,,BAO_0000218,
10349,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,1,,,50597,N,1,,CHEMBL623947,,BAO_0000218,
10350,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,1,,,50597,N,1,,CHEMBL623948,,BAO_0000218,
10351,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,1,,,50597,N,1,,CHEMBL623949,,BAO_0000218,
10352,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,1,,,50597,N,1,,CHEMBL623950,,BAO_0000218,
10353,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,1,,,50597,N,1,,CHEMBL874398,,BAO_0000218,
10354,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,1,,,50597,N,1,,CHEMBL623951,,BAO_0000218,
10355,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,1,,,50597,N,1,,CHEMBL623952,,BAO_0000218,
10356,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,1,,,50597,N,1,,CHEMBL623953,,BAO_0000218,
10357,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,1,,,50597,N,1,,CHEMBL623954,,BAO_0000218,
10358,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,1,,,50597,N,1,,CHEMBL623955,,BAO_0000218,
10359,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,1,,,50597,N,1,,CHEMBL623956,,BAO_0000218,
10360,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,1,,,50597,N,1,,CHEMBL627807,,BAO_0000218,
10361,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,1,,,50597,N,1,,CHEMBL627808,,BAO_0000218,
10362,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,1,,,50597,N,1,,CHEMBL627809,,BAO_0000218,
10363,,Intermediate,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,1,,,50597,N,1,,CHEMBL627810,,BAO_0000218,
10364,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",1,,,50597,N,1,,CHEMBL627811,,BAO_0000218,
10365,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",1,,,50597,N,1,,CHEMBL627812,,BAO_0000218,
10366,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",1,,,50597,N,1,,CHEMBL627813,,BAO_0000218,
10367,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",1,,,50597,N,1,,CHEMBL627814,,BAO_0000218,
10368,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",1,,,50597,N,1,,CHEMBL875336,,BAO_0000218,
10369,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",1,,,50597,N,1,,CHEMBL627815,,BAO_0000218,
10370,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",1,,,50597,N,1,,CHEMBL627816,,BAO_0000218,
10371,,Intermediate,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",1,,,50597,N,1,,CHEMBL627817,,BAO_0000218,
10372,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",1,,,50597,N,1,,CHEMBL627818,,BAO_0000218,
10373,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",1,,,50597,N,1,,CHEMBL627819,,BAO_0000218,
10374,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",1,,,50597,N,1,,CHEMBL627820,,BAO_0000218,
10375,,Intermediate,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",1,,,50597,N,1,,CHEMBL627821,,BAO_0000218,
10376,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,,,50597,N,1,,CHEMBL628464,,BAO_0000218,
10377,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,1,,,50597,N,1,,CHEMBL626239,,BAO_0000218,
10378,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,1,,,50597,N,1,,CHEMBL626240,,BAO_0000218,
10379,,Intermediate,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,1,,,50597,N,1,,CHEMBL626241,,BAO_0000218,
10380,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,1,,,50597,N,1,,CHEMBL626242,,BAO_0000218,
10381,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,1,,,50597,N,1,,CHEMBL626243,,BAO_0000218,
10382,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,,,50597,N,1,,CHEMBL626244,,BAO_0000218,
10383,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,1,,,50597,N,1,,CHEMBL626907,,BAO_0000218,
10384,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,,,50597,N,1,,CHEMBL626908,,BAO_0000218,
10385,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,,,50597,N,1,,CHEMBL626909,,BAO_0000218,
10386,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,,,50597,N,1,,CHEMBL626910,,BAO_0000218,
10387,,Intermediate,Percent total excretion of acetaminophen cysteine conjugate,1,,,50597,N,1,,CHEMBL875342,,BAO_0000218,
10388,,Intermediate,Percent total excretion of acetaminophen glucuronide,1,,,50597,N,1,,CHEMBL626911,,BAO_0000218,
10389,,Intermediate,Percent total excretion of acetaminophen sulfate,1,,,50597,N,1,,CHEMBL626912,,BAO_0000218,
10390,,Intermediate,Percent total excretion of acetaminophen-mercapturic acid,1,,,50597,N,1,,CHEMBL627065,,BAO_0000218,
10391,Urine,Intermediate,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,1,,,50597,N,1,,CHEMBL627066,,BAO_0000218,1088.0
10392,,Intermediate,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL627067,,BAO_0000218,
10393,Muscle tissue,Autocuration,Biodistribution of compound in rat muscle after 5 min of administration,1,,,22224,U,0,,CHEMBL627068,,BAO_0000218,2385.0
10394,Muscle tissue,Autocuration,Biodistribution of compound in rat muscle after 5 min of administration.,1,,,22224,U,0,,CHEMBL627069,,BAO_0000218,2385.0
10395,,Autocuration,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL627070,,BAO_0000218,
10396,,Autocuration,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL627071,,BAO_0000218,
10397,,Autocuration,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL627072,,BAO_0000218,
10398,,Autocuration,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL627073,,BAO_0000218,
10399,,Autocuration,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL625387,,BAO_0000218,
10400,,Autocuration,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL625388,,BAO_0000218,
10401,Plasma,Autocuration,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL625389,,BAO_0000218,1969.0
10402,Plasma,Autocuration,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,,22224,U,0,,CHEMBL875343,,BAO_0000218,1969.0
10403,,Intermediate,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),1,,,50497,N,1,,CHEMBL876795,,BAO_0000218,
10404,,Intermediate,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,1,,,50497,N,1,,CHEMBL626552,,BAO_0000218,
10405,,Intermediate,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,1,,,50497,N,1,,CHEMBL626553,,BAO_0000218,
10406,Plasma,Autocuration,The human biological plasma half life of the compound,1,,,22224,U,0,,CHEMBL626554,,BAO_0000366,1969.0
10407,Urine,Intermediate,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,,50597,N,1,,CHEMBL626555,,BAO_0000218,1088.0
10408,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,1,,,50597,N,1,,CHEMBL626556,,BAO_0000218,
10409,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,1,,,50597,N,1,,CHEMBL626557,,BAO_0000218,
10410,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,1,,,50597,N,1,,CHEMBL626558,,BAO_0000218,
10411,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,1,,,50597,N,1,,CHEMBL626559,,BAO_0000218,
10412,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,,50597,N,1,,CHEMBL626560,,BAO_0000218,
10413,,Intermediate,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,1,,,50597,N,1,,CHEMBL876803,,BAO_0000218,
10414,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,1,,,50597,N,1,,CHEMBL627964,,BAO_0000218,
10415,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,1,,,50597,N,1,,CHEMBL627965,,BAO_0000218,
10416,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,1,,,50597,N,1,,CHEMBL627966,,BAO_0000218,
10417,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,1,,,50597,N,1,,CHEMBL627967,,BAO_0000218,
10418,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,,50597,N,1,,CHEMBL627968,,BAO_0000218,
10419,,Intermediate,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,1,,,50597,N,1,,CHEMBL627969,,BAO_0000218,
10420,,Intermediate,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,,50597,N,1,,CHEMBL627970,,BAO_0000218,
10421,Blood,Intermediate,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,1,,,50597,N,1,,CHEMBL627971,,BAO_0000218,178.0
10422,Blood,Intermediate,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,1,,,50597,N,1,,CHEMBL627972,,BAO_0000218,178.0
10423,,Expert,Dissociation constant against binding to human cyclophilin A,1,,,180,D,9,,CHEMBL856029,,BAO_0000357,
10424,,Expert,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,1,,,11591,H,8,,CHEMBL627973,,BAO_0000019,
10425,,Autocuration,-Log C was determined by performing the electroshock minimum test,1,,,22224,U,0,,CHEMBL627974,,BAO_0000019,
10426,,Autocuration,-Log C was determined by performing the foot shock test,1,,,22224,U,0,,CHEMBL627975,,BAO_0000019,
10427,,Autocuration,-Log C was determined by performing the incl screen test,1,,,22224,U,0,,CHEMBL627976,,BAO_0000019,
10428,,Autocuration,-Log C was determined by performing the maximum electroshock test,1,,,22224,U,0,,CHEMBL627977,,BAO_0000019,
10429,,Autocuration,-Log C was determined by performing the pentylenetetrazole test,1,,,22224,U,0,,CHEMBL627978,,BAO_0000019,
10430,,Autocuration,Tested for experimental arotinoid inhibitory dose,1,,,22224,U,0,,CHEMBL627979,,BAO_0000019,
10431,,Autocuration,Negative log transformed activity,1,,,22224,U,0,,CHEMBL876804,,BAO_0000019,
10432,,Autocuration,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",1,,,22224,U,0,,CHEMBL627980,,BAO_0000019,
10433,,Intermediate,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,1,,,50512,N,1,,CHEMBL627981,,BAO_0000218,
10434,,Intermediate,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,1,,,50512,N,1,,CHEMBL627982,,BAO_0000218,
10435,,Intermediate,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,1,,,50512,N,1,,CHEMBL627983,,BAO_0000218,
10436,Ileum,Intermediate,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,1,,,50512,N,1,,CHEMBL627984,,BAO_0000218,2116.0
10437,,Autocuration,Solubility in water was determined; values expressed as -log,1,,,22229,U,0,,CHEMBL627985,,BAO_0000100,
10438,,Autocuration,Ratio of Kcat to that of Km was determined,1,,,22224,U,0,,CHEMBL627986,,BAO_0000019,
10439,,Autocuration,Observed first order rate constant,1,,,22224,U,0,,CHEMBL627987,,BAO_0000019,
10440,,Autocuration,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,1,,,22224,U,0,,CHEMBL627988,,BAO_0000019,
10441,,Intermediate,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,1,,,50597,N,1,,CHEMBL627989,,BAO_0000218,
10442,,Intermediate,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,1,,,50597,N,1,,CHEMBL627990,,BAO_0000218,
10443,,Intermediate,Oral Bioavailability after administration of 10 mg/kg in male rat,1,,,50597,N,1,,CHEMBL876805,,BAO_0000218,
10444,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),1,,,50597,N,1,,CHEMBL627991,,BAO_0000218,
10445,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL627992,,BAO_0000218,
10446,,Intermediate,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,,50597,N,1,,CHEMBL627993,,BAO_0000218,
10447,,Intermediate,Oral bioavailability at 1 mg/kg was determined in rat,1,,,50597,N,1,,CHEMBL622817,,BAO_0000218,
10448,,Intermediate,Oral bioavailability at 10 mg/kg was determined in rat,1,,,50597,N,1,,CHEMBL622818,,BAO_0000218,
10449,,Intermediate,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",1,,,50597,N,1,,CHEMBL622819,,BAO_0000218,
10450,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL872267,,BAO_0000218,
10451,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622820,,BAO_0000218,
10452,,Intermediate,Oral bioavailability after intravenous administration in rats at 24 uM/kg,1,,,50597,N,1,,CHEMBL622821,,BAO_0000218,
10453,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622822,,BAO_0000218,
10454,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622823,,BAO_0000218,
10455,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622824,,BAO_0000218,
10456,,Intermediate,Oral bioavailability in rat at a dose of 3 mg/kg,1,,,50597,N,1,,CHEMBL622825,,BAO_0000218,
10457,,Intermediate,Oral bioavailability in rat after oral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL622901,,BAO_0000218,
10458,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622902,,BAO_0000218,
10459,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL621844,,BAO_0000218,
10460,,Intermediate,Oral bioavailability in Dawley rats,1,,,50597,N,1,,CHEMBL621845,,BAO_0000218,
10461,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL621846,,BAO_0000218,
10462,,Intermediate,Oral bioavailability in rat (dose 30 mg/kg),1,,,50597,N,1,,CHEMBL621847,,BAO_0000218,
10463,,Intermediate,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,,,50597,N,1,,CHEMBL877609,,BAO_0000218,
10464,,Intermediate,Bioavailability in rat (dose 3 mg/kg i.v.),1,,,50597,N,1,,CHEMBL621848,,BAO_0000218,
10465,,Intermediate,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,,,50597,N,1,,CHEMBL621849,,BAO_0000218,
10466,,Intermediate,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,,,50597,N,1,,CHEMBL622030,,BAO_0000218,
10467,,Intermediate,Percent oral bioavailability determined in rats,1,,,50597,N,1,,CHEMBL622031,,BAO_0000218,
10468,,Intermediate,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,,50597,N,1,,CHEMBL622032,,BAO_0000218,
10469,,Intermediate,The compound was evaluated for bioavailability in rats; 32-51,1,,,50597,N,1,,CHEMBL622033,,BAO_0000218,
10470,,Intermediate,Bioavailability in rat (dose 20 mg/kg p.o.),1,,,50597,N,1,,CHEMBL622034,,BAO_0000218,
10471,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622035,,BAO_0000218,
10472,,Intermediate,Bioavailability percent in rat at the dose of 2 mg/kg,1,,,50597,N,1,,CHEMBL882966,,BAO_0000218,
10473,,Intermediate,Bioavailability was evaluated after 20 uM/kg of peroral administration,1,,,50597,N,1,,CHEMBL622036,,BAO_0000218,
10474,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622037,,BAO_0000218,
10475,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622038,,BAO_0000218,
10476,,Intermediate,Bioavailability in rats,1,,,50597,N,1,,CHEMBL622039,,BAO_0000218,
10477,Blood,Intermediate,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622040,,BAO_0000218,178.0
10478,Blood,Intermediate,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622041,,BAO_0000218,178.0
10479,Blood,Intermediate,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622042,,BAO_0000218,178.0
10480,Blood,Intermediate,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622043,,BAO_0000218,178.0
10481,Blood,Intermediate,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622044,,BAO_0000218,178.0
10482,Bone,Intermediate,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622045,,BAO_0000218,10000001.0
10483,Bone,Intermediate,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622046,,BAO_0000218,10000001.0
10484,Bone,Intermediate,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622047,,BAO_0000218,10000001.0
10485,Bone,Intermediate,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL877610,,BAO_0000218,10000001.0
10486,Brain,Intermediate,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622048,,BAO_0000218,955.0
10487,Brain,Intermediate,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622049,,BAO_0000218,955.0
10488,Brain,Intermediate,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622050,,BAO_0000218,955.0
10489,Brain,Intermediate,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622051,,BAO_0000218,955.0
10490,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622052,,BAO_0000218,
10491,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622053,,BAO_0000218,
10492,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622054,,BAO_0000218,
10493,,Intermediate,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622055,,BAO_0000218,
10494,,Intermediate,Oral bioavailability in rats was determined; High,1,,,50597,N,1,,CHEMBL622056,,BAO_0000218,
10495,,Intermediate,Oral bioavailability in the rat was determined,1,,,50597,N,1,,CHEMBL622057,,BAO_0000218,
10496,,Intermediate,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,1,,,50597,N,1,,CHEMBL628008,,BAO_0000218,
10497,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),1,,,50597,N,1,,CHEMBL622058,,BAO_0000218,
10498,,Intermediate,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL622059,,BAO_0000218,
10499,,Intermediate,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL622060,,BAO_0000218,
10500,,Intermediate,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL622061,,BAO_0000218,
10501,,Intermediate,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,50597,N,1,,CHEMBL622062,,BAO_0000218,
10502,,Intermediate,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,1,,,50597,N,1,,CHEMBL622063,,BAO_0000218,
10503,,Expert,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL877611,,BAO_0000218,
10504,,Intermediate,Oral bioavailability of compound in Sprague Dawley rats,1,,,50597,N,1,,CHEMBL622064,,BAO_0000218,
10505,,Intermediate,Oral bioavailability of compound in rat,1,,,50597,N,1,,CHEMBL622065,,BAO_0000218,
10506,,Intermediate,Oral bioavailability in rat (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL622066,,BAO_0000218,
10507,,Intermediate,Oral bioavailability of compound in rat was determined,1,,,50597,N,1,,CHEMBL622067,,BAO_0000218,
10508,,Intermediate,Oral bioavailability of compound in rats,1,,,50597,N,1,,CHEMBL622068,,BAO_0000218,
10509,,Intermediate,Oral bioavailability of compound was determined in rats,1,,,50597,N,1,,CHEMBL622069,,BAO_0000218,
10510,,Intermediate,Oral bioavailability at a dose of 30 mg/kg in rats,1,,,50597,N,1,,CHEMBL624796,,BAO_0000218,
10511,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg),1,,,50597,N,1,,CHEMBL624797,,BAO_0000218,
10512,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg),1,,,50597,N,1,,CHEMBL623053,,BAO_0000218,
10513,,Intermediate,Oral bioavailability evaluated in rat,1,,,50597,N,1,,CHEMBL623054,,BAO_0000218,
10514,,Intermediate,Oral bioavailability in fasted rat,1,,,50597,N,1,,CHEMBL623055,,BAO_0000218,
10515,,Intermediate,Oral bioavailability in fed rat,1,,,50597,N,1,,CHEMBL623056,,BAO_0000218,
10516,,Intermediate,Oral bioavailability in rat (mature male) (dose 30 mg/kg),1,,,50597,N,1,,CHEMBL623057,,BAO_0000218,
10517,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623058,,BAO_0000218,
10518,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,,,50597,N,1,,CHEMBL623059,,BAO_0000218,
10519,,Intermediate,Oral bioavailability in rat after administration of 10 mg/kg po,1,,,50597,N,1,,CHEMBL623060,,BAO_0000218,
10520,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623061,,BAO_0000218,
10521,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623062,,BAO_0000218,
10522,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623063,,BAO_0000218,
10523,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623064,,BAO_0000218,
10524,,Intermediate,Oral bioavailability in ratrs,1,,,50597,N,1,,CHEMBL623065,,BAO_0000218,
10525,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623066,,BAO_0000218,
10526,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623067,,BAO_0000218,
10527,,Intermediate,Oral bioavailability in rats was determined; High,1,,,50597,N,1,,CHEMBL623068,,BAO_0000218,
10528,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623069,,BAO_0000218,
10529,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623070,,BAO_0000218,
10530,,Intermediate,Oral bioavailability was calculated in rat,1,,,50597,N,1,,CHEMBL623071,,BAO_0000218,
10531,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL623072,,BAO_0000218,
10532,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL623073,,BAO_0000218,
10533,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL623074,,BAO_0000218,
10534,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL623075,,BAO_0000218,
10535,,Intermediate,Oral bioavailability after i.v. administration,1,,,50597,N,1,,CHEMBL623076,,BAO_0000218,
10536,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,50597,N,1,,CHEMBL623077,,BAO_0000218,
10537,,Intermediate,Oral bioavailability in rat (Sprague-Dawley),1,,,50597,N,1,,CHEMBL623078,,BAO_0000218,
10538,,Intermediate,Oral bioavailability in Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL623079,,BAO_0000218,
10539,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,50597,N,1,,CHEMBL623080,,BAO_0000218,
10540,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL623081,,BAO_0000218,
10541,,Intermediate,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,1,,,50597,N,1,,CHEMBL623082,,BAO_0000218,
10542,,Intermediate,Oral bioavailability in fasted rat,1,,,50597,N,1,,CHEMBL874400,,BAO_0000218,
10543,,Intermediate,Oral bioavailability in fed rat,1,,,50597,N,1,,CHEMBL623083,,BAO_0000218,
10544,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623084,,BAO_0000218,
10545,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623085,,BAO_0000218,
10546,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623086,,BAO_0000218,
10547,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623087,,BAO_0000218,
10548,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623088,,BAO_0000218,
10549,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623089,,BAO_0000218,
10550,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623090,,BAO_0000218,
10551,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623091,,BAO_0000218,
10552,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623092,,BAO_0000218,
10553,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623093,,BAO_0000218,
10554,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL874401,,BAO_0000218,
10555,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623094,,BAO_0000218,
10556,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL623095,,BAO_0000218,
10557,,Intermediate,Oral bioavailability in rat after peroral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL623096,,BAO_0000218,
10558,,Intermediate,Oral bioavailability in rat after peroral administration at 5 mg/kg,1,,,50597,N,1,,CHEMBL624913,,BAO_0000218,
10559,,Intermediate,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),1,,,50597,N,1,,CHEMBL624914,,BAO_0000218,
10560,,Intermediate,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,1,,,50597,N,1,,CHEMBL624915,,BAO_0000218,
10561,,Intermediate,Oral bioavailability in rat; Not measured,1,,,50597,N,1,,CHEMBL624916,,BAO_0000218,
10562,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL624917,,BAO_0000218,
10563,,Intermediate,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,1,,,50597,N,1,,CHEMBL625157,,BAO_0000218,
10564,Liver,Intermediate,In vitro metabolic potential in rat liver microsomes,1,,,50597,N,1,,CHEMBL625158,,BAO_0000218,2107.0
10565,,Intermediate,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",1,,,50597,N,1,,CHEMBL625159,,BAO_0000218,
10566,,Intermediate,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",1,,,50597,N,1,,CHEMBL625160,,BAO_0000218,
10567,,Intermediate,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,1,,,50597,N,1,,CHEMBL625161,,BAO_0000218,
10568,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL625162,,BAO_0000218,
10569,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL625163,,BAO_0000218,
10570,,Intermediate,Oral bioavailability in rats at 10 mg/kg,1,,,50597,N,1,,CHEMBL625164,,BAO_0000218,
10571,,Intermediate,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,50597,N,1,,CHEMBL625165,,BAO_0000218,
10572,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL625166,,BAO_0000218,
10573,,Intermediate,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,1,,,50597,N,1,,CHEMBL625167,,BAO_0000218,
10574,,Intermediate,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,1,,,50597,N,1,,CHEMBL625168,,BAO_0000218,
10575,,Intermediate,Plasma clearance of the compound,1,,,50597,N,1,,CHEMBL625169,,BAO_0000218,
10576,,Intermediate,Plasma clearance at 10 mg/kg in rat upon intravenous administration,1,,,50597,N,1,,CHEMBL626264,,BAO_0000218,
10577,,Intermediate,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,1,,,50597,N,1,,CHEMBL626265,,BAO_0000218,
10578,Plasma,Intermediate,The compound was tested for plasma clearance in rat,1,,,50597,N,1,,CHEMBL626266,,BAO_0000218,1969.0
10579,Plasma,Intermediate,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,1,,,50597,N,1,,CHEMBL626267,,BAO_0000218,1969.0
10580,,Intermediate,Plasma concentration upon oral administration of 1 mg/Kg in rats,1,,,50597,N,1,,CHEMBL626268,,BAO_0000218,
10581,,Intermediate,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,1,,,50597,N,1,,CHEMBL626269,,BAO_0000218,
10582,,Intermediate,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,1,,,50597,N,1,,CHEMBL626270,,BAO_0000218,
10583,,Intermediate,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL626271,,BAO_0000218,
10584,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",1,,,50597,N,1,,CHEMBL626272,,BAO_0000218,
10585,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,,,50597,N,1,,CHEMBL626273,,BAO_0000218,
10586,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,,,50597,N,1,,CHEMBL875346,,BAO_0000218,
10587,,Intermediate,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",1,,,50597,N,1,,CHEMBL626274,,BAO_0000218,
10588,,Intermediate,Compound was tested for protein binding in rat plasma,1,,,50597,N,1,,CHEMBL626275,,BAO_0000218,
10589,,Intermediate,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,1,,,50597,N,1,,CHEMBL624646,,BAO_0000218,
10590,,Intermediate,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,1,,,50597,N,1,,CHEMBL624647,,BAO_0000218,
10591,Liver,Intermediate,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,1,,,50597,N,1,,CHEMBL624648,,BAO_0000218,2107.0
10592,,Intermediate,Area under curve ratio was determined (po/iv) in rat,1,,,50597,N,1,,CHEMBL624649,,BAO_0000218,
10593,,Intermediate,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL624650,,BAO_0000218,
10594,,Intermediate,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL624651,,BAO_0000218,
10595,,Intermediate,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL624652,,BAO_0000218,
10596,,Intermediate,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,1,,,50597,N,1,,CHEMBL624653,,BAO_0000218,
10597,,Intermediate,Ratio of AUCbrain to AUCplasma,1,,,50597,N,1,,CHEMBL624654,,BAO_0000218,
10598,,Intermediate,Ratio of brain to plasma,1,,,50597,N,1,,CHEMBL624655,,BAO_0000218,
10599,,Intermediate,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,1,,,50597,N,1,,CHEMBL624656,,BAO_0000218,
10600,,Intermediate,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,,,50597,N,1,,CHEMBL624657,,BAO_0000218,
10601,,Intermediate,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,,,50597,N,1,,CHEMBL624658,,BAO_0000218,
10602,,Intermediate,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,1,,,50597,N,1,,CHEMBL624659,,BAO_0000218,
10603,,Intermediate,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,1,,,50597,N,1,,CHEMBL624660,,BAO_0000218,
10604,,Intermediate,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,1,,,50597,N,1,,CHEMBL624661,,BAO_0000218,
10605,,Intermediate,Steady state brain :blood ratio was determined,1,,,50597,N,1,,CHEMBL624662,,BAO_0000218,
10606,,Intermediate,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL625199,,BAO_0000218,
10607,,Intermediate,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,,,50597,N,1,,CHEMBL625200,,BAO_0000218,
10608,,Intermediate,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,,50597,N,1,,CHEMBL625201,,BAO_0000218,
10609,,Intermediate,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,,,50597,N,1,,CHEMBL625202,,BAO_0000218,
10610,,Intermediate,Percentage recovery after 3h incubation with rat hapatocytes was determined,1,,,50597,N,1,,CHEMBL625203,,BAO_0000218,
10611,,Intermediate,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,1,,,50597,N,1,,CHEMBL625204,,BAO_0000218,
10612,,Intermediate,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,1,,,50597,N,1,,CHEMBL625205,,BAO_0000218,
10613,,Intermediate,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,1,,,50597,N,1,,CHEMBL625206,,BAO_0000218,
10614,,Autocuration,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",1,,,22224,U,0,,CHEMBL625207,,BAO_0000019,
10615,,Autocuration,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,1,,,22224,U,0,,CHEMBL625208,,BAO_0000019,
10616,,Intermediate,In vivo absorption in Caco-2 cell line monolayers was determined,1,,,50587,N,1,,CHEMBL625209,495.0,BAO_0000218,
10617,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625210,,BAO_0000100,
10618,,Intermediate,Area under curve was determine after peroral administration at 10 mpk in Rat,1,,,50597,N,1,,CHEMBL625211,,BAO_0000218,
10619,,Intermediate,Area under curve was determine after peroral administration at 10 mpk in Rhesus,1,,,50797,N,1,,CHEMBL625212,,BAO_0000218,
10620,,Intermediate,Area under curve was determine after peroral administration at 160 mpk in Rat,1,,,50597,N,1,,CHEMBL625213,,BAO_0000218,
10621,,Intermediate,Area under curve was determine after peroral administration at 20 mpk in Rat,1,,,50597,N,1,,CHEMBL625214,,BAO_0000218,
10622,,Intermediate,Area under curve was determine after peroral administration at 50 mpk in Rat,1,,,50597,N,1,,CHEMBL874542,,BAO_0000218,
10623,,Autocuration,Calculated partition coefficient (clogP) (AlogP),1,,,22229,U,0,,CHEMBL625215,,BAO_0000100,
10624,,Autocuration,Activated partial thromboplastin time measured,1,,,22224,U,0,,CHEMBL625216,,BAO_0000019,
10625,,Autocuration,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),1,,,22224,U,0,,CHEMBL625217,,BAO_0000100,
10626,,Autocuration,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),1,,,22224,U,0,,CHEMBL625218,,BAO_0000100,
10627,Plasma,Intermediate,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,1,,,50588,N,1,,CHEMBL622864,,BAO_0000218,1969.0
10628,Plasma,Intermediate,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,1,,,50597,N,1,,CHEMBL622865,,BAO_0000218,1969.0
10629,Plasma,Intermediate,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,1,,,50597,N,1,,CHEMBL622866,,BAO_0000218,1969.0
10630,Plasma,Intermediate,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,1,,,50588,N,1,,CHEMBL622867,,BAO_0000218,1969.0
10631,Plasma,Intermediate,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,1,,,50512,N,1,,CHEMBL876808,,BAO_0000218,1969.0
10632,Brain,Autocuration,AUC in brain,1,,,22224,U,0,,CHEMBL627725,,BAO_0000019,955.0
10633,Serum,Autocuration,AUC in serum,1,,,22224,U,0,,CHEMBL627726,,BAO_0000019,1977.0
10634,Plasma,Autocuration,AUC was determined,1,,,22224,U,0,,CHEMBL627727,,BAO_0000019,1969.0
10635,Plasma,Autocuration,AUC of the compound.,1,,,22224,U,0,,CHEMBL627728,,BAO_0000019,1969.0
10636,Plasma,Autocuration,AUC value (0-4 hr),1,,,22224,U,0,,CHEMBL627729,,BAO_0000019,1969.0
10637,Plasma,Autocuration,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",1,,,22224,U,0,,CHEMBL627730,,BAO_0000019,1969.0
10638,Plasma,Autocuration,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,1,,,22224,U,0,,CHEMBL627731,,BAO_0000019,1969.0
10639,Plasma,Autocuration,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",1,,,22224,U,0,,CHEMBL627732,,BAO_0000019,1969.0
10640,Plasma,Autocuration,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",1,,,22224,U,0,,CHEMBL627733,,BAO_0000019,1969.0
10641,Plasma,Intermediate,AUC(area under curve) was determined after intravenous administration in rats,1,,,50597,N,1,,CHEMBL627734,,BAO_0000218,1969.0
10642,Plasma,Intermediate,AUC(area under curve) was determined after oral administration in rats,1,,,50597,N,1,,CHEMBL627735,,BAO_0000218,1969.0
10643,Plasma,Intermediate,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,1,,,50512,N,1,,CHEMBL627736,,BAO_0000218,1969.0
10644,Plasma,Intermediate,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,1,,,50597,N,1,,CHEMBL876809,,BAO_0000218,1969.0
10645,,Autocuration,Area Under Curve after oral dosing of 100 uM/Kg,1,,,22224,U,0,,CHEMBL627737,,BAO_0000019,
10646,,Autocuration,Area Under Curve after oral dosing of 30 uM/Kg,1,,,22224,U,0,,CHEMBL627738,,BAO_0000019,
10647,,Autocuration,Area Under Curve was measured by ploting the graph between concentration verses time,1,,,22224,U,0,,CHEMBL627739,,BAO_0000019,
10648,,Intermediate,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,1,,,50588,N,1,,CHEMBL626143,,BAO_0000218,
10649,,Autocuration,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,1,,,22224,U,0,,CHEMBL626144,,BAO_0000218,
10650,,Intermediate,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,1,,,50592,N,1,,CHEMBL626145,,BAO_0000218,
10651,,Intermediate,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,1,,,50597,N,1,,CHEMBL626146,,BAO_0000218,
10652,Blood,Intermediate,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,1,,,50597,N,1,,CHEMBL626147,,BAO_0000218,178.0
10653,,Autocuration,Area under curve (AUC) was determined,1,,,22224,U,0,,CHEMBL626148,,BAO_0000019,
10654,,Autocuration,Area under curve (AUC) following ip administration at 1 mg/kg,1,,,22224,U,0,,CHEMBL626149,,BAO_0000218,
10655,,Autocuration,Area under curve (AUC) was determined; ND is Not determined,1,,,22224,U,0,,CHEMBL626150,,BAO_0000019,
10656,,Intermediate,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,1,,,50588,N,1,,CHEMBL626151,,BAO_0000218,
10657,,Intermediate,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,1,,,50588,N,1,,CHEMBL626152,,BAO_0000218,
10658,,Intermediate,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,1,,,50588,N,1,,CHEMBL626153,,BAO_0000218,
10659,,Autocuration,Area under curve (AUR) was determined,1,,,22224,U,0,,CHEMBL626154,,BAO_0000019,
10660,,Autocuration,Area under curve at 1 uM/dg administered intravenously,1,,,22224,U,0,,CHEMBL626155,,BAO_0000019,
10661,,Autocuration,Area under curve at 10 uM/dg administered perorally,1,,,22224,U,0,,CHEMBL626156,,BAO_0000019,
10662,,Autocuration,Area under curve at 2 uM/dg administered intravenously,1,,,22224,U,0,,CHEMBL626157,,BAO_0000019,
10663,,Autocuration,Area under curve at 20 uM/dg administered perorally,1,,,22224,U,0,,CHEMBL626158,,BAO_0000019,
10664,,Intermediate,Area under curve at a peroral dose of 3 mg/kg in dog,1,,,50588,N,1,,CHEMBL626159,,BAO_0000218,
10665,,Intermediate,Area under curve at a peroral dose of 3 mg/kg in rat,1,,,50597,N,1,,CHEMBL626160,,BAO_0000218,
10666,,Intermediate,Area under curve at an iv dose of 1 mg/kg in dog,1,,,50588,N,1,,CHEMBL626161,,BAO_0000218,
10667,,Intermediate,Area under curve at an iv dose of 1 mg/kg in rat,1,,,50597,N,1,,CHEMBL626162,,BAO_0000218,
10668,,Autocuration,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,1,,,22224,U,0,,CHEMBL626163,,BAO_0000019,
10669,,Autocuration,Area under curve gives the effective duration for the angiotensin II antagonist effect.,1,,,22224,U,0,,CHEMBL626164,,BAO_0000019,
10670,,Intermediate,Area under curve measured as conc vs time after intravenous administration to mice.,1,,,50594,N,1,,CHEMBL626165,,BAO_0000218,
10671,,Intermediate,Area under curve measured as conc vs time after peroral administration to mice.,1,,,50594,N,1,,CHEMBL626166,,BAO_0000218,
10672,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,,,50588,N,1,,CHEMBL626167,,BAO_0000218,
10673,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,1,,,50588,N,1,,CHEMBL626168,,BAO_0000218,
10674,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,1,,,50588,N,1,,CHEMBL877463,,BAO_0000218,
10675,,Intermediate,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,1,,,50588,N,1,,CHEMBL626169,,BAO_0000218,
10676,Heart,Intermediate,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626170,,BAO_0000218,948.0
10677,Heart,Intermediate,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626171,,BAO_0000218,948.0
10678,Heart,Intermediate,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626172,,BAO_0000218,948.0
10679,Heart,Intermediate,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626173,,BAO_0000218,948.0
10680,Kidney,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626174,,BAO_0000218,2113.0
10681,Kidney,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626175,,BAO_0000218,2113.0
10682,Kidney,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626176,,BAO_0000218,2113.0
10683,Kidney,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL626177,,BAO_0000218,2113.0
10684,Kidney,Intermediate,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622499,,BAO_0000218,2113.0
10685,Liver,Intermediate,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622500,,BAO_0000218,2107.0
10686,Liver,Intermediate,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622501,,BAO_0000218,2107.0
10687,Liver,Intermediate,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622502,,BAO_0000218,2107.0
10688,Liver,Intermediate,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL622503,,BAO_0000218,2107.0
10689,Liver,Intermediate,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL877614,,BAO_0000218,2107.0
10690,Lung,Intermediate,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL624839,,BAO_0000218,2048.0
10691,Lung,Intermediate,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL624840,,BAO_0000218,2048.0
10692,Lung,Intermediate,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL624841,,BAO_0000218,2048.0
10693,Lung,Intermediate,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL624842,,BAO_0000218,2048.0
10694,Muscle tissue,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL624843,,BAO_0000218,2385.0
10695,Muscle tissue,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL624844,,BAO_0000218,2385.0
10696,Muscle tissue,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL624845,,BAO_0000218,2385.0
10697,Muscle tissue,Intermediate,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,1,,,50597,N,1,,CHEMBL621904,,BAO_0000218,2385.0
10698,Blood,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL621905,,BAO_0000218,178.0
10699,Blood,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL874382,,BAO_0000218,178.0
10700,Blood,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL621906,,BAO_0000218,178.0
10701,Brain,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL621907,,BAO_0000218,955.0
10702,Brain,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622096,,BAO_0000218,955.0
10703,Brain,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622097,,BAO_0000218,955.0
10704,Heart,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622098,,BAO_0000218,948.0
10705,Heart,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622099,,BAO_0000218,948.0
10706,Heart,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622100,,BAO_0000218,948.0
10707,Kidney,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622101,,BAO_0000218,2113.0
10708,Kidney,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622102,,BAO_0000218,2113.0
10709,Kidney,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622103,,BAO_0000218,2113.0
10710,Liver,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622104,,BAO_0000218,2107.0
10711,Liver,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622105,,BAO_0000218,2107.0
10712,Liver,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622106,,BAO_0000218,2107.0
10713,Lung,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622107,,BAO_0000218,2048.0
10714,Lung,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622108,,BAO_0000218,2048.0
10715,Lung,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622109,,BAO_0000218,2048.0
10716,Muscle tissue,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622110,,BAO_0000218,2385.0
10717,Muscle tissue,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622111,,BAO_0000218,2385.0
10718,Muscle tissue,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL874383,,BAO_0000218,2385.0
10719,Zone of skin,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622112,,BAO_0000218,14.0
10720,Zone of skin,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622113,,BAO_0000218,14.0
10721,Zone of skin,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622114,,BAO_0000218,14.0
10722,Spleen,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622115,,BAO_0000218,2106.0
10723,Spleen,Intermediate,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,1,,,50597,N,1,,CHEMBL622116,,BAO_0000218,2106.0
10724,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622117,,BAO_0000218,
10725,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622118,,BAO_0000218,
10726,,Intermediate,Oral bioavailability in rats at 6 mg/kg,1,,,50597,N,1,,CHEMBL622119,,BAO_0000218,
10727,,Intermediate,Oral bioavailability in rat (dose 6 mg/kg),1,,,50597,N,1,,CHEMBL622120,,BAO_0000218,
10728,,Intermediate,Oral bioavailability in rats at 6 mg/kg dose; Not tested,1,,,50597,N,1,,CHEMBL622121,,BAO_0000218,
10729,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622122,,BAO_0000218,
10730,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622123,,BAO_0000218,
10731,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL622124,,BAO_0000218,
10732,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL622125,,BAO_0000218,
10733,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL622126,,BAO_0000218,
10734,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL620455,,BAO_0000218,
10735,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL620456,,BAO_0000218,
10736,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL620457,,BAO_0000218,
10737,,Intermediate,Oral bioavailability was evaluated; Not tested,1,,,50597,N,1,,CHEMBL620458,,BAO_0000218,
10738,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL620459,,BAO_0000218,
10739,,Intermediate,Oral bioavailability in rat by oral dosing,1,,,50597,N,1,,CHEMBL620460,,BAO_0000218,
10740,,Intermediate,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,,,50597,N,1,,CHEMBL620461,,BAO_0000218,
10741,,Intermediate,Oral bioavailability in rat (Sprague-Dawley),1,,,50597,N,1,,CHEMBL620462,,BAO_0000218,
10742,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,50597,N,1,,CHEMBL620463,,BAO_0000218,
10743,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,50597,N,1,,CHEMBL620464,,BAO_0000218,
10744,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,50597,N,1,,CHEMBL620465,,BAO_0000218,
10745,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),1,,,50597,N,1,,CHEMBL620466,,BAO_0000218,
10746,,Intermediate,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,1,,,50597,N,1,,CHEMBL620467,,BAO_0000218,
10747,,Intermediate,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,1,,,50597,N,1,,CHEMBL620468,,BAO_0000218,
10748,,Intermediate,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,1,,,50597,N,1,,CHEMBL620469,,BAO_0000218,
10749,,Intermediate,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,1,,,50597,N,1,,CHEMBL620470,,BAO_0000218,
10750,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL620471,,BAO_0000218,
10751,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL620472,,BAO_0000218,
10752,,Intermediate,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,1,,,50597,N,1,,CHEMBL620473,,BAO_0000218,
10753,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL620474,,BAO_0000218,
10754,,Intermediate,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),1,,,50597,N,1,,CHEMBL620475,,BAO_0000218,
10755,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL620476,,BAO_0000218,
10756,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL620477,,BAO_0000218,
10757,,Intermediate,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,1,,,50597,N,1,,CHEMBL620478,,BAO_0000218,
10758,,Intermediate,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,1,,,50597,N,1,,CHEMBL618768,,BAO_0000218,
10759,,Intermediate,Oral bioavailability in rat after oral administration at 13 mg/kg dose,1,,,50597,N,1,,CHEMBL618769,,BAO_0000218,
10760,,Intermediate,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,1,,,50597,N,1,,CHEMBL618770,,BAO_0000218,
10761,,Intermediate,Oral bioavailability (dose 20 mg/kg p.o.),1,,,50597,N,1,,CHEMBL618771,,BAO_0000218,
10762,,Intermediate,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,1,,,50597,N,1,,CHEMBL618772,,BAO_0000218,
10763,,Intermediate,Oral bioavailability in rat at 10 mg/kg of the compound,1,,,50597,N,1,,CHEMBL618773,,BAO_0000218,
10764,,Intermediate,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,,,50597,N,1,,CHEMBL875842,,BAO_0000218,
10765,,Intermediate,Bioavailability in rat (dose 3 mg/kg i.v.),1,,,50597,N,1,,CHEMBL618774,,BAO_0000218,
10766,,Intermediate,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,,,50597,N,1,,CHEMBL618775,,BAO_0000218,
10767,,Intermediate,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,,,50597,N,1,,CHEMBL618776,,BAO_0000218,
10768,,Intermediate,Percent bioavailability (F) in rats after iv administration,1,,,50597,N,1,,CHEMBL618777,,BAO_0000218,
10769,,Intermediate,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL618778,,BAO_0000218,
10770,,Intermediate,Bioavailability in rat (dose 5 uM/kg p.o.),1,,,50597,N,1,,CHEMBL618779,,BAO_0000218,
10771,,Intermediate,Oral bioavailability,1,,,50597,N,1,,CHEMBL618780,,BAO_0000218,
10772,,Intermediate,Bioavailability in rat (dose 2 mg/kg p.o.),1,,,50597,N,1,,CHEMBL618781,,BAO_0000218,
10773,,Intermediate,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,1,,,50597,N,1,,CHEMBL618782,,BAO_0000218,
10774,,Intermediate,Oral bioavailability in rat (dose 20 mg/kg),1,,,50597,N,1,,CHEMBL618783,,BAO_0000218,
10775,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL618784,,BAO_0000218,
10776,,Intermediate,Percent oral bioavailability evaluated in rat,1,,,50597,N,1,,CHEMBL618785,,BAO_0000218,
10777,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL618786,,BAO_0000218,
10778,,Intermediate,Percent oral bioavailability in rat; Not determined,1,,,50597,N,1,,CHEMBL618787,,BAO_0000218,
10779,,Intermediate,Oral bioavailability in rat,1,,,50597,N,1,,CHEMBL618788,,BAO_0000218,
10780,,Intermediate,Bioavailability in rat,1,,,50597,N,1,,CHEMBL618789,,BAO_0000218,
10781,,Intermediate,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),1,,,50597,N,1,,CHEMBL618790,,BAO_0000218,
10782,,Intermediate,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),1,,,50597,N,1,,CHEMBL618791,,BAO_0000218,
10783,,Intermediate,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,1,,,50597,N,1,,CHEMBL875843,,BAO_0000218,
10784,,Intermediate,Oral bioavailability in rat (dose 20 mg/kg p.o.),1,,,50597,N,1,,CHEMBL618792,,BAO_0000218,
10785,,Intermediate,Cmax at a dose of 30 mg/kg in rat,1,,,50597,N,1,,CHEMBL623395,,BAO_0000218,
10786,,Autocuration,Cmax in monkeys at a dose of 1 mg/kg,1,,,22224,U,0,,CHEMBL623396,,BAO_0000218,
10787,,Intermediate,Cmax in rat,1,,,50597,N,1,,CHEMBL623397,,BAO_0000218,
10788,,Intermediate,Cmax in rats at a dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL623398,,BAO_0000218,
10789,,Intermediate,Cmax was measured in mice after an oral dose of 50 mg/kg.,1,,,50594,N,1,,CHEMBL623399,,BAO_0000218,
10790,,Autocuration,"Cmax value at a dose of 12.7 uM/kg, po",1,,,22224,U,0,,CHEMBL623400,,BAO_0000218,
10791,,Autocuration,"Cmax value at a dose of 6.3 uM/kg, iv",1,,,22224,U,0,,CHEMBL623401,,BAO_0000218,
10792,,Autocuration,"Cmax value at a dose of 7.1 uM/kg, iv",1,,,22224,U,0,,CHEMBL623402,,BAO_0000218,
10793,,Autocuration,Cmax value of compound was determined after 1 hr,1,,,22224,U,0,,CHEMBL623403,,BAO_0000218,
10794,,Autocuration,Cmax value of the compound,1,,,22224,U,0,,CHEMBL623404,,BAO_0000218,
10795,,Intermediate,Cmax value administered intraintestinal in rats.,1,,,50597,N,1,,CHEMBL625997,,BAO_0000218,
10796,,Intermediate,Cmax value administered perorally was determined in rat; Not determined,1,,,50597,N,1,,CHEMBL625998,,BAO_0000218,
10797,,Autocuration,Cmax value at the dose of 2.3 mg/kg,1,,,22224,U,0,,CHEMBL625999,,BAO_0000218,
10798,,Autocuration,Cmax value at the dose of 5 mg/kg,1,,,22224,U,0,,CHEMBL626000,,BAO_0000218,
10799,,Autocuration,Cmax value in the period of 8 hr after dosing. ,1,,,22224,U,0,,CHEMBL626001,,BAO_0000218,
10800,,Autocuration,Cmax value at a oral dose of 20 mg/kg; Not tested,1,,,22224,U,0,,CHEMBL626002,,BAO_0000218,
10801,,Autocuration,Cmax value at a oral dose of 20 mg/kg,1,,,22224,U,0,,CHEMBL626003,,BAO_0000218,
10802,,Intermediate,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,,,50597,N,1,,CHEMBL626004,,BAO_0000218,
10803,,Intermediate,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,1,,,50512,N,1,,CHEMBL626005,,BAO_0000218,
10804,,Intermediate,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,1,,,50597,N,1,,CHEMBL626006,,BAO_0000218,
10805,Plasma,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,1,,,50597,N,1,,CHEMBL626007,,BAO_0000218,1969.0
10806,Plasma,Intermediate,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,1,,,50594,N,1,,CHEMBL626008,,BAO_0000218,1969.0
10807,Liver,Intermediate,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,1,,,50588,N,1,,CHEMBL626009,,BAO_0000218,2107.0
10808,,Intermediate,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,1,,,50588,N,1,,CHEMBL626010,,BAO_0000218,
10809,Blood,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,1,,,50594,N,1,,CHEMBL626011,,BAO_0000218,178.0
10810,Blood,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,1,,,50594,N,1,,CHEMBL626012,,BAO_0000218,178.0
10811,Blood,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,1,,,50594,N,1,,CHEMBL626013,,BAO_0000218,178.0
10812,Blood,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,1,,,50594,N,1,,CHEMBL626014,,BAO_0000218,178.0
10813,Blood,Intermediate,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,1,,,50594,N,1,,CHEMBL877496,,BAO_0000218,178.0
10814,,Intermediate,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,1,,,50588,N,1,,CHEMBL626015,,BAO_0000218,
10815,,Intermediate,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,1,,,50588,N,1,,CHEMBL626016,,BAO_0000218,
10816,,Intermediate,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,1,,,50588,N,1,,CHEMBL626017,,BAO_0000218,
10817,Plasma,Intermediate,Bioavailability as maximal plasma concentration in dogs,1,,,50588,N,1,,CHEMBL626018,,BAO_0000218,1969.0
10818,Plasma,Intermediate,Bioavailability as maximal plasma concentration in dogs,1,,,50588,N,1,,CHEMBL626692,,BAO_0000218,1969.0
10819,Plasma,Intermediate,Bioavailability as maximal plasma concentration in rats,1,,,50597,N,1,,CHEMBL626693,,BAO_0000218,1969.0
10820,Plasma,Autocuration,Bioavailability as maximal plasma concentration in rats,1,,,22224,U,0,,CHEMBL626694,,BAO_0000218,1969.0
10821,Blood,Intermediate,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,,50588,N,1,,CHEMBL626695,,BAO_0000218,178.0
10822,Blood,Intermediate,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,,50588,N,1,,CHEMBL626696,,BAO_0000218,178.0
10823,Blood,Intermediate,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,,50588,N,1,,CHEMBL626697,,BAO_0000218,178.0
10824,Blood,Intermediate,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,1,,,50588,N,1,,CHEMBL626859,,BAO_0000218,178.0
10825,Blood,Intermediate,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,,50588,N,1,,CHEMBL626860,,BAO_0000218,178.0
10826,Blood,Intermediate,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,,50588,N,1,,CHEMBL626861,,BAO_0000218,178.0
10827,,Intermediate,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,,50597,N,1,,CHEMBL626296,,BAO_0000218,
10828,,Autocuration,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,1,,,22224,U,0,,CHEMBL626297,,BAO_0000218,
10829,Plasma,Autocuration,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,1,,,22224,U,0,,CHEMBL626298,,BAO_0000218,1969.0
10830,Plasma,Intermediate,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",1,,,50597,N,1,,CHEMBL626299,,BAO_0000218,1969.0
10831,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,1,,,50597,N,1,,CHEMBL626300,,BAO_0000218,1969.0
10832,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,1,,,50597,N,1,,CHEMBL626301,,BAO_0000218,1969.0
10833,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,1,,,50597,N,1,,CHEMBL626962,,BAO_0000218,1969.0
10834,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,1,,,50597,N,1,,CHEMBL626963,,BAO_0000218,1969.0
10835,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,1,,,50597,N,1,,CHEMBL626964,,BAO_0000218,1969.0
10836,Plasma,Intermediate,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,1,,,100710,N,1,,CHEMBL626965,,BAO_0000218,1969.0
10837,Plasma,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,,50594,N,1,,CHEMBL626966,,BAO_0000218,1969.0
10838,Plasma,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,,50594,N,1,,CHEMBL626967,,BAO_0000218,1969.0
10839,Plasma,Intermediate,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,1,,,100710,N,1,,CHEMBL626968,,BAO_0000218,1969.0
10840,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,1,,,50597,N,1,,CHEMBL626969,,BAO_0000218,948.0
10841,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,1,,,50597,N,1,,CHEMBL627126,,BAO_0000218,948.0
10842,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,1,,,50597,N,1,,CHEMBL631276,,BAO_0000218,948.0
10843,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,1,,,50597,N,1,,CHEMBL631277,,BAO_0000218,948.0
10844,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,1,,,50597,N,1,,CHEMBL631278,,BAO_0000218,948.0
10845,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,1,,,50597,N,1,,CHEMBL874457,,BAO_0000218,948.0
10846,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,1,,,50597,N,1,,CHEMBL631279,,BAO_0000218,948.0
10847,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,1,,,50597,N,1,,CHEMBL631280,,BAO_0000218,948.0
10848,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,1,,,50597,N,1,,CHEMBL631281,,BAO_0000218,948.0
10849,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,1,,,50597,N,1,,CHEMBL631968,,BAO_0000218,948.0
10850,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,1,,,50597,N,1,,CHEMBL631969,,BAO_0000218,948.0
10851,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,1,,,50597,N,1,,CHEMBL631970,,BAO_0000218,948.0
10852,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,1,,,50597,N,1,,CHEMBL631971,,BAO_0000218,948.0
10853,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,1,,,50597,N,1,,CHEMBL631972,,BAO_0000218,948.0
10854,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,1,,,50597,N,1,,CHEMBL630435,,BAO_0000218,948.0
10855,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,1,,,50597,N,1,,CHEMBL630436,,BAO_0000218,948.0
10856,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,1,,,50597,N,1,,CHEMBL630437,,BAO_0000218,948.0
10857,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,1,,,50597,N,1,,CHEMBL630438,,BAO_0000218,948.0
10858,Heart,Intermediate,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,1,,,50597,N,1,,CHEMBL630439,,BAO_0000218,948.0
10859,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,1,,,50597,N,1,,CHEMBL630440,,BAO_0000218,2113.0
10860,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,1,,,50597,N,1,,CHEMBL630441,,BAO_0000218,2113.0
10861,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,1,,,50597,N,1,,CHEMBL630442,,BAO_0000218,2113.0
10862,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,1,,,50597,N,1,,CHEMBL625234,,BAO_0000218,2113.0
10863,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,1,,,50597,N,1,,CHEMBL625235,,BAO_0000218,2113.0
10864,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,1,,,50597,N,1,,CHEMBL625236,,BAO_0000218,2113.0
10865,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,1,,,50597,N,1,,CHEMBL625237,,BAO_0000218,2113.0
10866,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,1,,,50597,N,1,,CHEMBL626125,,BAO_0000218,2113.0
10867,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,1,,,50597,N,1,,CHEMBL626126,,BAO_0000218,2113.0
10868,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,1,,,50597,N,1,,CHEMBL626127,,BAO_0000218,2113.0
10869,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,1,,,50597,N,1,,CHEMBL626128,,BAO_0000218,2113.0
10870,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,1,,,50597,N,1,,CHEMBL626129,,BAO_0000218,2113.0
10871,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,1,,,50597,N,1,,CHEMBL626130,,BAO_0000218,2113.0
10872,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,1,,,50597,N,1,,CHEMBL626131,,BAO_0000218,2113.0
10873,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,1,,,50597,N,1,,CHEMBL626132,,BAO_0000218,2113.0
10874,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,1,,,50597,N,1,,CHEMBL626752,,BAO_0000218,2113.0
10875,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,1,,,50597,N,1,,CHEMBL626753,,BAO_0000218,2113.0
10876,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,1,,,50597,N,1,,CHEMBL626754,,BAO_0000218,2113.0
10877,Kidney,Intermediate,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,1,,,50597,N,1,,CHEMBL626755,,BAO_0000218,2113.0
10878,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,1,,,50597,N,1,,CHEMBL626756,,BAO_0000218,2107.0
10879,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,1,,,50597,N,1,,CHEMBL626757,,BAO_0000218,2107.0
10880,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,1,,,50597,N,1,,CHEMBL626758,,BAO_0000218,2107.0
10881,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,1,,,50597,N,1,,CHEMBL626759,,BAO_0000218,2107.0
10882,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,1,,,50597,N,1,,CHEMBL626760,,BAO_0000218,2107.0
10883,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL626394,,BAO_0000218,
10884,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL626395,,BAO_0000218,
10885,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL626396,,BAO_0000218,
10886,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL626397,,BAO_0000218,
10887,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,,50588,N,1,,CHEMBL626398,,BAO_0000218,
10888,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL626399,,BAO_0000218,
10889,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL874653,,BAO_0000218,
10890,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL626400,,BAO_0000218,
10891,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL626401,,BAO_0000218,
10892,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL626402,,BAO_0000218,
10893,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL626403,,BAO_0000218,
10894,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL626404,,BAO_0000218,
10895,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL626405,,BAO_0000218,
10896,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL625529,,BAO_0000218,
10897,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL625530,,BAO_0000218,
10898,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL625531,,BAO_0000218,
10899,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL625532,,BAO_0000218,
10900,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL625533,,BAO_0000218,
10901,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL875474,,BAO_0000218,
10902,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL625534,,BAO_0000218,
10903,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL625535,,BAO_0000218,
10904,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL625536,,BAO_0000218,
10905,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL625537,,BAO_0000218,
10906,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL625538,,BAO_0000218,
10907,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL625539,,BAO_0000218,
10908,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL625540,,BAO_0000218,
10909,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL625541,,BAO_0000218,
10910,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL625542,,BAO_0000218,
10911,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL625543,,BAO_0000218,
10912,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL625544,,BAO_0000218,
10913,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL625545,,BAO_0000218,
10914,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL625546,,BAO_0000218,
10915,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL625547,,BAO_0000218,
10916,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL625548,,BAO_0000218,
10917,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL625549,,BAO_0000218,
10918,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL625550,,BAO_0000218,
10919,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL625551,,BAO_0000218,
10920,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL875475,,BAO_0000218,
10921,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL625552,,BAO_0000218,
10922,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL625553,,BAO_0000218,
10923,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL625554,,BAO_0000218,
10924,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,,50588,N,1,,CHEMBL625555,,BAO_0000218,
10925,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL625556,,BAO_0000218,
10926,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL624986,,BAO_0000218,
10927,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL624987,,BAO_0000218,
10928,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL624988,,BAO_0000218,
10929,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,1,,,50588,N,1,,CHEMBL624989,,BAO_0000218,1637.0
10930,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,1,,,50588,N,1,,CHEMBL624990,,BAO_0000218,1637.0
10931,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,1,,,50588,N,1,,CHEMBL874391,,BAO_0000218,1637.0
10932,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,1,,,50588,N,1,,CHEMBL624991,,BAO_0000218,1637.0
10933,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,1,,,50588,N,1,,CHEMBL624992,,BAO_0000218,1637.0
10934,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,1,,,50588,N,1,,CHEMBL624993,,BAO_0000218,1637.0
10935,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,1,,,50588,N,1,,CHEMBL624994,,BAO_0000218,1637.0
10936,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,1,,,50588,N,1,,CHEMBL624995,,BAO_0000218,1637.0
10937,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,1,,,50588,N,1,,CHEMBL624996,,BAO_0000218,1637.0
10938,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,1,,,50588,N,1,,CHEMBL624997,,BAO_0000218,1637.0
10939,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,1,,,50588,N,1,,CHEMBL624998,,BAO_0000218,1637.0
10940,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,1,,,50588,N,1,,CHEMBL624999,,BAO_0000218,1637.0
10941,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,1,,,50588,N,1,,CHEMBL882955,,BAO_0000218,1637.0
10942,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,1,,,50588,N,1,,CHEMBL625000,,BAO_0000218,1637.0
10943,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,1,,,50588,N,1,,CHEMBL625001,,BAO_0000218,1637.0
10944,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,1,,,50588,N,1,,CHEMBL625089,,BAO_0000218,1637.0
10945,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,1,,,50588,N,1,,CHEMBL625090,,BAO_0000218,1637.0
10946,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,1,,,50588,N,1,,CHEMBL625091,,BAO_0000218,1637.0
10947,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,1,,,50588,N,1,,CHEMBL625092,,BAO_0000218,1637.0
10948,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,1,,,50588,N,1,,CHEMBL625093,,BAO_0000218,1637.0
10949,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,1,,,50588,N,1,,CHEMBL625094,,BAO_0000218,1637.0
10950,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,1,,,50588,N,1,,CHEMBL625095,,BAO_0000218,1637.0
10951,,Intermediate,Compound was evaluated for its bioavailability in the dogs,1,,,50588,N,1,,CHEMBL625096,,BAO_0000218,
10952,,Intermediate,Compound was evaluated for its bioavailability in the rats,1,,,50597,N,1,,CHEMBL625097,,BAO_0000218,
10953,,Autocuration,Compound was evaluated for oral bioavailability,1,,,22224,U,0,,CHEMBL882956,,BAO_0000218,
10954,,Intermediate,Compound was evaluated for percentage of Oral bioavailability in rats,1,,,50597,N,1,,CHEMBL625098,,BAO_0000218,
10955,,Autocuration,Bioavailability in guinea pig,1,,,22224,U,0,,CHEMBL625099,,BAO_0000218,
10956,,Intermediate,Compound was evaluated for the oral bioavailability in rat,1,,,50597,N,1,,CHEMBL625100,,BAO_0000218,
10957,,Intermediate,Compound was evaluated for the oral bioavailability in dog,1,,,50588,N,1,,CHEMBL625101,,BAO_0000218,
10958,,Intermediate,Compound was evaluated for the oral bioavailability in rat,1,,,50597,N,1,,CHEMBL874396,,BAO_0000218,
10959,,Autocuration,Bioavailability in dog (dosed i.v.),1,,,22224,U,0,,CHEMBL625102,,BAO_0000218,
10960,,Intermediate,Compound was tested for in vivo bioavailability in dog,1,,,50588,N,1,,CHEMBL625103,,BAO_0000218,
10961,,Intermediate,Compound was tested for in vivo bioavailability in hamsters,1,,,100712,N,1,,CHEMBL625104,,BAO_0000218,
10962,,Autocuration,Compound was tested for in vivo bioavailability in monkey,1,,,22224,U,0,,CHEMBL625105,,BAO_0000218,
10963,,Intermediate,Compound was tested for in vivo bioavailability in rat,1,,,50597,N,1,,CHEMBL625106,,BAO_0000218,
10964,,Autocuration,Oral bioavailability in mouse,1,,,22224,U,0,,CHEMBL625107,,BAO_0000218,
10965,,Intermediate,Compound was tested for percent of oral bioavailability in mice; 56-74,1,,,50594,N,1,,CHEMBL625108,,BAO_0000218,
10966,,Autocuration,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),1,,,22224,U,0,,CHEMBL625109,,BAO_0000218,
10967,,Autocuration,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),1,,,22224,U,0,,CHEMBL625110,,BAO_0000218,
10968,,Autocuration,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),1,,,22224,U,0,,CHEMBL625111,,BAO_0000218,
10969,,Intermediate,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),1,,,50594,N,1,,CHEMBL625112,,BAO_0000218,
10970,,Intermediate,Oral bioavailability in nude mice,1,,,50594,N,1,,CHEMBL875334,,BAO_0000218,
10971,,Autocuration,Bioavailability in monkey (i.d. dosing),1,,,22224,U,0,,CHEMBL628617,,BAO_0000218,
10972,,Autocuration,Bioavailability in rat,1,,,22224,U,0,,CHEMBL628618,,BAO_0000218,
10973,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,1,,,22224,U,0,,CHEMBL628619,,BAO_0000218,
10974,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,1,,,22224,U,0,,CHEMBL628620,,BAO_0000218,
10975,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,,100710,N,1,,CHEMBL628621,,BAO_0000218,
10976,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,,100710,N,1,,CHEMBL628622,,BAO_0000218,
10977,,Intermediate,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,,100710,N,1,,CHEMBL628623,,BAO_0000218,
10978,Plasma,Intermediate,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,1,,,100710,N,1,,CHEMBL628624,,BAO_0000218,1969.0
10979,Plasma,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,,50594,N,1,,CHEMBL628625,,BAO_0000218,1969.0
10980,Plasma,Intermediate,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,1,,,100710,N,1,,CHEMBL628626,,BAO_0000218,1969.0
10981,Plasma,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,,50594,N,1,,CHEMBL627041,,BAO_0000218,1969.0
10982,Plasma,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,,50594,N,1,,CHEMBL627042,,BAO_0000218,1969.0
10983,Plasma,Intermediate,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,,50594,N,1,,CHEMBL627043,,BAO_0000218,1969.0
10984,Plasma,Autocuration,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,1,,,22224,U,0,,CHEMBL627044,,BAO_0000218,1969.0
10985,Plasma,Intermediate,Cmax in mouse plasma,1,,,50594,N,1,,CHEMBL627045,,BAO_0000218,1969.0
10986,Plasma,Autocuration,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,1,,,22224,U,0,,CHEMBL627046,,BAO_0000218,1969.0
10987,Plasma,Intermediate,Maximal plasma concentration in rat,1,,,50597,N,1,,CHEMBL627047,,BAO_0000218,1969.0
10988,Plasma,Intermediate,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,1,,,50597,N,1,,CHEMBL627048,,BAO_0000218,1969.0
10989,,Intermediate,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,1,,,50597,N,1,,CHEMBL627049,,BAO_0000218,
10990,,Intermediate,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,1,,,50597,N,1,,CHEMBL627050,,BAO_0000218,
10991,,Intermediate,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,1,,,50597,N,1,,CHEMBL627051,,BAO_0000218,
10992,,Intermediate,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,1,,,50597,N,1,,CHEMBL627052,,BAO_0000218,
10993,,Intermediate,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,1,,,50597,N,1,,CHEMBL627053,,BAO_0000218,
10994,,Intermediate,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,1,,,50597,N,1,,CHEMBL627054,,BAO_0000218,
10995,,Intermediate,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL627055,,BAO_0000218,
10996,,Intermediate,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL627056,,BAO_0000218,
10997,,Intermediate,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,,,50594,N,1,,CHEMBL627057,,BAO_0000218,
10998,,Intermediate,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL627058,,BAO_0000218,
10999,,Intermediate,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,50594,N,1,,CHEMBL626211,,BAO_0000218,
11000,,Autocuration,Maximum Concentration of the compound.,1,,,22224,U,0,,CHEMBL626212,,BAO_0000218,
11001,,Intermediate,Maximum Concentration was measured after iv administration into Beagle dog,1,,,50588,N,1,,CHEMBL626213,,BAO_0000218,
11002,,Intermediate,Maximum Concentration was measured after iv administration into Beagle dog.,1,,,50588,N,1,,CHEMBL626214,,BAO_0000218,
11003,,Intermediate,Maximum Concentration was measured after po administration into Beagle dog,1,,,50588,N,1,,CHEMBL626215,,BAO_0000218,
11004,,Intermediate,Maximum Concentration was measured after po administration into Beagle dog.,1,,,50588,N,1,,CHEMBL626216,,BAO_0000218,
11005,Blood,Autocuration,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,1,,,22224,U,0,,CHEMBL626217,,BAO_0000218,178.0
11006,Blood,Autocuration,Maximum blood level reached after an iv dose of 12.2 uM/kg,1,,,22224,U,0,,CHEMBL626218,,BAO_0000218,178.0
11007,Blood,Autocuration,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,1,,,22224,U,0,,CHEMBL626219,,BAO_0000218,178.0
11008,Blood,Autocuration,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,1,,,22224,U,0,,CHEMBL626220,,BAO_0000218,178.0
11009,Blood,Autocuration,Maximum blood level reached after an oral dose of 5.0 mg/kg,1,,,22224,U,0,,CHEMBL626221,,BAO_0000218,178.0
11010,Blood,Autocuration,Maximum blood level reached at dose of 10.6 uM/kg orally,1,,,22224,U,0,,CHEMBL626222,,BAO_0000218,178.0
11011,,Intermediate,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,1,,,50512,N,1,,CHEMBL626223,,BAO_0000218,
11012,,Intermediate,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,1,,,50512,N,1,,CHEMBL626224,,BAO_0000218,
11013,Brain,Intermediate,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL626225,,BAO_0000218,955.0
11014,Brain,Intermediate,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL626226,,BAO_0000218,955.0
11015,Brain,Intermediate,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,1,,,50597,N,1,,CHEMBL626227,,BAO_0000218,955.0
11016,Brain,Intermediate,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL626228,,BAO_0000218,955.0
11017,,Intermediate,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL626229,,BAO_0000218,
11018,,Intermediate,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL626921,,BAO_0000218,
11019,,Intermediate,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,1,,,50597,N,1,,CHEMBL876793,,BAO_0000218,
11020,,Intermediate,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL625309,,BAO_0000218,
11021,,Intermediate,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,,,50278,N,1,,CHEMBL625310,,BAO_0000218,
11022,,Autocuration,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,1,,,22224,U,0,,CHEMBL625311,,BAO_0000218,
11023,,Intermediate,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,1,,,50597,N,1,,CHEMBL625312,,BAO_0000218,
11024,,Autocuration,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,1,,,22224,U,0,,CHEMBL625313,,BAO_0000218,
11025,,Intermediate,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,1,,,50594,N,1,,CHEMBL625314,,BAO_0000218,
11026,,Intermediate,Maximum concentration in male rats after iv administration of 20 mg/kg,1,,,50597,N,1,,CHEMBL625315,,BAO_0000218,
11027,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,1,,,50597,N,1,,CHEMBL625316,,BAO_0000218,2107.0
11028,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,1,,,50597,N,1,,CHEMBL625317,,BAO_0000218,2107.0
11029,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,1,,,50597,N,1,,CHEMBL625318,,BAO_0000218,2107.0
11030,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,1,,,50597,N,1,,CHEMBL625319,,BAO_0000218,2107.0
11031,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,1,,,50597,N,1,,CHEMBL625320,,BAO_0000218,2107.0
11032,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,1,,,50597,N,1,,CHEMBL625321,,BAO_0000218,2107.0
11033,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,1,,,50597,N,1,,CHEMBL625322,,BAO_0000218,2107.0
11034,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,1,,,50597,N,1,,CHEMBL876801,,BAO_0000218,2107.0
11035,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,1,,,50597,N,1,,CHEMBL625323,,BAO_0000218,2107.0
11036,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,1,,,50597,N,1,,CHEMBL625324,,BAO_0000218,2107.0
11037,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,1,,,50597,N,1,,CHEMBL625325,,BAO_0000218,2107.0
11038,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,1,,,50597,N,1,,CHEMBL625326,,BAO_0000218,2107.0
11039,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,1,,,50597,N,1,,CHEMBL625327,,BAO_0000218,2107.0
11040,Liver,Intermediate,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,1,,,50597,N,1,,CHEMBL625328,,BAO_0000218,2107.0
11041,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,1,,,50597,N,1,,CHEMBL625329,,BAO_0000218,2048.0
11042,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,1,,,50597,N,1,,CHEMBL625330,,BAO_0000218,2048.0
11043,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,1,,,50597,N,1,,CHEMBL627774,,BAO_0000218,2048.0
11044,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,1,,,50597,N,1,,CHEMBL627775,,BAO_0000218,2048.0
11045,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,1,,,50597,N,1,,CHEMBL627949,,BAO_0000218,2048.0
11046,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,1,,,50597,N,1,,CHEMBL627950,,BAO_0000218,2048.0
11047,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,1,,,50597,N,1,,CHEMBL627951,,BAO_0000218,2048.0
11048,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,1,,,50597,N,1,,CHEMBL627952,,BAO_0000218,2048.0
11049,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,1,,,50597,N,1,,CHEMBL627953,,BAO_0000218,2048.0
11050,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,1,,,50597,N,1,,CHEMBL627954,,BAO_0000218,2048.0
11051,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,1,,,50597,N,1,,CHEMBL627955,,BAO_0000218,2048.0
11052,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,1,,,50597,N,1,,CHEMBL627956,,BAO_0000218,2048.0
11053,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,1,,,50597,N,1,,CHEMBL876802,,BAO_0000218,2048.0
11054,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,1,,,50597,N,1,,CHEMBL627957,,BAO_0000218,2048.0
11055,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,1,,,50597,N,1,,CHEMBL627958,,BAO_0000218,2048.0
11056,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,1,,,50597,N,1,,CHEMBL627959,,BAO_0000218,2048.0
11057,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,1,,,50597,N,1,,CHEMBL627960,,BAO_0000218,2048.0
11058,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,1,,,50597,N,1,,CHEMBL627961,,BAO_0000218,2048.0
11059,Lung,Intermediate,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,1,,,50597,N,1,,CHEMBL627962,,BAO_0000218,2048.0
11060,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL627963,,BAO_0000218,
11061,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624759,,BAO_0000218,
11062,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624760,,BAO_0000218,
11063,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624761,,BAO_0000218,
11064,,Intermediate,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL877607,,BAO_0000218,
11065,Liver,Intermediate,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624762,,BAO_0000218,2107.0
11066,Liver,Intermediate,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624763,,BAO_0000218,2107.0
11067,Liver,Intermediate,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624764,,BAO_0000218,2107.0
11068,Liver,Intermediate,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624765,,BAO_0000218,2107.0
11069,Liver,Intermediate,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL624766,,BAO_0000218,2107.0
11070,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL624767,,BAO_0000218,
11071,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL624768,,BAO_0000218,
11072,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL624769,,BAO_0000218,
11073,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL624770,,BAO_0000218,
11074,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,,50588,N,1,,CHEMBL624771,,BAO_0000218,
11075,,Intermediate,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL624772,,BAO_0000218,
11076,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL624773,,BAO_0000218,
11077,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL624774,,BAO_0000218,
11078,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL624775,,BAO_0000218,
11079,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL624776,,BAO_0000218,
11080,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL624777,,BAO_0000218,
11081,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL624778,,BAO_0000218,
11082,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL624779,,BAO_0000218,
11083,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL624780,,BAO_0000218,
11084,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL624781,,BAO_0000218,
11085,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL877608,,BAO_0000218,
11086,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL624782,,BAO_0000218,
11087,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL624783,,BAO_0000218,
11088,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL624784,,BAO_0000218,
11089,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL624785,,BAO_0000218,
11090,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL624786,,BAO_0000218,
11091,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL624787,,BAO_0000218,
11092,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL628676,,BAO_0000218,
11093,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL621842,,BAO_0000218,
11094,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL621843,,BAO_0000218,
11095,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL623873,,BAO_0000218,
11096,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL623874,,BAO_0000218,
11097,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL623875,,BAO_0000218,
11098,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL623876,,BAO_0000218,
11099,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL623877,,BAO_0000218,
11100,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL623878,,BAO_0000218,
11101,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL623879,,BAO_0000218,
11102,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL623880,,BAO_0000218,
11103,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL623881,,BAO_0000218,
11104,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL623957,,BAO_0000218,
11105,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL623958,,BAO_0000218,
11106,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL623959,,BAO_0000218,
11107,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL623960,,BAO_0000218,
11108,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL623961,,BAO_0000218,
11109,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL623962,,BAO_0000218,
11110,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,,50588,N,1,,CHEMBL624676,,BAO_0000218,
11111,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL624677,,BAO_0000218,
11112,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL624678,,BAO_0000218,
11113,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL624679,,BAO_0000218,
11114,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL624680,,BAO_0000218,
11115,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,1,,,22224,U,0,,CHEMBL624849,,BAO_0000218,
11116,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,1,,,22224,U,0,,CHEMBL624850,,BAO_0000218,
11117,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,1,,,22224,U,0,,CHEMBL874399,,BAO_0000218,
11118,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,1,,,22224,U,0,,CHEMBL624851,,BAO_0000218,
11119,,Autocuration,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,1,,,22224,U,0,,CHEMBL624852,,BAO_0000218,
11120,,Autocuration,Oral bioavailability in rat (dose 10 mg/kg),1,,,22224,U,0,,CHEMBL624853,,BAO_0000218,
11121,,Autocuration,Oral bioavailability in rat (Sprague-Dawley),1,,,22224,U,0,,CHEMBL624854,,BAO_0000218,
11122,,Autocuration,Oral bioavailability in rat,1,,,22224,U,0,,CHEMBL624855,,BAO_0000218,
11123,,Autocuration,Oral bioavailability in rats was determined in vivo,1,,,22224,U,0,,CHEMBL624856,,BAO_0000218,
11124,,Autocuration,Oral bioavailability in dog,1,,,22224,U,0,,CHEMBL882957,,BAO_0000218,
11125,,Autocuration,Oral bioavailability of compound in monkey,1,,,22224,U,0,,CHEMBL624857,,BAO_0000218,
11126,,Intermediate,Oral bioavailability of compound in rat,1,,,50597,N,1,,CHEMBL622202,,BAO_0000218,
11127,,Autocuration,Bioavailability in rat of PMEA prodrug,1,,,22224,U,0,,CHEMBL622203,,BAO_0000218,
11128,,Intermediate,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,1,,,50597,N,1,,CHEMBL625522,,BAO_0000218,
11129,,Autocuration,Serum conc at 3 hours following 25 mg/kg dose,1,,,22224,U,0,,CHEMBL622868,,BAO_0000218,
11130,Urine,Autocuration,Urine conc 0-5 hours following 25 mg/kg dose,1,,,22224,U,0,,CHEMBL622869,,BAO_0000218,1088.0
11131,Urine,Autocuration,Urine conc 0-24 hours following 25 mg/kg dose,1,,,22224,U,0,,CHEMBL622870,,BAO_0000218,1088.0
11132,,Autocuration,Oral bioavailability in African green monkeys; 20-25,1,,,22224,U,0,,CHEMBL622871,,BAO_0000218,
11133,,Intermediate,Oral bioavailability in cynomolgus monkey.,1,,,100710,N,1,,CHEMBL620560,,BAO_0000218,
11134,,Autocuration,Oral bioavailability in dog,1,,,22224,U,0,,CHEMBL620561,,BAO_0000218,
11135,,Intermediate,Oral bioavailability in dog at 10 mg/kg oral dose,1,,,50588,N,1,,CHEMBL620562,,BAO_0000218,
11136,,Intermediate,Oral bioavailability in hamster at 10 mg/kg oral dose,1,,,100712,N,1,,CHEMBL620563,,BAO_0000218,
11137,,Intermediate,Oral bioavailability in rat at 10 mg/kg oral dose,1,,,50597,N,1,,CHEMBL620564,,BAO_0000218,
11138,,Autocuration,Oral bioavailability in rat,1,,,22224,U,0,,CHEMBL872265,,BAO_0000218,
11139,,Autocuration,Oral bioavailability in rat,1,,,22224,U,0,,CHEMBL620565,,BAO_0000218,
11140,,Autocuration,Oral bioavailability,1,,,22224,U,0,,CHEMBL620566,,BAO_0000218,
11141,,Autocuration,Oral bioavailability was determined; range 49-102%,1,,,22224,U,0,,CHEMBL620567,,BAO_0000218,
11142,,Intermediate,Oral bioavailability was determined in dogs,1,,,50588,N,1,,CHEMBL620568,,BAO_0000218,
11143,,Autocuration,Oral bioavailability in rat,1,,,22224,U,0,,CHEMBL620569,,BAO_0000218,
11144,,Autocuration,Oral bioavailability,1,,,22224,U,0,,CHEMBL620570,,BAO_0000218,
11145,,Autocuration,Oral bioavailability was determined; Not orally available,1,,,22224,U,0,,CHEMBL620571,,BAO_0000218,
11146,,Intermediate,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),1,,,50594,N,1,,CHEMBL620572,,BAO_0000218,
11147,,Autocuration,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),1,,,22224,U,0,,CHEMBL620573,,BAO_0000218,
11148,,Autocuration,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,1,,,22224,U,0,,CHEMBL620574,,BAO_0000218,
11149,,Autocuration,Oral bioavailability in Rhesus monkey,1,,,22224,U,0,,CHEMBL620575,,BAO_0000218,
11150,,Autocuration,Oral bioavailability in dog (female mongrel),1,,,22224,U,0,,CHEMBL620576,,BAO_0000218,
11151,,Autocuration,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,1,,,22224,U,0,,CHEMBL875846,,BAO_0000218,
11152,,Autocuration,Oral bioavailability in dog,1,,,22224,U,0,,CHEMBL620577,,BAO_0000218,
11153,,Autocuration,Percentage Bioavailability was evaluated.,1,,,22224,U,0,,CHEMBL620578,,BAO_0000218,
11154,,Autocuration,Bioavailability in rat administered i.d.,1,,,22224,U,0,,CHEMBL620579,,BAO_0000218,
11155,,Autocuration,Bioavailability,1,,,22224,U,0,,CHEMBL621248,,BAO_0000218,
11156,,Autocuration,Bioavailability in dog (male Beagle) i.v. administration,1,,,22224,U,0,,CHEMBL625390,,BAO_0000218,
11157,,Autocuration,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",1,,,22224,U,0,,CHEMBL625391,,BAO_0000218,
11158,,Autocuration,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),1,,,22224,U,0,,CHEMBL872266,,BAO_0000218,
11159,,Autocuration,Oral bioavailability in rat (Sprague-Dawley) (male),1,,,22224,U,0,,CHEMBL625392,,BAO_0000218,
11160,,Intermediate,The oral bioavailability was measured on rats after oral administration,1,,,50597,N,1,,CHEMBL625393,,BAO_0000218,
11161,,Intermediate,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL625394,,BAO_0000218,
11162,,Intermediate,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,,,50797,N,1,,CHEMBL625395,,BAO_0000218,
11163,,Autocuration,Bioavailability in rat (dose 10 mg/kg i.d.),1,,,22224,U,0,,CHEMBL625396,,BAO_0000218,
11164,,Autocuration,Bioavailability in dog (male Beagle) i.v. administration,1,,,22224,U,0,,CHEMBL625397,,BAO_0000218,
11165,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625398,,BAO_0000218,
11166,Blood,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625399,,BAO_0000218,178.0
11167,Cerebellum,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL626074,,BAO_0000218,2037.0
11168,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL626075,,BAO_0000218,
11169,Plasma,Intermediate,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL626076,,BAO_0000218,1969.0
11170,Plasma,Intermediate,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,,,50797,N,1,,CHEMBL626077,,BAO_0000218,1969.0
11171,Blood,Intermediate,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),1,,,50597,N,1,,CHEMBL626078,,BAO_0000218,178.0
11172,Blood,Autocuration,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),1,,,22224,U,0,,CHEMBL625846,,BAO_0000218,178.0
11173,Blood,Autocuration,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),1,,,22224,U,0,,CHEMBL625847,,BAO_0000218,178.0
11174,,Expert,Maximum concentration observed in rats at an oral dose of 50 mg/kg,1,,,50597,N,1,,CHEMBL625848,,BAO_0000218,
11175,Plasma,Intermediate,Maximum concentration of compound in plasma administered orally to rats,1,,,50597,N,1,,CHEMBL625849,,BAO_0000218,1969.0
11176,Plasma,Intermediate,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",1,,,50588,N,1,,CHEMBL626023,,BAO_0000218,1969.0
11177,Plasma,Intermediate,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",1,,,50588,N,1,,CHEMBL626024,,BAO_0000218,1969.0
11178,Plasma,Intermediate,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",1,,,50588,N,1,,CHEMBL626025,,BAO_0000218,1969.0
11179,,Autocuration,Maximum concentration after 10 mg/kg by oral administration,1,,,22224,U,0,,CHEMBL626026,,BAO_0000218,
11180,,Autocuration,Maximum concentration at a dose of 1.5 mg/kg,1,,,22224,U,0,,CHEMBL626027,,BAO_0000218,
11181,,Autocuration,Maximum concentration at a dose of 2.0 mg/kg,1,,,22224,U,0,,CHEMBL626028,,BAO_0000218,
11182,Plasma,Intermediate,Maximum concentration in dog plasma,1,,,50588,N,1,,CHEMBL626029,,BAO_0000218,1969.0
11183,Plasma,Autocuration,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,1,,,22224,U,0,,CHEMBL626030,,BAO_0000218,1969.0
11184,Plasma,Autocuration,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,1,,,22224,U,0,,CHEMBL626031,,BAO_0000218,1969.0
11185,Plasma,Autocuration,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,1,,,22224,U,0,,CHEMBL626032,,BAO_0000218,1969.0
11186,Plasma,Autocuration,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,1,,,22224,U,0,,CHEMBL626033,,BAO_0000218,1969.0
11187,Plasma,Autocuration,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,1,,,22224,U,0,,CHEMBL626034,,BAO_0000218,1969.0
11188,Plasma,Intermediate,Maximum concentration in plasma after oral administration in dog (25 mg/kg),1,,,50588,N,1,,CHEMBL626035,,BAO_0000218,1969.0
11189,Plasma,Autocuration,Maximum concentration in plasma at Tmax,1,,,22224,U,0,,CHEMBL626036,,BAO_0000218,1969.0
11190,Plasma,Expert,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,1,,,50588,N,1,,CHEMBL626037,,BAO_0000218,1969.0
11191,Plasma,Intermediate,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,1,,,100712,N,1,,CHEMBL626038,,BAO_0000218,1969.0
11192,Plasma,Intermediate,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,1,,,50597,N,1,,CHEMBL626039,,BAO_0000218,1969.0
11193,Plasma,Intermediate,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,1,,,50597,N,1,,CHEMBL626040,,BAO_0000218,1969.0
11194,Plasma,Intermediate,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,1,,,50592,N,1,,CHEMBL626041,,BAO_0000218,1969.0
11195,,Autocuration,Maximum concentration was calculated,1,,,22224,U,0,,CHEMBL626042,,BAO_0000218,
11196,,Autocuration,Maximum concentration was calculated.,1,,,22224,U,0,,CHEMBL626043,,BAO_0000218,
11197,,Autocuration,Maximum concentration at a peroral dose of 10 mg/kg,1,,,22224,U,0,,CHEMBL626044,,BAO_0000218,
11198,,Autocuration,Maximum concentration of the drug at 10 uM/dg administered perorally,1,,,22224,U,0,,CHEMBL626045,,BAO_0000218,
11199,,Autocuration,Maximum concentration of the drug at 2 uM/dg administered intravenously,1,,,22224,U,0,,CHEMBL626046,,BAO_0000218,
11200,Plasma,Intermediate,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",1,,,50588,N,1,,CHEMBL626047,,BAO_0000218,1969.0
11201,Plasma,Intermediate,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",1,,,100712,N,1,,CHEMBL626048,,BAO_0000218,1969.0
11202,Plasma,Intermediate,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",1,,,50597,N,1,,CHEMBL626049,,BAO_0000218,1969.0
11203,Plasma,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,1,,,50597,N,1,,CHEMBL626050,,BAO_0000218,1969.0
11204,Plasma,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,1,,,50588,N,1,,CHEMBL874541,,BAO_0000218,1969.0
11205,Plasma,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,1,,,100712,N,1,,CHEMBL622826,,BAO_0000218,1969.0
11206,Plasma,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,1,,,100712,N,1,,CHEMBL622827,,BAO_0000218,1969.0
11207,Plasma,Intermediate,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,1,,,50597,N,1,,CHEMBL622828,,BAO_0000218,1969.0
11208,Plasma,Intermediate,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,1,,,50597,N,1,,CHEMBL622829,,BAO_0000218,1969.0
11209,,Intermediate,Maximum concentration reached following intravenous administration in male rat,1,,,50597,N,1,,CHEMBL876806,,BAO_0000218,
11210,,Intermediate,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,1,,,50588,N,1,,CHEMBL622830,,BAO_0000218,
11211,,Intermediate,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,1,,,50597,N,1,,CHEMBL622831,,BAO_0000218,
11212,,Intermediate,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,1,,,50588,N,1,,CHEMBL626794,,BAO_0000218,
11213,,Intermediate,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL626795,,BAO_0000218,
11214,,Intermediate,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL626796,,BAO_0000218,
11215,,Intermediate,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL626797,,BAO_0000218,
11216,,Intermediate,Maximum drug concentration is determined after oral dosing in rats.,1,,,50597,N,1,,CHEMBL626798,,BAO_0000218,
11217,,Intermediate,Maximum observed concentration in oral (5 mg/kg) fasted dogs,1,,,50588,N,1,,CHEMBL626799,,BAO_0000218,
11218,,Intermediate,Maximum observed concentration in oral (5 mg/kg) fed dogs,1,,,50588,N,1,,CHEMBL626800,,BAO_0000218,
11219,Plasma,Autocuration,Maximum plasma concentration,1,,,22224,U,0,,CHEMBL626801,,BAO_0000218,1969.0
11220,Plasma,Intermediate,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,1,,,50597,N,1,,CHEMBL876816,,BAO_0000218,1969.0
11221,Plasma,Intermediate,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,1,,,50597,N,1,,CHEMBL626802,,BAO_0000218,1969.0
11222,Plasma,Intermediate,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,1,,,50588,N,1,,CHEMBL626803,,BAO_0000218,1969.0
11223,Plasma,Autocuration,Maximum plasma concentration following oral administration of 30 umol/kg,1,,,22224,U,0,,CHEMBL626804,,BAO_0000218,1969.0
11224,Plasma,Intermediate,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,1,,,50597,N,1,,CHEMBL626805,,BAO_0000218,1969.0
11225,Plasma,Intermediate,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626309,,BAO_0000218,1969.0
11226,Plasma,Intermediate,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626310,,BAO_0000218,1969.0
11227,Plasma,Intermediate,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626311,,BAO_0000218,1969.0
11228,Plasma,Intermediate,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626312,,BAO_0000218,1969.0
11229,Uterus,Intermediate,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626313,,BAO_0000218,995.0
11230,Uterus,Intermediate,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626314,,BAO_0000218,995.0
11231,Uterus,Intermediate,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626315,,BAO_0000218,995.0
11232,Uterus,Intermediate,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626316,,BAO_0000218,995.0
11233,Uterus,Intermediate,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,50597,N,1,,CHEMBL626317,,BAO_0000218,995.0
11234,,Intermediate,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,50597,N,1,,CHEMBL626318,,BAO_0000218,
11235,,Intermediate,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,50597,N,1,,CHEMBL626319,,BAO_0000218,
11236,,Intermediate,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,50597,N,1,,CHEMBL626320,,BAO_0000218,
11237,,Intermediate,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,50597,N,1,,CHEMBL875053,,BAO_0000218,
11238,,Intermediate,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,50597,N,1,,CHEMBL626321,,BAO_0000218,
11239,,Intermediate,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,50597,N,1,,CHEMBL626322,,BAO_0000218,
11240,,Intermediate,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,50597,N,1,,CHEMBL626323,,BAO_0000218,
11241,,Intermediate,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,50597,N,1,,CHEMBL626324,,BAO_0000218,
11242,,Intermediate,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,50597,N,1,,CHEMBL626325,,BAO_0000218,
11243,,Intermediate,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,50597,N,1,,CHEMBL626326,,BAO_0000218,
11244,,Intermediate,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,50597,N,1,,CHEMBL626327,,BAO_0000218,
11245,,Intermediate,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,50597,N,1,,CHEMBL626328,,BAO_0000218,
11246,Blood,Intermediate,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL626329,,BAO_0000218,178.0
11247,Blood,Intermediate,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL626330,,BAO_0000218,178.0
11248,Blood,Intermediate,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL626331,,BAO_0000218,178.0
11249,Blood,Intermediate,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL626332,,BAO_0000218,178.0
11250,Blood,Intermediate,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL626333,,BAO_0000218,178.0
11251,Blood,Intermediate,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL626334,,BAO_0000218,178.0
11252,Blood,Intermediate,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL626335,,BAO_0000218,178.0
11253,Blood,Intermediate,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624798,,BAO_0000218,178.0
11254,Brain,Intermediate,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624799,,BAO_0000218,955.0
11255,Brain,Intermediate,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624800,,BAO_0000218,955.0
11256,Brain,Intermediate,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624801,,BAO_0000218,955.0
11257,Brain,Intermediate,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624802,,BAO_0000218,955.0
11258,Brain,Intermediate,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624803,,BAO_0000218,955.0
11259,Brain,Intermediate,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624804,,BAO_0000218,955.0
11260,Brain,Intermediate,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624805,,BAO_0000218,955.0
11261,Brain,Intermediate,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",1,,,50597,N,1,,CHEMBL624806,,BAO_0000218,955.0
11262,,Intermediate,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624807,,BAO_0000218,
11263,,Intermediate,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624808,,BAO_0000218,
11264,,Intermediate,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624809,,BAO_0000218,
11265,,Intermediate,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624810,,BAO_0000218,
11266,,Intermediate,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL877618,,BAO_0000218,
11267,,Intermediate,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624811,,BAO_0000218,
11268,,Intermediate,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624812,,BAO_0000218,
11269,,Intermediate,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624813,,BAO_0000218,
11270,,Intermediate,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624814,,BAO_0000218,
11271,,Intermediate,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624815,,BAO_0000218,
11272,,Intermediate,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624816,,BAO_0000218,
11273,,Intermediate,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624817,,BAO_0000218,
11274,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL624818,,BAO_0000218,
11275,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL624819,,BAO_0000218,
11276,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL624820,,BAO_0000218,
11277,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL624821,,BAO_0000218,
11278,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,,50588,N,1,,CHEMBL624822,,BAO_0000218,
11279,,Intermediate,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL624823,,BAO_0000218,
11280,,Intermediate,Observed diffusion coefficient in organic solvent for Escherichia coli,1,,,50212,N,1,,CHEMBL624824,,BAO_0000218,
11281,Blood,Intermediate,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,50597,N,1,,CHEMBL624825,,BAO_0000218,178.0
11282,Blood,Intermediate,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,50597,N,1,,CHEMBL624826,,BAO_0000218,178.0
11283,Cardiac atrium,Intermediate,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,50597,N,1,,CHEMBL876817,,BAO_0000218,2081.0
11284,Cardiac atrium,Intermediate,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,50597,N,1,,CHEMBL624827,,BAO_0000218,2081.0
11285,,Intermediate,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,50597,N,1,,CHEMBL624828,,BAO_0000218,
11286,,Intermediate,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,50597,N,1,,CHEMBL624829,,BAO_0000218,
11287,Liver,Intermediate,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,50597,N,1,,CHEMBL624830,,BAO_0000218,2107.0
11288,Liver,Intermediate,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,50597,N,1,,CHEMBL624831,,BAO_0000218,2107.0
11289,Cardiac atrium,Intermediate,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,50597,N,1,,CHEMBL624832,,BAO_0000218,2081.0
11290,Cardiac atrium,Intermediate,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,50597,N,1,,CHEMBL624833,,BAO_0000218,2081.0
11291,,Intermediate,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,50597,N,1,,CHEMBL624834,,BAO_0000218,
11292,,Intermediate,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,50597,N,1,,CHEMBL624835,,BAO_0000218,
11293,Spleen,Intermediate,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,50597,N,1,,CHEMBL624836,,BAO_0000218,2106.0
11294,Spleen,Intermediate,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,50597,N,1,,CHEMBL624837,,BAO_0000218,2106.0
11295,Blood,Intermediate,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL624838,,BAO_0000218,178.0
11296,Blood,Intermediate,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL622188,,BAO_0000218,178.0
11297,Heart,Intermediate,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL622189,,BAO_0000218,948.0
11298,Heart,Intermediate,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,1,,,50597,N,1,,CHEMBL622190,,BAO_0000218,948.0
11299,Heart,Intermediate,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625170,,BAO_0000218,948.0
11300,Kidney,Intermediate,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625171,,BAO_0000218,2113.0
11301,Kidney,Intermediate,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625172,,BAO_0000218,2113.0
11302,Kidney,Intermediate,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625173,,BAO_0000218,2113.0
11303,Liver,Intermediate,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625174,,BAO_0000218,2107.0
11304,Liver,Intermediate,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625175,,BAO_0000218,2107.0
11305,Liver,Intermediate,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,1,,,50597,N,1,,CHEMBL625176,,BAO_0000218,2107.0
11306,Lung,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625177,,BAO_0000218,2048.0
11307,Lung,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625178,,BAO_0000218,2048.0
11308,Lung,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,1,,,50597,N,1,,CHEMBL625179,,BAO_0000218,2048.0
11309,Lung,Intermediate,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,,,50597,N,1,,CHEMBL625180,,BAO_0000218,2048.0
11310,,Autocuration,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",1,,,22224,U,0,,CHEMBL625181,,BAO_0000218,
11311,Urine,Intermediate,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,1,,,50594,N,1,,CHEMBL625182,,BAO_0000218,1088.0
11312,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL625183,,BAO_0000218,
11313,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL875848,,BAO_0000218,
11314,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL622260,,BAO_0000218,
11315,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL622261,,BAO_0000218,
11316,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL622262,,BAO_0000218,
11317,Kidney,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL622263,,BAO_0000218,2113.0
11318,Kidney,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL622418,,BAO_0000218,2113.0
11319,Liver,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL622419,,BAO_0000218,2107.0
11320,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL623388,,BAO_0000218,
11321,Liver,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL623389,,BAO_0000218,2107.0
11322,,Intermediate,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL623390,,BAO_0000218,
11323,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL623391,,BAO_0000218,
11324,Blood,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL623392,,BAO_0000218,178.0
11325,Cerebellum,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL623393,,BAO_0000218,2037.0
11326,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL623394,,BAO_0000218,
11327,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL618885,,BAO_0000218,
11328,Liver,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL618886,,BAO_0000218,2107.0
11329,,Intermediate,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL618887,,BAO_0000218,
11330,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL619535,,BAO_0000218,
11331,Blood,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL619536,,BAO_0000218,178.0
11332,Cerebellum,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL619537,,BAO_0000218,2037.0
11333,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL619705,,BAO_0000218,
11334,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL619706,,BAO_0000218,
11335,Liver,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL619707,,BAO_0000218,2107.0
11336,,Intermediate,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL619708,,BAO_0000218,
11337,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625219,,BAO_0000218,
11338,Blood,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625220,,BAO_0000218,178.0
11339,Cerebellum,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625221,,BAO_0000218,2037.0
11340,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625222,,BAO_0000218,
11341,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625223,,BAO_0000218,
11342,Liver,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625224,,BAO_0000218,2107.0
11343,,Intermediate,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,50594,N,1,,CHEMBL625225,,BAO_0000218,
11344,Blood,Intermediate,Biodistribution in Rat blood after 24 hours of iv administration,1,,,50597,N,1,,CHEMBL625226,,BAO_0000218,178.0
11345,Blood,Intermediate,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL625227,,BAO_0000218,178.0
11346,Blood,Intermediate,Biodistribution in Rat blood after 30 minutes of iv administration,1,,,50597,N,1,,CHEMBL625228,,BAO_0000218,178.0
11347,Blood,Intermediate,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL875354,,BAO_0000218,178.0
11348,Blood,Intermediate,Biodistribution in Rat blood after 5 minutes of iv administration,1,,,50597,N,1,,CHEMBL625229,,BAO_0000218,178.0
11349,Blood,Intermediate,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL625230,,BAO_0000218,178.0
11350,Heart,Intermediate,Biodistribution in Rat heart after 24 hours of iv administration,1,,,50597,N,1,,CHEMBL625231,,BAO_0000218,948.0
11351,Heart,Intermediate,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL625900,,BAO_0000218,948.0
11352,Heart,Intermediate,Biodistribution in Rat heart after 30 minutes of iv administration,1,,,50597,N,1,,CHEMBL625901,,BAO_0000218,948.0
11353,Heart,Intermediate,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL625902,,BAO_0000218,948.0
11354,Heart,Intermediate,Biodistribution in Rat heart after 5 minutes of iv administration,1,,,50597,N,1,,CHEMBL625903,,BAO_0000218,948.0
11355,Heart,Intermediate,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL625904,,BAO_0000218,948.0
11356,Liver,Intermediate,Biodistribution in Rat liver after 24 hours of iv administration,1,,,50597,N,1,,CHEMBL625905,,BAO_0000218,2107.0
11357,Liver,Intermediate,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL627861,,BAO_0000218,2107.0
11358,Liver,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration,1,,,50597,N,1,,CHEMBL627862,,BAO_0000218,2107.0
11359,Liver,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL627863,,BAO_0000218,2107.0
11360,Liver,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration,1,,,50597,N,1,,CHEMBL627769,,BAO_0000218,2107.0
11361,Plasma,Intermediate,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,,,50588,N,1,,CHEMBL627770,,BAO_0000218,1969.0
11362,,Intermediate,Cmax in cynomolgus monkey (PO dose),1,,,100710,N,1,,CHEMBL627771,,BAO_0000218,
11363,,Intermediate,Cmax in rat (PO dose),1,,,50597,N,1,,CHEMBL627772,,BAO_0000218,
11364,,Intermediate,Cmax in rat (PO dose),1,,,50597,N,1,,CHEMBL627773,,BAO_0000218,
11365,Plasma,Intermediate,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL621922,,BAO_0000218,1969.0
11366,Plasma,Intermediate,Cmax in rat plasma after oral dose (10 mg/kg),1,,,50597,N,1,,CHEMBL621923,,BAO_0000218,1969.0
11367,Plasma,Autocuration,Cmax in plasma after oral dose (10 mg/kg),1,,,22224,U,0,,CHEMBL621924,,BAO_0000218,1969.0
11368,Plasma,Intermediate,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,1,,,50588,N,1,,CHEMBL621925,,BAO_0000218,1969.0
11369,Plasma,Autocuration,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,1,,,22224,U,0,,CHEMBL621926,,BAO_0000218,1969.0
11370,Plasma,Intermediate,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,1,,,50592,N,1,,CHEMBL621927,,BAO_0000218,1969.0
11371,Plasma,Intermediate,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,1,,,50597,N,1,,CHEMBL621928,,BAO_0000218,1969.0
11372,Plasma,Intermediate,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,1,,,50597,N,1,,CHEMBL621929,,BAO_0000218,1969.0
11373,Plasma,Intermediate,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,1,,,50594,N,1,,CHEMBL621930,,BAO_0000218,1969.0
11374,Plasma,Intermediate,Maximum plasma concentration after oral dosing in rat,1,,,50597,N,1,,CHEMBL621931,,BAO_0000218,1969.0
11375,Plasma,Autocuration,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL621932,,BAO_0000218,1969.0
11376,Plasma,Autocuration,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL621933,,BAO_0000218,1969.0
11377,Plasma,Intermediate,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,1,,,50588,N,1,,CHEMBL621934,,BAO_0000218,1969.0
11378,Plasma,Intermediate,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,1,,,50588,N,1,,CHEMBL621935,,BAO_0000218,1969.0
11379,Plasma,Intermediate,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,1,,,50597,N,1,,CHEMBL621936,,BAO_0000218,1969.0
11380,Plasma,Autocuration,Maximum plasma concentration was determined,1,,,22224,U,0,,CHEMBL621937,,BAO_0000218,1969.0
11381,Plasma,Autocuration,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL621938,,BAO_0000218,1969.0
11382,Plasma,Autocuration,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL621939,,BAO_0000218,1969.0
11383,Plasma,Autocuration,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL621940,,BAO_0000218,1969.0
11384,Plasma,Autocuration,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL621941,,BAO_0000218,1969.0
11385,Plasma,Autocuration,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL621942,,BAO_0000218,1969.0
11386,Plasma,Autocuration,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL626178,,BAO_0000218,1969.0
11387,Plasma,Autocuration,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL626179,,BAO_0000218,1969.0
11388,Plasma,Autocuration,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL626180,,BAO_0000218,1969.0
11389,Plasma,Intermediate,Plasma Cmax in rat (PO dose),1,,,50597,N,1,,CHEMBL626181,,BAO_0000218,1969.0
11390,,Intermediate,Maximum serum concentration after po dose of 5.22 mg/kg in rats,1,,,50597,N,1,,CHEMBL626182,,BAO_0000218,
11391,,Intermediate,Maximum serum concentration after po dose of 5.46 mg/kg in rats,1,,,50597,N,1,,CHEMBL626183,,BAO_0000218,
11392,,Intermediate,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,1,,,50597,N,1,,CHEMBL626184,,BAO_0000218,
11393,,Intermediate,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,1,,,50597,N,1,,CHEMBL626185,,BAO_0000218,
11394,Plasma,Intermediate,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,1,,,50588,N,1,,CHEMBL626186,,BAO_0000218,1969.0
11395,Plasma,Intermediate,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,1,,,50588,N,1,,CHEMBL877589,,BAO_0000218,1969.0
11396,,Autocuration,Maximum concentration of the drug at 1 uM/dg administered intravenously,1,,,22224,U,0,,CHEMBL626187,,BAO_0000218,
11397,,Autocuration,Maximum concentration of the drug at 20 uM/dg administered perorally,1,,,22224,U,0,,CHEMBL626188,,BAO_0000218,
11398,,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,1,,,22224,U,0,,CHEMBL626189,,BAO_0000218,
11399,Blood,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,1,,,22224,U,0,,CHEMBL626855,,BAO_0000218,178.0
11400,Blood,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,1,,,22224,U,0,,CHEMBL623781,,BAO_0000218,178.0
11401,Blood,Autocuration,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,1,,,22224,U,0,,CHEMBL623782,,BAO_0000218,178.0
11402,Plasma,Intermediate,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,1,,,50597,N,1,,CHEMBL623783,,BAO_0000218,1969.0
11403,Plasma,Intermediate,Cmax in dog plasma after 1mg/kg oral dose,1,,,50588,N,1,,CHEMBL623784,,BAO_0000218,1969.0
11404,Plasma,Intermediate,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,1,,,50588,N,1,,CHEMBL623785,,BAO_0000218,1969.0
11405,Plasma,Intermediate,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,1,,,50597,N,1,,CHEMBL623786,,BAO_0000218,1969.0
11406,,Intermediate,Oral maximum concentration in rat,1,,,50597,N,1,,CHEMBL623787,,BAO_0000218,
11407,,Intermediate,Oral maximum concentration in rat,1,,,50597,N,1,,CHEMBL623788,,BAO_0000218,
11408,Plasma,Intermediate,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,1,,,50594,N,1,,CHEMBL623789,,BAO_0000218,1969.0
11409,Blood,Intermediate,Peak concentration in blood after intravenous administration to mice,1,,,50594,N,1,,CHEMBL623790,,BAO_0000218,178.0
11410,Blood,Intermediate,Peak concentration in blood after peroral administration to mice,1,,,50594,N,1,,CHEMBL623791,,BAO_0000218,178.0
11411,Plasma,Intermediate,Peak concentration in rat plasma was determined,1,,,50597,N,1,,CHEMBL623792,,BAO_0000218,1969.0
11412,Plasma,Autocuration,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,1,,,22224,U,0,,CHEMBL623793,,BAO_0000218,1969.0
11413,Plasma,Intermediate,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,1,,,50594,N,1,,CHEMBL623794,,BAO_0000218,1969.0
11414,Plasma,Intermediate,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,1,,,50597,N,1,,CHEMBL623795,,BAO_0000218,1969.0
11415,,Intermediate,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623796,,BAO_0000218,
11416,,Intermediate,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623797,,BAO_0000218,
11417,,Intermediate,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623798,,BAO_0000218,
11418,,Intermediate,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623799,,BAO_0000218,
11419,Intestine,Intermediate,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624490,,BAO_0000218,160.0
11420,Intestine,Intermediate,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624491,,BAO_0000218,160.0
11421,Intestine,Intermediate,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624492,,BAO_0000218,160.0
11422,Intestine,Intermediate,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624493,,BAO_0000218,160.0
11423,Intestine,Intermediate,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL877595,,BAO_0000218,160.0
11424,Intestine,Intermediate,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624494,,BAO_0000218,160.0
11425,Intestine,Intermediate,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624495,,BAO_0000218,160.0
11426,Intestine,Intermediate,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624681,,BAO_0000218,160.0
11427,,Intermediate,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624682,,BAO_0000218,
11428,,Intermediate,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624683,,BAO_0000218,
11429,,Intermediate,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624684,,BAO_0000218,
11430,,Intermediate,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624685,,BAO_0000218,
11431,,Intermediate,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624686,,BAO_0000218,
11432,,Intermediate,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624687,,BAO_0000218,
11433,,Intermediate,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624688,,BAO_0000218,
11434,,Intermediate,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL627161,,BAO_0000218,
11435,,Intermediate,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL622127,,BAO_0000218,
11436,,Intermediate,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL622128,,BAO_0000218,
11437,,Intermediate,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL874384,,BAO_0000218,
11438,,Intermediate,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624898,,BAO_0000218,
11439,,Intermediate,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624899,,BAO_0000218,
11440,,Intermediate,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624900,,BAO_0000218,
11441,,Intermediate,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624901,,BAO_0000218,
11442,,Intermediate,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624902,,BAO_0000218,
11443,,Intermediate,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624903,,BAO_0000218,
11444,,Intermediate,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624904,,BAO_0000218,
11445,,Intermediate,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624905,,BAO_0000218,
11446,,Intermediate,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624906,,BAO_0000218,
11447,,Intermediate,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624907,,BAO_0000218,
11448,,Intermediate,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624908,,BAO_0000218,
11449,,Intermediate,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624909,,BAO_0000218,
11450,,Intermediate,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624910,,BAO_0000218,
11451,Muscle tissue,Intermediate,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624911,,BAO_0000218,2385.0
11452,Muscle tissue,Intermediate,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL874388,,BAO_0000218,2385.0
11453,Muscle tissue,Intermediate,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL624912,,BAO_0000218,2385.0
11454,Muscle tissue,Intermediate,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL622930,,BAO_0000218,2385.0
11455,Muscle tissue,Intermediate,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623121,,BAO_0000218,2385.0
11456,Muscle tissue,Intermediate,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623122,,BAO_0000218,2385.0
11457,Muscle tissue,Intermediate,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623123,,BAO_0000218,2385.0
11458,Muscle tissue,Intermediate,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623124,,BAO_0000218,2385.0
11459,,Intermediate,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623125,,BAO_0000218,
11460,,Intermediate,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623126,,BAO_0000218,
11461,,Intermediate,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623127,,BAO_0000218,
11462,,Intermediate,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623128,,BAO_0000218,
11463,,Intermediate,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623129,,BAO_0000218,
11464,,Intermediate,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623130,,BAO_0000218,
11465,,Intermediate,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623131,,BAO_0000218,
11466,,Intermediate,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL623132,,BAO_0000218,
11467,Liver,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL623133,,BAO_0000218,2107.0
11468,,Intermediate,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL623134,,BAO_0000218,
11469,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL874389,,BAO_0000218,
11470,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL623135,,BAO_0000218,
11471,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL623136,,BAO_0000218,
11472,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL623137,,BAO_0000218,
11473,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL623138,,BAO_0000218,
11474,Kidney,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL623139,,BAO_0000218,2113.0
11475,Kidney,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL623140,,BAO_0000218,2113.0
11476,Liver,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL623141,,BAO_0000218,2107.0
11477,Liver,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL623142,,BAO_0000218,2107.0
11478,,Intermediate,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL623143,,BAO_0000218,
11479,Urine,Intermediate,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,1,,,50594,N,1,,CHEMBL623144,,BAO_0000218,1088.0
11480,Urine,Intermediate,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,1,,,50597,N,1,,CHEMBL623405,,BAO_0000218,1088.0
11481,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624074,,BAO_0000218,
11482,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624075,,BAO_0000218,
11483,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624076,,BAO_0000218,
11484,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624077,,BAO_0000218,
11485,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624078,,BAO_0000218,
11486,Kidney,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624079,,BAO_0000218,2113.0
11487,Kidney,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624261,,BAO_0000218,2113.0
11488,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624262,,BAO_0000218,
11489,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624263,,BAO_0000218,
11490,,Intermediate,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624264,,BAO_0000218,
11491,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624265,,BAO_0000218,
11492,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624266,,BAO_0000218,
11493,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624267,,BAO_0000218,
11494,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624268,,BAO_0000218,
11495,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL875227,,BAO_0000218,
11496,Kidney,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624269,,BAO_0000218,2113.0
11497,Kidney,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624270,,BAO_0000218,2113.0
11498,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,,50597,N,1,,CHEMBL624271,,BAO_0000218,
11499,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624272,,BAO_0000218,
11500,,Intermediate,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,50597,N,1,,CHEMBL624273,,BAO_0000218,
11501,Urine,Intermediate,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL624274,,BAO_0000218,1088.0
11502,Urine,Intermediate,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL624275,,BAO_0000218,1088.0
11503,Urine,Intermediate,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL624276,,BAO_0000218,1088.0
11504,Urine,Intermediate,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,1,,,50597,N,1,,CHEMBL624277,,BAO_0000218,1088.0
11505,,Autocuration,% dose converted to 2-amino-5-chlorophenyl sulfate,1,,,22224,U,0,,CHEMBL624278,,BAO_0000019,
11506,,Autocuration,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),1,,,22224,U,0,,CHEMBL624279,,BAO_0000019,
11507,Feces,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,,,50597,N,1,,CHEMBL624280,,BAO_0000218,1988.0
11508,Feces,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,,,50597,N,1,,CHEMBL624281,,BAO_0000218,1988.0
11509,Feces,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,,,50597,N,1,,CHEMBL622933,,BAO_0000218,1988.0
11510,Feces,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,,,50597,N,1,,CHEMBL622934,,BAO_0000218,1988.0
11511,Liver,Intermediate,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL622935,,BAO_0000218,2107.0
11512,Liver,Intermediate,Biodistribution in Rat liver after 5 minutes of iv administration,1,,,50597,N,1,,CHEMBL622936,,BAO_0000218,2107.0
11513,Liver,Intermediate,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL875228,,BAO_0000218,2107.0
11514,Lung,Intermediate,Biodistribution in Rat lung after 24 hours of iv administration,1,,,50597,N,1,,CHEMBL622937,,BAO_0000218,2048.0
11515,Lung,Intermediate,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL622938,,BAO_0000218,2048.0
11516,Lung,Intermediate,Biodistribution in Rat lung after 30 minutes of iv administration,1,,,50597,N,1,,CHEMBL619736,,BAO_0000218,2048.0
11517,Lung,Intermediate,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL625117,,BAO_0000218,2048.0
11518,Lung,Intermediate,Biodistribution in Rat lung after 5 minutes of iv administration,1,,,50597,N,1,,CHEMBL625118,,BAO_0000218,2048.0
11519,Lung,Intermediate,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,1,,,50597,N,1,,CHEMBL625119,,BAO_0000218,2048.0
11520,Cerebellum,Intermediate,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",1,,,50597,N,1,,CHEMBL625120,,BAO_0000218,2037.0
11521,,Intermediate,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",1,,,50597,N,1,,CHEMBL625121,,BAO_0000218,
11522,Thalamus,Intermediate,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",1,,,50597,N,1,,CHEMBL625122,,BAO_0000218,10000006.0
11523,Blood,Intermediate,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL622204,,BAO_0000218,178.0
11524,Blood,Intermediate,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL877503,,BAO_0000218,178.0
11525,Blood,Intermediate,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL627127,,BAO_0000218,178.0
11526,Hippocampus,Autocuration,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,22224,U,0,,CHEMBL627128,,BAO_0000218,10000000.0
11527,Hippocampus,Autocuration,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,22224,U,0,,CHEMBL627129,,BAO_0000218,10000000.0
11528,Hippocampus,Autocuration,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,22224,U,0,,CHEMBL627130,,BAO_0000218,10000000.0
11529,Brain,Intermediate,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL627131,,BAO_0000218,955.0
11530,Brain,Intermediate,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL627132,,BAO_0000218,955.0
11531,Brain,Intermediate,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL627133,,BAO_0000218,955.0
11532,Cerebellum,Intermediate,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL627134,,BAO_0000218,2037.0
11533,Cerebellum,Intermediate,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL627135,,BAO_0000218,2037.0
11534,Cerebellum,Intermediate,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL627136,,BAO_0000218,2037.0
11535,,Intermediate,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL628435,,BAO_0000218,
11536,,Intermediate,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL628436,,BAO_0000218,
11537,,Intermediate,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL628437,,BAO_0000218,
11538,Heart,Intermediate,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL628438,,BAO_0000218,948.0
11539,Heart,Intermediate,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL628439,,BAO_0000218,948.0
11540,Heart,Intermediate,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL628440,,BAO_0000218,948.0
11541,Hippocampus,Intermediate,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL628441,,BAO_0000218,10000000.0
11542,Hippocampus,Intermediate,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL628442,,BAO_0000218,10000000.0
11543,Hippocampus,Intermediate,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL628443,,BAO_0000218,10000000.0
11544,Kidney,Intermediate,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL628444,,BAO_0000218,2113.0
11545,Kidney,Intermediate,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL628445,,BAO_0000218,2113.0
11546,Kidney,Intermediate,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL877504,,BAO_0000218,2113.0
11547,Liver,Intermediate,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL628446,,BAO_0000218,2107.0
11548,Liver,Intermediate,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL626874,,BAO_0000218,2107.0
11549,Liver,Intermediate,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL626875,,BAO_0000218,2107.0
11550,Lung,Intermediate,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL626876,,BAO_0000218,2048.0
11551,Lung,Intermediate,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL626877,,BAO_0000218,2048.0
11552,Lung,Intermediate,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL626878,,BAO_0000218,2048.0
11553,Muscle tissue,Intermediate,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL626879,,BAO_0000218,2385.0
11554,Plasma,Autocuration,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,1,,,22224,U,0,,CHEMBL626880,,BAO_0000218,1969.0
11555,Plasma,Intermediate,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,1,,,50594,N,1,,CHEMBL626881,,BAO_0000218,1969.0
11556,Plasma,Intermediate,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,1,,,50597,N,1,,CHEMBL626882,,BAO_0000218,1969.0
11557,Plasma,Intermediate,Peak plasma concentration was measured in dogs,1,,,50588,N,1,,CHEMBL626883,,BAO_0000218,1969.0
11558,,Intermediate,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,50597,N,1,,CHEMBL626884,,BAO_0000218,
11559,,Intermediate,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,,,50597,N,1,,CHEMBL626885,,BAO_0000218,
11560,,Intermediate,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,,,50597,N,1,,CHEMBL626886,,BAO_0000218,
11561,,Intermediate,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,,,50597,N,1,,CHEMBL626887,,BAO_0000218,
11562,,Intermediate,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,50597,N,1,,CHEMBL626888,,BAO_0000218,
11563,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,1,,,50588,N,1,,CHEMBL626889,,BAO_0000218,
11564,,Autocuration,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,1,,,22224,U,0,,CHEMBL626761,,BAO_0000218,
11565,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,1,,,50588,N,1,,CHEMBL626762,,BAO_0000218,
11566,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,1,,,50588,N,1,,CHEMBL626763,,BAO_0000218,
11567,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,1,,,50597,N,1,,CHEMBL626764,,BAO_0000218,
11568,,Intermediate,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,1,,,50597,N,1,,CHEMBL626765,,BAO_0000218,
11569,,Intermediate,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,1,,,50588,N,1,,CHEMBL626766,,BAO_0000218,
11570,,Intermediate,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,1,,,50597,N,1,,CHEMBL626767,,BAO_0000218,
11571,,Intermediate,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,1,,,50597,N,1,,CHEMBL626768,,BAO_0000218,
11572,,Intermediate,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,1,,,50588,N,1,,CHEMBL626769,,BAO_0000218,
11573,,Intermediate,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,1,,,50588,N,1,,CHEMBL874463,,BAO_0000218,
11574,,Autocuration,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,1,,,22224,U,0,,CHEMBL626770,,BAO_0000218,
11575,,Autocuration,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,1,,,22224,U,0,,CHEMBL626771,,BAO_0000218,
11576,,Intermediate,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,1,,,50597,N,1,,CHEMBL626772,,BAO_0000218,
11577,,Intermediate,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,,,100710,N,1,,CHEMBL626773,,BAO_0000218,
11578,,Intermediate,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,1,,,50594,N,1,,CHEMBL626774,,BAO_0000218,
11579,,Intermediate,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,,,50588,N,1,,CHEMBL626775,,BAO_0000218,
11580,,Intermediate,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,,,50588,N,1,,CHEMBL626776,,BAO_0000218,
11581,,Intermediate,Maximum concentration (Cmax) in rat when administered orally,1,,,50597,N,1,,CHEMBL626777,,BAO_0000218,
11582,Plasma,Autocuration,Maximal concentration in monkey plasma after 25 mg/kg oral dose,1,,,22224,U,0,,CHEMBL626778,,BAO_0000218,1969.0
11583,,Autocuration,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",1,,,22224,U,0,,CHEMBL626779,,BAO_0000218,
11584,,Autocuration,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",1,,,22224,U,0,,CHEMBL626780,,BAO_0000218,
11585,Plasma,Autocuration,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,1,,,22224,U,0,,CHEMBL626781,,BAO_0000218,1969.0
11586,,Intermediate,Pharmacokinetic profile Cmax was evaluated in rats,1,,,50597,N,1,,CHEMBL632164,,BAO_0000218,
11587,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),1,,,50588,N,1,,CHEMBL632165,,BAO_0000218,
11588,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),1,,,50594,N,1,,CHEMBL632166,,BAO_0000218,
11589,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),1,,,50588,N,1,,CHEMBL632167,,BAO_0000218,
11590,,Intermediate,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),1,,,50594,N,1,,CHEMBL632168,,BAO_0000218,
11591,Plasma,Autocuration,Cmax in rat plasma,1,,,22224,U,0,,CHEMBL632169,,BAO_0000218,1969.0
11592,Plasma,Intermediate,Cmax in dog plasma after 30mg/kg oral dose,1,,,50588,N,1,,CHEMBL632170,,BAO_0000218,1969.0
11593,Plasma,Intermediate,Cmax in rat plasma after 30mg/kg oral dose,1,,,50597,N,1,,CHEMBL632171,,BAO_0000218,1969.0
11594,Plasma,Intermediate,Plasma level in rats at 30 mg/kg,1,,,50597,N,1,,CHEMBL632172,,BAO_0000218,1969.0
11595,Plasma,Intermediate,Tested for maximum plasma concentration in mice,1,,,50594,N,1,,CHEMBL632173,,BAO_0000218,1969.0
11596,,Intermediate,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL632174,,BAO_0000218,
11597,,Intermediate,The Cmax values in female wistar rats.,1,,,50597,N,1,,CHEMBL632175,,BAO_0000218,
11598,Plasma,Intermediate,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,1,,,50588,N,1,,CHEMBL632176,,BAO_0000218,1969.0
11599,Plasma,Intermediate,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,1,,,50597,N,1,,CHEMBL632177,,BAO_0000218,1969.0
11600,Plasma,Intermediate,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,1,,,50597,N,1,,CHEMBL632178,,BAO_0000218,1969.0
11601,,Intermediate,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,1,,,50597,N,1,,CHEMBL632179,,BAO_0000218,
11602,Blood,Intermediate,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,1,,,50597,N,1,,CHEMBL632180,,BAO_0000218,178.0
11603,Blood,Intermediate,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,1,,,50597,N,1,,CHEMBL632181,,BAO_0000218,178.0
11604,Blood,Intermediate,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,1,,,50597,N,1,,CHEMBL632182,,BAO_0000218,178.0
11605,Blood,Autocuration,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,1,,,22224,U,0,,CHEMBL632183,,BAO_0000218,178.0
11606,,Intermediate,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,1,,,50588,N,1,,CHEMBL632184,,BAO_0000218,
11607,,Intermediate,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,1,,,50597,N,1,,CHEMBL874470,,BAO_0000218,
11608,,Intermediate,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL631302,,BAO_0000218,
11609,,Intermediate,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL631303,,BAO_0000218,
11610,,Intermediate,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL631304,,BAO_0000218,
11611,,Intermediate,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL631305,,BAO_0000218,
11612,,Intermediate,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL631306,,BAO_0000218,
11613,,Intermediate,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL631307,,BAO_0000218,
11614,,Intermediate,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL631308,,BAO_0000218,
11615,,Intermediate,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625557,,BAO_0000218,
11616,Spleen,Intermediate,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625558,,BAO_0000218,2106.0
11617,Spleen,Intermediate,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625559,,BAO_0000218,2106.0
11618,Spleen,Intermediate,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625560,,BAO_0000218,2106.0
11619,Spleen,Intermediate,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625561,,BAO_0000218,2106.0
11620,Spleen,Intermediate,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625562,,BAO_0000218,2106.0
11621,Spleen,Intermediate,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL875320,,BAO_0000218,2106.0
11622,Spleen,Intermediate,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625563,,BAO_0000218,2106.0
11623,Spleen,Intermediate,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625564,,BAO_0000218,2106.0
11624,Uterus,Intermediate,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625565,,BAO_0000218,995.0
11625,Uterus,Intermediate,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625566,,BAO_0000218,995.0
11626,Uterus,Intermediate,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625567,,BAO_0000218,995.0
11627,Uterus,Intermediate,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL625568,,BAO_0000218,995.0
11628,Uterus,Intermediate,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL628217,,BAO_0000218,995.0
11629,Uterus,Intermediate,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL628218,,BAO_0000218,995.0
11630,Uterus,Intermediate,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL628219,,BAO_0000218,995.0
11631,Uterus,Intermediate,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",1,,,50597,N,1,,CHEMBL628220,,BAO_0000218,995.0
11632,,Autocuration,Distribution in the blood after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628221,,BAO_0000019,
11633,,Autocuration,Distribution in the blood after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL628222,,BAO_0000019,
11634,,Autocuration,Distribution in the blood after 30 min of intravenous administration,1,,,22224,U,0,,CHEMBL628223,,BAO_0000019,
11635,,Autocuration,Distribution in the blood after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628224,,BAO_0000019,
11636,,Autocuration,Distribution in the blood after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628225,,BAO_0000019,
11637,,Autocuration,Distribution in the blood after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL628226,,BAO_0000019,
11638,,Autocuration,Distribution in the bone after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628227,,BAO_0000019,
11639,,Autocuration,Distribution in the bone after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL875481,,BAO_0000019,
11640,,Autocuration,Distribution in the bone after 30 min of intravenous administration,1,,,22224,U,0,,CHEMBL628228,,BAO_0000019,
11641,,Autocuration,Distribution in the bone after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628229,,BAO_0000019,
11642,,Autocuration,Distribution in the bone after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628230,,BAO_0000019,
11643,,Autocuration,Distribution in the bone after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL628231,,BAO_0000019,
11644,,Autocuration,Distribution in the heart after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628232,,BAO_0000019,
11645,,Autocuration,Distribution in the heart after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL628233,,BAO_0000019,
11646,,Autocuration,Distribution in the heart after 30 min of intravenous administration,1,,,22224,U,0,,CHEMBL628234,,BAO_0000019,
11647,,Autocuration,Distribution in the heart after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628235,,BAO_0000019,
11648,,Autocuration,Distribution in the heart after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628236,,BAO_0000019,
11649,,Autocuration,Distribution in the heart after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL628237,,BAO_0000019,
11650,,Autocuration,Distribution in the kidneys after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628238,,BAO_0000019,
11651,,Autocuration,Distribution in the kidneys after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL628239,,BAO_0000019,
11652,,Autocuration,Distribution in the kidneys after 30 min of intravenous administration,1,,,22224,U,0,,CHEMBL628240,,BAO_0000019,
11653,,Autocuration,Distribution in the kidneys after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628241,,BAO_0000019,
11654,,Autocuration,Distribution in the kidneys after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628242,,BAO_0000019,
11655,,Autocuration,Distribution in the kidneys after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL875482,,BAO_0000019,
11656,,Autocuration,Distribution in the liver after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628243,,BAO_0000019,
11657,,Autocuration,Distribution in the liver after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL628244,,BAO_0000019,
11658,,Autocuration,Distribution in the liver after 30 min of intravenous administration,1,,,22224,U,0,,CHEMBL628245,,BAO_0000019,
11659,,Autocuration,Distribution in the liver after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628246,,BAO_0000019,
11660,,Autocuration,Distribution in the liver after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628247,,BAO_0000019,
11661,,Autocuration,Distribution in the liver after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL628248,,BAO_0000019,
11662,,Autocuration,Distribution in the lung after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628249,,BAO_0000019,
11663,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",1,,,50594,N,1,,CHEMBL625452,,BAO_0000218,
11664,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",1,,,50594,N,1,,CHEMBL625453,,BAO_0000218,
11665,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",1,,,50594,N,1,,CHEMBL625454,,BAO_0000218,
11666,,Intermediate,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",1,,,50594,N,1,,CHEMBL623844,,BAO_0000218,
11667,,Intermediate,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,1,,,50597,N,1,,CHEMBL623845,,BAO_0000218,
11668,,Intermediate,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,1,,,50597,N,1,,CHEMBL623846,,BAO_0000218,
11669,,Autocuration,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,1,,,22224,U,0,,CHEMBL623847,,BAO_0000218,
11670,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,100710,N,1,,CHEMBL623848,,BAO_0000218,
11671,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,,100710,N,1,,CHEMBL623849,,BAO_0000218,
11672,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,100710,N,1,,CHEMBL623850,,BAO_0000218,
11673,,Intermediate,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,,100710,N,1,,CHEMBL623851,,BAO_0000218,
11674,,Autocuration,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,22224,U,0,,CHEMBL623852,,BAO_0000218,
11675,,Intermediate,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,,,50506,N,1,,CHEMBL624551,,BAO_0000218,
11676,,Intermediate,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,,,50506,N,1,,CHEMBL624552,,BAO_0000218,
11677,,Autocuration,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,22224,U,0,,CHEMBL624553,,BAO_0000218,
11678,,Autocuration,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,1,,,22224,U,0,,CHEMBL624554,,BAO_0000218,
11679,,Intermediate,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,,,50597,N,1,,CHEMBL624555,,BAO_0000218,
11680,,Intermediate,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,,50597,N,1,,CHEMBL624741,,BAO_0000218,
11681,,Intermediate,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",1,,,50588,N,1,,CHEMBL624742,,BAO_0000218,
11682,,Intermediate,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",1,,,100712,N,1,,CHEMBL624743,,BAO_0000218,
11683,,Intermediate,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",1,,,50597,N,1,,CHEMBL877606,,BAO_0000218,
11684,,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,1,,,22224,U,0,,CHEMBL624744,,BAO_0000218,
11685,Blood,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,1,,,22224,U,0,,CHEMBL624745,,BAO_0000218,178.0
11686,Blood,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,1,,,22224,U,0,,CHEMBL624746,,BAO_0000218,178.0
11687,Blood,Autocuration,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,1,,,22224,U,0,,CHEMBL624747,,BAO_0000218,178.0
11688,,Autocuration,Oral absorption expressed as Area under curve was determined,1,,,22224,U,0,,CHEMBL624748,,BAO_0000019,
11689,,Intermediate,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,1,,,50588,N,1,,CHEMBL622504,,BAO_0000218,
11690,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",1,,,50588,N,1,,CHEMBL622505,,BAO_0000218,
11691,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,,,100712,N,1,,CHEMBL622506,,BAO_0000218,
11692,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,,,100712,N,1,,CHEMBL622507,,BAO_0000218,
11693,,Intermediate,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",1,,,50597,N,1,,CHEMBL622508,,BAO_0000218,
11694,,Autocuration,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,1,,,22224,U,0,,CHEMBL622509,,BAO_0000019,
11695,,Intermediate,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,50597,N,1,,CHEMBL622510,,BAO_0000218,
11696,,Intermediate,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),1,,,50597,N,1,,CHEMBL622511,,BAO_0000218,
11697,,Intermediate,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,,,100710,N,1,,CHEMBL622512,,BAO_0000218,
11698,,Intermediate,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,,,100710,N,1,,CHEMBL622513,,BAO_0000218,
11699,,Intermediate,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,1,,,100710,N,1,,CHEMBL622514,,BAO_0000218,
11700,,Intermediate,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,,,50588,N,1,,CHEMBL622515,,BAO_0000218,
11701,,Intermediate,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,1,,,50588,N,1,,CHEMBL622516,,BAO_0000218,
11702,,Intermediate,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,,,50597,N,1,,CHEMBL622517,,BAO_0000218,
11703,,Intermediate,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,1,,,50597,N,1,,CHEMBL622518,,BAO_0000218,
11704,,Intermediate,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,1,,,50597,N,1,,CHEMBL622519,,BAO_0000218,
11705,Muscle tissue,Intermediate,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL622520,,BAO_0000218,2385.0
11706,Muscle tissue,Intermediate,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL622521,,BAO_0000218,2385.0
11707,Zone of skin,Intermediate,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50594,N,1,,CHEMBL625113,,BAO_0000218,14.0
11708,Zone of skin,Intermediate,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL625114,,BAO_0000218,14.0
11709,Zone of skin,Intermediate,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL874397,,BAO_0000218,14.0
11710,Spleen,Intermediate,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL625115,,BAO_0000218,2106.0
11711,Spleen,Intermediate,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL625116,,BAO_0000218,2106.0
11712,Spleen,Intermediate,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL623932,,BAO_0000218,2106.0
11713,Striatum,Intermediate,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL623933,,BAO_0000218,2435.0
11714,Striatum,Intermediate,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL623934,,BAO_0000218,2435.0
11715,Striatum,Intermediate,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL623935,,BAO_0000218,2435.0
11716,Thyroid gland,Intermediate,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,50597,N,1,,CHEMBL623936,,BAO_0000218,2046.0
11717,Thyroid gland,Intermediate,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,50597,N,1,,CHEMBL623937,,BAO_0000218,2046.0
11718,Thyroid gland,Intermediate,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,50597,N,1,,CHEMBL623938,,BAO_0000218,2046.0
11719,,Intermediate,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL623939,,BAO_0000218,
11720,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,,50594,N,1,,CHEMBL623940,,BAO_0000218,
11721,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,,50594,N,1,,CHEMBL623941,,BAO_0000218,
11722,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL627216,,BAO_0000218,
11723,,Intermediate,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL623942,,BAO_0000218,
11724,Brain,Intermediate,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL618793,,BAO_0000218,955.0
11725,Brain,Intermediate,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL618794,,BAO_0000218,955.0
11726,Brain,Intermediate,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL618795,,BAO_0000218,955.0
11727,,Intermediate,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL618796,,BAO_0000218,
11728,,Intermediate,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL618797,,BAO_0000218,
11729,Kidney,Intermediate,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,,,50594,N,1,,CHEMBL618798,,BAO_0000218,2113.0
11730,Kidney,Intermediate,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL618799,,BAO_0000218,2113.0
11731,Kidney,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,,50594,N,1,,CHEMBL618800,,BAO_0000218,2113.0
11732,Kidney,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,,50594,N,1,,CHEMBL618801,,BAO_0000218,2113.0
11733,Kidney,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL618802,,BAO_0000218,2113.0
11734,Kidney,Intermediate,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL618803,,BAO_0000218,2113.0
11735,Liver,Intermediate,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,,,50594,N,1,,CHEMBL618804,,BAO_0000218,2107.0
11736,Liver,Intermediate,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL618805,,BAO_0000218,2107.0
11737,Liver,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,,50594,N,1,,CHEMBL618806,,BAO_0000218,2107.0
11738,Liver,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,,50594,N,1,,CHEMBL618807,,BAO_0000218,2107.0
11739,Liver,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL618808,,BAO_0000218,2107.0
11740,Liver,Intermediate,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL618809,,BAO_0000218,2107.0
11741,Muscle tissue,Intermediate,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL618810,,BAO_0000218,2385.0
11742,Muscle tissue,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,,50594,N,1,,CHEMBL618811,,BAO_0000218,2385.0
11743,Muscle tissue,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,,50594,N,1,,CHEMBL875844,,BAO_0000218,2385.0
11744,Muscle tissue,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL618812,,BAO_0000218,2385.0
11745,Muscle tissue,Intermediate,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL618813,,BAO_0000218,2385.0
11746,,Intermediate,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL618814,,BAO_0000218,
11747,,Intermediate,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL618815,,BAO_0000218,
11748,,Intermediate,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL618816,,BAO_0000218,
11749,,Intermediate,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL618817,,BAO_0000218,
11750,,Intermediate,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL620544,,BAO_0000218,
11751,,Intermediate,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,1,,,50597,N,1,,CHEMBL626230,,BAO_0000218,
11752,,Intermediate,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,1,,,50597,N,1,,CHEMBL626231,,BAO_0000218,
11753,,Intermediate,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,1,,,50597,N,1,,CHEMBL626232,,BAO_0000218,
11754,Plasma,Intermediate,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,1,,,50588,N,1,,CHEMBL626233,,BAO_0000218,1969.0
11755,Plasma,Intermediate,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,1,,,50597,N,1,,CHEMBL626234,,BAO_0000218,1969.0
11756,Plasma,Intermediate,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,1,,,50597,N,1,,CHEMBL875341,,BAO_0000218,1969.0
11757,Plasma,Intermediate,The maximum plasma concentration (100 mg/kg) administered orally in human,1,,,50587,N,1,,CHEMBL626235,,BAO_0000218,1969.0
11758,Plasma,Autocuration,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,1,,,22224,U,0,,CHEMBL626236,,BAO_0000218,1969.0
11759,Plasma,Autocuration,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,1,,,22224,U,0,,CHEMBL626237,,BAO_0000218,1969.0
11760,Plasma,Intermediate,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,1,,,50588,N,1,,CHEMBL626238,,BAO_0000218,1969.0
11761,Plasma,Intermediate,The maximum plasma concentration (200 mg/kg) administered orally in human,1,,,50587,N,1,,CHEMBL622412,,BAO_0000218,1969.0
11762,Plasma,Intermediate,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,1,,,50597,N,1,,CHEMBL623114,,BAO_0000218,1969.0
11763,Plasma,Autocuration,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,1,,,22224,U,0,,CHEMBL623115,,BAO_0000218,1969.0
11764,Plasma,Autocuration,The maximum plasma concentration (25 mg/kg) administered orally in monkey,1,,,22224,U,0,,CHEMBL623116,,BAO_0000218,1969.0
11765,Plasma,Autocuration,The maximum plasma concentration (30 mg/kg) administered orally in dog,1,,,22224,U,0,,CHEMBL623117,,BAO_0000218,1969.0
11766,Plasma,Intermediate,The maximum plasma concentration (400 mg/kg) administered orally in human,1,,,50587,N,1,,CHEMBL623118,,BAO_0000218,1969.0
11767,Plasma,Intermediate,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,1,,,50597,N,1,,CHEMBL623119,,BAO_0000218,1969.0
11768,Plasma,Intermediate,The maximum plasma concentration (50 mg/kg) administered orally in rat,1,,,50597,N,1,,CHEMBL623120,,BAO_0000218,1969.0
11769,Plasma,Intermediate,The maximum plasma concentration (800 mg/kg) administered orally in human,1,,,50587,N,1,,CHEMBL623286,,BAO_0000218,1969.0
11770,Plasma,Intermediate,The maximum plasma concentration was measured on rats,1,,,50597,N,1,,CHEMBL623287,,BAO_0000218,1969.0
11771,Plasma,Intermediate,The maximum plasma concentration was measured on rats after oral administration,1,,,50597,N,1,,CHEMBL623288,,BAO_0000218,1969.0
11772,Plasma,Intermediate,Plasma drug Cmax in rat (PO dose),1,,,50597,N,1,,CHEMBL623289,,BAO_0000218,1969.0
11773,,Autocuration,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,1,,,22224,U,0,,CHEMBL623290,,BAO_0000218,
11774,Plasma,Intermediate,maximum Plasma concentration in Dog was determined after Peroral administration,1,,,50588,N,1,,CHEMBL623291,,BAO_0000218,1969.0
11775,Plasma,Intermediate,maximum Plasma concentration in Rats was determined after Peroral administration,1,,,50597,N,1,,CHEMBL623292,,BAO_0000218,1969.0
11776,Plasma,Intermediate,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,,,50588,N,1,,CHEMBL623293,,BAO_0000218,1969.0
11777,Plasma,Autocuration,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,1,,,22224,U,0,,CHEMBL623294,,BAO_0000218,1969.0
11778,Plasma,Intermediate,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,,,50597,N,1,,CHEMBL623295,,BAO_0000218,1969.0
11779,,Intermediate,maximum concentration was measured when administered through oral route in mice,1,,,50594,N,1,,CHEMBL623296,,BAO_0000218,
11780,,Intermediate,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,1,,,50594,N,1,,CHEMBL875349,,BAO_0000218,
11781,,Autocuration,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,1,,,22224,U,0,,CHEMBL623297,,BAO_0000019,
11782,,Autocuration,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,1,,,22224,U,0,,CHEMBL623298,,BAO_0000019,
11783,,Autocuration,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,1,,,22224,U,0,,CHEMBL623299,,BAO_0000019,
11784,,Intermediate,Pharmacokinetic parameter was evaluated in rats,1,,,50597,N,1,,CHEMBL623300,,BAO_0000218,
11785,,Intermediate,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,,,50594,N,1,,CHEMBL623301,,BAO_0000218,
11786,,Intermediate,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,1,,,50594,N,1,,CHEMBL623302,,BAO_0000218,
11787,,Intermediate,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,,,50594,N,1,,CHEMBL623303,,BAO_0000218,
11788,,Intermediate,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,1,,,50594,N,1,,CHEMBL623304,,BAO_0000218,
11789,,Intermediate,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,1,,,50594,N,1,,CHEMBL623305,,BAO_0000218,
11790,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,1,,,50597,N,1,,CHEMBL623306,,BAO_0000218,1969.0
11791,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,1,,,50597,N,1,,CHEMBL623307,,BAO_0000218,1969.0
11792,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,1,,,50597,N,1,,CHEMBL623308,,BAO_0000218,1969.0
11793,Plasma,Intermediate,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,1,,,50594,N,1,,CHEMBL623309,,BAO_0000218,1969.0
11794,,Intermediate,Plasma Concentration after 120 min of oral administration to mice,1,,,50594,N,1,,CHEMBL623310,,BAO_0000218,
11795,,Intermediate,Plasma Concentration after 30 min of oral administration to mice,1,,,50594,N,1,,CHEMBL623311,,BAO_0000218,
11796,,Intermediate,Plasma Concentration after 60 min of oral administration to mice,1,,,100710,N,1,,CHEMBL623312,,BAO_0000218,
11797,,Intermediate,Plasma Concentration after 60 min of oral administration to mice; Not determined,1,,,50594,N,1,,CHEMBL875350,,BAO_0000218,
11798,,Intermediate,Plasma Concentration after 90 min of oral administration to mice,1,,,50594,N,1,,CHEMBL628635,,BAO_0000218,
11799,,Intermediate,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL628636,,BAO_0000218,
11800,,Intermediate,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL628637,,BAO_0000218,
11801,,Intermediate,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,1,,,50597,N,1,,CHEMBL628058,,BAO_0000218,
11802,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,1,,,50597,N,1,,CHEMBL628059,,BAO_0000218,
11803,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,1,,,50597,N,1,,CHEMBL628060,,BAO_0000218,
11804,,Autocuration,Distribution in the lung after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL628061,,BAO_0000019,
11805,,Autocuration,Distribution in the lung after 30 min of intravenous administration,1,,,22224,U,0,,CHEMBL628062,,BAO_0000019,
11806,,Autocuration,Distribution in the lung after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628063,,BAO_0000019,
11807,,Autocuration,Distribution in the lung after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628064,,BAO_0000019,
11808,,Autocuration,Distribution in the lung after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL628065,,BAO_0000019,
11809,Muscle tissue,Autocuration,Distribution in the muscle after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628066,,BAO_0000019,2385.0
11810,Muscle tissue,Autocuration,Distribution in the muscle after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL628067,,BAO_0000019,2385.0
11811,Muscle tissue,Intermediate,Distribution in the muscle after 30 min of intravenous administration,1,,,50594,N,1,,CHEMBL874646,,BAO_0000218,2385.0
11812,Muscle tissue,Autocuration,Distribution in the muscle after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628068,,BAO_0000019,2385.0
11813,Muscle tissue,Autocuration,Distribution in the muscle after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628069,,BAO_0000019,2385.0
11814,Muscle tissue,Autocuration,Distribution in the muscle after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL628070,,BAO_0000019,2385.0
11815,Spleen,Autocuration,Distribution in the spleen after 120 min of intravenous administration,1,,,22224,U,0,,CHEMBL628071,,BAO_0000019,2106.0
11816,Spleen,Autocuration,Distribution in the spleen after 15 min of intravenous administration,1,,,22224,U,0,,CHEMBL628072,,BAO_0000019,2106.0
11817,Spleen,Autocuration,Distribution in the spleen after 30 min of intravenous administration,1,,,22224,U,0,,CHEMBL628073,,BAO_0000019,2106.0
11818,Spleen,Autocuration,Distribution in the spleen after 5 min of intravenous administration,1,,,22224,U,0,,CHEMBL628074,,BAO_0000019,2106.0
11819,Spleen,Autocuration,Distribution in the spleen after 60 min of intravenous administration,1,,,22224,U,0,,CHEMBL628075,,BAO_0000019,2106.0
11820,Spleen,Autocuration,Distribution in the spleen after 90 min of intravenous administration,1,,,22224,U,0,,CHEMBL628076,,BAO_0000019,2106.0
11821,Adrenal cortex,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL628077,,BAO_0000218,1235.0
11822,Blood,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL628078,,BAO_0000218,178.0
11823,Liver,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL628079,,BAO_0000218,2107.0
11824,Female gonad,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL628080,,BAO_0000218,992.0
11825,Thyroid gland,Intermediate,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL628081,,BAO_0000218,2046.0
11826,Adrenal cortex,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL628082,,BAO_0000218,1235.0
11827,Blood,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL874647,,BAO_0000218,178.0
11828,Liver,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL626406,,BAO_0000218,2107.0
11829,Female gonad,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL626407,,BAO_0000218,992.0
11830,Thyroid gland,Intermediate,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,1,,,50597,N,1,,CHEMBL626408,,BAO_0000218,2046.0
11831,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",1,,,50597,N,1,,CHEMBL626409,,BAO_0000218,178.0
11832,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",1,,,50597,N,1,,CHEMBL626410,,BAO_0000218,178.0
11833,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",1,,,50597,N,1,,CHEMBL626411,,BAO_0000218,178.0
11834,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",1,,,50597,N,1,,CHEMBL626412,,BAO_0000218,178.0
11835,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",1,,,50597,N,1,,CHEMBL626413,,BAO_0000218,178.0
11836,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",1,,,50597,N,1,,CHEMBL626414,,BAO_0000218,178.0
11837,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",1,,,50597,N,1,,CHEMBL626415,,BAO_0000218,178.0
11838,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",1,,,50597,N,1,,CHEMBL626416,,BAO_0000218,178.0
11839,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",1,,,50597,N,1,,CHEMBL627062,,BAO_0000218,178.0
11840,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",1,,,50597,N,1,,CHEMBL627063,,BAO_0000218,178.0
11841,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",1,,,50597,N,1,,CHEMBL627064,,BAO_0000218,178.0
11842,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",1,,,50597,N,1,,CHEMBL627227,,BAO_0000218,178.0
11843,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",1,,,50597,N,1,,CHEMBL627228,,BAO_0000218,178.0
11844,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",1,,,50597,N,1,,CHEMBL627229,,BAO_0000218,178.0
11845,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",1,,,50597,N,1,,CHEMBL625792,,BAO_0000218,178.0
11846,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",1,,,50597,N,1,,CHEMBL625793,,BAO_0000218,178.0
11847,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",1,,,50597,N,1,,CHEMBL625794,,BAO_0000218,178.0
11848,Blood,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",1,,,50597,N,1,,CHEMBL625795,,BAO_0000218,178.0
11849,,Intermediate,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,1,,,50594,N,1,,CHEMBL625796,,BAO_0000218,
11850,,Intermediate,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,,,50588,N,1,,CHEMBL625797,,BAO_0000218,
11851,,Intermediate,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,,,50588,N,1,,CHEMBL625798,,BAO_0000218,
11852,,Autocuration,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL875613,,BAO_0000218,
11853,,Autocuration,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL625799,,BAO_0000218,
11854,,Autocuration,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL625800,,BAO_0000218,
11855,,Autocuration,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL625801,,BAO_0000218,
11856,,Autocuration,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL625802,,BAO_0000218,
11857,,Autocuration,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL625803,,BAO_0000218,
11858,,Autocuration,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,1,,,22224,U,0,,CHEMBL625804,,BAO_0000019,
11859,,Autocuration,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,1,,,22224,U,0,,CHEMBL622530,,BAO_0000218,
11860,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,1,,,50594,N,1,,CHEMBL622531,,BAO_0000218,
11861,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,,50594,N,1,,CHEMBL622532,,BAO_0000218,
11862,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL623176,,BAO_0000218,
11863,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,,,50594,N,1,,CHEMBL623177,,BAO_0000218,
11864,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,,50594,N,1,,CHEMBL623178,,BAO_0000218,
11865,,Intermediate,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,1,,,50594,N,1,,CHEMBL623179,,BAO_0000218,
11866,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,,,50594,N,1,,CHEMBL623180,,BAO_0000218,
11867,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL623181,,BAO_0000218,
11868,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL624131,,BAO_0000218,
11869,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),1,,,50594,N,1,,CHEMBL624132,,BAO_0000218,
11870,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL624133,,BAO_0000218,
11871,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,1,,,50594,N,1,,CHEMBL624846,,BAO_0000218,
11872,,Intermediate,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL624847,,BAO_0000218,
11873,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL624848,,BAO_0000218,
11874,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,,50594,N,1,,CHEMBL625012,,BAO_0000218,
11875,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL625013,,BAO_0000218,
11876,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,1,,,50594,N,1,,CHEMBL625014,,BAO_0000218,
11877,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),1,,,50594,N,1,,CHEMBL625015,,BAO_0000218,
11878,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL625016,,BAO_0000218,
11879,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,1,,,50594,N,1,,CHEMBL625017,,BAO_0000218,
11880,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL625018,,BAO_0000218,
11881,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL625019,,BAO_0000218,
11882,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL625020,,BAO_0000218,
11883,,Intermediate,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,1,,,50594,N,1,,CHEMBL625021,,BAO_0000218,
11884,,Intermediate,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,50597,N,1,,CHEMBL625022,,BAO_0000218,
11885,,Intermediate,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,1,,,50594,N,1,,CHEMBL625023,,BAO_0000218,
11886,,Intermediate,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,1,,,100710,N,1,,CHEMBL625024,,BAO_0000218,
11887,,Intermediate,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,,,100710,N,1,,CHEMBL627626,,BAO_0000218,
11888,Brain,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,1,,,22224,U,0,,CHEMBL627627,,BAO_0000218,955.0
11889,Serum,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,1,,,22224,U,0,,CHEMBL627628,,BAO_0000218,1977.0
11890,Brain,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,1,,,22224,U,0,,CHEMBL627629,,BAO_0000218,955.0
11891,Serum,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,1,,,22224,U,0,,CHEMBL627630,,BAO_0000218,1977.0
11892,,Autocuration,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),1,,,22224,U,0,,CHEMBL627631,,BAO_0000019,
11893,,Autocuration,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),1,,,22224,U,0,,CHEMBL629515,,BAO_0000218,
11894,Spleen,Intermediate,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL629516,,BAO_0000218,2106.0
11895,Spleen,Intermediate,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL629517,,BAO_0000218,2106.0
11896,Spleen,Intermediate,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL629518,,BAO_0000218,2106.0
11897,,Intermediate,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,50594,N,1,,CHEMBL877499,,BAO_0000218,
11898,,Intermediate,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,,50594,N,1,,CHEMBL629519,,BAO_0000218,
11899,,Intermediate,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,50594,N,1,,CHEMBL629520,,BAO_0000218,
11900,,Intermediate,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,50594,N,1,,CHEMBL629521,,BAO_0000218,
11901,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),1,,,50594,N,1,,CHEMBL629522,,BAO_0000218,
11902,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),1,,,50594,N,1,,CHEMBL629523,,BAO_0000218,
11903,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),1,,,50594,N,1,,CHEMBL629524,,BAO_0000218,
11904,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),1,,,50594,N,1,,CHEMBL629525,,BAO_0000218,
11905,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),1,,,50594,N,1,,CHEMBL629526,,BAO_0000218,
11906,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),1,,,50594,N,1,,CHEMBL629527,,BAO_0000218,
11907,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),1,,,50594,N,1,,CHEMBL629528,,BAO_0000218,
11908,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),1,,,50594,N,1,,CHEMBL629529,,BAO_0000218,
11909,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),1,,,50594,N,1,,CHEMBL629530,,BAO_0000218,
11910,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),1,,,50594,N,1,,CHEMBL629531,,BAO_0000218,
11911,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),1,,,50594,N,1,,CHEMBL628656,,BAO_0000218,
11912,,Intermediate,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),1,,,50594,N,1,,CHEMBL628657,,BAO_0000218,
11913,,Intermediate,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628658,,BAO_0000218,
11914,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628659,,BAO_0000218,
11915,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL877500,,BAO_0000218,
11916,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628660,,BAO_0000218,
11917,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628661,,BAO_0000218,
11918,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628662,,BAO_0000218,
11919,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628663,,BAO_0000218,
11920,,Intermediate,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628664,,BAO_0000218,
11921,Blood,Intermediate,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628665,,BAO_0000218,178.0
11922,Blood,Intermediate,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628666,,BAO_0000218,178.0
11923,Blood,Intermediate,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628667,,BAO_0000218,178.0
11924,Blood,Intermediate,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628668,,BAO_0000218,178.0
11925,Blood,Intermediate,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628669,,BAO_0000218,178.0
11926,Blood,Intermediate,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628670,,BAO_0000218,178.0
11927,Blood,Intermediate,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628671,,BAO_0000218,178.0
11928,Bone,Intermediate,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL628672,,BAO_0000218,10000001.0
11929,Bone,Intermediate,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL630300,,BAO_0000218,10000001.0
11930,Bone,Intermediate,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629787,,BAO_0000218,10000001.0
11931,Bone,Intermediate,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629788,,BAO_0000218,10000001.0
11932,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629789,,BAO_0000218,955.0
11933,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629790,,BAO_0000218,955.0
11934,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629791,,BAO_0000218,955.0
11935,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629792,,BAO_0000218,955.0
11936,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629793,,BAO_0000218,955.0
11937,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629794,,BAO_0000218,955.0
11938,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,1,,,50597,N,1,,CHEMBL874459,,BAO_0000218,
11939,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,1,,,50597,N,1,,CHEMBL629795,,BAO_0000218,
11940,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,1,,,50597,N,1,,CHEMBL629796,,BAO_0000218,
11941,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,1,,,50597,N,1,,CHEMBL629797,,BAO_0000218,
11942,,Intermediate,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,1,,,50597,N,1,,CHEMBL629798,,BAO_0000218,
11943,Adrenal gland,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629799,,BAO_0000218,2369.0
11944,Adrenal gland,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629800,,BAO_0000218,2369.0
11945,Adrenal gland,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629801,,BAO_0000218,2369.0
11946,Adrenal gland,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,1,,,50597,N,1,,CHEMBL629802,,BAO_0000218,2369.0
11947,Adrenal gland,Intermediate,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629803,,BAO_0000218,2369.0
11948,Blood,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629804,,BAO_0000218,178.0
11949,Blood,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629805,,BAO_0000218,178.0
11950,Blood,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629806,,BAO_0000218,178.0
11951,Blood,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629807,,BAO_0000218,178.0
11952,Blood,Intermediate,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629808,,BAO_0000218,178.0
11953,Brain,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629809,,BAO_0000218,955.0
11954,Brain,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629810,,BAO_0000218,955.0
11955,Brain,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629811,,BAO_0000218,955.0
11956,Brain,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629812,,BAO_0000218,955.0
11957,Brain,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629813,,BAO_0000218,955.0
11958,Brain,Intermediate,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL874460,,BAO_0000218,955.0
11959,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629814,,BAO_0000218,
11960,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629815,,BAO_0000218,
11961,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629816,,BAO_0000218,
11962,,Intermediate,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL629817,,BAO_0000218,
11963,Kidney,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL626643,,BAO_0000218,2113.0
11964,Kidney,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL626644,,BAO_0000218,2113.0
11965,Kidney,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL626806,,BAO_0000218,2113.0
11966,Kidney,Intermediate,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL626807,,BAO_0000218,2113.0
11967,Liver,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627261,,BAO_0000218,2107.0
11968,Liver,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627262,,BAO_0000218,2107.0
11969,Liver,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627263,,BAO_0000218,2107.0
11970,Liver,Intermediate,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627264,,BAO_0000218,2107.0
11971,Lung,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627265,,BAO_0000218,2048.0
11972,Lung,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627266,,BAO_0000218,2048.0
11973,Lung,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627267,,BAO_0000218,2048.0
11974,Lung,Intermediate,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627268,,BAO_0000218,2048.0
11975,Muscle tissue,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627269,,BAO_0000218,2385.0
11976,Muscle tissue,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627270,,BAO_0000218,2385.0
11977,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",1,,,50597,N,1,,CHEMBL627271,,BAO_0000218,
11978,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",1,,,50597,N,1,,CHEMBL627946,,BAO_0000218,
11979,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",1,,,50597,N,1,,CHEMBL875472,,BAO_0000218,
11980,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",1,,,50597,N,1,,CHEMBL627947,,BAO_0000218,
11981,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",1,,,50597,N,1,,CHEMBL627948,,BAO_0000218,
11982,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",1,,,50597,N,1,,CHEMBL628113,,BAO_0000218,
11983,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",1,,,50597,N,1,,CHEMBL628114,,BAO_0000218,
11984,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",1,,,50597,N,1,,CHEMBL628115,,BAO_0000218,
11985,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",1,,,50597,N,1,,CHEMBL628116,,BAO_0000218,
11986,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",1,,,50597,N,1,,CHEMBL628117,,BAO_0000218,
11987,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",1,,,50597,N,1,,CHEMBL628118,,BAO_0000218,
11988,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",1,,,50597,N,1,,CHEMBL628119,,BAO_0000218,
11989,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",1,,,50597,N,1,,CHEMBL628120,,BAO_0000218,
11990,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",1,,,50597,N,1,,CHEMBL628121,,BAO_0000218,
11991,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",1,,,50597,N,1,,CHEMBL628122,,BAO_0000218,
11992,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",1,,,50597,N,1,,CHEMBL627297,,BAO_0000218,
11993,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",1,,,50597,N,1,,CHEMBL627298,,BAO_0000218,
11994,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",1,,,50597,N,1,,CHEMBL627299,,BAO_0000218,
11995,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",1,,,50597,N,1,,CHEMBL627300,,BAO_0000218,
11996,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",1,,,50597,N,1,,CHEMBL627301,,BAO_0000218,
11997,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",1,,,50597,N,1,,CHEMBL627302,,BAO_0000218,
11998,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",1,,,50597,N,1,,CHEMBL627303,,BAO_0000218,
11999,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",1,,,50597,N,1,,CHEMBL627304,,BAO_0000218,
12000,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",1,,,50597,N,1,,CHEMBL627305,,BAO_0000218,
12001,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,,,50597,N,1,,CHEMBL627306,,BAO_0000218,
12002,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",1,,,50597,N,1,,CHEMBL623982,,BAO_0000218,
12003,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",1,,,50597,N,1,,CHEMBL623983,,BAO_0000218,
12004,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",1,,,50597,N,1,,CHEMBL623984,,BAO_0000218,
12005,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",1,,,50597,N,1,,CHEMBL623985,,BAO_0000218,
12006,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",1,,,50597,N,1,,CHEMBL623986,,BAO_0000218,
12007,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",1,,,50597,N,1,,CHEMBL623987,,BAO_0000218,
12008,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",1,,,50597,N,1,,CHEMBL623988,,BAO_0000218,
12009,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",1,,,50597,N,1,,CHEMBL623989,,BAO_0000218,
12010,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",1,,,50597,N,1,,CHEMBL622215,,BAO_0000218,
12011,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",1,,,50597,N,1,,CHEMBL622216,,BAO_0000218,
12012,,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",1,,,50597,N,1,,CHEMBL877481,,BAO_0000218,
12013,,Autocuration,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),1,,,22224,U,0,,CHEMBL622217,,BAO_0000218,
12014,,Intermediate,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,,,50594,N,1,,CHEMBL622218,,BAO_0000218,
12015,,Intermediate,Pharmacokinetic profile AUC was evaluated in rats,1,,,50597,N,1,,CHEMBL622219,,BAO_0000218,
12016,,Autocuration,Pharmacokinetic property (Area under curve),1,,,22224,U,0,,CHEMBL622220,,BAO_0000019,
12017,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",1,,,50588,N,1,,CHEMBL622221,,BAO_0000218,
12018,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",1,,,50594,N,1,,CHEMBL622222,,BAO_0000218,
12019,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",1,,,50588,N,1,,CHEMBL622223,,BAO_0000218,
12020,,Intermediate,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",1,,,50594,N,1,,CHEMBL622224,,BAO_0000218,
12021,,Autocuration,Plasma concentration (AUC) was determined,1,,,22224,U,0,,CHEMBL622225,,BAO_0000019,
12022,,Autocuration,Plasma concentration (AUC) was determined; Not detectable,1,,,22224,U,0,,CHEMBL622226,,BAO_0000019,
12023,,Intermediate,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),1,,,50512,N,1,,CHEMBL624154,,BAO_0000218,
12024,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,1,,,50597,N,1,,CHEMBL624155,,BAO_0000218,
12025,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,,,50597,N,1,,CHEMBL624156,,BAO_0000218,
12026,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,1,,,50597,N,1,,CHEMBL624157,,BAO_0000218,
12027,,Intermediate,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,1,,,50597,N,1,,CHEMBL624158,,BAO_0000218,
12028,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,1,,,50597,N,1,,CHEMBL624159,,BAO_0000218,
12029,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,1,,,50597,N,1,,CHEMBL624160,,BAO_0000218,
12030,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,1,,,50597,N,1,,CHEMBL624161,,BAO_0000218,
12031,,Intermediate,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,1,,,50597,N,1,,CHEMBL624162,,BAO_0000218,
12032,,Intermediate,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,1,,,50588,N,1,,CHEMBL624163,,BAO_0000218,
12033,,Intermediate,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL624164,,BAO_0000218,
12034,,Intermediate,The AUC(0-infinity) values in female wistar rats.,1,,,50597,N,1,,CHEMBL624165,,BAO_0000218,
12035,,Intermediate,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL624166,,BAO_0000218,
12036,,Intermediate,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",1,,,50597,N,1,,CHEMBL624167,,BAO_0000218,
12037,,Intermediate,The AUC(0-t)values in female wistar rats.,1,,,50597,N,1,,CHEMBL624168,,BAO_0000218,
12038,,Intermediate,The Area under the concentration time curve of compound was measured on rats,1,,,50597,N,1,,CHEMBL624169,,BAO_0000218,
12039,,Intermediate,The area under curve (100 mg/kg) administered orally in humans,1,,,50587,N,1,,CHEMBL624170,,BAO_0000218,
12040,,Autocuration,The area under curve (12.5 mg/kg) administered intravenously in marmoset,1,,,22224,U,0,,CHEMBL624171,,BAO_0000218,
12041,,Autocuration,The area under curve (12.5 mg/kg) administered intravenously in monkey,1,,,22224,U,0,,CHEMBL624172,,BAO_0000218,
12042,,Intermediate,The area under curve (15 mg/kg) administered intravenously in dog,1,,,50588,N,1,,CHEMBL624173,,BAO_0000218,
12043,,Intermediate,The area under curve (200 mg/kg) administered orally in humans,1,,,50587,N,1,,CHEMBL877488,,BAO_0000218,
12044,,Intermediate,The area under curve (25 mg/kg) administered intravenously in rat,1,,,50597,N,1,,CHEMBL624174,,BAO_0000218,
12045,,Autocuration,The area under curve (25 mg/kg) administered orally in marmoset,1,,,22224,U,0,,CHEMBL624175,,BAO_0000218,
12046,,Autocuration,The area under curve (25 mg/kg) administered orally in monkey,1,,,22224,U,0,,CHEMBL624176,,BAO_0000218,
12047,,Intermediate,The area under curve (30 mg/kg) administered orally in dog,1,,,50588,N,1,,CHEMBL624177,,BAO_0000218,
12048,,Intermediate,The area under curve (400 mg/kg) administered orally in humans,1,,,50587,N,1,,CHEMBL624178,,BAO_0000218,
12049,,Intermediate,The area under curve (50 mg/kg) administered orally in fasted rat,1,,,50597,N,1,,CHEMBL624179,,BAO_0000218,
12050,,Intermediate,The area under curve (50 mg/kg) administered orally in rat,1,,,50597,N,1,,CHEMBL627689,,BAO_0000218,
12051,,Intermediate,The area under curve (800 mg/kg) administered orally in humans,1,,,50587,N,1,,CHEMBL627690,,BAO_0000218,
12052,,Autocuration,The compound was evaluated for area under the curve,1,,,22224,U,0,,CHEMBL627691,,BAO_0000019,
12053,,Autocuration,The compound was evaluated for area under the curve in marmosets,1,,,22224,U,0,,CHEMBL627692,,BAO_0000019,
12054,,Autocuration,The compound was evaluated for area under the curve in marmosets,1,,,22224,U,0,,CHEMBL627693,,BAO_0000019,
12055,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,50597,N,1,,CHEMBL627694,,BAO_0000218,
12056,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,50597,N,1,,CHEMBL627695,,BAO_0000218,
12057,,Autocuration,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),1,,,22224,U,0,,CHEMBL627696,,BAO_0000218,
12058,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,50597,N,1,,CHEMBL627697,,BAO_0000218,
12059,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,50597,N,1,,CHEMBL627698,,BAO_0000218,
12060,,Intermediate,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,50597,N,1,,CHEMBL627699,,BAO_0000218,
12061,,Intermediate,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,1,,,50597,N,1,,CHEMBL627700,,BAO_0000218,
12062,,Intermediate,Total drug exposure is determined after oral dosing in rats.,1,,,50597,N,1,,CHEMBL627701,,BAO_0000218,
12063,,Autocuration,Total drug exposure (5 mg/kg) when administered intravenously,1,,,22224,U,0,,CHEMBL627702,,BAO_0000218,
12064,,Autocuration,Total drug exposure (5 mg/kg) when administered orally,1,,,22224,U,0,,CHEMBL627703,,BAO_0000218,
12065,,Autocuration,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,1,,,22224,U,0,,CHEMBL626873,,BAO_0000218,
12066,,Intermediate,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,,,50597,N,1,,CHEMBL629583,,BAO_0000218,
12067,,Intermediate,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,,,50588,N,1,,CHEMBL629584,,BAO_0000218,
12068,,Intermediate,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,,,50588,N,1,,CHEMBL629585,,BAO_0000218,
12069,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629586,,BAO_0000218,955.0
12070,Brain,Intermediate,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629587,,BAO_0000218,955.0
12071,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629588,,BAO_0000218,
12072,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629589,,BAO_0000218,
12073,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629590,,BAO_0000218,
12074,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629591,,BAO_0000218,
12075,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629592,,BAO_0000218,
12076,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629593,,BAO_0000218,
12077,,Intermediate,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629594,,BAO_0000218,
12078,Heart,Intermediate,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL629595,,BAO_0000218,948.0
12079,Heart,Intermediate,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL630290,,BAO_0000218,948.0
12080,Heart,Intermediate,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627137,,BAO_0000218,948.0
12081,Heart,Intermediate,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627138,,BAO_0000218,948.0
12082,Heart,Intermediate,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627139,,BAO_0000218,948.0
12083,Heart,Intermediate,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627140,,BAO_0000218,948.0
12084,Heart,Intermediate,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627141,,BAO_0000218,948.0
12085,Kidney,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627142,,BAO_0000218,2113.0
12086,Kidney,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627143,,BAO_0000218,2113.0
12087,Kidney,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL874449,,BAO_0000218,2113.0
12088,Kidney,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627144,,BAO_0000218,2113.0
12089,Kidney,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627145,,BAO_0000218,2113.0
12090,Kidney,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627146,,BAO_0000218,2113.0
12091,Kidney,Intermediate,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627147,,BAO_0000218,2113.0
12092,Liver,Intermediate,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627148,,BAO_0000218,2107.0
12093,Lung,Intermediate,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627149,,BAO_0000218,2048.0
12094,Lung,Intermediate,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL632160,,BAO_0000218,2048.0
12095,Lung,Intermediate,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL632161,,BAO_0000218,2048.0
12096,Lung,Intermediate,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL632162,,BAO_0000218,2048.0
12097,Lung,Intermediate,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL632163,,BAO_0000218,2048.0
12098,Lung,Intermediate,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL874469,,BAO_0000218,2048.0
12099,Lung,Intermediate,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627182,,BAO_0000218,2048.0
12100,Muscle tissue,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627183,,BAO_0000218,2385.0
12101,Muscle tissue,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627184,,BAO_0000218,2385.0
12102,Muscle tissue,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627185,,BAO_0000218,2385.0
12103,Muscle tissue,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627186,,BAO_0000218,2385.0
12104,Muscle tissue,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627187,,BAO_0000218,2385.0
12105,Muscle tissue,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627188,,BAO_0000218,2385.0
12106,Muscle tissue,Intermediate,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627189,,BAO_0000218,2385.0
12107,,Intermediate,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627190,,BAO_0000218,
12108,Liver,Intermediate,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627191,,BAO_0000218,2107.0
12109,Liver,Intermediate,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627192,,BAO_0000218,2107.0
12110,Liver,Intermediate,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL627193,,BAO_0000218,2107.0
12111,Muscle tissue,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL874590,,BAO_0000218,2385.0
12112,Muscle tissue,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627194,,BAO_0000218,2385.0
12113,Muscle tissue,Intermediate,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627195,,BAO_0000218,2385.0
12114,Female gonad,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627196,,BAO_0000218,992.0
12115,Female gonad,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627197,,BAO_0000218,992.0
12116,Female gonad,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627198,,BAO_0000218,992.0
12117,Female gonad,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,1,,,50597,N,1,,CHEMBL627199,,BAO_0000218,992.0
12118,Female gonad,Intermediate,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627200,,BAO_0000218,992.0
12119,Plasma,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627201,,BAO_0000218,1969.0
12120,Plasma,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627202,,BAO_0000218,1969.0
12121,Plasma,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627203,,BAO_0000218,1969.0
12122,Plasma,Intermediate,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627204,,BAO_0000218,1969.0
12123,Spleen,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627205,,BAO_0000218,2106.0
12124,Spleen,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627206,,BAO_0000218,2106.0
12125,Spleen,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627207,,BAO_0000218,2106.0
12126,Spleen,Intermediate,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627208,,BAO_0000218,2106.0
12127,Thyroid gland,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627209,,BAO_0000218,2046.0
12128,Thyroid gland,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627210,,BAO_0000218,2046.0
12129,Thyroid gland,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627211,,BAO_0000218,2046.0
12130,Thyroid gland,Intermediate,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627212,,BAO_0000218,2046.0
12131,Uterus,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL627213,,BAO_0000218,995.0
12132,Uterus,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL626599,,BAO_0000218,995.0
12133,Uterus,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL626600,,BAO_0000218,995.0
12134,Uterus,Intermediate,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,50597,N,1,,CHEMBL626601,,BAO_0000218,995.0
12135,,Autocuration,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,1,,,22224,U,0,,CHEMBL627484,,BAO_0000019,
12136,Plasma,Intermediate,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),1,,,100710,N,1,,CHEMBL627485,,BAO_0000218,1969.0
12137,Plasma,Intermediate,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,1,,,100710,N,1,,CHEMBL628147,,BAO_0000218,1969.0
12138,Plasma,Intermediate,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,1,,,100710,N,1,,CHEMBL628148,,BAO_0000218,1969.0
12139,Plasma,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),1,,,50588,N,1,,CHEMBL628149,,BAO_0000218,1969.0
12140,Plasma,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,1,,,50588,N,1,,CHEMBL628150,,BAO_0000218,1969.0
12141,Plasma,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,1,,,50588,N,1,,CHEMBL628318,,BAO_0000218,1969.0
12142,Plasma,Intermediate,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,1,,,50588,N,1,,CHEMBL628319,,BAO_0000218,1969.0
12143,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,,,50588,N,1,,CHEMBL875609,,BAO_0000218,
12144,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,1,,,22224,U,0,,CHEMBL628320,,BAO_0000019,
12145,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,1,,,22224,U,0,,CHEMBL628321,,BAO_0000019,
12146,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,1,,,22224,U,0,,CHEMBL628322,,BAO_0000019,
12147,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,1,,,22224,U,0,,CHEMBL628323,,BAO_0000019,
12148,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,1,,,22224,U,0,,CHEMBL628324,,BAO_0000019,
12149,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,1,,,22224,U,0,,CHEMBL628325,,BAO_0000019,
12150,,Autocuration,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,1,,,22224,U,0,,CHEMBL628326,,BAO_0000019,
12151,Adrenal medulla,Intermediate,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",1,,,50588,N,1,,CHEMBL628327,,BAO_0000218,1236.0
12152,Adrenal medulla,Intermediate,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",1,,,50588,N,1,,CHEMBL628328,,BAO_0000218,1236.0
12153,Blood,Intermediate,"Concentration of compound in blood of dog 1, after administering intravenously",1,,,50588,N,1,,CHEMBL628329,,BAO_0000218,178.0
12154,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",1,,,50597,N,1,,CHEMBL628330,,BAO_0000218,2107.0
12155,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",1,,,50597,N,1,,CHEMBL628331,,BAO_0000218,2107.0
12156,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",1,,,50597,N,1,,CHEMBL628332,,BAO_0000218,2107.0
12157,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",1,,,50597,N,1,,CHEMBL628333,,BAO_0000218,2107.0
12158,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",1,,,50597,N,1,,CHEMBL628334,,BAO_0000218,2107.0
12159,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",1,,,50597,N,1,,CHEMBL628335,,BAO_0000218,2107.0
12160,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",1,,,50597,N,1,,CHEMBL628336,,BAO_0000218,2107.0
12161,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,,,50597,N,1,,CHEMBL628337,,BAO_0000218,2107.0
12162,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",1,,,50597,N,1,,CHEMBL628338,,BAO_0000218,2107.0
12163,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",1,,,50597,N,1,,CHEMBL875610,,BAO_0000218,2107.0
12164,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",1,,,50597,N,1,,CHEMBL628339,,BAO_0000218,2107.0
12165,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",1,,,50597,N,1,,CHEMBL628340,,BAO_0000218,2107.0
12166,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",1,,,50597,N,1,,CHEMBL628341,,BAO_0000218,2107.0
12167,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",1,,,50597,N,1,,CHEMBL622214,,BAO_0000218,2107.0
12168,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",1,,,50597,N,1,,CHEMBL623167,,BAO_0000218,2107.0
12169,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",1,,,50597,N,1,,CHEMBL623168,,BAO_0000218,2107.0
12170,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",1,,,50597,N,1,,CHEMBL623169,,BAO_0000218,2107.0
12171,Liver,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",1,,,50597,N,1,,CHEMBL623170,,BAO_0000218,2107.0
12172,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",1,,,50597,N,1,,CHEMBL627224,,BAO_0000218,2048.0
12173,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",1,,,50597,N,1,,CHEMBL875634,,BAO_0000218,2048.0
12174,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",1,,,50597,N,1,,CHEMBL627225,,BAO_0000218,2048.0
12175,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",1,,,50597,N,1,,CHEMBL627226,,BAO_0000218,2048.0
12176,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",1,,,50597,N,1,,CHEMBL626083,,BAO_0000218,2048.0
12177,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",1,,,50597,N,1,,CHEMBL626084,,BAO_0000218,2048.0
12178,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",1,,,50597,N,1,,CHEMBL626085,,BAO_0000218,2048.0
12179,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",1,,,50597,N,1,,CHEMBL626086,,BAO_0000218,2048.0
12180,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",1,,,50597,N,1,,CHEMBL626087,,BAO_0000218,2048.0
12181,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",1,,,50597,N,1,,CHEMBL626088,,BAO_0000218,2048.0
12182,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",1,,,50597,N,1,,CHEMBL626089,,BAO_0000218,2048.0
12183,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",1,,,50597,N,1,,CHEMBL626090,,BAO_0000218,2048.0
12184,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",1,,,50597,N,1,,CHEMBL626091,,BAO_0000218,2048.0
12185,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",1,,,50597,N,1,,CHEMBL626092,,BAO_0000218,2048.0
12186,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",1,,,50597,N,1,,CHEMBL626093,,BAO_0000218,2048.0
12187,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",1,,,50597,N,1,,CHEMBL626094,,BAO_0000218,2048.0
12188,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",1,,,50597,N,1,,CHEMBL626095,,BAO_0000218,2048.0
12189,Lung,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",1,,,50597,N,1,,CHEMBL626096,,BAO_0000218,2048.0
12190,,Autocuration,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,1,,,22224,U,0,,CHEMBL626097,,BAO_0000218,
12191,,Intermediate,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,,,50597,N,1,,CHEMBL626098,,BAO_0000218,
12192,Plasma,Autocuration,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,1,,,22224,U,0,,CHEMBL626099,,BAO_0000218,1969.0
12193,Plasma,Autocuration,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,1,,,22224,U,0,,CHEMBL626100,,BAO_0000218,1969.0
12194,Plasma,Intermediate,AUC 0-inf in dog,1,,,50588,N,1,,CHEMBL626101,,BAO_0000218,1969.0
12195,Plasma,Intermediate,AUC 0-inf in guinea pig,1,,,50512,N,1,,CHEMBL626102,,BAO_0000218,1969.0
12196,Plasma,Intermediate,AUC 0-t in dog,1,,,50588,N,1,,CHEMBL626103,,BAO_0000218,1969.0
12197,Plasma,Intermediate,AUC 0-t in guinea pig,1,,,50512,N,1,,CHEMBL628391,,BAO_0000218,1969.0
12198,,Intermediate,The compound was tested for brain to plasma partition in rat,1,,,50597,N,1,,CHEMBL628392,,BAO_0000218,
12199,,Intermediate,The compound was tested for brain to plasma partition in rat.,1,,,50597,N,1,,CHEMBL628393,,BAO_0000218,
12200,Blood,Autocuration,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,1,,,22224,U,0,,CHEMBL628394,,BAO_0000019,178.0
12201,,Intermediate,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,1,,,50588,N,1,,CHEMBL628395,,BAO_0000218,
12202,,Autocuration,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,1,,,22224,U,0,,CHEMBL628396,,BAO_0000218,
12203,,Intermediate,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,,,50592,N,1,,CHEMBL628397,,BAO_0000218,
12204,,Intermediate,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,1,,,50597,N,1,,CHEMBL628398,,BAO_0000218,
12205,,Intermediate,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,1,,,50797,N,1,,CHEMBL628399,,BAO_0000218,
12206,,Intermediate,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,1,,,50588,N,1,,CHEMBL628400,,BAO_0000218,
12207,,Intermediate,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,1,,,50597,N,1,,CHEMBL874907,,BAO_0000218,
12208,,Autocuration,Area under curve of the compound was determined,1,,,22224,U,0,,CHEMBL628401,,BAO_0000019,
12209,Plasma,Autocuration,AUC in monkeys at a dose of 1 mg/kg,1,,,22224,U,0,,CHEMBL628402,,BAO_0000218,1969.0
12210,Plasma,Intermediate,AUC in rats at a dose of 1 mg/kg,1,,,50597,N,1,,CHEMBL628403,,BAO_0000218,1969.0
12211,,Autocuration,Compound was evaluated for the overall absorbance loss at pH of 2,1,,,22224,U,0,,CHEMBL628404,,BAO_0000019,
12212,,Autocuration,Compound was evaluated for the overall absorbance loss at pH of 4,1,,,22224,U,0,,CHEMBL628405,,BAO_0000019,
12213,,Autocuration,Compound was evaluated for the overall absorbance loss at pH of 7,1,,,22224,U,0,,CHEMBL628406,,BAO_0000019,
12214,,Intermediate,Compound was evaluated for its absorption in the rats,1,,,50597,N,1,,CHEMBL628407,,BAO_0000218,
12215,Urine,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,,,50597,N,1,,CHEMBL628408,,BAO_0000218,1088.0
12216,Urine,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,1,,,50597,N,1,,CHEMBL629171,,BAO_0000218,1088.0
12217,Urine,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,,,50597,N,1,,CHEMBL629172,,BAO_0000218,1088.0
12218,Urine,Intermediate,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,1,,,50597,N,1,,CHEMBL629173,,BAO_0000218,1088.0
12219,,Intermediate,In vitro percent permeability into rat ileum,1,,,50597,N,1,,CHEMBL629174,,BAO_0000218,
12220,,Intermediate,In vitro percent permeability into rat ileum; Range is 10-17,1,,,50597,N,1,,CHEMBL629175,,BAO_0000218,
12221,,Intermediate,In vitro percent permeability into rat ileum; Range is 10-18,1,,,50597,N,1,,CHEMBL629176,,BAO_0000218,
12222,,Intermediate,In vitro percent permeability into rat ileum; Range is 10-19,1,,,50597,N,1,,CHEMBL629177,,BAO_0000218,
12223,,Intermediate,In vitro percent permeability into rat ileum; Range is 12-15,1,,,50597,N,1,,CHEMBL629178,,BAO_0000218,
12224,,Intermediate,In vitro percent permeability into rat ileum; Range is 13-19,1,,,50597,N,1,,CHEMBL631869,,BAO_0000218,
12225,,Intermediate,In vitro percent permeability into rat ileum; Range is 14-17,1,,,50597,N,1,,CHEMBL631870,,BAO_0000218,
12226,,Intermediate,In vitro percent permeability into rat ileum; Range is 15-18,1,,,50597,N,1,,CHEMBL631871,,BAO_0000218,
12227,,Intermediate,In vitro percent permeability into rat ileum; Range is 2-5,1,,,50597,N,1,,CHEMBL631872,,BAO_0000218,
12228,Ileum,Autocuration,In vitro percent permeability into rat ileum; Range is 23-42,1,,,22224,U,0,,CHEMBL875775,,BAO_0000221,2116.0
12229,,Intermediate,In vitro percent permeability into rat ileum; Range is 28-36,1,,,50597,N,1,,CHEMBL631873,,BAO_0000218,
12230,,Intermediate,In vitro percent permeability into rat ileum; Range is 29-35,1,,,50597,N,1,,CHEMBL631874,,BAO_0000218,
12231,,Intermediate,In vitro percent permeability into rat ileum; Range is 46-66,1,,,50597,N,1,,CHEMBL631875,,BAO_0000218,
12232,,Intermediate,In vitro percent permeability into rat ileum; Range is 50-68,1,,,50597,N,1,,CHEMBL631876,,BAO_0000218,
12233,,Intermediate,In vitro percent permeability into rat ileum; Range is 78-81,1,,,50597,N,1,,CHEMBL631877,,BAO_0000218,
12234,,Intermediate,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,1,,,50597,N,1,,CHEMBL631878,,BAO_0000218,
12235,,Intermediate,In vitro percent permeability into rat ileum; nd indicates not detected,1,,,50597,N,1,,CHEMBL631879,,BAO_0000218,
12236,,Intermediate,In vitro percent permeability into rat ileum; nt indicates not detected,1,,,50597,N,1,,CHEMBL631880,,BAO_0000218,
12237,,Intermediate,In vitro percent permeability into rat ileum; nt indicates not tested,1,,,50597,N,1,,CHEMBL631881,,BAO_0000218,
12238,,Intermediate,Compound was tested for oral absorption in bile-duct cannulated rats,1,,,50597,N,1,,CHEMBL631882,,BAO_0000218,
12239,,Intermediate,Compound was tested for oral absorption in bile-duct cannulated rats.,1,,,50597,N,1,,CHEMBL630749,,BAO_0000218,
12240,,Intermediate,Oral absorption using Caco-2 cell monolayers.,1,,,50587,N,1,,CHEMBL630750,,BAO_0000218,
12241,,Intermediate,Percent of the drug absorbed after administration to humans was determined,1,,,50587,N,1,,CHEMBL630253,,BAO_0000218,
12242,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,,,50597,N,1,,CHEMBL630254,,BAO_0000218,1969.0
12243,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,,,50597,N,1,,CHEMBL630255,,BAO_0000218,1969.0
12244,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,,,50597,N,1,,CHEMBL630256,,BAO_0000218,1969.0
12245,Liver,Intermediate,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL875781,,BAO_0000218,2107.0
12246,Liver,Intermediate,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL630257,,BAO_0000218,2107.0
12247,Liver,Intermediate,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,50597,N,1,,CHEMBL630258,,BAO_0000218,2107.0
12248,,Intermediate,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",1,,,50597,N,1,,CHEMBL630259,,BAO_0000218,
12249,Striatum,Intermediate,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",1,,,50597,N,1,,CHEMBL630260,,BAO_0000218,2435.0
12250,Striatum,Intermediate,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",1,,,50597,N,1,,CHEMBL630261,,BAO_0000218,2435.0
12251,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,1,,,50597,N,1,,CHEMBL630262,,BAO_0000218,
12252,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,1,,,50597,N,1,,CHEMBL630263,,BAO_0000218,
12253,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,1,,,50597,N,1,,CHEMBL630264,,BAO_0000218,
12254,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,1,,,50597,N,1,,CHEMBL630265,,BAO_0000218,
12255,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,1,,,50597,N,1,,CHEMBL630266,,BAO_0000218,
12256,Kidney,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,1,,,50597,N,1,,CHEMBL630267,,BAO_0000218,2113.0
12257,Kidney,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,1,,,50597,N,1,,CHEMBL630268,,BAO_0000218,2113.0
12258,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,1,,,50597,N,1,,CHEMBL630269,,BAO_0000218,
12259,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,1,,,50597,N,1,,CHEMBL630270,,BAO_0000218,
12260,Lung,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,1,,,50597,N,1,,CHEMBL630141,,BAO_0000218,2048.0
12261,Lung,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,1,,,50597,N,1,,CHEMBL630142,,BAO_0000218,2048.0
12262,Muscle tissue,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,1,,,50597,N,1,,CHEMBL630143,,BAO_0000218,2385.0
12263,Muscle tissue,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,1,,,50597,N,1,,CHEMBL630144,,BAO_0000218,2385.0
12264,Prostate gland,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,1,,,50597,N,1,,CHEMBL630145,,BAO_0000218,2367.0
12265,Prostate gland,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,1,,,50597,N,1,,CHEMBL630146,,BAO_0000218,2367.0
12266,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,1,,,50597,N,1,,CHEMBL630147,,BAO_0000218,
12267,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,1,,,50597,N,1,,CHEMBL630148,,BAO_0000218,
12268,,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,1,,,50597,N,1,,CHEMBL630149,,BAO_0000218,
12269,Spleen,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,1,,,50597,N,1,,CHEMBL630150,,BAO_0000218,2106.0
12270,Spleen,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,1,,,50597,N,1,,CHEMBL630151,,BAO_0000218,2106.0
12271,Thyroid gland,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,1,,,50597,N,1,,CHEMBL632031,,BAO_0000218,2046.0
12272,Thyroid gland,Intermediate,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,1,,,50597,N,1,,CHEMBL632032,,BAO_0000218,2046.0
12273,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,1,,,50597,N,1,,CHEMBL632033,,BAO_0000218,
12274,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,1,,,50597,N,1,,CHEMBL632034,,BAO_0000218,
12275,Muscle tissue,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,1,,,50597,N,1,,CHEMBL632035,,BAO_0000218,2385.0
12276,,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,1,,,50597,N,1,,CHEMBL632036,,BAO_0000218,
12277,Thyroid gland,Intermediate,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,1,,,50597,N,1,,CHEMBL632037,,BAO_0000218,2046.0
12278,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,,,50597,N,1,,CHEMBL632038,,BAO_0000218,178.0
12279,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,,,50597,N,1,,CHEMBL632039,,BAO_0000218,178.0
12280,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,,,50597,N,1,,CHEMBL632040,,BAO_0000218,178.0
12281,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,,,50597,N,1,,CHEMBL632041,,BAO_0000218,178.0
12282,Blood,Intermediate,"Concentration of compound in blood of dog 2, after administering intravenously",1,,,50588,N,1,,CHEMBL632042,,BAO_0000218,178.0
12283,,Intermediate,"Concentration of compound in left ventricle of dog 1, after administering intravenously",1,,,50588,N,1,,CHEMBL632043,,BAO_0000218,
12284,,Intermediate,"Concentration of compound in left ventricle of dog 2, after administering intravenously",1,,,50588,N,1,,CHEMBL632044,,BAO_0000218,
12285,Liver,Intermediate,"Concentration of compound in liver of dog 1, after administering intravenously",1,,,50588,N,1,,CHEMBL632045,,BAO_0000218,2107.0
12286,Liver,Intermediate,"Concentration of compound in liver of dog 2, after administering intravenously",1,,,50588,N,1,,CHEMBL632046,,BAO_0000218,2107.0
12287,Lung,Intermediate,"Concentration of compound in lung of dog 1, after administering intravenously",1,,,50588,N,1,,CHEMBL632047,,BAO_0000218,2048.0
12288,Lung,Intermediate,"Concentration of compound in lung of dog 2, after administering intravenously",1,,,50588,N,1,,CHEMBL632048,,BAO_0000218,2048.0
12289,Muscle tissue,Intermediate,"Concentration of compound in muscle of dog 1, after administering intravenously",1,,,50588,N,1,,CHEMBL632049,,BAO_0000218,2385.0
12290,Muscle tissue,Intermediate,"Concentration of compound in muscle of dog 2, after administering intravenously",1,,,50588,N,1,,CHEMBL876418,,BAO_0000218,2385.0
12291,Spleen,Intermediate,"Concentration of compound in spleen of dog 1,after administering intravenously",1,,,50588,N,1,,CHEMBL632050,,BAO_0000218,2106.0
12292,Spleen,Intermediate,"Concentration of compound in spleen of dog 2, after administering intravenously",1,,,50588,N,1,,CHEMBL632051,,BAO_0000218,2106.0
12293,,Autocuration,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,1,,,22224,U,0,,CHEMBL632052,,BAO_0000218,
12294,,Autocuration,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,1,,,22224,U,0,,CHEMBL632053,,BAO_0000218,
12295,,Autocuration,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,1,,,22224,U,0,,CHEMBL632054,,BAO_0000218,
12296,,Autocuration,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,1,,,22224,U,0,,CHEMBL632055,,BAO_0000218,
12297,,Autocuration,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,1,,,22224,U,0,,CHEMBL631181,,BAO_0000218,
12298,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,1,,,22224,U,0,,CHEMBL631182,,BAO_0000218,
12299,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,,,22224,U,0,,CHEMBL631183,,BAO_0000218,
12300,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,22224,U,0,,CHEMBL631184,,BAO_0000218,
12301,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,22224,U,0,,CHEMBL629774,,BAO_0000218,
12302,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,22224,U,0,,CHEMBL629775,,BAO_0000218,
12303,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,22224,U,0,,CHEMBL876549,,BAO_0000218,
12304,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL628172,,BAO_0000218,
12305,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,,,22224,U,0,,CHEMBL628173,,BAO_0000218,
12306,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,1,,,22224,U,0,,CHEMBL628174,,BAO_0000218,
12307,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,1,,,22224,U,0,,CHEMBL628175,,BAO_0000218,
12308,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,,,22224,U,0,,CHEMBL628176,,BAO_0000218,
12309,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,,,22224,U,0,,CHEMBL628177,,BAO_0000218,
12310,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL628178,,BAO_0000218,
12311,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,,,22224,U,0,,CHEMBL628179,,BAO_0000218,
12312,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,1,,,22224,U,0,,CHEMBL628180,,BAO_0000218,
12313,,Autocuration,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,1,,,22224,U,0,,CHEMBL628181,,BAO_0000218,
12314,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,22224,U,0,,CHEMBL628182,,BAO_0000218,
12315,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,22224,U,0,,CHEMBL628183,,BAO_0000218,
12316,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,1,,,22224,U,0,,CHEMBL628184,,BAO_0000218,
12317,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,22224,U,0,,CHEMBL628185,,BAO_0000218,
12318,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL875617,,BAO_0000218,
12319,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,1,,,22224,U,0,,CHEMBL628186,,BAO_0000218,
12320,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,22224,U,0,,CHEMBL628187,,BAO_0000218,
12321,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,,,22224,U,0,,CHEMBL628188,,BAO_0000218,
12322,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,1,,,22224,U,0,,CHEMBL628189,,BAO_0000218,
12323,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,1,,,22224,U,0,,CHEMBL628190,,BAO_0000218,
12324,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,,,22224,U,0,,CHEMBL628191,,BAO_0000218,
12325,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,1,,,22224,U,0,,CHEMBL626513,,BAO_0000218,
12326,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",1,,,50597,N,1,,CHEMBL626514,,BAO_0000218,2046.0
12327,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",1,,,50597,N,1,,CHEMBL626515,,BAO_0000218,2046.0
12328,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",1,,,50597,N,1,,CHEMBL626516,,BAO_0000218,2046.0
12329,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",1,,,50597,N,1,,CHEMBL626517,,BAO_0000218,2046.0
12330,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",1,,,50597,N,1,,CHEMBL626518,,BAO_0000218,2046.0
12331,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",1,,,50597,N,1,,CHEMBL626519,,BAO_0000218,2046.0
12332,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",1,,,50597,N,1,,CHEMBL626520,,BAO_0000218,2046.0
12333,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",1,,,50597,N,1,,CHEMBL626521,,BAO_0000218,2046.0
12334,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",1,,,50597,N,1,,CHEMBL626522,,BAO_0000218,2046.0
12335,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",1,,,50597,N,1,,CHEMBL626523,,BAO_0000218,2046.0
12336,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",1,,,50597,N,1,,CHEMBL626524,,BAO_0000218,2046.0
12337,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",1,,,50597,N,1,,CHEMBL626688,,BAO_0000218,2046.0
12338,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",1,,,50597,N,1,,CHEMBL626689,,BAO_0000218,2046.0
12339,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",1,,,50597,N,1,,CHEMBL626690,,BAO_0000218,2046.0
12340,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",1,,,50597,N,1,,CHEMBL626691,,BAO_0000218,2046.0
12341,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",1,,,50597,N,1,,CHEMBL627319,,BAO_0000218,2046.0
12342,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",1,,,50597,N,1,,CHEMBL624052,,BAO_0000218,2046.0
12343,Thyroid gland,Intermediate,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",1,,,50597,N,1,,CHEMBL624053,,BAO_0000218,2046.0
12344,,Intermediate,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL624054,,BAO_0000218,
12345,,Intermediate,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL624055,,BAO_0000218,
12346,,Intermediate,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL624056,,BAO_0000218,
12347,Uterus,Intermediate,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL624057,,BAO_0000218,995.0
12348,Uterus,Intermediate,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL622281,,BAO_0000218,995.0
12349,Uterus,Intermediate,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL622282,,BAO_0000218,995.0
12350,Uterus,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL622283,,BAO_0000218,995.0
12351,Uterus,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL622284,,BAO_0000218,995.0
12352,Uterus,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL622285,,BAO_0000218,995.0
12353,Uterus,Intermediate,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,50597,N,1,,CHEMBL622286,,BAO_0000218,995.0
12354,,Autocuration,Distribution coefficient (D %) between octanol and buffer of pH 7.4,1,,,22224,U,0,,CHEMBL622287,,BAO_0000100,
12355,,Intermediate,Partition coefficient (logD7.4),1,,,50594,N,1,,CHEMBL622288,,BAO_0000218,
12356,,Intermediate,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,,,50594,N,1,,CHEMBL622289,,BAO_0000218,
12357,Brain,Intermediate,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,,,50594,N,1,,CHEMBL622290,,BAO_0000218,955.0
12358,,Intermediate,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,,,50594,N,1,,CHEMBL622291,,BAO_0000218,
12359,Brain,Intermediate,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,,,50594,N,1,,CHEMBL622292,,BAO_0000218,955.0
12360,,Intermediate,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,,,50594,N,1,,CHEMBL622293,,BAO_0000218,
12361,Brain,Intermediate,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,,,50594,N,1,,CHEMBL622294,,BAO_0000218,955.0
12362,,Intermediate,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,,,50594,N,1,,CHEMBL622295,,BAO_0000218,
12363,Brain,Intermediate,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,,,50597,N,1,,CHEMBL622296,,BAO_0000218,955.0
12364,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,1,,,50597,N,1,,CHEMBL874409,,BAO_0000218,1969.0
12365,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,,,50597,N,1,,CHEMBL622297,,BAO_0000218,1969.0
12366,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,,,50597,N,1,,CHEMBL622298,,BAO_0000218,1969.0
12367,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,,,50597,N,1,,CHEMBL622299,,BAO_0000218,1969.0
12368,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,,,50597,N,1,,CHEMBL622300,,BAO_0000218,1969.0
12369,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,,,50597,N,1,,CHEMBL622301,,BAO_0000218,1969.0
12370,Plasma,Intermediate,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,,,50597,N,1,,CHEMBL622302,,BAO_0000218,1969.0
12371,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,,,50597,N,1,,CHEMBL622303,,BAO_0000218,1969.0
12372,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,,,50597,N,1,,CHEMBL622304,,BAO_0000218,1969.0
12373,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,1,,,50597,N,1,,CHEMBL622305,,BAO_0000218,1969.0
12374,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,,,50597,N,1,,CHEMBL622306,,BAO_0000218,1969.0
12375,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,1,,,50597,N,1,,CHEMBL626864,,BAO_0000218,1969.0
12376,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,,,50597,N,1,,CHEMBL626865,,BAO_0000218,1969.0
12377,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,1,,,50597,N,1,,CHEMBL626866,,BAO_0000218,1969.0
12378,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,,,50597,N,1,,CHEMBL626867,,BAO_0000218,1969.0
12379,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,,,50597,N,1,,CHEMBL626868,,BAO_0000218,1969.0
12380,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,1,,,50597,N,1,,CHEMBL626869,,BAO_0000218,1969.0
12381,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,,,50597,N,1,,CHEMBL626870,,BAO_0000218,1969.0
12382,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,1,,,50597,N,1,,CHEMBL626871,,BAO_0000218,1969.0
12383,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,,,50597,N,1,,CHEMBL626872,,BAO_0000218,1969.0
12384,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,,,50597,N,1,,CHEMBL632185,,BAO_0000218,1969.0
12385,Plasma,Intermediate,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,1,,,50597,N,1,,CHEMBL632186,,BAO_0000218,1969.0
12386,,Autocuration,Amount of acetic acid produced by the compound,1,,,22224,U,0,,CHEMBL629310,,BAO_0000019,
12387,,Autocuration,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,1,,,22224,U,0,,CHEMBL629311,,BAO_0000019,
12388,,Intermediate,Log of (Cbrain/Cblood) in rats,1,,,50597,N,1,,CHEMBL629312,,BAO_0000218,
12389,,Autocuration,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629313,,BAO_0000221,
12390,,Autocuration,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629314,,BAO_0000221,
12391,,Autocuration,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629315,,BAO_0000221,
12392,,Autocuration,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629316,,BAO_0000219,
12393,,Autocuration,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629317,,BAO_0000221,
12394,,Autocuration,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629318,,BAO_0000019,
12395,,Autocuration,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL877497,,BAO_0000019,
12396,,Autocuration,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629319,,BAO_0000019,
12397,,Autocuration,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629320,,BAO_0000019,
12398,,Autocuration,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629496,,BAO_0000019,
12399,,Autocuration,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629497,,BAO_0000019,
12400,,Autocuration,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629498,,BAO_0000019,
12401,,Autocuration,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629499,,BAO_0000019,
12402,,Autocuration,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629500,,BAO_0000019,
12403,,Autocuration,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629501,,BAO_0000019,
12404,,Autocuration,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),1,,,22224,U,0,,CHEMBL629502,,BAO_0000019,
12405,,Autocuration,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,1,,,22224,U,0,,CHEMBL629503,,BAO_0000218,
12406,,Intermediate,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,1,,,50588,N,1,,CHEMBL629504,,BAO_0000218,
12407,,Autocuration,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,1,,,22224,U,0,,CHEMBL629505,,BAO_0000019,
12408,,Autocuration,Compound was evaluated for total body clearance,1,,,22224,U,0,,CHEMBL629506,,BAO_0000019,
12409,,Autocuration,Compound was evaluated for volume of distribution at steady state,1,,,22224,U,0,,CHEMBL629507,,BAO_0000019,
12410,,Autocuration,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,1,,,22224,U,0,,CHEMBL877498,,BAO_0000019,
12411,,Autocuration,Percentage of the diamine which is monoprotonated at pH 7.4,1,,,22224,U,0,,CHEMBL629508,,BAO_0000019,
12412,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,1,,,22224,U,0,,CHEMBL629509,,BAO_0000019,
12413,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,,,50597,N,1,,CHEMBL629510,,BAO_0000218,178.0
12414,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,,50597,N,1,,CHEMBL629511,,BAO_0000218,178.0
12415,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,,50597,N,1,,CHEMBL629512,,BAO_0000218,178.0
12416,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,,50597,N,1,,CHEMBL629513,,BAO_0000218,178.0
12417,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,,,50597,N,1,,CHEMBL629514,,BAO_0000218,178.0
12418,Blood,Intermediate,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,,50597,N,1,,CHEMBL628447,,BAO_0000218,178.0
12419,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,,,50597,N,1,,CHEMBL628448,,BAO_0000218,178.0
12420,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,,,50597,N,1,,CHEMBL628449,,BAO_0000218,178.0
12421,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,,,50597,N,1,,CHEMBL631119,,BAO_0000218,178.0
12422,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,,,50597,N,1,,CHEMBL631120,,BAO_0000218,178.0
12423,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,,,50597,N,1,,CHEMBL631121,,BAO_0000218,178.0
12424,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,1,,,50597,N,1,,CHEMBL874458,,BAO_0000218,178.0
12425,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,,50597,N,1,,CHEMBL631122,,BAO_0000218,178.0
12426,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,,50597,N,1,,CHEMBL631123,,BAO_0000218,178.0
12427,Blood,Intermediate,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,,50597,N,1,,CHEMBL631124,,BAO_0000218,178.0
12428,Blood,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,,50597,N,1,,CHEMBL631125,,BAO_0000218,178.0
12429,Blood,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,,50597,N,1,,CHEMBL631290,,BAO_0000218,178.0
12430,Blood,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,,50597,N,1,,CHEMBL631291,,BAO_0000218,178.0
12431,Blood,Intermediate,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,,50597,N,1,,CHEMBL631292,,BAO_0000218,178.0
12432,Blood,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,,50597,N,1,,CHEMBL631293,,BAO_0000218,178.0
12433,Blood,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,,50597,N,1,,CHEMBL631294,,BAO_0000218,178.0
12434,Blood,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,,50597,N,1,,CHEMBL631295,,BAO_0000218,178.0
12435,Blood,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,,,50597,N,1,,CHEMBL631296,,BAO_0000218,178.0
12436,Blood,Intermediate,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,,50597,N,1,,CHEMBL631297,,BAO_0000218,178.0
12437,,Autocuration,Maximum biodistribution (Bmax) was determined.,1,,,22224,U,0,,CHEMBL631298,,BAO_0000218,
12438,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,1,,,50594,N,1,,CHEMBL631299,,BAO_0000218,
12439,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,1,,,50594,N,1,,CHEMBL631300,,BAO_0000218,
12440,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,1,,,50594,N,1,,CHEMBL631301,,BAO_0000218,
12441,,Intermediate,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,1,,,50594,N,1,,CHEMBL630291,,BAO_0000218,
12442,,Autocuration,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,22224,U,0,,CHEMBL630292,,BAO_0000218,
12443,,Autocuration,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,1,,,22224,U,0,,CHEMBL630293,,BAO_0000218,
12444,,Autocuration,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL630294,,BAO_0000218,
12445,,Autocuration,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,1,,,22224,U,0,,CHEMBL630295,,BAO_0000218,
12446,,Autocuration,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,1,,,22224,U,0,,CHEMBL630296,,BAO_0000218,
12447,,Autocuration,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626782,,BAO_0000218,
12448,,Autocuration,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626783,,BAO_0000218,
12449,,Autocuration,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,22224,U,0,,CHEMBL626784,,BAO_0000218,
12450,,Autocuration,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,1,,,22224,U,0,,CHEMBL626785,,BAO_0000218,
12451,,Autocuration,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626786,,BAO_0000218,
12452,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL626787,,BAO_0000218,
12453,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,1,,,22224,U,0,,CHEMBL626788,,BAO_0000218,
12454,,Autocuration,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,,,22224,U,0,,CHEMBL625927,,BAO_0000218,
12455,Blood,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL625928,,BAO_0000218,178.0
12456,Blood,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,,50597,N,1,,CHEMBL625929,,BAO_0000218,178.0
12457,Blood,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,,,50597,N,1,,CHEMBL625930,,BAO_0000218,178.0
12458,Blood,Intermediate,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",1,,,50597,N,1,,CHEMBL625931,,BAO_0000218,178.0
12459,Blood,Intermediate,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,1,,,50597,N,1,,CHEMBL627230,,BAO_0000218,178.0
12460,Blood,Intermediate,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627231,,BAO_0000218,178.0
12461,Blood,Intermediate,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,,50597,N,1,,CHEMBL627232,,BAO_0000218,178.0
12462,Blood,Intermediate,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,,,50597,N,1,,CHEMBL627233,,BAO_0000218,178.0
12463,Blood,Intermediate,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL875470,,BAO_0000218,178.0
12464,Blood,Intermediate,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627234,,BAO_0000218,178.0
12465,Blood,Intermediate,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627235,,BAO_0000218,178.0
12466,Blood,Intermediate,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627236,,BAO_0000218,178.0
12467,Blood,Intermediate,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627237,,BAO_0000218,178.0
12468,Blood,Intermediate,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627238,,BAO_0000218,178.0
12469,Blood,Intermediate,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627239,,BAO_0000218,178.0
12470,Blood,Intermediate,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627240,,BAO_0000218,178.0
12471,Blood,Intermediate,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627241,,BAO_0000218,178.0
12472,Blood,Intermediate,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627242,,BAO_0000218,178.0
12473,Blood,Intermediate,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,1,,,50597,N,1,,CHEMBL627243,,BAO_0000218,178.0
12474,Blood,Intermediate,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,,50597,N,1,,CHEMBL627244,,BAO_0000218,178.0
12475,Blood,Intermediate,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627245,,BAO_0000218,178.0
12476,Blood,Intermediate,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627246,,BAO_0000218,178.0
12477,Blood,Intermediate,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627247,,BAO_0000218,178.0
12478,Blood,Intermediate,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627248,,BAO_0000218,178.0
12479,Blood,Intermediate,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627249,,BAO_0000218,178.0
12480,Blood,Intermediate,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL625569,,BAO_0000218,178.0
12481,Blood,Intermediate,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL625570,,BAO_0000218,178.0
12482,Blood,Intermediate,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL625571,,BAO_0000218,178.0
12483,Blood,Intermediate,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,,50597,N,1,,CHEMBL625572,,BAO_0000218,178.0
12484,Blood,Intermediate,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,,50597,N,1,,CHEMBL625573,,BAO_0000218,178.0
12485,Blood,Intermediate,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,1,,,50597,N,1,,CHEMBL625574,,BAO_0000218,178.0
12486,Blood,Intermediate,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,,50597,N,1,,CHEMBL626245,,BAO_0000218,178.0
12487,Blood,Intermediate,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL626246,,BAO_0000218,178.0
12488,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,22224,U,0,,CHEMBL626247,,BAO_0000218,
12489,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,22224,U,0,,CHEMBL626248,,BAO_0000218,
12490,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,1,,,22224,U,0,,CHEMBL626249,,BAO_0000218,
12491,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,22224,U,0,,CHEMBL626420,,BAO_0000218,
12492,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,,,22224,U,0,,CHEMBL626421,,BAO_0000218,
12493,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,,,22224,U,0,,CHEMBL626422,,BAO_0000218,
12494,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,22224,U,0,,CHEMBL626423,,BAO_0000218,
12495,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL626424,,BAO_0000218,
12496,,Intermediate,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,1,,,50588,N,1,,CHEMBL626425,,BAO_0000218,
12497,,Intermediate,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,1,,,50597,N,1,,CHEMBL875476,,BAO_0000218,
12498,,Intermediate,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,1,,,100710,N,1,,CHEMBL626426,,BAO_0000218,
12499,,Autocuration,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,1,,,22224,U,0,,CHEMBL626427,,BAO_0000100,
12500,,Autocuration,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,1,,,22224,U,0,,CHEMBL626428,,BAO_0000100,
12501,,Autocuration,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,1,,,22224,U,0,,CHEMBL626429,,BAO_0000019,
12502,Urine,Autocuration,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,1,,,22224,U,0,,CHEMBL625025,,BAO_0000019,1088.0
12503,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL625026,,BAO_0000218,178.0
12504,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL625027,,BAO_0000218,178.0
12505,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL874410,,BAO_0000218,178.0
12506,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL625028,,BAO_0000218,178.0
12507,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL625029,,BAO_0000218,178.0
12508,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL625030,,BAO_0000218,178.0
12509,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL625031,,BAO_0000218,178.0
12510,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL625032,,BAO_0000218,178.0
12511,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL625033,,BAO_0000218,178.0
12512,Blood,Intermediate,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL625034,,BAO_0000218,178.0
12513,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624872,,BAO_0000218,948.0
12514,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624873,,BAO_0000218,948.0
12515,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624874,,BAO_0000218,948.0
12516,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624875,,BAO_0000218,948.0
12517,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624876,,BAO_0000218,948.0
12518,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624877,,BAO_0000218,948.0
12519,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624878,,BAO_0000218,948.0
12520,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624879,,BAO_0000218,948.0
12521,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624880,,BAO_0000218,948.0
12522,Heart,Intermediate,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624881,,BAO_0000218,948.0
12523,Heart,Intermediate,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",1,,,50597,N,1,,CHEMBL624882,,BAO_0000218,948.0
12524,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624883,,BAO_0000218,2113.0
12525,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624884,,BAO_0000218,2113.0
12526,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624885,,BAO_0000218,2113.0
12527,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624886,,BAO_0000218,2113.0
12528,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624887,,BAO_0000218,2113.0
12529,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624888,,BAO_0000218,2113.0
12530,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624889,,BAO_0000218,2113.0
12531,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624890,,BAO_0000218,2113.0
12532,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL621964,,BAO_0000218,2113.0
12533,Kidney,Intermediate,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL621965,,BAO_0000218,2113.0
12534,Liver,Intermediate,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL621966,,BAO_0000218,2107.0
12535,Liver,Intermediate,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL621967,,BAO_0000218,2107.0
12536,Liver,Intermediate,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL622164,,BAO_0000218,2107.0
12537,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),1,,,22224,U,0,,CHEMBL623097,,BAO_0000019,
12538,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),1,,,22224,U,0,,CHEMBL623098,,BAO_0000019,
12539,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,1,,,22224,U,0,,CHEMBL623099,,BAO_0000019,
12540,,Autocuration,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,1,,,22224,U,0,,CHEMBL623100,,BAO_0000019,
12541,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",1,,,50597,N,1,,CHEMBL628673,,BAO_0000218,
12542,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",1,,,50597,N,1,,CHEMBL628674,,BAO_0000218,
12543,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",1,,,50597,N,1,,CHEMBL628675,,BAO_0000218,
12544,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",1,,,50597,N,1,,CHEMBL627644,,BAO_0000218,
12545,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",1,,,50597,N,1,,CHEMBL627645,,BAO_0000218,
12546,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",1,,,50597,N,1,,CHEMBL627646,,BAO_0000218,
12547,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",1,,,50597,N,1,,CHEMBL627647,,BAO_0000218,
12548,,Intermediate,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",1,,,50597,N,1,,CHEMBL627648,,BAO_0000218,
12549,,Intermediate,Free level in rat plasma,1,,,50597,N,1,,CHEMBL627649,,BAO_0000218,
12550,,Autocuration,Level reaching in blood plasma of rat or human was determined,1,,,22224,U,0,,CHEMBL628313,,BAO_0000019,
12551,,Intermediate,Log (Cbrain/Cblood) in rats,1,,,50597,N,1,,CHEMBL628314,,BAO_0000218,
12552,,Autocuration,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,1,,,22224,U,0,,CHEMBL628315,,BAO_0000019,
12553,,Autocuration,Mean percentage of compound transport through membrane; expressed as membrane transport,1,,,22224,U,0,,CHEMBL628316,,BAO_0000019,
12554,,Autocuration,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,1,,,22224,U,0,,CHEMBL628317,,BAO_0000218,
12555,,Autocuration,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,1,,,22224,U,0,,CHEMBL628473,,BAO_0000019,
12556,,Autocuration,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",1,,,22224,U,0,,CHEMBL628474,,BAO_0000019,
12557,,Autocuration,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,1,,,22224,U,0,,CHEMBL628475,,BAO_0000019,
12558,,Autocuration,Net water uptake by a carrier mediated transport (%cm) mechanism,1,,,22224,U,0,,CHEMBL628476,,BAO_0000019,
12559,,Autocuration,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,22224,U,0,,CHEMBL628477,,BAO_0000218,
12560,,Intermediate,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,,,50506,N,1,,CHEMBL628478,,BAO_0000218,
12561,,Intermediate,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,,,50506,N,1,,CHEMBL628479,,BAO_0000218,
12562,,Autocuration,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,22224,U,0,,CHEMBL628480,,BAO_0000218,
12563,,Autocuration,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",1,,,22224,U,0,,CHEMBL628481,,BAO_0000218,
12564,,Intermediate,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,,,50597,N,1,,CHEMBL628482,,BAO_0000218,
12565,,Intermediate,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,,50597,N,1,,CHEMBL628483,,BAO_0000218,
12566,Plasma,Intermediate,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,,,50597,N,1,,CHEMBL628484,,BAO_0000218,1969.0
12567,Plasma,Intermediate,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,,50597,N,1,,CHEMBL628485,,BAO_0000218,1969.0
12568,Plasma,Intermediate,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",1,,,100710,N,1,,CHEMBL628486,,BAO_0000218,1969.0
12569,Plasma,Intermediate,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",1,,,50587,N,1,,CHEMBL628487,,BAO_0000218,1969.0
12570,Plasma,Intermediate,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,,,50597,N,1,,CHEMBL628488,,BAO_0000218,1969.0
12571,Plasma,Intermediate,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,,50597,N,1,,CHEMBL628489,,BAO_0000218,1969.0
12572,Plasma,Intermediate,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,,50597,N,1,,CHEMBL628490,,BAO_0000218,1969.0
12573,,Intermediate,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,100710,N,1,,CHEMBL628491,,BAO_0000218,
12574,,Intermediate,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,100710,N,1,,CHEMBL877507,,BAO_0000218,
12575,,Autocuration,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,,22224,U,0,,CHEMBL628492,,BAO_0000218,
12576,,Autocuration,% metabolized in monkey S-9 after 2 hours (10 ug/mL),1,,,22224,U,0,,CHEMBL628493,,BAO_0000019,
12577,,Autocuration,% metabolized in monkey S-9 after 2 hours (1 ug/ml),1,,,22224,U,0,,CHEMBL628494,,BAO_0000019,
12578,,Autocuration,% metabolized in monkey S-9 after 2 hours (10 ug/ml),1,,,22224,U,0,,CHEMBL628495,,BAO_0000019,
12579,,Intermediate,Permeability in Caco-2 assay at 10E-6,1,,,50587,N,1,,CHEMBL628496,,BAO_0000218,
12580,Brain,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,1,,,22224,U,0,,CHEMBL628497,,BAO_0000218,955.0
12581,Brain,Autocuration,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,1,,,22224,U,0,,CHEMBL628498,,BAO_0000218,955.0
12582,,Autocuration,Plasma protein binding was determined,1,,,22224,U,0,,CHEMBL628499,,BAO_0000019,
12583,,Autocuration,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL627656,,BAO_0000218,
12584,,Autocuration,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,22224,U,0,,CHEMBL627657,,BAO_0000218,
12585,,Autocuration,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,1,,,22224,U,0,,CHEMBL626808,,BAO_0000218,
12586,,Autocuration,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626809,,BAO_0000218,
12587,,Autocuration,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626810,,BAO_0000218,
12588,,Autocuration,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,22224,U,0,,CHEMBL626811,,BAO_0000218,
12589,,Autocuration,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,1,,,22224,U,0,,CHEMBL874465,,BAO_0000218,
12590,,Autocuration,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626812,,BAO_0000218,
12591,,Autocuration,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626813,,BAO_0000218,
12592,,Autocuration,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,1,,,22224,U,0,,CHEMBL626814,,BAO_0000218,
12593,,Autocuration,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,1,,,22224,U,0,,CHEMBL626815,,BAO_0000019,
12594,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL628566,,BAO_0000019,
12595,,Autocuration,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,,,22229,U,0,,CHEMBL628567,,BAO_0000100,
12596,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL628568,,BAO_0000100,
12597,,Intermediate,C max in dog,1,,,50588,N,1,,CHEMBL628569,,BAO_0000218,
12598,,Intermediate,C max in guinea pig,1,,,50512,N,1,,CHEMBL628570,,BAO_0000218,
12599,,Autocuration,C max value was evaluated,1,,,22224,U,0,,CHEMBL628571,,BAO_0000218,
12600,,Autocuration,Cmax value after oral dose of 0.1 mg//kg,1,,,22224,U,0,,CHEMBL628572,,BAO_0000218,
12601,,Autocuration,Cmax value after oral dose of 0.3 mg/kg,1,,,22224,U,0,,CHEMBL628573,,BAO_0000218,
12602,,Autocuration,Cmax value after oral dose of 1 mg/kg,1,,,22224,U,0,,CHEMBL628574,,BAO_0000218,
12603,,Autocuration,Cmax value after oral dose of 10 mg/kg,1,,,22224,U,0,,CHEMBL628575,,BAO_0000218,
12604,,Autocuration,Cmax value after oral dose of 23.4 mg/kg,1,,,22224,U,0,,CHEMBL628576,,BAO_0000218,
12605,,Autocuration,Cmax value after oral dose of 3 mg/kg,1,,,22224,U,0,,CHEMBL628577,,BAO_0000218,
12606,,Autocuration,Cmax value after oral dose of 3.87 mg/kg,1,,,22224,U,0,,CHEMBL628578,,BAO_0000218,
12607,,Intermediate,Cmax value in female Beagle dogs,1,,,50588,N,1,,CHEMBL874466,,BAO_0000218,
12608,,Intermediate,Cmax value in male rats,1,,,50597,N,1,,CHEMBL628579,,BAO_0000218,
12609,Plasma,Intermediate,Cmax value in rat plasma when administered 20 mg/kg perorally,1,,,50597,N,1,,CHEMBL628580,,BAO_0000218,1969.0
12610,Plasma,Intermediate,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,,50588,N,1,,CHEMBL628581,,BAO_0000218,1969.0
12611,Plasma,Intermediate,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,,50588,N,1,,CHEMBL628582,,BAO_0000218,1969.0
12612,,Intermediate,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,1,,,50588,N,1,,CHEMBL628583,,BAO_0000218,
12613,,Autocuration,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,1,,,22224,U,0,,CHEMBL625782,,BAO_0000218,
12614,,Intermediate,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,1,,,50592,N,1,,CHEMBL625783,,BAO_0000218,
12615,,Intermediate,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,1,,,50597,N,1,,CHEMBL625784,,BAO_0000218,
12616,Plasma,Intermediate,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,1,,,50797,N,1,,CHEMBL625785,,BAO_0000218,1969.0
12617,,Intermediate,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,1,,,50597,N,1,,CHEMBL625786,,BAO_0000218,
12618,,Autocuration,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,1,,,22224,U,0,,CHEMBL874467,,BAO_0000019,
12619,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,,,50588,N,1,,CHEMBL625787,,BAO_0000218,
12620,,Intermediate,cytotoxicity against HIV protease enzyme.,1,,,50677,N,1,,CHEMBL625964,,BAO_0000218,
12621,,Intermediate,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,1,,,50594,N,1,,CHEMBL625965,,BAO_0000218,
12622,,Intermediate,Apparent clearance in mice after oral administration of 100 mg/kg of dose,1,,,50594,N,1,,CHEMBL625966,,BAO_0000218,
12623,Plasma,Intermediate,The plasma clearance in dog.,1,,,50588,N,1,,CHEMBL625967,,BAO_0000218,1969.0
12624,Plasma,Intermediate,The plasma clearance in rat.,1,,,50597,N,1,,CHEMBL625968,,BAO_0000218,1969.0
12625,Plasma,Intermediate,Clearance from plasma in male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL625969,,BAO_0000218,1969.0
12626,Plasma,Intermediate,Clearance from plasma in male cynomolgus monkeys,1,,,100710,N,1,,CHEMBL625970,,BAO_0000218,1969.0
12627,Plasma,Intermediate,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",1,,,50588,N,1,,CHEMBL625971,,BAO_0000218,1969.0
12628,Plasma,Intermediate,Clearance of compound in dog plasma,1,,,50588,N,1,,CHEMBL625972,,BAO_0000218,1969.0
12629,Plasma,Intermediate,Clearance of compound in human plasma,1,,,50587,N,1,,CHEMBL625973,,BAO_0000218,1969.0
12630,,Intermediate,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,1,,,50588,N,1,,CHEMBL625974,,BAO_0000218,
12631,,Intermediate,Clearance of compound when administered intravenously as an individual dose to a single dog.,1,,,50588,N,1,,CHEMBL625975,,BAO_0000218,
12632,Plasma,Intermediate,"Clearance (10 mg/kg, intravenously) in dog plasma",1,,,50588,N,1,,CHEMBL625976,,BAO_0000218,1969.0
12633,,Intermediate,Clearance value in dog,1,,,50588,N,1,,CHEMBL625977,,BAO_0000218,
12634,,Intermediate,Clearance value in guinea pig,1,,,50512,N,1,,CHEMBL625978,,BAO_0000218,
12635,,Intermediate,Clearance values in rats after iv administration.,1,,,50597,N,1,,CHEMBL874468,,BAO_0000218,
12636,Plasma,Autocuration,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,1,,,22224,U,0,,CHEMBL625421,,BAO_0000218,1969.0
12637,,Intermediate,In vivo clearance (5 mg/kg) was determined in rabbits,1,,,50592,N,1,,CHEMBL625422,,BAO_0000218,
12638,,Intermediate,Plasma Clearance rate was determined for the compound in rats,1,,,50597,N,1,,CHEMBL625423,,BAO_0000218,
12639,,Autocuration,Plasma Clearance rate was determined for the compound in squirrel monkeys,1,,,22224,U,0,,CHEMBL625424,,BAO_0000218,
12640,,Intermediate,Plasma clearance in rat,1,,,50597,N,1,,CHEMBL625425,,BAO_0000218,
12641,,Autocuration,Plasma clearance of the compound,1,,,22224,U,0,,CHEMBL625426,,BAO_0000218,
12642,,Intermediate,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,1,,,50512,N,1,,CHEMBL625427,,BAO_0000218,
12643,,Intermediate,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,1,,,50512,N,1,,CHEMBL625428,,BAO_0000218,
12644,,Autocuration,Plasma clearance was determined,1,,,22224,U,0,,CHEMBL625429,,BAO_0000218,
12645,,Intermediate,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,1,,,50588,N,1,,CHEMBL625430,,BAO_0000218,
12646,,Intermediate,Plasma clearance rate was determined for the compound in rats,1,,,50597,N,1,,CHEMBL625431,,BAO_0000218,
12647,,Autocuration,Plasma clearance rate was determined for the compound in squirrel monkeys,1,,,22224,U,0,,CHEMBL627307,,BAO_0000218,
12648,,Autocuration,Slow clearance (CL) was determined,1,,,22224,U,0,,CHEMBL627308,,BAO_0000218,
12649,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,,,22224,U,0,,CHEMBL627309,,BAO_0000218,
12650,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,1,,,22224,U,0,,CHEMBL627310,,BAO_0000218,
12651,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,1,,,22224,U,0,,CHEMBL627311,,BAO_0000218,
12652,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,,,22224,U,0,,CHEMBL627312,,BAO_0000218,
12653,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,1,,,22224,U,0,,CHEMBL627313,,BAO_0000218,
12654,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,,,22224,U,0,,CHEMBL627314,,BAO_0000218,
12655,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,,,22224,U,0,,CHEMBL627315,,BAO_0000218,
12656,,Autocuration,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL627316,,BAO_0000218,
12657,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,22224,U,0,,CHEMBL627317,,BAO_0000218,
12658,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,22224,U,0,,CHEMBL627318,,BAO_0000218,
12659,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,1,,,22224,U,0,,CHEMBL627999,,BAO_0000218,
12660,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,22224,U,0,,CHEMBL628000,,BAO_0000218,
12661,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,,,22224,U,0,,CHEMBL628001,,BAO_0000218,
12662,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL628002,,BAO_0000218,
12663,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,,,22224,U,0,,CHEMBL625610,,BAO_0000218,
12664,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,22224,U,0,,CHEMBL625611,,BAO_0000218,
12665,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,1,,,22224,U,0,,CHEMBL625612,,BAO_0000218,
12666,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,1,,,22224,U,0,,CHEMBL625613,,BAO_0000218,
12667,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,22224,U,0,,CHEMBL875479,,BAO_0000218,
12668,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,,,22224,U,0,,CHEMBL625614,,BAO_0000218,
12669,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,,,22224,U,0,,CHEMBL625615,,BAO_0000218,
12670,,Autocuration,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,1,,,22224,U,0,,CHEMBL626302,,BAO_0000218,
12671,Blood,Intermediate,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL626303,,BAO_0000218,178.0
12672,Blood,Intermediate,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,,50597,N,1,,CHEMBL627420,,BAO_0000218,178.0
12673,,Intermediate,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,1,,,50597,N,1,,CHEMBL627421,,BAO_0000218,
12674,,Intermediate,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,1,,,50597,N,1,,CHEMBL625695,,BAO_0000218,
12675,,Intermediate,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,1,,,50597,N,1,,CHEMBL625696,,BAO_0000218,
12676,Brain,Intermediate,Distribution of compound in mice brain was measured after 1 hr,1,,,50594,N,1,,CHEMBL875606,,BAO_0000218,955.0
12677,Brain,Intermediate,Distribution of compound in mice brain was measured after 24 hr r,1,,,50594,N,1,,CHEMBL625697,,BAO_0000218,955.0
12678,Brain,Intermediate,Distribution of compound in mice brain was measured after 2 hr,1,,,50594,N,1,,CHEMBL625698,,BAO_0000218,955.0
12679,Brain,Intermediate,Distribution of compound in mice brain was measured after 3 hr,1,,,50594,N,1,,CHEMBL625699,,BAO_0000218,955.0
12680,Brain,Intermediate,Distribution of compound in mice brain was measured after 6 hr,1,,,50594,N,1,,CHEMBL625700,,BAO_0000218,955.0
12681,,Intermediate,Distribution of compound in mice liver was measured after 1 hr,1,,,50594,N,1,,CHEMBL625701,,BAO_0000218,
12682,,Intermediate,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,1,,,50594,N,1,,CHEMBL625702,,BAO_0000218,
12683,,Intermediate,Distribution of compound in mice liver was measured after 2 hr,1,,,50594,N,1,,CHEMBL625703,,BAO_0000218,
12684,,Intermediate,Distribution of compound in mice liver was measured after 3 hr,1,,,50594,N,1,,CHEMBL625704,,BAO_0000218,
12685,,Intermediate,Distribution of compound in mice liver was measured after 6 hr,1,,,50594,N,1,,CHEMBL625705,,BAO_0000218,
12686,Adrenal medulla,Intermediate,Distribution in dog adrenal medulla 30 min after administration.,1,,,50588,N,1,,CHEMBL625706,,BAO_0000218,1236.0
12687,Adrenal medulla,Intermediate,Distribution in dog adrenal medulla 72 hours after administration.,1,,,50588,N,1,,CHEMBL625707,,BAO_0000218,1236.0
12688,,Intermediate,Distribution in female dog Ovary 24 hours after administration.,1,,,50588,N,1,,CHEMBL625708,,BAO_0000218,
12689,,Intermediate,Distribution in female dog Ovary 72 hours after administration.,1,,,50588,N,1,,CHEMBL625709,,BAO_0000218,
12690,,Intermediate,Distribution in female dog adipose 24 hours after administration.,1,,,50588,N,1,,CHEMBL624180,,BAO_0000218,
12691,,Intermediate,Distribution in female dog adipose 72 hours after administration.,1,,,50588,N,1,,CHEMBL624181,,BAO_0000218,
12692,Adrenal cortex,Intermediate,Distribution in female dog adrenal cortex 72 hours after administration.,1,,,50588,N,1,,CHEMBL624182,,BAO_0000218,1235.0
12693,Adrenal cortex,Intermediate,Distribution in female dog adrenal cortex 72 hours after administration.,1,,,50588,N,1,,CHEMBL624183,,BAO_0000218,1235.0
12694,Liver,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624184,,BAO_0000218,2107.0
12695,Liver,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL877489,,BAO_0000218,2107.0
12696,Liver,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624185,,BAO_0000218,2107.0
12697,Liver,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624186,,BAO_0000218,2107.0
12698,Liver,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624187,,BAO_0000218,2107.0
12699,Liver,Intermediate,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624188,,BAO_0000218,2107.0
12700,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624189,,BAO_0000218,2048.0
12701,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624190,,BAO_0000218,2048.0
12702,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624191,,BAO_0000218,2048.0
12703,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624192,,BAO_0000218,2048.0
12704,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624193,,BAO_0000218,2048.0
12705,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624194,,BAO_0000218,2048.0
12706,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624891,,BAO_0000218,2048.0
12707,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL624892,,BAO_0000218,2048.0
12708,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL624893,,BAO_0000218,2048.0
12709,Lung,Intermediate,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL627632,,BAO_0000218,2048.0
12710,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL627633,,BAO_0000218,
12711,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL627634,,BAO_0000218,
12712,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL627635,,BAO_0000218,
12713,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL627636,,BAO_0000218,
12714,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL626816,,BAO_0000218,
12715,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626817,,BAO_0000218,
12716,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL626818,,BAO_0000218,
12717,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626819,,BAO_0000218,
12718,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL626820,,BAO_0000218,
12719,,Intermediate,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626821,,BAO_0000218,
12720,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626822,,BAO_0000218,2046.0
12721,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626823,,BAO_0000218,2046.0
12722,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL626824,,BAO_0000218,2046.0
12723,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626825,,BAO_0000218,2046.0
12724,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL626826,,BAO_0000218,2046.0
12725,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626827,,BAO_0000218,2046.0
12726,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL626828,,BAO_0000218,2046.0
12727,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626829,,BAO_0000218,2046.0
12728,Thyroid gland,Intermediate,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626830,,BAO_0000218,2046.0
12729,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL627150,,BAO_0000218,
12730,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL627151,,BAO_0000218,
12731,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,50597,N,1,,CHEMBL627152,,BAO_0000218,
12732,,Intermediate,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL627153,,BAO_0000218,
12733,,Autocuration,Rate of acetate production by the compound was determined,1,,,22224,U,0,,CHEMBL627154,,BAO_0000019,
12734,,Autocuration,Rate of acetate production by the compound was determined; Not determined,1,,,22224,U,0,,CHEMBL627155,,BAO_0000019,
12735,,Autocuration,Rate of hydrolysis of nitrocefin by compound was evaluated in water,1,,,22224,U,0,,CHEMBL627156,,BAO_0000019,
12736,,Autocuration,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,1,,,22224,U,0,,CHEMBL627157,,BAO_0000019,
12737,,Intermediate,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,,,50592,N,1,,CHEMBL627158,,BAO_0000218,
12738,Plasma,Intermediate,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,,,50592,N,1,,CHEMBL627159,,BAO_0000218,1969.0
12739,,Intermediate,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,,,50594,N,1,,CHEMBL627160,,BAO_0000218,
12740,,Intermediate,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,,,50597,N,1,,CHEMBL628540,,BAO_0000218,
12741,Plasma,Intermediate,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,,,50597,N,1,,CHEMBL628541,,BAO_0000218,1969.0
12742,Plasma,Intermediate,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,,,50597,N,1,,CHEMBL628542,,BAO_0000218,1969.0
12743,,Autocuration,Solubility after at a pH 1.2,1,,,22229,U,0,,CHEMBL628543,,BAO_0000100,
12744,,Autocuration,Solubility after at pH 1.2,1,,,22229,U,0,,CHEMBL628544,,BAO_0000100,
12745,,Autocuration,Solubility after injection of water,1,,,22229,U,0,,CHEMBL628545,,BAO_0000100,
12746,,Autocuration,Statistical significance of IC 50 values; Expressed as R value,1,,,22224,U,0,,CHEMBL628546,,BAO_0000019,
12747,,Autocuration,Systemic availability with respect to methyldopa was determined,1,,,22224,U,0,,CHEMBL874455,,BAO_0000019,
12748,,Intermediate,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,1,,,50597,N,1,,CHEMBL628547,,BAO_0000218,
12749,Plasma,Intermediate,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,1,,,50597,N,1,,CHEMBL628548,,BAO_0000218,1969.0
12750,Feces,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL628549,,BAO_0000218,1988.0
12751,Feces,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL628550,,BAO_0000218,1988.0
12752,Feces,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",1,,,50592,N,1,,CHEMBL628551,,BAO_0000218,1988.0
12753,Urine,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",1,,,50592,N,1,,CHEMBL628552,,BAO_0000218,1088.0
12754,Urine,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",1,,,50592,N,1,,CHEMBL628553,,BAO_0000218,1088.0
12755,Urine,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",1,,,50592,N,1,,CHEMBL628554,,BAO_0000218,1088.0
12756,Urine,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",1,,,50592,N,1,,CHEMBL628555,,BAO_0000218,1088.0
12757,Urine,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",1,,,50592,N,1,,CHEMBL628556,,BAO_0000218,1088.0
12758,Kidney,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL628557,,BAO_0000218,2113.0
12759,Feces,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL628558,,BAO_0000218,1988.0
12760,Feces,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",1,,,50592,N,1,,CHEMBL628559,,BAO_0000218,1988.0
12761,Feces,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL628560,,BAO_0000218,1988.0
12762,Urine,Intermediate,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",1,,,50592,N,1,,CHEMBL874456,,BAO_0000218,1088.0
12763,Feces,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",1,,,50592,N,1,,CHEMBL628561,,BAO_0000218,1988.0
12764,Feces,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",1,,,50592,N,1,,CHEMBL628562,,BAO_0000218,1988.0
12765,Urine,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",1,,,50592,N,1,,CHEMBL628563,,BAO_0000218,1088.0
12766,Urine,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",1,,,50592,N,1,,CHEMBL628564,,BAO_0000218,1088.0
12767,Urine,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",1,,,50592,N,1,,CHEMBL628565,,BAO_0000218,1088.0
12768,Urine,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",1,,,50592,N,1,,CHEMBL631248,,BAO_0000218,1088.0
12769,Urine,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",1,,,50592,N,1,,CHEMBL631249,,BAO_0000218,1088.0
12770,Kidney,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL627214,,BAO_0000218,2113.0
12771,Feces,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL874591,,BAO_0000218,1988.0
12772,Feces,Intermediate,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",1,,,50592,N,1,,CHEMBL627215,,BAO_0000218,1988.0
12773,Feces,Intermediate,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,1,,,50592,N,1,,CHEMBL625471,,BAO_0000218,1988.0
12774,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,1,,,50592,N,1,,CHEMBL625472,,BAO_0000218,
12775,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,1,,,50592,N,1,,CHEMBL625473,,BAO_0000218,
12776,,Intermediate,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,1,,,50588,N,1,,CHEMBL625474,,BAO_0000218,
12777,,Intermediate,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,1,,,50588,N,1,,CHEMBL625475,,BAO_0000218,
12778,,Intermediate,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,1,,,50597,N,1,,CHEMBL625476,,BAO_0000218,
12779,,Intermediate,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,1,,,50597,N,1,,CHEMBL625477,,BAO_0000218,
12780,,Intermediate,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,1,,,50597,N,1,,CHEMBL625478,,BAO_0000218,
12781,esophageal tunica muscularis mucosae,Intermediate,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,1,,,50597,N,1,,CHEMBL625479,,BAO_0000218,
12782,esophageal tunica muscularis mucosae,Intermediate,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,1,,,50597,N,1,,CHEMBL625480,,BAO_0000218,
12783,Plasma,Intermediate,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,1,,,50597,N,1,,CHEMBL625481,,BAO_0000218,1969.0
12784,,Intermediate,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,1,,,50597,N,1,,CHEMBL625482,,BAO_0000218,
12785,,Intermediate,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,1,,,50597,N,1,,CHEMBL625483,,BAO_0000218,
12786,,Intermediate,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,1,,,50597,N,1,,CHEMBL625484,,BAO_0000218,
12787,,Intermediate,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,1,,,50597,N,1,,CHEMBL625485,,BAO_0000218,
12788,Plasma,Intermediate,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,1,,,50588,N,1,,CHEMBL625486,,BAO_0000218,1969.0
12789,Plasma,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL625487,,BAO_0000218,1969.0
12790,Plasma,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL625488,,BAO_0000218,1969.0
12791,Plasma,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL625489,,BAO_0000218,1969.0
12792,Plasma,Intermediate,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL625490,,BAO_0000218,1969.0
12793,Plasma,Intermediate,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,1,,,50588,N,1,,CHEMBL625491,,BAO_0000218,1969.0
12794,Plasma,Intermediate,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,1,,,50597,N,1,,CHEMBL625492,,BAO_0000218,1969.0
12795,Plasma,Intermediate,plasma clearance in human,1,,,50587,N,1,,CHEMBL625493,,BAO_0000218,1969.0
12796,,Intermediate,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,,,50597,N,1,,CHEMBL625494,,BAO_0000218,
12797,,Intermediate,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,,,50597,N,1,,CHEMBL625495,,BAO_0000218,
12798,,Intermediate,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,,,50597,N,1,,CHEMBL625496,,BAO_0000218,
12799,,Autocuration,1-Octanol/water partition coefficient measured at 7.4,1,,,22229,U,0,,CHEMBL625497,,BAO_0000100,
12800,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625498,,BAO_0000100,
12801,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL625499,,BAO_0000019,
12802,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625500,,BAO_0000100,
12803,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625501,,BAO_0000100,
12804,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625502,,BAO_0000100,
12805,,Autocuration,Calculated partition coefficient (clogP) (relative to BAY K 8644),1,,,22229,U,0,,CHEMBL625503,,BAO_0000100,
12806,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625504,,BAO_0000100,
12807,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625505,,BAO_0000100,
12808,,Autocuration,Calculated partition coefficient of the compound,1,,,22229,U,0,,CHEMBL625506,,BAO_0000100,
12809,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL625507,,BAO_0000019,
12810,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625508,,BAO_0000100,
12811,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625509,,BAO_0000100,
12812,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625510,,BAO_0000100,
12813,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL883125,,BAO_0000100,
12814,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625511,,BAO_0000100,
12815,,Autocuration,Partition coefficient of the compound,1,,,22224,U,0,,CHEMBL874650,,BAO_0000019,
12816,,Autocuration,Partition coefficient of the compound,1,,,22224,U,0,,CHEMBL625512,,BAO_0000019,
12817,,Autocuration,Partition coefficient of compound was determined,1,,,22224,U,0,,CHEMBL625513,,BAO_0000019,
12818,,Autocuration,Partition coefficient was determined,1,,,22224,U,0,,CHEMBL625514,,BAO_0000019,
12819,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625515,,BAO_0000100,
12820,,Autocuration,partition coefficient of compound was determined,1,,,22229,U,0,,CHEMBL625516,,BAO_0000100,
12821,,Intermediate,The total body administered intravenously in dog,1,,,50588,N,1,,CHEMBL625517,,BAO_0000218,
12822,,Intermediate,The total body administered intravenously in rats,1,,,50597,N,1,,CHEMBL625518,,BAO_0000218,
12823,,Intermediate,Time taken for the administration to female NIH mice weighing 25-30 g.,1,,,50594,N,1,,CHEMBL625519,,BAO_0000218,
12824,,Autocuration,Time taken for the administration,1,,,22224,U,0,,CHEMBL625520,,BAO_0000019,
12825,,Intermediate,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,1,,,50588,N,1,,CHEMBL874651,,BAO_0000218,
12826,,Autocuration,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,1,,,22224,U,0,,CHEMBL625521,,BAO_0000218,
12827,,Intermediate,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,,,50592,N,1,,CHEMBL623171,,BAO_0000218,
12828,,Intermediate,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,1,,,50597,N,1,,CHEMBL623853,,BAO_0000218,
12829,,Autocuration,Plasma clearance for the compound was determined.,1,,,22224,U,0,,CHEMBL623854,,BAO_0000019,
12830,,Autocuration,CLog P value of the compound,1,,,22224,U,0,,CHEMBL874405,,BAO_0000100,
12831,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL623855,,BAO_0000100,
12832,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL623856,,BAO_0000100,
12833,,Autocuration,ClogP value of the compound; nd ='no data',1,,,22224,U,0,,CHEMBL623857,,BAO_0000100,
12834,,Autocuration,ClogP value of the compound; nd ='not determined',1,,,22224,U,0,,CHEMBL623858,,BAO_0000100,
12835,,Autocuration,CLog P was determined,1,,,22224,U,0,,CHEMBL623859,,BAO_0000100,
12836,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL839829,,BAO_0000100,
12837,,Autocuration,CLogP was calculated,1,,,22224,U,0,,CHEMBL623860,,BAO_0000019,
12838,,Autocuration,CLogP value was determined,1,,,22224,U,0,,CHEMBL623861,,BAO_0000019,
12839,,Autocuration,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,1,,,22224,U,0,,CHEMBL623862,,BAO_0000019,
12840,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL874406,,BAO_0000100,
12841,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL623863,,BAO_0000100,
12842,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624021,,BAO_0000100,
12843,Adrenal medulla,Intermediate,Distribution in female dog adrenal medulla 24 hours after administration.,1,,,50588,N,1,,CHEMBL624022,,BAO_0000218,1236.0
12844,Adrenal medulla,Intermediate,Distribution in female dog adrenal medulla 72 hours after administration.,1,,,50588,N,1,,CHEMBL624023,,BAO_0000218,1236.0
12845,,Intermediate,Distribution in female dog bile 24 hours after administration.,1,,,50588,N,1,,CHEMBL624024,,BAO_0000218,
12846,,Intermediate,Distribution in female dog bile 72 hr after administration.,1,,,50588,N,1,,CHEMBL624025,,BAO_0000218,
12847,,Intermediate,Distribution in female dog blood 24 hours after administration.,1,,,50588,N,1,,CHEMBL624026,,BAO_0000218,
12848,,Intermediate,Distribution in female dog blood 72 hours after administration.,1,,,50588,N,1,,CHEMBL624027,,BAO_0000218,
12849,,Intermediate,Distribution in female dog heart 24 hours after administration.,1,,,50588,N,1,,CHEMBL624028,,BAO_0000218,
12850,,Intermediate,Distribution in female dog heart 72 hours after administration.,1,,,50588,N,1,,CHEMBL624029,,BAO_0000218,
12851,,Intermediate,Distribution in female dog kidney 24 hours after administration.,1,,,50588,N,1,,CHEMBL624030,,BAO_0000218,
12852,,Intermediate,Distribution in female dog kidney 72 hours after administration.,1,,,50588,N,1,,CHEMBL624031,,BAO_0000218,
12853,Intestine,Intermediate,Distribution in female dog large intestine 24 hours after administration.,1,,,50588,N,1,,CHEMBL624032,,BAO_0000218,160.0
12854,Intestine,Intermediate,Distribution in female dog large intestine 72 hours after administration.,1,,,50588,N,1,,CHEMBL874407,,BAO_0000218,160.0
12855,,Intermediate,Distribution in female dog liver 24 hours after administration.,1,,,50588,N,1,,CHEMBL624033,,BAO_0000218,
12856,,Intermediate,Distribution in female dog liver 72 hours after administration.,1,,,50588,N,1,,CHEMBL624034,,BAO_0000218,
12857,,Intermediate,Distribution in female dog lung 24 hours after administration.,1,,,50588,N,1,,CHEMBL624035,,BAO_0000218,
12858,,Intermediate,Distribution in female dog lung 72 hours after administration.,1,,,50588,N,1,,CHEMBL624036,,BAO_0000218,
12859,Muscle tissue,Intermediate,Distribution in female dog muscle 24 hours after administration.,1,,,50588,N,1,,CHEMBL624037,,BAO_0000218,2385.0
12860,Muscle tissue,Intermediate,Distribution in female dog muscle 72 hours after administration.,1,,,50588,N,1,,CHEMBL624038,,BAO_0000218,2385.0
12861,,Intermediate,Distribution in female dog pancreas 24 hours after administration.,1,,,50588,N,1,,CHEMBL624039,,BAO_0000218,
12862,,Intermediate,Distribution in female dog pancreas 72 hours after administration.,1,,,50588,N,1,,CHEMBL624040,,BAO_0000218,
12863,Intestine,Intermediate,Distribution in female dog small intestine 24 hours after administration.,1,,,50588,N,1,,CHEMBL624041,,BAO_0000218,160.0
12864,Intestine,Intermediate,Distribution in female dog small intestine 72 hours after administration.,1,,,50588,N,1,,CHEMBL624042,,BAO_0000218,160.0
12865,Spleen,Intermediate,Distribution in female dog spleen 24 hours after administration.,1,,,50588,N,1,,CHEMBL624043,,BAO_0000218,2106.0
12866,Spleen,Intermediate,Distribution in female dog spleen 72 hours after administration.,1,,,50588,N,1,,CHEMBL624044,,BAO_0000218,2106.0
12867,Stomach,Intermediate,Distribution in female dog stomach 24 hours after administration.,1,,,50588,N,1,,CHEMBL624045,,BAO_0000218,945.0
12868,Stomach,Intermediate,Distribution in female dog stomach 72 hours after administration.,1,,,50588,N,1,,CHEMBL624046,,BAO_0000218,945.0
12869,Thyroid gland,Intermediate,Distribution in female dog thyroid 24 hours after administration.,1,,,50588,N,1,,CHEMBL624047,,BAO_0000218,2046.0
12870,Thyroid gland,Intermediate,Distribution in female dog thyroid 72 hours after administration.,1,,,50588,N,1,,CHEMBL624048,,BAO_0000218,2046.0
12871,Urine,Intermediate,Distribution in female dog urine 24 hours after administration.,1,,,50588,N,1,,CHEMBL874408,,BAO_0000218,1088.0
12872,Urine,Intermediate,Distribution in female dog urine 72 hr after administration.,1,,,50588,N,1,,CHEMBL624049,,BAO_0000218,1088.0
12873,Plasma,Autocuration,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,1,,,22224,U,0,,CHEMBL624050,,BAO_0000218,1969.0
12874,,Autocuration,Plasma concentration at 7 hr after intravenous dosing,1,,,22224,U,0,,CHEMBL624051,,BAO_0000019,
12875,,Intermediate,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,1,,,50597,N,1,,CHEMBL623278,,BAO_0000218,
12876,,Intermediate,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,1,,,50597,N,1,,CHEMBL623279,,BAO_0000218,
12877,,Intermediate,Plasma concentration of 3 mg/kg iv after 1 hr in rats,1,,,50597,N,1,,CHEMBL623280,,BAO_0000218,
12878,,Intermediate,Plasma concentration of 3 mg/kg iv after 2 hr in rats,1,,,50597,N,1,,CHEMBL623963,,BAO_0000218,
12879,,Intermediate,Plasma concentration of 3 mg/kg iv after 4 hr in rats,1,,,50597,N,1,,CHEMBL623964,,BAO_0000218,
12880,,Intermediate,Plasma concentration of 3 mg/kg iv after 6 hr in rats,1,,,50597,N,1,,CHEMBL623965,,BAO_0000218,
12881,,Intermediate,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,1,,,50597,N,1,,CHEMBL623966,,BAO_0000218,
12882,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,1,,,50597,N,1,,CHEMBL874415,,BAO_0000218,
12883,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,1,,,50597,N,1,,CHEMBL623967,,BAO_0000218,
12884,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,1,,,50597,N,1,,CHEMBL623968,,BAO_0000218,
12885,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,1,,,50597,N,1,,CHEMBL623969,,BAO_0000218,
12886,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,1,,,50597,N,1,,CHEMBL628409,,BAO_0000218,
12887,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,1,,,50597,N,1,,CHEMBL628410,,BAO_0000218,
12888,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,1,,,50597,N,1,,CHEMBL628411,,BAO_0000218,
12889,,Intermediate,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,1,,,50597,N,1,,CHEMBL628412,,BAO_0000218,
12890,,Autocuration,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,1,,,22224,U,0,,CHEMBL628413,,BAO_0000019,
12891,Plasma,Autocuration,The concentration in plasmat; Not determined,1,,,22224,U,0,,CHEMBL628414,,BAO_0000019,1969.0
12892,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in blood,1,,,50597,N,1,,CHEMBL628415,,BAO_0000218,
12893,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in brown fat,1,,,50597,N,1,,CHEMBL628416,,BAO_0000218,
12894,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in heart,1,,,50597,N,1,,CHEMBL628417,,BAO_0000218,
12895,Liver,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in liver,1,,,50597,N,1,,CHEMBL874908,,BAO_0000218,2107.0
12896,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in plasma,1,,,50597,N,1,,CHEMBL628418,,BAO_0000218,
12897,Muscle tissue,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,1,,,50597,N,1,,CHEMBL628419,,BAO_0000218,2385.0
12898,,Intermediate,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,1,,,50597,N,1,,CHEMBL628420,,BAO_0000218,
12899,,Autocuration,Water solubility at 37 degree C.,1,,,22224,U,0,,CHEMBL628421,,BAO_0000019,
12900,,Autocuration,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,1,,,22229,U,0,,CHEMBL626726,,BAO_0000100,
12901,,Autocuration,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,,,22229,U,0,,CHEMBL626727,,BAO_0000100,
12902,Blood,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626728,,BAO_0000218,178.0
12903,Blood,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626729,,BAO_0000218,178.0
12904,Blood,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626730,,BAO_0000218,178.0
12905,Blood,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626731,,BAO_0000218,178.0
12906,Blood,Intermediate,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626732,,BAO_0000218,178.0
12907,Heart,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626733,,BAO_0000218,948.0
12908,Heart,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626734,,BAO_0000218,948.0
12909,Heart,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626735,,BAO_0000218,948.0
12910,Heart,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL874909,,BAO_0000218,948.0
12911,Heart,Intermediate,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626736,,BAO_0000218,948.0
12912,Kidney,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL626737,,BAO_0000218,2113.0
12913,Kidney,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630999,,BAO_0000218,2113.0
12914,Kidney,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631000,,BAO_0000218,2113.0
12915,Kidney,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631001,,BAO_0000218,2113.0
12916,Kidney,Intermediate,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631002,,BAO_0000218,2113.0
12917,Liver,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631003,,BAO_0000218,2107.0
12918,Liver,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631004,,BAO_0000218,2107.0
12919,Liver,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631005,,BAO_0000218,2107.0
12920,Liver,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631006,,BAO_0000218,2107.0
12921,Liver,Intermediate,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631007,,BAO_0000218,2107.0
12922,Lung,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631008,,BAO_0000218,2048.0
12923,Lung,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631009,,BAO_0000218,2048.0
12924,Lung,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631010,,BAO_0000218,2048.0
12925,Lung,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631011,,BAO_0000218,2048.0
12926,Lung,Intermediate,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL631012,,BAO_0000218,2048.0
12927,Thyroid gland,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630271,,BAO_0000218,2046.0
12928,Thyroid gland,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630272,,BAO_0000218,2046.0
12929,Thyroid gland,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630273,,BAO_0000218,2046.0
12930,Thyroid gland,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630274,,BAO_0000218,2046.0
12931,Thyroid gland,Intermediate,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630275,,BAO_0000218,2046.0
12932,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL875782,,BAO_0000218,
12933,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630276,,BAO_0000218,
12934,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630277,,BAO_0000218,
12935,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630278,,BAO_0000218,
12936,,Intermediate,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,1,,,50597,N,1,,CHEMBL630279,,BAO_0000218,
12937,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,1,,,22224,U,0,,CHEMBL630280,,BAO_0000019,
12938,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,22224,U,0,,CHEMBL630281,,BAO_0000019,
12939,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,1,,,50592,N,1,,CHEMBL630282,,BAO_0000218,
12940,,Intermediate,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,1,,,50592,N,1,,CHEMBL630283,,BAO_0000218,
12941,,Autocuration,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),1,,,22224,U,0,,CHEMBL630284,,BAO_0000019,
12942,,Autocuration,Alkylating activity was determined,1,,,22224,U,0,,CHEMBL630285,,BAO_0000019,
12943,,Autocuration,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),1,,Microsomes,22224,U,0,,CHEMBL630286,,BAO_0000251,
12944,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",1,,,50592,N,1,,CHEMBL630069,,BAO_0000218,
12945,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",1,,,50592,N,1,,CHEMBL630070,,BAO_0000218,
12946,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",1,,,50592,N,1,,CHEMBL630071,,BAO_0000218,
12947,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",1,,,50592,N,1,,CHEMBL630072,,BAO_0000218,
12948,,Intermediate,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",1,,,50592,N,1,,CHEMBL875110,,BAO_0000218,
12949,,Intermediate,Compound was tested for antidiuretic activity in rats,1,,,50597,N,1,,CHEMBL630073,,BAO_0000218,
12950,,Autocuration,Compound was tested for inactivation kinetic values,1,,,22224,U,0,,CHEMBL630074,,BAO_0000019,
12951,,Autocuration,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,1,,,22224,U,0,,CHEMBL630075,,BAO_0000218,
12952,,Autocuration,Dissociation rate calculated from the first-order equation using the t1/2 value,1,,,22224,U,0,,CHEMBL630076,,BAO_0000019,
12953,,Autocuration,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,1,,,22229,U,0,,CHEMBL630077,,BAO_0000100,
12954,,Autocuration,Aqueous solubility was measured,1,,,22229,U,0,,CHEMBL630078,,BAO_0000100,
12955,,Autocuration,Aqueous solubility was measured at a pH 4,1,,,22229,U,0,,CHEMBL630079,,BAO_0000100,
12956,,Autocuration,Aqueous solubility (pH 7),1,,,22229,U,0,,CHEMBL630080,,BAO_0000100,
12957,,Autocuration,Aqueous solubility was measured at a pH 9,1,,,22229,U,0,,CHEMBL630081,,BAO_0000100,
12958,,Autocuration,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",1,,,22224,U,0,,CHEMBL630082,,BAO_0000019,
12959,,Autocuration,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",1,,,22224,U,0,,CHEMBL630083,,BAO_0000019,
12960,,Autocuration,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",1,,,22224,U,0,,CHEMBL630084,,BAO_0000019,
12961,,Autocuration,Aqueous solubility of the compound,1,,,22229,U,0,,CHEMBL629198,,BAO_0000100,
12962,,Autocuration,Aqueous solubility at 37 degree Celsius at pH 7.38,1,,,22229,U,0,,CHEMBL629199,,BAO_0000100,
12963,,Autocuration,Aqueous solubility in pH 7.4 phosphate buffer,1,,,22229,U,0,,CHEMBL629200,,BAO_0000100,
12964,,Intermediate,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,1,,,50588,N,1,,CHEMBL629201,,BAO_0000218,
12965,,Intermediate,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,1,,,50588,N,1,,CHEMBL629202,,BAO_0000218,
12966,,Intermediate,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,1,,,50587,N,1,,CHEMBL875111,,BAO_0000218,
12967,,Intermediate,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,1,,,50587,N,1,,CHEMBL629203,,BAO_0000218,
12968,,Intermediate,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,1,,,50587,N,1,,CHEMBL629204,,BAO_0000218,
12969,,Intermediate,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,1,,,50587,N,1,,CHEMBL629205,,BAO_0000218,
12970,,Intermediate,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,1,,,50587,N,1,,CHEMBL629206,,BAO_0000218,
12971,,Autocuration,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,1,,,22224,U,0,,CHEMBL631185,,BAO_0000019,
12972,,Intermediate,Compound was evaluated for the average bile flow rat in rats,1,,,50597,N,1,,CHEMBL631186,,BAO_0000218,
12973,,Intermediate,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,,,50592,N,1,,CHEMBL631187,,BAO_0000218,
12974,,Intermediate,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,,,50592,N,1,,CHEMBL631188,,BAO_0000218,
12975,,Autocuration,Average half life period was determined,1,,,22224,U,0,,CHEMBL876419,,BAO_0000019,
12976,,Autocuration,Average half life period was determined,1,,,22224,U,0,,CHEMBL631189,,BAO_0000019,
12977,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,,,50602,N,1,,CHEMBL631190,,BAO_0000218,
12978,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,,,50602,N,1,,CHEMBL631191,,BAO_0000218,
12979,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,1,,,50602,N,1,,CHEMBL631192,,BAO_0000218,
12980,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,1,,,50602,N,1,,CHEMBL632400,,BAO_0000218,
12981,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,,,50602,N,1,,CHEMBL630564,,BAO_0000218,
12982,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,,,50602,N,1,,CHEMBL630565,,BAO_0000218,
12983,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,1,,,50602,N,1,,CHEMBL630566,,BAO_0000218,
12984,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,1,,,50602,N,1,,CHEMBL631229,,BAO_0000218,
12985,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,1,,,50602,N,1,,CHEMBL631230,,BAO_0000218,
12986,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL876428,,BAO_0000100,
12987,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631231,,BAO_0000100,
12988,,Autocuration,Calculated partition coefficient (clogP) (MacLogP),1,,,22229,U,0,,CHEMBL631232,,BAO_0000100,
12989,,Autocuration,Hydrophilicity was determined,1,,,22224,U,0,,CHEMBL631233,,BAO_0000019,
12990,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631234,,BAO_0000100,
12991,,Autocuration,Increased absorption was determined,1,,,22224,U,0,,CHEMBL883126,,BAO_0000019,
12992,,Autocuration,Lipophilicity value was evaluated,1,,,22224,U,0,,CHEMBL631235,,BAO_0000100,
12993,,Autocuration,Log P value of the compound.,1,,,22224,U,0,,CHEMBL631236,,BAO_0000100,
12994,,Autocuration,Partition coefficient of compound was determined,1,,,22224,U,0,,CHEMBL631237,,BAO_0000019,
12995,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631238,,BAO_0000100,
12996,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL876429,,BAO_0000100,
12997,,Autocuration,Partition coefficient was measured by medchem software; Not calculated,1,,,22224,U,0,,CHEMBL631414,,BAO_0000019,
12998,,Autocuration,Partition coefficient was measured by octanol-water using standard shake-flask method,1,,,22224,U,0,,CHEMBL631415,,BAO_0000100,
12999,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631416,,BAO_0000100,
13000,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL631417,,BAO_0000019,
13001,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631418,,BAO_0000100,
13002,,Autocuration,The Octanol/Water partition coefficient CLogP,1,,,22229,U,0,,CHEMBL631419,,BAO_0000100,
13003,,Autocuration,The pharmacokinetic parameter C Log p was reported,1,,,22224,U,0,,CHEMBL631420,,BAO_0000019,
13004,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631421,,BAO_0000100,
13005,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631422,,BAO_0000100,
13006,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL631423,,BAO_0000100,
13007,Plasma,Intermediate,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL876430,,BAO_0000218,1969.0
13008,Plasma,Intermediate,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL631424,,BAO_0000218,1969.0
13009,Plasma,Intermediate,Compound was administered intravenously in dog to evaluate plasma clearance values,1,,,50588,N,1,,CHEMBL631425,,BAO_0000218,1969.0
13010,Plasma,Autocuration,Compound was administered intravenously in monkey to evaluate plasma clearance values,1,,,22224,U,0,,CHEMBL631426,,BAO_0000218,1969.0
13011,Plasma,Intermediate,Compound was administered intravenously in mouse to evaluate plasma clearance values,1,,,50594,N,1,,CHEMBL631427,,BAO_0000218,1969.0
13012,Plasma,Intermediate,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,1,,,50588,N,1,,CHEMBL631428,,BAO_0000218,1969.0
13013,Liver,Intermediate,Intrinsic clearance in Rhesus liver microsome,1,,Microsomes,50797,N,1,,CHEMBL631429,,BAO_0000218,2107.0
13014,Liver,Intermediate,Intrinsic clearance in dog liver microsome,1,,Microsomes,50588,N,1,,CHEMBL631430,,BAO_0000218,2107.0
13015,Liver,Intermediate,Intrinsic clearance in rat liver microsome,1,,Microsomes,50597,N,1,,CHEMBL631431,,BAO_0000218,2107.0
13016,Plasma,Intermediate,Low plasma clearance was calculated in rhesus monkey,1,,,50797,N,1,,CHEMBL631432,,BAO_0000218,1969.0
13017,,Intermediate,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,1,,,50588,N,1,,CHEMBL631433,,BAO_0000218,
13018,,Autocuration,Plasma clearance after intravenous dose of 0.3 mg/kg,1,,,22224,U,0,,CHEMBL631434,,BAO_0000218,
13019,,Autocuration,Plasma clearance after intravenous dose of 1 mg/kg,1,,,22224,U,0,,CHEMBL631435,,BAO_0000218,
13020,,Autocuration,Plasma clearance after intravenous dose of 3 mg/kg,1,,,22224,U,0,,CHEMBL631436,,BAO_0000218,
13021,,Autocuration,Plasma clearance after intravenous dose of 3.87 mg/kg,1,,,22224,U,0,,CHEMBL631437,,BAO_0000218,
13022,,Intermediate,Plasma clearance after peroral administration at 10 mpk in Rat,1,,,50597,N,1,,CHEMBL631438,,BAO_0000218,
13023,,Intermediate,Plasma clearance after peroral administration at 10 mpk in Rhesus,1,,,50797,N,1,,CHEMBL876431,,BAO_0000218,
13024,,Intermediate,Plasma clearance after peroral administration at 10 mpk in dog,1,,,50588,N,1,,CHEMBL631439,,BAO_0000218,
13025,,Intermediate,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,1,,,50597,N,1,,CHEMBL631440,,BAO_0000218,
13026,,Autocuration,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),1,,,22224,U,0,,CHEMBL631441,,BAO_0000019,
13027,,Autocuration,Critical Micellar concentration was determined,1,,,22224,U,0,,CHEMBL631442,,BAO_0000019,
13028,,Autocuration,Critical Micellar concentration of the compound. was determined,1,,,22224,U,0,,CHEMBL626525,,BAO_0000019,
13029,,Autocuration,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,1,,,22224,U,0,,CHEMBL627168,,BAO_0000019,
13030,,Autocuration,Critical micellar concentration was measured in water by the dye solubilization method,1,,,22224,U,0,,CHEMBL875618,,BAO_0000019,
13031,,Autocuration,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,1,,,22224,U,0,,CHEMBL626612,,BAO_0000019,
13032,,Autocuration,CMR value (relative to BAY K 8644),1,,,22224,U,0,,CHEMBL626613,,BAO_0000019,
13033,,Autocuration,Carbamoylating activity was determined,1,,,22224,U,0,,CHEMBL626614,,BAO_0000019,
13034,,Autocuration,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,1,,,22224,U,0,,CHEMBL626615,,BAO_0000218,
13035,,Autocuration,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,1,,,22224,U,0,,CHEMBL626616,,BAO_0000019,
13036,,Autocuration,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,1,,,22224,U,0,,CHEMBL626617,,BAO_0000019,
13037,Plasma,Intermediate,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,1,,,50588,N,1,,CHEMBL626618,,BAO_0000218,1969.0
13038,Plasma,Intermediate,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,1,,,50597,N,1,,CHEMBL626619,,BAO_0000218,1969.0
13039,,Intermediate,"Clearance rate at 0.46 mg/kg, iv, in dogs",1,,,50588,N,1,,CHEMBL626620,,BAO_0000218,
13040,,Intermediate,"Clearance rate at 5.5 mg/kg, iv, in rat",1,,,50597,N,1,,CHEMBL626621,,BAO_0000218,
13041,,Intermediate,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,,,100710,N,1,,CHEMBL626622,,BAO_0000218,
13042,,Intermediate,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,,,100710,N,1,,CHEMBL626623,,BAO_0000218,
13043,,Intermediate,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,,,50588,N,1,,CHEMBL626624,,BAO_0000218,
13044,,Intermediate,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,,,50597,N,1,,CHEMBL626625,,BAO_0000218,
13045,Liver,Intermediate,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,,,50597,N,1,,CHEMBL626626,,BAO_0000218,2107.0
13046,,Autocuration,Tested for the total clearance of the compound,1,,,22224,U,0,,CHEMBL626627,,BAO_0000218,
13047,,Intermediate,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,1,,,50588,N,1,,CHEMBL626628,,BAO_0000218,
13048,,Autocuration,Total body clearance was determined,1,,,22224,U,0,,CHEMBL626629,,BAO_0000218,
13049,,Intermediate,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,,50597,N,1,,CHEMBL626630,,BAO_0000218,
13050,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,,50597,N,1,,CHEMBL626631,,BAO_0000218,
13051,,Autocuration,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,1,,,22229,U,0,,CHEMBL626632,,BAO_0000100,
13052,,Autocuration,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,,,22229,U,0,,CHEMBL626633,,BAO_0000100,
13053,,Autocuration,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,1,,,22229,U,0,,CHEMBL626634,,BAO_0000100,
13054,,Autocuration,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,1,,,22229,U,0,,CHEMBL626635,,BAO_0000100,
13055,,Autocuration,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,,,22229,U,0,,CHEMBL626636,,BAO_0000100,
13056,,Autocuration,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,1,,,22229,U,0,,CHEMBL626637,,BAO_0000100,
13057,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),1,,,50339,N,1,,CHEMBL626638,,BAO_0000218,
13058,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,1,,,50339,N,1,,CHEMBL626639,,BAO_0000218,
13059,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,1,,,50339,N,1,,CHEMBL626640,,BAO_0000218,
13060,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,1,,,50339,N,1,,CHEMBL626641,,BAO_0000218,
13061,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,1,,,50339,N,1,,CHEMBL627272,,BAO_0000218,
13062,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,1,,,50339,N,1,,CHEMBL627273,,BAO_0000218,
13063,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),1,,,50339,N,1,,CHEMBL627441,,BAO_0000218,
13064,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),1,,,50339,N,1,,CHEMBL628355,,BAO_0000218,
13065,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),1,,,50339,N,1,,CHEMBL628356,,BAO_0000218,
13066,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),1,,,50339,N,1,,CHEMBL628357,,BAO_0000218,
13067,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),1,,,50339,N,1,,CHEMBL628358,,BAO_0000218,
13068,,Intermediate,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),1,,,50339,N,1,,CHEMBL622307,,BAO_0000218,
13069,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,1,,,22224,U,0,,CHEMBL622527,,BAO_0000019,
13070,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,1,,,22224,U,0,,CHEMBL622528,,BAO_0000019,
13071,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,1,,,22224,U,0,,CHEMBL622529,,BAO_0000019,
13072,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,1,,,22224,U,0,,CHEMBL622992,,BAO_0000019,
13073,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,1,,,22224,U,0,,CHEMBL622993,,BAO_0000019,
13074,,Autocuration,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,1,,,22224,U,0,,CHEMBL622994,,BAO_0000019,
13075,,Intermediate,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",1,,,50597,N,1,,CHEMBL622995,,BAO_0000218,
13076,,Intermediate,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",1,,,50597,N,1,,CHEMBL622996,,BAO_0000218,
13077,,Intermediate,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",1,,,50597,N,1,,CHEMBL622997,,BAO_0000218,
13078,,Intermediate,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",1,,,50597,N,1,,CHEMBL622998,,BAO_0000218,
13079,,Autocuration,Cp max following ip administration at 1 mg/kg,1,,,22224,U,0,,CHEMBL622999,,BAO_0000218,
13080,Plasma,Autocuration,Maximum concentration in plasma was reported at 0.5 hour,1,,,22224,U,0,,CHEMBL623000,,BAO_0000218,1969.0
13081,Plasma,Autocuration,Maximum concentration in plasma was reported at 2 hour,1,,,22224,U,0,,CHEMBL623001,,BAO_0000218,1969.0
13082,,Intermediate,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,1,,,50594,N,1,,CHEMBL623002,,BAO_0000218,
13083,,Autocuration,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),1,,,22229,U,0,,CHEMBL623003,,BAO_0000100,
13084,,Autocuration,Steady state concentration was evaluated,1,,,22224,U,0,,CHEMBL623004,,BAO_0000019,
13085,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL623005,,BAO_0000019,
13086,,Autocuration,Partition coefficient (logD7.4),1,,,22224,U,0,,CHEMBL623006,,BAO_0000019,
13087,Liver,Intermediate,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,1,,,50597,N,1,,CHEMBL623007,,BAO_0000218,2107.0
13088,Bone,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,1,,,50597,N,1,,CHEMBL623008,,BAO_0000218,10000001.0
13089,Cerebellum,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,,,50597,N,1,,CHEMBL876654,,BAO_0000218,2037.0
13090,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,1,,,50597,N,1,,CHEMBL623009,,BAO_0000218,
13091,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,1,,,50597,N,1,,CHEMBL623010,,BAO_0000218,
13092,Heart,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,1,,,50597,N,1,,CHEMBL623011,,BAO_0000218,948.0
13093,Intestine,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,1,,,50597,N,1,,CHEMBL623012,,BAO_0000218,160.0
13094,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,1,,,22224,U,0,,CHEMBL623013,,BAO_0000019,
13095,,Autocuration,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,22224,U,0,,CHEMBL623014,,BAO_0000019,
13096,Urine,Autocuration,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,1,,,22224,U,0,,CHEMBL623015,,BAO_0000019,1088.0
13097,Urine,Autocuration,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,,22224,U,0,,CHEMBL623016,,BAO_0000019,1088.0
13098,Urine,Autocuration,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,1,,,22224,U,0,,CHEMBL624858,,BAO_0000019,1088.0
13099,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,1,,,50597,N,1,,CHEMBL624859,,BAO_0000218,
13100,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,50597,N,1,,CHEMBL624860,,BAO_0000218,
13101,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,,50597,N,1,,CHEMBL624861,,BAO_0000218,
13102,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,1,,,50597,N,1,,CHEMBL624862,,BAO_0000218,
13103,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,1,,,50597,N,1,,CHEMBL624863,,BAO_0000218,
13104,,Intermediate,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,,50597,N,1,,CHEMBL876655,,BAO_0000218,
13105,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,,,50588,N,1,,CHEMBL624864,,BAO_0000218,
13106,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,,,50588,N,1,,CHEMBL624865,,BAO_0000218,
13107,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,,50588,N,1,,CHEMBL624866,,BAO_0000218,
13108,,Expert,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,1,,,50588,N,1,,CHEMBL624867,,BAO_0000218,
13109,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,,,50588,N,1,,CHEMBL624868,,BAO_0000218,
13110,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,1,,,50588,N,1,,CHEMBL628450,,BAO_0000218,
13111,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,,,50588,N,1,,CHEMBL628451,,BAO_0000218,
13112,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,,,50588,N,1,,CHEMBL628452,,BAO_0000218,
13113,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,,50588,N,1,,CHEMBL628453,,BAO_0000218,
13114,,Intermediate,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,1,,,50588,N,1,,CHEMBL628454,,BAO_0000218,
13115,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,,,50588,N,1,,CHEMBL628455,,BAO_0000218,
13116,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,,,50588,N,1,,CHEMBL628456,,BAO_0000218,
13117,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,,50588,N,1,,CHEMBL628457,,BAO_0000218,
13118,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,1,,,50588,N,1,,CHEMBL877505,,BAO_0000218,
13119,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,1,,,50588,N,1,,CHEMBL628458,,BAO_0000218,
13120,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,,,50588,N,1,,CHEMBL628459,,BAO_0000218,
13121,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,,,50588,N,1,,CHEMBL628460,,BAO_0000218,
13122,,Intermediate,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,,,50588,N,1,,CHEMBL628461,,BAO_0000218,
13123,,Autocuration,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",1,,,22224,U,0,,CHEMBL628462,,BAO_0000218,
13124,,Intermediate,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,50588,N,1,,CHEMBL628463,,BAO_0000218,
13125,,Expert,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",1,,,50597,N,1,,CHEMBL625666,,BAO_0000218,
13126,,Autocuration,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,22224,U,0,,CHEMBL625667,,BAO_0000218,
13127,,Expert,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,50597,N,1,,CHEMBL625668,,BAO_0000218,
13128,,Intermediate,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,50597,N,1,,CHEMBL625669,,BAO_0000218,
13129,,Autocuration,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,1,,,22224,U,0,,CHEMBL625670,,BAO_0000019,
13130,,Intermediate,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,1,,,50597,N,1,,CHEMBL625671,,BAO_0000218,
13131,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,1,,,50602,N,1,,CHEMBL625672,,BAO_0000218,
13132,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,1,,,50602,N,1,,CHEMBL625673,,BAO_0000218,
13133,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,1,,,50602,N,1,,CHEMBL625674,,BAO_0000218,
13134,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,1,,,50602,N,1,,CHEMBL625675,,BAO_0000218,
13135,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,,,50602,N,1,,CHEMBL627637,,BAO_0000218,
13136,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,1,,,50602,N,1,,CHEMBL627638,,BAO_0000218,
13137,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,1,,,50602,N,1,,CHEMBL627639,,BAO_0000218,
13138,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,1,,,50602,N,1,,CHEMBL627640,,BAO_0000218,
13139,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,1,,,50602,N,1,,CHEMBL627641,,BAO_0000218,
13140,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,,,50602,N,1,,CHEMBL627642,,BAO_0000218,
13141,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,,,50602,N,1,,CHEMBL877506,,BAO_0000218,
13142,,Intermediate,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,,,50594,N,1,,CHEMBL627275,,BAO_0000218,
13143,,Intermediate,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",1,,,50506,N,1,,CHEMBL627643,,BAO_0000218,
13144,,Intermediate,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,,,50506,N,1,,CHEMBL631246,,BAO_0000218,
13145,,Intermediate,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,,,50506,N,1,,CHEMBL631247,,BAO_0000218,
13146,,Intermediate,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,,,50506,N,1,,CHEMBL629532,,BAO_0000218,
13147,,Intermediate,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,1,,,50506,N,1,,CHEMBL629533,,BAO_0000218,
13148,,Intermediate,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,,,50506,N,1,,CHEMBL629534,,BAO_0000218,
13149,,Intermediate,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,1,,,50506,N,1,,CHEMBL629535,,BAO_0000218,
13150,,Autocuration,Pharmacokinetic parameter :drug bound to plasma was reported,1,,,22224,U,0,,CHEMBL625932,,BAO_0000019,
13151,,Autocuration,compound was evaluated for drug bound in plasma,1,,,22224,U,0,,CHEMBL625933,,BAO_0000019,
13152,,Intermediate,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,1,,,50597,N,1,,CHEMBL625934,,BAO_0000218,
13153,,Autocuration,Bioavailability,1,,,22224,U,0,,CHEMBL625935,,BAO_0000218,
13154,,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,1,,,50597,N,1,,CHEMBL625936,,BAO_0000218,
13155,,Intermediate,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,1,,,50597,N,1,,CHEMBL625937,,BAO_0000218,
13156,,Intermediate,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,,,50588,N,1,,CHEMBL625938,,BAO_0000218,
13157,Bile,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,1,,,50597,N,1,,CHEMBL625939,,BAO_0000218,1970.0
13158,Bile,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,1,,,50597,N,1,,CHEMBL625940,,BAO_0000218,1970.0
13159,Bile,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,1,,,50597,N,1,,CHEMBL874464,,BAO_0000218,1970.0
13160,Bile,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,1,,,50597,N,1,,CHEMBL625941,,BAO_0000218,1970.0
13161,Bile,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,1,,,50597,N,1,,CHEMBL625942,,BAO_0000218,1970.0
13162,Bile,Intermediate,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,1,,,50597,N,1,,CHEMBL625943,,BAO_0000218,1970.0
13163,Serum,Intermediate,In vitro protein binding in human serum at 5 ug/ml,1,,,50587,N,1,,CHEMBL625944,,BAO_0000218,1977.0
13164,,Autocuration,Serum protein binding ability was measured,1,,,22224,U,0,,CHEMBL625945,,BAO_0000019,
13165,,Autocuration,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),1,,,22224,U,0,,CHEMBL625946,,BAO_0000019,
13166,,Autocuration,Oral bioavailability in dog,1,,,22224,U,0,,CHEMBL625947,,BAO_0000218,
13167,,Intermediate,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,,,50597,N,1,,CHEMBL625948,,BAO_0000218,
13168,,Autocuration,Absolute oral bioavailability at an iv dose of 14 mg/kg,1,,,22224,U,0,,CHEMBL625949,,BAO_0000218,
13169,,Autocuration,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,1,,,22224,U,0,,CHEMBL625950,,BAO_0000218,
13170,,Autocuration,Oral bioavailability (dose 15 mg/kg i.v.),1,,,22224,U,0,,CHEMBL625951,,BAO_0000218,
13171,,Autocuration,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,1,,,22224,U,0,,CHEMBL625952,,BAO_0000218,
13172,,Autocuration,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,1,,,22224,U,0,,CHEMBL625953,,BAO_0000218,
13173,,Autocuration,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,1,,,22224,U,0,,CHEMBL625954,,BAO_0000218,
13174,,Autocuration,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,1,,,22224,U,0,,CHEMBL882959,,BAO_0000218,
13175,,Intermediate,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,1,,,50588,N,1,,CHEMBL625955,,BAO_0000218,
13176,,Autocuration,Bioavailability in ferret,1,,,22224,U,0,,CHEMBL625956,,BAO_0000218,
13177,,Intermediate,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,1,,,100710,N,1,,CHEMBL625957,,BAO_0000218,
13178,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,,50597,N,1,,CHEMBL625958,,BAO_0000218,
13179,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,,50597,N,1,,CHEMBL625959,,BAO_0000218,
13180,,Intermediate,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,,50597,N,1,,CHEMBL626642,,BAO_0000218,
13181,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,,50597,N,1,,CHEMBL631330,,BAO_0000218,
13182,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,,50597,N,1,,CHEMBL631331,,BAO_0000218,
13183,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,,50597,N,1,,CHEMBL631332,,BAO_0000218,
13184,,Intermediate,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,,50597,N,1,,CHEMBL631333,,BAO_0000218,
13185,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,,50597,N,1,,CHEMBL632018,,BAO_0000218,
13186,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,,50597,N,1,,CHEMBL632019,,BAO_0000218,
13187,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,,50597,N,1,,CHEMBL632020,,BAO_0000218,
13188,,Intermediate,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,,50597,N,1,,CHEMBL632021,,BAO_0000218,
13189,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,,50597,N,1,,CHEMBL632022,,BAO_0000218,
13190,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,,50597,N,1,,CHEMBL632023,,BAO_0000218,
13191,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,,50597,N,1,,CHEMBL632024,,BAO_0000218,
13192,,Intermediate,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,,50597,N,1,,CHEMBL874472,,BAO_0000218,
13193,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,,50597,N,1,,CHEMBL632025,,BAO_0000218,
13194,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,,50597,N,1,,CHEMBL632026,,BAO_0000218,
13195,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,,50597,N,1,,CHEMBL632027,,BAO_0000218,
13196,,Intermediate,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,,50597,N,1,,CHEMBL632028,,BAO_0000218,
13197,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,,50597,N,1,,CHEMBL626430,,BAO_0000218,
13198,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,,50597,N,1,,CHEMBL626431,,BAO_0000218,
13199,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,,50597,N,1,,CHEMBL626432,,BAO_0000218,
13200,,Intermediate,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,,50597,N,1,,CHEMBL626433,,BAO_0000218,
13201,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,,50597,N,1,,CHEMBL626434,,BAO_0000218,
13202,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,,50597,N,1,,CHEMBL627280,,BAO_0000218,
13203,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,,50597,N,1,,CHEMBL627281,,BAO_0000218,
13204,,Intermediate,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,,50597,N,1,,CHEMBL627282,,BAO_0000218,
13205,,Autocuration,Total body clearance was measured at given dose,1,,,22224,U,0,,CHEMBL627283,,BAO_0000019,
13206,,Autocuration,Total body clearance was measured at given dose.,1,,,22224,U,0,,CHEMBL627284,,BAO_0000218,
13207,,Intermediate,Metabolic clearance from the body in rat,1,,,50597,N,1,,CHEMBL627285,,BAO_0000218,
13208,,Autocuration,Renal clearance from the body,1,,,22224,U,0,,CHEMBL627286,,BAO_0000218,
13209,,Intermediate,Renal clearance from the body in rat,1,,,50597,N,1,,CHEMBL875477,,BAO_0000218,
13210,,Intermediate,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,1,,,50597,N,1,,CHEMBL627287,,BAO_0000218,
13211,,Intermediate,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,1,,,50588,N,1,,CHEMBL627288,,BAO_0000218,
13212,,Intermediate,Total clearance from the body in rat,1,,,50597,N,1,,CHEMBL627289,,BAO_0000218,
13213,Plasma,Intermediate,Clearance into cortex from rat plasma or PBS,1,,,50597,N,1,,CHEMBL627290,,BAO_0000218,1969.0
13214,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,1,,,22224,U,0,,CHEMBL627291,,BAO_0000218,
13215,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,1,,,22224,U,0,,CHEMBL627292,,BAO_0000218,
13216,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,1,,,22224,U,0,,CHEMBL627293,,BAO_0000218,
13217,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,1,,,22224,U,0,,CHEMBL627294,,BAO_0000218,
13218,,Autocuration,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,1,,,22224,U,0,,CHEMBL875478,,BAO_0000218,
13219,,Autocuration,Clearance was determined,1,,,22224,U,0,,CHEMBL627295,,BAO_0000218,
13220,,Intermediate,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,1,,,50594,N,1,,CHEMBL627296,,BAO_0000218,
13221,,Intermediate,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,1,,,50592,N,1,,CHEMBL626119,,BAO_0000218,
13222,,Intermediate,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,1,,,50597,N,1,,CHEMBL626120,,BAO_0000218,
13223,,Intermediate,Clearance in rat after iv dose (100 ug/kg),1,,,50597,N,1,,CHEMBL626121,,BAO_0000218,
13224,,Autocuration,Clearance in guinea pig,1,,,22224,U,0,,CHEMBL626122,,BAO_0000218,
13225,,Intermediate,Compound was evaluated for clearance in rat,1,,,50597,N,1,,CHEMBL626123,,BAO_0000218,
13226,,Intermediate,Compound was evaluated for the clearance in dog,1,,,50588,N,1,,CHEMBL623456,,BAO_0000218,
13227,,Intermediate,Compound was evaluated for the clearance in rat,1,,,50597,N,1,,CHEMBL623457,,BAO_0000218,
13228,,Intermediate,Compound was tested in vivo for clearance after iv administration in the rat,1,,,50597,N,1,,CHEMBL623458,,BAO_0000218,
13229,,Autocuration,IV clearance determined at an iv dose of 14 mg/kg,1,,,22224,U,0,,CHEMBL623459,,BAO_0000218,
13230,,Autocuration,IV clearance determined at an iv dose of 15.2 mg/kg,1,,,22224,U,0,,CHEMBL875484,,BAO_0000218,
13231,,Autocuration,IV clearance determined at an iv dose of 15 mg/kg,1,,,22224,U,0,,CHEMBL623460,,BAO_0000218,
13232,,Autocuration,IV clearance determined at an peroral dose of 30 mg/kg.,1,,,22224,U,0,,CHEMBL623461,,BAO_0000218,
13233,,Autocuration,IV clearance determined at an peroral dose of 30.2 mg/kg.,1,,,22224,U,0,,CHEMBL623462,,BAO_0000218,
13234,,Autocuration,IV clearance determined at an peroral dose of 30.3 mg/kg.,1,,,22224,U,0,,CHEMBL627386,,BAO_0000218,
13235,Kidney,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,1,,,50597,N,1,,CHEMBL627387,,BAO_0000218,2113.0
13236,Liver,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,1,,,50597,N,1,,CHEMBL627388,,BAO_0000218,2107.0
13237,Lung,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,1,,,50597,N,1,,CHEMBL627389,,BAO_0000218,2048.0
13238,Muscle tissue,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,1,,,50597,N,1,,CHEMBL627390,,BAO_0000218,2385.0
13239,Plasma,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,1,,,50597,N,1,,CHEMBL627391,,BAO_0000218,1969.0
13240,,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,,,50597,N,1,,CHEMBL627392,,BAO_0000218,
13241,Spleen,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,1,,,50597,N,1,,CHEMBL627393,,BAO_0000218,2106.0
13242,Trachea,Intermediate,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,1,,,50597,N,1,,CHEMBL627394,,BAO_0000218,3126.0
13243,Bone,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,1,,,50597,N,1,,CHEMBL627395,,BAO_0000218,10000001.0
13244,Cerebellum,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,,,50597,N,1,,CHEMBL875485,,BAO_0000218,2037.0
13245,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,1,,,50597,N,1,,CHEMBL627396,,BAO_0000218,
13246,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,1,,,50597,N,1,,CHEMBL627397,,BAO_0000218,
13247,Heart,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,1,,,50597,N,1,,CHEMBL627398,,BAO_0000218,948.0
13248,Bone,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,1,,,50597,N,1,,CHEMBL627399,,BAO_0000218,10000001.0
13249,Kidney,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,1,,,50597,N,1,,CHEMBL627400,,BAO_0000218,2113.0
13250,Liver,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,1,,,50597,N,1,,CHEMBL627401,,BAO_0000218,2107.0
13251,Lung,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,1,,,50597,N,1,,CHEMBL627402,,BAO_0000218,2048.0
13252,Muscle tissue,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,1,,,50597,N,1,,CHEMBL627403,,BAO_0000218,2385.0
13253,Plasma,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,1,,,50597,N,1,,CHEMBL627404,,BAO_0000218,1969.0
13254,,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,,,50597,N,1,,CHEMBL623101,,BAO_0000218,
13255,Spleen,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,1,,,50597,N,1,,CHEMBL877480,,BAO_0000218,2106.0
13256,Trachea,Intermediate,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,1,,,50597,N,1,,CHEMBL623102,,BAO_0000218,3126.0
13257,Bone,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,1,,,50597,N,1,,CHEMBL623103,,BAO_0000218,10000001.0
13258,Cerebellum,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,,,50597,N,1,,CHEMBL623104,,BAO_0000218,2037.0
13259,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,1,,,50597,N,1,,CHEMBL623105,,BAO_0000218,
13260,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,1,,,50597,N,1,,CHEMBL623106,,BAO_0000218,
13261,Heart,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,1,,,50597,N,1,,CHEMBL623107,,BAO_0000218,948.0
13262,Intestine,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,1,,,50597,N,1,,CHEMBL623108,,BAO_0000218,160.0
13263,Kidney,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,1,,,50597,N,1,,CHEMBL623109,,BAO_0000218,2113.0
13264,Liver,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,1,,,50597,N,1,,CHEMBL623110,,BAO_0000218,2107.0
13265,Lung,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,1,,,50597,N,1,,CHEMBL623111,,BAO_0000218,2048.0
13266,Muscle tissue,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,1,,,50597,N,1,,CHEMBL625060,,BAO_0000218,2385.0
13267,Plasma,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,1,,,50597,N,1,,CHEMBL625061,,BAO_0000218,1969.0
13268,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,,,50597,N,1,,CHEMBL625062,,BAO_0000218,
13269,Spleen,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,1,,,50597,N,1,,CHEMBL625063,,BAO_0000218,2106.0
13270,Trachea,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,1,,,50597,N,1,,CHEMBL625064,,BAO_0000218,3126.0
13271,Bone,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,1,,,50597,N,1,,CHEMBL625065,,BAO_0000218,10000001.0
13272,Cerebellum,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,,,50597,N,1,,CHEMBL625066,,BAO_0000218,2037.0
13273,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,1,,,50597,N,1,,CHEMBL625067,,BAO_0000218,
13274,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,1,,,50597,N,1,,CHEMBL625068,,BAO_0000218,
13275,Heart,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,1,,,50597,N,1,,CHEMBL622159,,BAO_0000218,948.0
13276,Intestine,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,1,,,50597,N,1,,CHEMBL622160,,BAO_0000218,160.0
13277,Kidney,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,1,,,50597,N,1,,CHEMBL622161,,BAO_0000218,2113.0
13278,Lung,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,1,,,50597,N,1,,CHEMBL622162,,BAO_0000218,2048.0
13279,Muscle tissue,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,1,,,50597,N,1,,CHEMBL622163,,BAO_0000218,2385.0
13280,Plasma,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,1,,,50597,N,1,,CHEMBL622313,,BAO_0000218,1969.0
13281,,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,,,50597,N,1,,CHEMBL622314,,BAO_0000218,
13282,Spleen,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,1,,,50597,N,1,,CHEMBL622315,,BAO_0000218,2106.0
13283,Trachea,Intermediate,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,1,,,50597,N,1,,CHEMBL622316,,BAO_0000218,3126.0
13284,,Intermediate,Normal diffusion coefficient in water for Escherichia coli,1,,,50212,N,1,,CHEMBL877486,,BAO_0000218,
13285,,Autocuration,Average max percent decrease in RVR (renal vascular resistance) was determined,1,,,22224,U,0,,CHEMBL622317,,BAO_0000019,
13286,,Autocuration,Average max percent decrease in RVR (renal vascular resistance) was determined.,1,,,22224,U,0,,CHEMBL622318,,BAO_0000019,
13287,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,1,,,22224,U,0,,CHEMBL622319,,BAO_0000019,
13288,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,1,,,22224,U,0,,CHEMBL622320,,BAO_0000019,
13289,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,1,,,22224,U,0,,CHEMBL622321,,BAO_0000019,
13290,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,1,,,22224,U,0,,CHEMBL622322,,BAO_0000019,
13291,,Autocuration,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,1,,,22224,U,0,,CHEMBL622323,,BAO_0000019,
13292,,Intermediate,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,1,,,50597,N,1,,CHEMBL622324,,BAO_0000218,
13293,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,,,50588,N,1,,CHEMBL622325,,BAO_0000218,1088.0
13294,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,,50588,N,1,,CHEMBL622326,,BAO_0000218,1088.0
13295,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",1,,,50588,N,1,,CHEMBL877487,,BAO_0000218,1088.0
13296,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,,50588,N,1,,CHEMBL622327,,BAO_0000218,1088.0
13297,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",1,,,50588,N,1,,CHEMBL622328,,BAO_0000218,1088.0
13298,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,,,50588,N,1,,CHEMBL622329,,BAO_0000218,1088.0
13299,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,,50588,N,1,,CHEMBL622330,,BAO_0000218,1088.0
13300,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,,,50588,N,1,,CHEMBL622331,,BAO_0000218,1088.0
13301,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,,50588,N,1,,CHEMBL622332,,BAO_0000218,1088.0
13302,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",1,,,50588,N,1,,CHEMBL622333,,BAO_0000218,1088.0
13303,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,,,22224,U,0,,CHEMBL627658,,BAO_0000218,1088.0
13304,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",1,,,22224,U,0,,CHEMBL630428,,BAO_0000218,1088.0
13305,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,,,22224,U,0,,CHEMBL630429,,BAO_0000218,1088.0
13306,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",1,,,22224,U,0,,CHEMBL630430,,BAO_0000218,1088.0
13307,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",1,,,22224,U,0,,CHEMBL630431,,BAO_0000218,1088.0
13308,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,,50597,N,1,,CHEMBL630432,,BAO_0000218,1088.0
13309,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,,,50597,N,1,,CHEMBL630433,,BAO_0000218,1088.0
13310,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,,,50597,N,1,,CHEMBL630434,,BAO_0000218,1088.0
13311,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,,,50597,N,1,,CHEMBL629372,,BAO_0000218,1088.0
13312,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",1,,,50597,N,1,,CHEMBL629553,,BAO_0000218,1088.0
13313,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,,,50597,N,1,,CHEMBL629554,,BAO_0000218,1088.0
13314,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,,,50597,N,1,,CHEMBL874447,,BAO_0000218,1088.0
13315,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,,,50597,N,1,,CHEMBL629555,,BAO_0000218,1088.0
13316,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,,,50597,N,1,,CHEMBL629556,,BAO_0000218,1088.0
13317,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",1,,,50597,N,1,,CHEMBL629557,,BAO_0000218,1088.0
13318,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,,,50597,N,1,,CHEMBL629558,,BAO_0000218,1088.0
13319,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,,,50597,N,1,,CHEMBL629559,,BAO_0000218,1088.0
13320,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,,,50597,N,1,,CHEMBL629560,,BAO_0000218,1088.0
13321,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,,,50588,N,1,,CHEMBL629561,,BAO_0000218,1088.0
13322,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,,50588,N,1,,CHEMBL629562,,BAO_0000218,1088.0
13323,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,,,50588,N,1,,CHEMBL629563,,BAO_0000218,1088.0
13324,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,,50588,N,1,,CHEMBL629564,,BAO_0000218,1088.0
13325,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,,,50588,N,1,,CHEMBL629565,,BAO_0000218,1088.0
13326,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,,50588,N,1,,CHEMBL629566,,BAO_0000218,1088.0
13327,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,,50588,N,1,,CHEMBL629567,,BAO_0000218,1088.0
13328,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,,,50588,N,1,,CHEMBL629568,,BAO_0000218,1088.0
13329,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",1,,,50588,N,1,,CHEMBL629569,,BAO_0000218,1088.0
13330,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,,,50588,N,1,,CHEMBL629570,,BAO_0000218,1088.0
13331,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,,,22224,U,0,,CHEMBL629571,,BAO_0000218,1088.0
13332,,Autocuration,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,,,22224,U,0,,CHEMBL629572,,BAO_0000218,
13333,,Autocuration,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,,,22224,U,0,,CHEMBL629573,,BAO_0000218,
13334,,Autocuration,Bioavailability (dose 20 mg/kg),1,,,22224,U,0,,CHEMBL629574,,BAO_0000218,
13335,,Autocuration,Bioavailability in dog,1,,,22224,U,0,,CHEMBL629575,,BAO_0000218,
13336,,Autocuration,Bioavailability in rat (Sprague-Dawley) (male),1,,,22224,U,0,,CHEMBL874448,,BAO_0000218,
13337,,Autocuration,Bioavailability in monkey (dose 10 mg/kg i.d.),1,,,22224,U,0,,CHEMBL629576,,BAO_0000218,
13338,,Autocuration,Bioavailability in rat,1,,,22224,U,0,,CHEMBL629577,,BAO_0000218,
13339,,Autocuration,Bioavailability in rat,1,,,22224,U,0,,CHEMBL629578,,BAO_0000218,
13340,,Autocuration,Bioavailability in dog (dose 3.0 mg/kg p.o.),1,,,22224,U,0,,CHEMBL629579,,BAO_0000218,
13341,,Autocuration,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,1,,,22224,U,0,,CHEMBL882958,,BAO_0000218,
13342,,Intermediate,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,1,,,50505,N,1,,CHEMBL629580,,BAO_0000218,
13343,,Autocuration,Bioavailability,1,,,22224,U,0,,CHEMBL629581,,BAO_0000218,
13344,,Autocuration,Bioavailability in squirrel monkey,1,,,22224,U,0,,CHEMBL629582,,BAO_0000218,
13345,,Intermediate,Bioavailability was evaluated in dog,1,,,50588,N,1,,CHEMBL628522,,BAO_0000218,
13346,,Intermediate,Bioavailability was evaluated in hamster,1,,,100712,N,1,,CHEMBL625432,,BAO_0000218,
13347,,Autocuration,Bioavailability in rat,1,,,22224,U,0,,CHEMBL625433,,BAO_0000218,
13348,Plasma,Intermediate,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL625434,,BAO_0000218,1969.0
13349,Plasma,Intermediate,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,1,,,50597,N,1,,CHEMBL625435,,BAO_0000218,1969.0
13350,,Autocuration,Bioavailability in rat (dose 10 mg/kg p.o.),1,,,22224,U,0,,CHEMBL625436,,BAO_0000218,
13351,,Intermediate,Bioavailability was measured in cynomolgus monkeys.,1,,,100710,N,1,,CHEMBL874588,,BAO_0000218,
13352,,Intermediate,Bioavailability was measured in nude mice.,1,,,50594,N,1,,CHEMBL625437,,BAO_0000218,
13353,,Autocuration,Bioavailability in ferret (dose 10 mg/kg i.d.),1,,,22224,U,0,,CHEMBL625438,,BAO_0000218,
13354,,Autocuration,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),1,,,22224,U,0,,CHEMBL625439,,BAO_0000218,
13355,,Autocuration,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",1,,,22224,U,0,,CHEMBL625440,,BAO_0000218,
13356,,Autocuration,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),1,,,22224,U,0,,CHEMBL625441,,BAO_0000218,
13357,,Autocuration,Bioavailability in rat (dose 10 mg/kg i.d.),1,,,22224,U,0,,CHEMBL625442,,BAO_0000218,
13358,,Intermediate,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,,50597,N,1,,CHEMBL625443,,BAO_0000218,
13359,,Autocuration,Bioavailability was determined; extremely poor,1,,,22224,U,0,,CHEMBL625444,,BAO_0000218,
13360,,Intermediate,% bioavailability in mice after oral administration of prodrug,1,,,50594,N,1,,CHEMBL625445,,BAO_0000218,
13361,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,1,,,50588,N,1,,CHEMBL625446,,BAO_0000218,
13362,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,1,,,50588,N,1,,CHEMBL882960,,BAO_0000218,
13363,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,1,,,50588,N,1,,CHEMBL625447,,BAO_0000218,
13364,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,1,,,50588,N,1,,CHEMBL625448,,BAO_0000218,
13365,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,1,,,50588,N,1,,CHEMBL625449,,BAO_0000218,
13366,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),1,,,50588,N,1,,CHEMBL874589,,BAO_0000218,
13367,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,1,,,50588,N,1,,CHEMBL625450,,BAO_0000218,
13368,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,1,,,50588,N,1,,CHEMBL625451,,BAO_0000218,
13369,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,1,,,50588,N,1,,CHEMBL626584,,BAO_0000218,
13370,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,1,,,50588,N,1,,CHEMBL626585,,BAO_0000218,
13371,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,1,,,50588,N,1,,CHEMBL626586,,BAO_0000218,
13372,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,1,,,50588,N,1,,CHEMBL626587,,BAO_0000218,
13373,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,1,,,50588,N,1,,CHEMBL626588,,BAO_0000218,
13374,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,1,,,50588,N,1,,CHEMBL626589,,BAO_0000218,
13375,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,1,,,50588,N,1,,CHEMBL626590,,BAO_0000218,
13376,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,1,,,50588,N,1,,CHEMBL626591,,BAO_0000218,
13377,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,1,,,50588,N,1,,CHEMBL627181,,BAO_0000218,
13378,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,1,,,50588,N,1,,CHEMBL628083,,BAO_0000218,
13379,,Autocuration,IV clearance determined at an peroral dose of 15 mg/kg.,1,,,22224,U,0,,CHEMBL628084,,BAO_0000218,
13380,,Expert,Mouse oral clearance was measured against Hymenolepiasis nana.,1,,,50064,N,1,,CHEMBL628085,,BAO_0000218,
13381,,Expert,Mouse oral clearance was measured against Nematospiroides dubius,1,,,50545,N,1,,CHEMBL628086,,BAO_0000218,
13382,,Autocuration,Mouse oral clearance was measured against N. dubius; NT is Not Tested,1,,,22224,U,0,,CHEMBL628087,,BAO_0000218,
13383,,Intermediate,Mouse oral clearance was measured against N. nana; NT is Not Tested,1,,,50594,N,1,,CHEMBL628088,,BAO_0000218,
13384,,Autocuration,Mouse oral clearance was measured against N. nana; NT is Not Tested,1,,,22224,U,0,,CHEMBL628089,,BAO_0000218,
13385,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL628090,,BAO_0000218,
13386,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL628091,,BAO_0000218,
13387,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL628092,,BAO_0000218,
13388,,Autocuration,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL628093,,BAO_0000218,
13389,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL875607,,BAO_0000218,
13390,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL625710,,BAO_0000218,
13391,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL625711,,BAO_0000218,
13392,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL625712,,BAO_0000218,
13393,,Autocuration,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,1,,,22224,U,0,,CHEMBL625713,,BAO_0000218,
13394,,Intermediate,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,1,,,50588,N,1,,CHEMBL625714,,BAO_0000218,
13395,,Intermediate,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,1,,,50797,N,1,,CHEMBL625715,,BAO_0000218,
13396,,Intermediate,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,1,,,50597,N,1,,CHEMBL625716,,BAO_0000218,
13397,,Intermediate,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,1,,,50597,N,1,,CHEMBL625717,,BAO_0000218,
13398,,Intermediate,Plasma clearance was determined for the compound in rats,1,,,50597,N,1,,CHEMBL625718,,BAO_0000218,
13399,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,1,,,50597,N,1,,CHEMBL625719,,BAO_0000218,
13400,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,1,,,50597,N,1,,CHEMBL625720,,BAO_0000218,
13401,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,1,,,50597,N,1,,CHEMBL625721,,BAO_0000218,
13402,,Intermediate,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,1,,,50597,N,1,,CHEMBL625722,,BAO_0000218,
13403,,Intermediate,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,1,,,50597,N,1,,CHEMBL625723,,BAO_0000218,
13404,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,1,,,50545,N,1,,CHEMBL625724,,BAO_0000218,
13405,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,1,,,50545,N,1,,CHEMBL625725,,BAO_0000218,
13406,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,1,,,50545,N,1,,CHEMBL625726,,BAO_0000218,
13407,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,1,,,50545,N,1,,CHEMBL875608,,BAO_0000218,
13408,,Intermediate,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,1,,,50545,N,1,,CHEMBL625727,,BAO_0000218,
13409,Urine,Autocuration,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,1,,,22224,U,0,,CHEMBL625728,,BAO_0000218,1088.0
13410,,Autocuration,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,1,,,22224,U,0,,CHEMBL625729,,BAO_0000218,
13411,,Autocuration,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,1,,,22224,U,0,,CHEMBL625730,,BAO_0000218,
13412,Urine,Autocuration,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,1,,,22224,U,0,,CHEMBL625731,,BAO_0000218,1088.0
13413,Urine,Autocuration,Urinary clearance was determined in rat at 25 mg/kg os dosage,1,,,22224,U,0,,CHEMBL626417,,BAO_0000218,1088.0
13414,Urine,Intermediate,Urinary clearance was determined at 100 mg/kg oral dosage in human,1,,,50587,N,1,,CHEMBL626418,,BAO_0000218,1088.0
13415,Urine,Intermediate,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,1,,,50588,N,1,,CHEMBL626419,,BAO_0000218,1088.0
13416,Plasma,Intermediate,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,1,,,50588,N,1,,CHEMBL626592,,BAO_0000218,1969.0
13417,Plasma,Intermediate,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,,,50597,N,1,,CHEMBL626593,,BAO_0000218,1969.0
13418,,Intermediate,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,,50597,N,1,,CHEMBL626594,,BAO_0000218,
13419,,Intermediate,Clearance rate in dogs,1,,,50588,N,1,,CHEMBL625035,,BAO_0000218,
13420,,Autocuration,Compound was measured for intrinsic clearance,1,,,22224,U,0,,CHEMBL625036,,BAO_0000019,
13421,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625037,,BAO_0000100,
13422,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625038,,BAO_0000100,
13423,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625039,,BAO_0000100,
13424,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625040,,BAO_0000100,
13425,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625041,,BAO_0000100,
13426,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625042,,BAO_0000100,
13427,,Autocuration,Partition coefficient of the compound,1,,,22224,U,0,,CHEMBL874411,,BAO_0000019,
13428,,Autocuration,Permeability,1,,,22224,U,0,,CHEMBL625043,,BAO_0000019,
13429,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625044,,BAO_0000100,
13430,,Autocuration,Partition coefficient (logD),1,,,22224,U,0,,CHEMBL625045,,BAO_0000019,
13431,,Autocuration,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,,,22229,U,0,,CHEMBL625046,,BAO_0000100,
13432,,Autocuration,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,,,22229,U,0,,CHEMBL625047,,BAO_0000100,
13433,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625048,,BAO_0000100,
13434,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625049,,BAO_0000100,
13435,,Autocuration,Calculated logarithm of partition coefficient (P) was determined,1,,,22229,U,0,,CHEMBL625050,,BAO_0000100,
13436,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625051,,BAO_0000100,
13437,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL874412,,BAO_0000100,
13438,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625052,,BAO_0000100,
13439,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL625053,,BAO_0000100,
13440,,Autocuration,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,1,,,22224,U,0,,CHEMBL623250,,BAO_0000019,
13441,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,1,,,22224,U,0,,CHEMBL623251,,BAO_0000019,
13442,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,1,,,22224,U,0,,CHEMBL623252,,BAO_0000019,
13443,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,1,,,22224,U,0,,CHEMBL623253,,BAO_0000019,
13444,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,1,,,22224,U,0,,CHEMBL623254,,BAO_0000019,
13445,,Autocuration,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,1,,,22224,U,0,,CHEMBL623255,,BAO_0000019,
13446,,Autocuration,Percent degradation of compound at a pH of 1 over a 18 hr period,1,,,22224,U,0,,CHEMBL626831,,BAO_0000019,
13447,,Autocuration,Percent degradation of compound at pH of 1 over an 18 hr period,1,,,22224,U,0,,CHEMBL877494,,BAO_0000019,
13448,,Autocuration,Delta Logarithm of Partition Coefficient value was determined.,1,,,22224,U,0,,CHEMBL626832,,BAO_0000019,
13449,,Autocuration,Delta logPoct-cyc,1,,,22224,U,0,,CHEMBL626833,,BAO_0000019,
13450,,Autocuration,Lipophilicity estimated on reversed phase TLC,1,,,22224,U,0,,CHEMBL626834,,BAO_0000100,
13451,,Autocuration,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,1,,,22224,U,0,,CHEMBL626835,,BAO_0000019,
13452,,Autocuration,Delta logPoct-cyc,1,,,22224,U,0,,CHEMBL626836,,BAO_0000019,
13453,,Autocuration,Change in logarithm of partition coefficient of the compound,1,,,22229,U,0,,CHEMBL626837,,BAO_0000100,
13454,,Autocuration,Delta logD (pH 6.5),1,,,22224,U,0,,CHEMBL626838,,BAO_0000019,
13455,,Autocuration,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",1,,,22224,U,0,,CHEMBL626839,,BAO_0000100,
13456,,Autocuration,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,1,,,22224,U,0,,CHEMBL626840,,BAO_0000019,
13457,,Autocuration,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),1,,,22224,U,0,,CHEMBL626841,,BAO_0000019,
13458,,Autocuration,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,1,,,22224,U,0,,CHEMBL626842,,BAO_0000219,
13459,,Autocuration,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,1,,,22224,U,0,,CHEMBL626843,,BAO_0000219,
13460,,Intermediate,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,1,,,50597,N,1,,CHEMBL626844,,BAO_0000218,
13461,,Intermediate,Amount of deuterium retained was reported after normal workup in rats,1,,,50597,N,1,,CHEMBL877495,,BAO_0000218,
13462,,Intermediate,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,1,,,50597,N,1,,CHEMBL626845,,BAO_0000218,
13463,,Intermediate,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,1,,,50597,N,1,,CHEMBL626846,,BAO_0000218,
13464,,Intermediate,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,,,50597,N,1,,CHEMBL626847,,BAO_0000218,
13465,,Intermediate,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,,,50597,N,1,,CHEMBL628677,,BAO_0000218,
13466,,Intermediate,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,1,,,50597,N,1,,CHEMBL628678,,BAO_0000218,
13467,,Autocuration,Compound was subjected to electrochemical oxidation,1,,,22224,U,0,,CHEMBL628679,,BAO_0000019,
13468,,Autocuration,Compound was subjected to photochemical oxidation,1,,,22224,U,0,,CHEMBL628680,,BAO_0000019,
13469,,Autocuration,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,1,,,22224,U,0,,CHEMBL628681,,BAO_0000019,
13470,,Autocuration,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,1,,,22224,U,0,,CHEMBL628682,,BAO_0000019,
13471,,Autocuration,Oxidation of compound by methemoglobin in presence of hydroperoxide,1,,,22224,U,0,,CHEMBL628683,,BAO_0000019,
13472,,Intermediate,Percent diffusion through fuzzy rat skin after 48 h of incubation,1,,,50597,N,1,,CHEMBL628684,,BAO_0000218,
13473,,Autocuration,Dissociation constant (pKa),1,,,22229,U,0,,CHEMBL877501,,BAO_0000100,
13474,,Autocuration,Dissociation constant value of the compound; ND means not determined.,1,,,22224,U,0,,CHEMBL628685,,BAO_0000100,
13475,Blood,Intermediate,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,1,,,50597,N,1,,CHEMBL628686,,BAO_0000218,178.0
13476,Blood,Intermediate,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,,50597,N,1,,CHEMBL628687,,BAO_0000218,178.0
13477,,Intermediate,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,1,,,50597,N,1,,CHEMBL628688,,BAO_0000218,
13478,,Intermediate,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,,50597,N,1,,CHEMBL628689,,BAO_0000218,
13479,Liver,Intermediate,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,1,,,50597,N,1,,CHEMBL628690,,BAO_0000218,2107.0
13480,Liver,Intermediate,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,,,50597,N,1,,CHEMBL629363,,BAO_0000218,2107.0
13481,Spleen,Intermediate,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,1,,,50597,N,1,,CHEMBL629364,,BAO_0000218,2106.0
13482,Spleen,Intermediate,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,,50597,N,1,,CHEMBL629365,,BAO_0000218,2106.0
13483,,Intermediate,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,1,,,50597,N,1,,CHEMBL629366,,BAO_0000218,
13484,Urine,Intermediate,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,1,,,50597,N,1,,CHEMBL629367,,BAO_0000218,1088.0
13485,Feces,Intermediate,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,,50597,N,1,,CHEMBL629368,,BAO_0000218,1988.0
13486,Urine,Intermediate,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,,,50597,N,1,,CHEMBL877502,,BAO_0000218,1088.0
13487,Cerebellum,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,1,,,50594,N,1,,CHEMBL629369,,BAO_0000218,2037.0
13488,Brain,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,1,,,50594,N,1,,CHEMBL629370,,BAO_0000218,955.0
13489,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",1,,,22224,U,0,,CHEMBL629371,,BAO_0000218,1088.0
13490,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,,,22224,U,0,,CHEMBL626276,,BAO_0000218,1088.0
13491,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",1,,,22224,U,0,,CHEMBL626277,,BAO_0000218,1088.0
13492,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",1,,,22224,U,0,,CHEMBL631250,,BAO_0000218,1088.0
13493,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,,50597,N,1,,CHEMBL631251,,BAO_0000218,1088.0
13494,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,,,50597,N,1,,CHEMBL631252,,BAO_0000218,1088.0
13495,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",1,,,50597,N,1,,CHEMBL631253,,BAO_0000218,1088.0
13496,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,,,50597,N,1,,CHEMBL631254,,BAO_0000218,1088.0
13497,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,,,50597,N,1,,CHEMBL631255,,BAO_0000218,1088.0
13498,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,,,50597,N,1,,CHEMBL631256,,BAO_0000218,1088.0
13499,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,,,50597,N,1,,CHEMBL631257,,BAO_0000218,1088.0
13500,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",1,,,50597,N,1,,CHEMBL628009,,BAO_0000218,1088.0
13501,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,,,50597,N,1,,CHEMBL628010,,BAO_0000218,1088.0
13502,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,,,50597,N,1,,CHEMBL628011,,BAO_0000218,1088.0
13503,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",1,,,50597,N,1,,CHEMBL628012,,BAO_0000218,1088.0
13504,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,,,50597,N,1,,CHEMBL628013,,BAO_0000218,1088.0
13505,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,,,50597,N,1,,CHEMBL628014,,BAO_0000218,1088.0
13506,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",1,,,50588,N,1,,CHEMBL628015,,BAO_0000218,1088.0
13507,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,,50588,N,1,,CHEMBL628016,,BAO_0000218,1088.0
13508,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",1,,,50588,N,1,,CHEMBL874461,,BAO_0000218,1088.0
13509,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,,50588,N,1,,CHEMBL628017,,BAO_0000218,1088.0
13510,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,,,50588,N,1,,CHEMBL628018,,BAO_0000218,1088.0
13511,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,,50588,N,1,,CHEMBL628019,,BAO_0000218,1088.0
13512,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,,50588,N,1,,CHEMBL628020,,BAO_0000218,1088.0
13513,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,,,50588,N,1,,CHEMBL628021,,BAO_0000218,1088.0
13514,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,,,50588,N,1,,CHEMBL628022,,BAO_0000218,1088.0
13515,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,,,50588,N,1,,CHEMBL628023,,BAO_0000218,1088.0
13516,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,,,22224,U,0,,CHEMBL628024,,BAO_0000218,1088.0
13517,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",1,,,22224,U,0,,CHEMBL628025,,BAO_0000218,1088.0
13518,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,,,22224,U,0,,CHEMBL628026,,BAO_0000218,1088.0
13519,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",1,,,22224,U,0,,CHEMBL628027,,BAO_0000218,1088.0
13520,Urine,Autocuration,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",1,,,22224,U,0,,CHEMBL628028,,BAO_0000218,1088.0
13521,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,,50597,N,1,,CHEMBL628029,,BAO_0000218,1088.0
13522,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",1,,,50597,N,1,,CHEMBL628030,,BAO_0000218,1088.0
13523,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,,,50597,N,1,,CHEMBL628031,,BAO_0000218,1088.0
13524,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",1,,,50597,N,1,,CHEMBL628032,,BAO_0000218,1088.0
13525,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,,,50597,N,1,,CHEMBL628033,,BAO_0000218,1088.0
13526,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",1,,,50597,N,1,,CHEMBL628034,,BAO_0000218,1088.0
13527,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,,,50597,N,1,,CHEMBL628035,,BAO_0000218,1088.0
13528,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",1,,,50597,N,1,,CHEMBL628036,,BAO_0000218,1088.0
13529,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,,,50597,N,1,,CHEMBL874462,,BAO_0000218,1088.0
13530,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,1,,,50588,N,1,,CHEMBL628037,,BAO_0000218,
13531,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,1,,,50588,N,1,,CHEMBL628123,,BAO_0000218,
13532,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,1,,,50588,N,1,,CHEMBL628124,,BAO_0000218,
13533,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,1,,,50588,N,1,,CHEMBL628125,,BAO_0000218,
13534,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,1,,,50588,N,1,,CHEMBL628126,,BAO_0000218,
13535,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),1,,,50588,N,1,,CHEMBL628127,,BAO_0000218,
13536,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,1,,,50588,N,1,,CHEMBL628128,,BAO_0000218,
13537,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,1,,,50588,N,1,,CHEMBL628129,,BAO_0000218,
13538,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,1,,,50588,N,1,,CHEMBL628130,,BAO_0000218,
13539,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,1,,,50588,N,1,,CHEMBL628131,,BAO_0000218,
13540,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,1,,,50588,N,1,,CHEMBL628132,,BAO_0000218,
13541,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,1,,,50588,N,1,,CHEMBL628133,,BAO_0000218,
13542,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,1,,,50588,N,1,,CHEMBL628134,,BAO_0000218,
13543,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,1,,,50588,N,1,,CHEMBL628135,,BAO_0000218,
13544,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,1,,,50588,N,1,,CHEMBL628136,,BAO_0000218,
13545,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,1,,,50588,N,1,,CHEMBL628137,,BAO_0000218,
13546,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,1,,,50588,N,1,,CHEMBL628138,,BAO_0000218,
13547,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,1,,,50588,N,1,,CHEMBL628139,,BAO_0000218,
13548,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,1,,,50588,N,1,,CHEMBL628140,,BAO_0000218,
13549,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,1,,,50588,N,1,,CHEMBL628141,,BAO_0000218,
13550,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,1,,,50588,N,1,,CHEMBL628142,,BAO_0000218,
13551,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,1,,,50588,N,1,,CHEMBL628143,,BAO_0000218,
13552,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,1,,,50588,N,1,,CHEMBL628144,,BAO_0000218,
13553,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,1,,,50588,N,1,,CHEMBL628145,,BAO_0000218,
13554,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,1,,,50588,N,1,,CHEMBL628146,,BAO_0000218,
13555,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,1,,,50588,N,1,,CHEMBL625355,,BAO_0000218,
13556,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,1,,,50588,N,1,,CHEMBL625356,,BAO_0000218,
13557,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,1,,,50588,N,1,,CHEMBL625357,,BAO_0000218,
13558,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,1,,,50588,N,1,,CHEMBL625527,,BAO_0000218,
13559,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),1,,,50588,N,1,,CHEMBL875473,,BAO_0000218,
13560,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,1,,,50588,N,1,,CHEMBL625528,,BAO_0000218,
13561,,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,1,,,50597,N,1,,CHEMBL626304,,BAO_0000218,
13562,Artery,Intermediate,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,1,,,50588,N,1,,CHEMBL624138,,BAO_0000218,1637.0
13563,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624139,,BAO_0000100,
13564,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624140,,BAO_0000100,
13565,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624141,,BAO_0000100,
13566,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624142,,BAO_0000100,
13567,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624143,,BAO_0000100,
13568,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624144,,BAO_0000100,
13569,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624145,,BAO_0000100,
13570,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624146,,BAO_0000100,
13571,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624147,,BAO_0000100,
13572,,Autocuration,Calculated partition coefficient (clogP) (MacLogP),1,,,22229,U,0,,CHEMBL883123,,BAO_0000100,
13573,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL624148,,BAO_0000019,
13574,,Autocuration,Kinetic parameter was determined,1,,,22224,U,0,,CHEMBL874416,,BAO_0000019,
13575,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624149,,BAO_0000100,
13576,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL624150,,BAO_0000100,
13577,,Autocuration,Lipophilicity was determined,1,,,22224,U,0,,CHEMBL624151,,BAO_0000100,
13578,,Autocuration,Lipophilicity was determined,1,,,22224,U,0,,CHEMBL624152,,BAO_0000100,
13579,,Autocuration,Lipophilicity was determined,1,,,22224,U,0,,CHEMBL622139,,BAO_0000100,
13580,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL622140,,BAO_0000100,
13581,,Autocuration,Lipophilicity was determined,1,,,22224,U,0,,CHEMBL622141,,BAO_0000100,
13582,,Autocuration,Lipophilicity in octanol-water,1,,,22224,U,0,,CHEMBL622142,,BAO_0000100,
13583,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL622143,,BAO_0000100,
13584,,Autocuration,Octanol-water partition coefficient was determined,1,,,22229,U,0,,CHEMBL622144,,BAO_0000100,
13585,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL877473,,BAO_0000019,
13586,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL622145,,BAO_0000100,
13587,,Autocuration,Partition coefficient was determined; ND means not determined,1,,,22224,U,0,,CHEMBL622146,,BAO_0000019,
13588,,Autocuration,Calculated partition coefficient (clogP),1,,,22229,U,0,,CHEMBL622147,,BAO_0000100,
13589,,Autocuration,Partition coefficient of the compound,1,,,22224,U,0,,CHEMBL622148,,BAO_0000019,
13590,,Autocuration,Permeability was determined,1,,,22224,U,0,,CHEMBL883124,,BAO_0000019,
13591,,Autocuration,The compound was evaluated for the partition coefficient,1,,,22229,U,0,,CHEMBL622149,,BAO_0000100,
13592,,Autocuration,Partition coefficient (logP),1,,,22224,U,0,,CHEMBL622150,,BAO_0000019,
13593,,Autocuration,The lipophilicity was reported,1,,,22224,U,0,,CHEMBL622151,,BAO_0000100,
13594,,Autocuration,logarithm of the octanol-water partition coefficient for the compound,1,,,22229,U,0,,CHEMBL622152,,BAO_0000100,
13595,,Autocuration,Clogp value was determined,1,,,22224,U,0,,CHEMBL622153,,BAO_0000019,
13596,,Autocuration,Clp at a dose of 1.5 mg/kg,1,,,22224,U,0,,CHEMBL877474,,BAO_0000218,
13597,,Autocuration,Clp at a dose of 2.0 mg/kg,1,,,22224,U,0,,CHEMBL622154,,BAO_0000218,
13598,Plasma,Autocuration,"Clp, plasma clearance at a dose of 10 mg/kg",1,,,22224,U,0,,CHEMBL622155,,BAO_0000218,1969.0
13599,Plasma,Autocuration,"Clp, plasma clearance at a dose of 50 mg/kg",1,,,22224,U,0,,CHEMBL622156,,BAO_0000218,1969.0
13600,Plasma,Intermediate,Compound was tested for plasma clearance in rat,1,,,50597,N,1,,CHEMBL622157,,BAO_0000218,1969.0
13601,Plasma,Intermediate,Compound was tested for plasma clearance in rat; Not determined,1,,,50597,N,1,,CHEMBL622158,,BAO_0000218,1969.0
13602,,Intermediate,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,1,,,50597,N,1,,CHEMBL622807,,BAO_0000218,
13603,,Intermediate,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,1,,,50797,N,1,,CHEMBL622808,,BAO_0000218,
13604,,Autocuration,Plasma clearance by iv administration at a dose 0.003 ug/mL,1,,,22224,U,0,,CHEMBL622809,,BAO_0000218,
13605,,Autocuration,Plasma clearance determined,1,,,22224,U,0,,CHEMBL622810,,BAO_0000218,
13606,,Intermediate,Plasma clearance after iv administration at 3 mg/kg in hamster,1,,,100712,N,1,,CHEMBL876653,,BAO_0000218,
13607,,Intermediate,Plasma clearance after iv administration at 4 mg/kg in hamster,1,,,100712,N,1,,CHEMBL622811,,BAO_0000218,
13608,,Intermediate,Rate of clearance in rat was determined,1,,,50597,N,1,,CHEMBL622986,,BAO_0000218,
13609,Plasma,Intermediate,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,1,,,50597,N,1,,CHEMBL622987,,BAO_0000218,1969.0
13610,Plasma,Intermediate,Total plasma clearance after iv dose of 5.10 mg/kg in rats,1,,,50597,N,1,,CHEMBL622988,,BAO_0000218,1969.0
13611,Plasma,Intermediate,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,1,,,50597,N,1,,CHEMBL622989,,BAO_0000218,1969.0
13612,Plasma,Intermediate,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,1,,,50597,N,1,,CHEMBL622990,,BAO_0000218,1969.0
13613,Plasma,Autocuration,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,1,,,22224,U,0,,CHEMBL622991,,BAO_0000218,1969.0
13614,Plasma,Intermediate,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,,,50597,N,1,,CHEMBL622227,,BAO_0000218,1969.0
13615,Plasma,Intermediate,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,,,50588,N,1,,CHEMBL622228,,BAO_0000218,1969.0
13616,,Intermediate,Clpl value in rat,1,,,50597,N,1,,CHEMBL622229,,BAO_0000218,
13617,,Intermediate,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,1,,,50512,N,1,,CHEMBL622230,,BAO_0000218,
13618,,Intermediate,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,1,,,50597,N,1,,CHEMBL622231,,BAO_0000218,
13619,,Intermediate,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,1,,,100710,N,1,,CHEMBL622232,,BAO_0000218,
13620,,Autocuration,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL622233,,BAO_0000218,
13621,,Autocuration,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL622234,,BAO_0000218,
13622,,Autocuration,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL622235,,BAO_0000218,
13623,,Autocuration,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL622236,,BAO_0000218,
13624,,Autocuration,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL622237,,BAO_0000218,
13625,,Autocuration,Cmax in minutes at a po dose of 10.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL877482,,BAO_0000218,
13626,,Autocuration,Cmax in minutes at a po dose of 20.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL622238,,BAO_0000218,
13627,,Autocuration,Cmax in minutes at a po dose of 40.0(pmol/g/h).,1,,,22224,U,0,,CHEMBL622239,,BAO_0000218,
13628,Blood,Autocuration,Cmax was calculated as maximum concentration reached in the blood,1,,,22224,U,0,,CHEMBL622240,,BAO_0000218,178.0
13629,Blood,Autocuration,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,1,,,22224,U,0,,CHEMBL622241,,BAO_0000218,178.0
13630,,Intermediate,Cmax was determine after peroral administration at 10 mpk in Rat,1,,,50597,N,1,,CHEMBL631013,,BAO_0000218,
13631,,Intermediate,Cmax was determine after peroral administration at 10 mpk in Rhesus,1,,,50797,N,1,,CHEMBL631014,,BAO_0000218,
13632,,Intermediate,Cmax was determine after peroral administration at 10 mpk in dog,1,,,50588,N,1,,CHEMBL631015,,BAO_0000218,
13633,,Intermediate,Cmax was determine after peroral administration at 160 mpk in Rat,1,,,50597,N,1,,CHEMBL631016,,BAO_0000218,
13634,,Intermediate,Cmax was determine after peroral administration at 20 mpk in Rat,1,,,50597,N,1,,CHEMBL631017,,BAO_0000218,
13635,,Intermediate,Cmax was determine after peroral administration at 50 mpk in Rat,1,,,50597,N,1,,CHEMBL631018,,BAO_0000218,
13636,,Autocuration,Cmax was determined,1,,,22224,U,0,,CHEMBL631019,,BAO_0000218,
13637,Brain,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,1,,,50594,N,1,,CHEMBL875761,,BAO_0000218,955.0
13638,Brain,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,1,,,50594,N,1,,CHEMBL631020,,BAO_0000218,955.0
13639,Brain,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,1,,,50594,N,1,,CHEMBL631669,,BAO_0000218,955.0
13640,Brain,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,1,,,50594,N,1,,CHEMBL631670,,BAO_0000218,955.0
13641,Striatum,Intermediate,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,1,,,50594,N,1,,CHEMBL631671,,BAO_0000218,2435.0
13642,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,1,,,50597,N,1,,CHEMBL631672,,BAO_0000218,178.0
13643,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,1,,,50597,N,1,,CHEMBL631673,,BAO_0000218,178.0
13644,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,1,,,50597,N,1,,CHEMBL631856,,BAO_0000218,178.0
13645,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,1,,,50597,N,1,,CHEMBL631857,,BAO_0000218,178.0
13646,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,1,,,50597,N,1,,CHEMBL631858,,BAO_0000218,178.0
13647,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,1,,,50597,N,1,,CHEMBL631859,,BAO_0000218,178.0
13648,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,1,,,50597,N,1,,CHEMBL631860,,BAO_0000218,178.0
13649,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,1,,,50597,N,1,,CHEMBL631861,,BAO_0000218,178.0
13650,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,1,,,50597,N,1,,CHEMBL631862,,BAO_0000218,178.0
13651,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,1,,,50597,N,1,,CHEMBL631863,,BAO_0000218,178.0
13652,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,1,,,50597,N,1,,CHEMBL631864,,BAO_0000218,178.0
13653,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,1,,,50597,N,1,,CHEMBL631865,,BAO_0000218,178.0
13654,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,1,,,50597,N,1,,CHEMBL631866,,BAO_0000218,178.0
13655,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,1,,,50597,N,1,,CHEMBL629360,,BAO_0000218,178.0
13656,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,1,,,50597,N,1,,CHEMBL629361,,BAO_0000218,178.0
13657,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,1,,,50597,N,1,,CHEMBL629362,,BAO_0000218,178.0
13658,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,1,,,50597,N,1,,CHEMBL630740,,BAO_0000218,178.0
13659,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,1,,,50597,N,1,,CHEMBL630741,,BAO_0000218,178.0
13660,Blood,Intermediate,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,1,,,50597,N,1,,CHEMBL630742,,BAO_0000218,178.0
13661,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,1,,,50597,N,1,,CHEMBL630743,,BAO_0000218,
13662,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,1,,,50597,N,1,,CHEMBL630744,,BAO_0000218,
13663,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,1,,,50597,N,1,,CHEMBL630745,,BAO_0000218,
13664,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,1,,,50597,N,1,,CHEMBL630746,,BAO_0000218,
13665,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,1,,,50597,N,1,,CHEMBL630747,,BAO_0000218,
13666,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,1,,,50597,N,1,,CHEMBL630748,,BAO_0000218,
13667,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,1,,,50597,N,1,,CHEMBL632056,,BAO_0000218,
13668,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,1,,,50597,N,1,,CHEMBL632057,,BAO_0000218,
13669,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,1,,,50597,N,1,,CHEMBL632058,,BAO_0000218,
13670,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,1,,,50597,N,1,,CHEMBL632059,,BAO_0000218,
13671,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,1,,,50597,N,1,,CHEMBL632060,,BAO_0000218,
13672,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,1,,,50597,N,1,,CHEMBL632061,,BAO_0000218,
13673,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,1,,,50597,N,1,,CHEMBL629207,,BAO_0000218,
13674,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,1,,,50597,N,1,,CHEMBL629208,,BAO_0000218,
13675,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,1,,,50597,N,1,,CHEMBL629209,,BAO_0000218,
13676,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,1,,,50597,N,1,,CHEMBL629210,,BAO_0000218,
13677,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,1,,,50597,N,1,,CHEMBL629211,,BAO_0000218,
13678,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,1,,,50597,N,1,,CHEMBL629212,,BAO_0000218,
13679,,Intermediate,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,1,,,50597,N,1,,CHEMBL629213,,BAO_0000218,
13680,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,,,50597,N,1,,CHEMBL629214,,BAO_0000218,1088.0
13681,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",1,,,50597,N,1,,CHEMBL629215,,BAO_0000218,1088.0
13682,Urine,Intermediate,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",1,,,50597,N,1,,CHEMBL635154,,BAO_0000218,1088.0
13683,,Intermediate,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL629216,,BAO_0000218,
13684,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL629217,,BAO_0000218,
13685,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL629218,,BAO_0000218,
13686,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL629219,,BAO_0000218,
13687,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL629220,,BAO_0000218,
13688,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL629221,,BAO_0000218,
13689,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL631127,,BAO_0000218,
13690,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL631128,,BAO_0000218,
13691,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL631129,,BAO_0000218,
13692,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL631130,,BAO_0000218,
13693,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL631131,,BAO_0000218,
13694,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL631132,,BAO_0000218,
13695,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL631133,,BAO_0000218,
13696,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL631134,,BAO_0000218,
13697,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL875120,,BAO_0000218,
13698,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL631135,,BAO_0000218,
13699,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL631136,,BAO_0000218,
13700,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL631137,,BAO_0000218,
13701,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL631138,,BAO_0000218,
13702,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,1,,,50597,N,1,,CHEMBL631139,,BAO_0000218,
13703,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL631140,,BAO_0000218,
13704,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,50597,N,1,,CHEMBL631141,,BAO_0000218,
13705,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,,50597,N,1,,CHEMBL631142,,BAO_0000218,
13706,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,,50597,N,1,,CHEMBL631143,,BAO_0000218,
13707,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,50597,N,1,,CHEMBL631144,,BAO_0000218,
13708,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL631145,,BAO_0000218,
13709,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL631146,,BAO_0000218,
13710,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL631147,,BAO_0000218,
13711,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL631148,,BAO_0000218,
13712,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL631149,,BAO_0000218,
13713,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL631150,,BAO_0000218,
13714,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL631151,,BAO_0000218,
13715,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL631152,,BAO_0000218,
13716,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL631443,,BAO_0000218,
13717,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL631444,,BAO_0000218,
13718,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL631445,,BAO_0000218,
13719,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,,50588,N,1,,CHEMBL631446,,BAO_0000218,
13720,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL631447,,BAO_0000218,
13721,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,,50588,N,1,,CHEMBL631448,,BAO_0000218,
13722,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,1,,,50588,N,1,,CHEMBL631449,,BAO_0000218,
13723,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,,50588,N,1,,CHEMBL631450,,BAO_0000218,
13724,,Intermediate,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,,50588,N,1,,CHEMBL629724,,BAO_0000218,
13725,Zone of skin,Intermediate,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL629725,,BAO_0000218,14.0
13726,Zone of skin,Intermediate,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL629726,,BAO_0000218,14.0
13727,Spleen,Intermediate,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL629727,,BAO_0000218,2106.0
13728,Spleen,Intermediate,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630404,,BAO_0000218,2106.0
13729,Spleen,Intermediate,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630405,,BAO_0000218,2106.0
13730,Spleen,Intermediate,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630406,,BAO_0000218,2106.0
13731,Stomach,Intermediate,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630407,,BAO_0000218,945.0
13732,Stomach,Intermediate,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630573,,BAO_0000218,945.0
13733,Stomach,Intermediate,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630574,,BAO_0000218,945.0
13734,Stomach,Intermediate,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630575,,BAO_0000218,945.0
13735,,Intermediate,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630576,,BAO_0000218,
13736,,Intermediate,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630577,,BAO_0000218,
13737,,Intermediate,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630578,,BAO_0000218,
13738,,Intermediate,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,50594,N,1,,CHEMBL630579,,BAO_0000218,
13739,Kidney,Intermediate,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),1,,,50594,N,1,,CHEMBL630580,,BAO_0000218,2113.0
13740,Kidney,Intermediate,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,1,,,50594,N,1,,CHEMBL630581,,BAO_0000218,2113.0
13741,Kidney,Intermediate,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),1,,,50594,N,1,,CHEMBL630582,,BAO_0000218,2113.0
13742,,Intermediate,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,1,,,50594,N,1,,CHEMBL630583,,BAO_0000218,
13743,,Intermediate,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),1,,,50594,N,1,,CHEMBL630584,,BAO_0000218,
13744,,Intermediate,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,1,,,50594,N,1,,CHEMBL630585,,BAO_0000218,
13745,,Intermediate,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),1,,,50594,N,1,,CHEMBL630586,,BAO_0000218,
13746,,Intermediate,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,1,,,50594,N,1,,CHEMBL630587,,BAO_0000218,
13747,,Intermediate,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),1,,,50594,N,1,,CHEMBL630588,,BAO_0000218,
13748,,Intermediate,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,1,,,50594,N,1,,CHEMBL630589,,BAO_0000218,
13749,,Intermediate,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),1,,,50594,N,1,,CHEMBL630590,,BAO_0000218,
13750,Feces,Autocuration,Removal of 238-Plutonium(IV) in feces at 24 h,1,,,22224,U,0,,CHEMBL630591,,BAO_0000019,1988.0
13751,Feces,Autocuration,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),1,,,22224,U,0,,CHEMBL630592,,BAO_0000019,1988.0
13752,,Autocuration,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,1,,,22224,U,0,,CHEMBL630593,,BAO_0000019,
13753,,Autocuration,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),1,,,22224,U,0,,CHEMBL630594,,BAO_0000019,
13754,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),1,,,22224,U,0,,CHEMBL630595,,BAO_0000019,1088.0
13755,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),1,,,22224,U,0,,CHEMBL630596,,BAO_0000019,1088.0
13756,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-24 h,1,,,22224,U,0,,CHEMBL630597,,BAO_0000019,1088.0
13757,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),1,,,22224,U,0,,CHEMBL630598,,BAO_0000019,1088.0
13758,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-4 h,1,,,22224,U,0,,CHEMBL630599,,BAO_0000019,1088.0
13759,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),1,,,22224,U,0,,CHEMBL630600,,BAO_0000019,1088.0
13760,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine after 4-24 h,1,,,22224,U,0,,CHEMBL630601,,BAO_0000019,1088.0
13761,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),1,,,22224,U,0,,CHEMBL630602,,BAO_0000019,1088.0
13762,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),1,,,22224,U,0,,CHEMBL630603,,BAO_0000019,1088.0
13763,Urine,Autocuration,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),1,,,22224,U,0,,CHEMBL630604,,BAO_0000019,1088.0
13764,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL624869,,BAO_0000218,178.0
13765,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL624870,,BAO_0000218,178.0
13766,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL623189,,BAO_0000218,178.0
13767,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623190,,BAO_0000218,178.0
13768,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623191,,BAO_0000218,178.0
13769,,Intermediate,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623192,,BAO_0000218,
13770,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623193,,BAO_0000218,
13771,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL623194,,BAO_0000218,
13772,,Intermediate,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623195,,BAO_0000218,
13773,,Intermediate,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623196,,BAO_0000218,
13774,,Intermediate,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,1,,,50597,N,1,,CHEMBL623197,,BAO_0000218,
13775,,Intermediate,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623198,,BAO_0000218,
13776,,Intermediate,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,,,50597,N,1,,CHEMBL623199,,BAO_0000218,
13777,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623200,,BAO_0000218,2385.0
13778,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623201,,BAO_0000218,2385.0
13779,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623202,,BAO_0000218,2385.0
13780,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623203,,BAO_0000218,2385.0
13781,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623204,,BAO_0000218,2385.0
13782,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,1,,,50597,N,1,,CHEMBL623205,,BAO_0000218,2385.0
13783,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623206,,BAO_0000218,2385.0
13784,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,1,,,50597,N,1,,CHEMBL623207,,BAO_0000218,2385.0
13785,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,1,,,50597,N,1,,CHEMBL623208,,BAO_0000218,2385.0
13786,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623209,,BAO_0000218,2385.0
13787,Muscle tissue,Intermediate,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,,,50597,N,1,,CHEMBL623210,,BAO_0000218,2385.0
13788,,Intermediate,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623211,,BAO_0000218,
13789,Uterus,Intermediate,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,,50597,N,1,,CHEMBL623212,,BAO_0000218,995.0
13790,,Autocuration,Tested in vitro for intrinsic activity relative to quinpirole,1,,,22224,U,0,,CHEMBL623213,,BAO_0000019,
13791,,Autocuration,"Relative ion enhancement, determined in pulsed ultrafiltration",1,,,22224,U,0,,CHEMBL623214,,BAO_0000019,
13792,,Autocuration,% ionization at the pH 7.4 at 37 degree Centigrade,1,,,22224,U,0,,CHEMBL623215,,BAO_0000019,
13793,,Autocuration,Percentage ionization was measured,1,,,22224,U,0,,CHEMBL623216,,BAO_0000019,
13794,,Intermediate,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,1,,,50591,N,1,,CHEMBL623217,,BAO_0000218,
13795,,Autocuration,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,1,,,22224,U,0,,CHEMBL623218,,BAO_0000019,
13796,,Autocuration,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,1,,,22224,U,0,,CHEMBL623913,,BAO_0000019,
13797,,Autocuration,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,1,,,22224,U,0,,CHEMBL623914,,BAO_0000019,
13798,,Autocuration,Compound was evaluated for the partition coefficient in octanol/water,1,,,22229,U,0,,CHEMBL623915,,BAO_0000100,
13799,,Autocuration,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),1,,,22229,U,0,,CHEMBL624080,,BAO_0000100,
13800,,Autocuration,Equilibrium constant measured by the pulse radiolysis at pH 7,1,,,22224,U,0,,CHEMBL624081,,BAO_0000019,
13801,,Intermediate,In vitro hydrolytic rate constant determined in human blood,1,,,50587,N,1,,CHEMBL624082,,BAO_0000218,
13802,,Intermediate,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,1,,,50587,N,1,,CHEMBL625054,,BAO_0000218,
13803,,Autocuration,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,1,,,22224,U,0,,CHEMBL877485,,BAO_0000019,
13804,,Intermediate,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,1,,,50594,N,1,,CHEMBL625055,,BAO_0000218,
13805,,Intermediate,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,1,,,50594,N,1,,CHEMBL625056,,BAO_0000218,
13806,,Intermediate,In vitro oxidation of compound in presence of human plasma,1,,,50587,N,1,,CHEMBL625057,,BAO_0000218,
13807,,Autocuration,In vitro oxidation of compound in presence of hydrogen peroxide,1,,,22224,U,0,,CHEMBL625058,,BAO_0000019,
13808,,Intermediate,In vitro oxidation of compound in presence of mouse brain homogenate,1,,,50594,N,1,,CHEMBL625059,,BAO_0000218,
13809,,Intermediate,In vitro oxidation of compound in presence of mouse liver homogenate,1,,,50594,N,1,,CHEMBL629536,,BAO_0000218,
13810,,Intermediate,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,,50597,N,1,,CHEMBL629537,,BAO_0000218,
13811,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,,50597,N,1,,CHEMBL629538,,BAO_0000218,
13812,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,,50597,N,1,,CHEMBL629539,,BAO_0000218,
13813,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,,50597,N,1,,CHEMBL874445,,BAO_0000218,
13814,,Intermediate,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,,50597,N,1,,CHEMBL629540,,BAO_0000218,
13815,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,,50597,N,1,,CHEMBL629541,,BAO_0000218,
13816,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,,50597,N,1,,CHEMBL629542,,BAO_0000218,
13817,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,,50597,N,1,,CHEMBL630243,,BAO_0000218,
13818,,Intermediate,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,,50597,N,1,,CHEMBL630244,,BAO_0000218,
13819,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,,50597,N,1,,CHEMBL630245,,BAO_0000218,
13820,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,,50597,N,1,,CHEMBL630246,,BAO_0000218,
13821,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,,50597,N,1,,CHEMBL630247,,BAO_0000218,
13822,,Intermediate,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,,50597,N,1,,CHEMBL630248,,BAO_0000218,
13823,Blood,Intermediate,Biodistribution in rat blood at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630249,,BAO_0000218,178.0
13824,Blood,Intermediate,Biodistribution in rat blood at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630250,,BAO_0000218,178.0
13825,Blood,Intermediate,Biodistribution in rat blood at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630251,,BAO_0000218,178.0
13826,Blood,Intermediate,Biodistribution in rat blood at 3 hr after dose administration.,1,,,50597,N,1,,CHEMBL630252,,BAO_0000218,178.0
13827,Blood,Intermediate,Biodistribution in rat blood at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630408,,BAO_0000218,178.0
13828,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630409,,BAO_0000218,2037.0
13829,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL874446,,BAO_0000218,2037.0
13830,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630410,,BAO_0000218,2037.0
13831,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630411,,BAO_0000218,2037.0
13832,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630412,,BAO_0000218,2037.0
13833,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630413,,BAO_0000218,2037.0
13834,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 3 hr after dose administration.,1,,,50597,N,1,,CHEMBL630414,,BAO_0000218,2037.0
13835,Cerebellum,Intermediate,Biodistribution in rat cerebellum at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630415,,BAO_0000218,2037.0
13836,,Intermediate,Biodistribution in rat cortex at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630416,,BAO_0000218,
13837,,Intermediate,Biodistribution in rat cortex at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630417,,BAO_0000218,
13838,,Intermediate,Biodistribution in rat cortex at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630418,,BAO_0000218,
13839,,Intermediate,Biodistribution in rat cortex at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630419,,BAO_0000218,
13840,,Intermediate,Biodistribution in rat cortex at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630420,,BAO_0000218,
13841,,Intermediate,Biodistribution in rat cortex at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630421,,BAO_0000218,
13842,,Intermediate,Biodistribution in rat cortex at 3 hr after dose administration.,1,,,50597,N,1,,CHEMBL630422,,BAO_0000218,
13843,,Intermediate,Biodistribution in rat cortex at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630423,,BAO_0000218,
13844,Heart,Intermediate,Biodistribution in rat heart at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630424,,BAO_0000218,948.0
13845,Heart,Intermediate,Biodistribution in rat heart at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630425,,BAO_0000218,948.0
13846,Heart,Intermediate,Biodistribution in rat heart at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL629462,,BAO_0000218,948.0
13847,Heart,Intermediate,Biodistribution in rat heart at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630426,,BAO_0000218,948.0
13848,Heart,Intermediate,Biodistribution in rat heart at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630427,,BAO_0000218,948.0
13849,Heart,Intermediate,Biodistribution in rat heart at 3 hr after dose administration.,1,,,50597,N,1,,CHEMBL625877,,BAO_0000218,948.0
13850,Heart,Intermediate,Biodistribution in rat heart at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625878,,BAO_0000218,948.0
13851,Hippocampus,Intermediate,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625879,,BAO_0000218,10000000.0
13852,Hippocampus,Intermediate,Biodistribution in rat hippocampus at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625880,,BAO_0000218,10000000.0
13853,Hippocampus,Intermediate,Biodistribution in rat hippocampus at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625881,,BAO_0000218,10000000.0
13854,Hippocampus,Intermediate,Biodistribution in rat hippocampus at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625882,,BAO_0000218,10000000.0
13855,Hippocampus,Intermediate,Biodistribution in rat hippocampus at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625883,,BAO_0000218,10000000.0
13856,Kidney,Intermediate,Biodistribution in rat kidney at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625884,,BAO_0000218,2113.0
13857,Kidney,Intermediate,Biodistribution in rat kidney at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625885,,BAO_0000218,2113.0
13858,Kidney,Intermediate,Biodistribution in rat kidney at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628649,,BAO_0000218,2113.0
13859,Kidney,Intermediate,Biodistribution in rat kidney at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628650,,BAO_0000218,2113.0
13860,Kidney,Intermediate,Biodistribution in rat kidney at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628651,,BAO_0000218,2113.0
13861,Kidney,Intermediate,Biodistribution in rat kidney at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628652,,BAO_0000218,2113.0
13862,Kidney,Intermediate,Biodistribution in rat kidney at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628653,,BAO_0000218,2113.0
13863,Liver,Intermediate,Biodistribution in rat liver at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628654,,BAO_0000218,2107.0
13864,Liver,Intermediate,Biodistribution in rat liver at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628655,,BAO_0000218,2107.0
13865,Liver,Intermediate,Biodistribution in rat liver at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625238,,BAO_0000218,2107.0
13866,Liver,Intermediate,Biodistribution in rat liver at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625239,,BAO_0000218,2107.0
13867,Liver,Intermediate,Biodistribution in rat liver at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625240,,BAO_0000218,2107.0
13868,Liver,Intermediate,Biodistribution in rat liver at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625241,,BAO_0000218,2107.0
13869,Liver,Intermediate,Biodistribution in rat liver at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625242,,BAO_0000218,2107.0
13870,Lung,Intermediate,Biodistribution in rat lung at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL874587,,BAO_0000218,2048.0
13871,Lung,Intermediate,Biodistribution in rat lung at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625405,,BAO_0000218,2048.0
13872,Lung,Intermediate,Biodistribution in rat lung at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625406,,BAO_0000218,2048.0
13873,Lung,Intermediate,Biodistribution in rat lung at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625407,,BAO_0000218,2048.0
13874,Lung,Intermediate,Biodistribution in rat lung at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625408,,BAO_0000218,2048.0
13875,Lung,Intermediate,Biodistribution in rat lung at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL625409,,BAO_0000218,2048.0
13876,Thoracic aorta,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,1,,,50597,N,1,,CHEMBL625410,,BAO_0000218,1515.0
13877,Thoracic aorta,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,1,,,50597,N,1,,CHEMBL625411,,BAO_0000218,1515.0
13878,Thoracic aorta,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,1,,,50597,N,1,,CHEMBL625412,,BAO_0000218,1515.0
13879,Thoracic aorta,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,1,,,50597,N,1,,CHEMBL625413,,BAO_0000218,1515.0
13880,Thoracic aorta,Intermediate,Percent of maximal contractile response to compound in rat thoracic aorta strips v,1,,,50597,N,1,,CHEMBL625414,,BAO_0000218,1515.0
13881,Thoracic aorta,Intermediate,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,1,,,50597,N,1,,CHEMBL625415,,BAO_0000218,1515.0
13882,Thoracic aorta,Intermediate,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,1,,,50597,N,1,,CHEMBL625416,,BAO_0000218,1515.0
13883,Urine,Intermediate,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,1,,,50597,N,1,,CHEMBL625417,,BAO_0000218,1088.0
13884,Feces,Intermediate,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,1,,,50597,N,1,,CHEMBL625418,,BAO_0000218,1988.0
13885,Urine,Intermediate,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,1,,,50597,N,1,,CHEMBL625419,,BAO_0000218,1088.0
13886,,Intermediate,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,1,,,50597,N,1,,CHEMBL625420,,BAO_0000218,
13887,,Intermediate,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,1,,,50597,N,1,,CHEMBL626996,,BAO_0000218,
13888,Feces,Intermediate,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",1,,,50597,N,1,,CHEMBL626997,,BAO_0000218,1988.0
13889,Urine,Intermediate,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",1,,,50597,N,1,,CHEMBL626998,,BAO_0000218,1088.0
13890,,Intermediate,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",1,,,50597,N,1,,CHEMBL626999,,BAO_0000218,
13891,,Intermediate,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,1,,,50594,N,1,,CHEMBL627000,,BAO_0000218,
13892,,Intermediate,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,1,,,50594,N,1,,CHEMBL627001,,BAO_0000218,
13893,,Intermediate,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,1,,,50594,N,1,,CHEMBL627002,,BAO_0000218,
13894,,Intermediate,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,1,,,50594,N,1,,CHEMBL627003,,BAO_0000218,
13895,Urine,Intermediate,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,1,,,50594,N,1,,CHEMBL627004,,BAO_0000218,1088.0
13896,Urine,Intermediate,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,1,,,50594,N,1,,CHEMBL627005,,BAO_0000218,1088.0
13897,Urine,Intermediate,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,1,,,50594,N,1,,CHEMBL874594,,BAO_0000218,1088.0
13898,Urine,Intermediate,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,1,,,50594,N,1,,CHEMBL627006,,BAO_0000218,1088.0
13899,Urine,Intermediate,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,1,,,50594,N,1,,CHEMBL627007,,BAO_0000218,1088.0
13900,Urine,Intermediate,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,1,,,50594,N,1,,CHEMBL627884,,BAO_0000218,1088.0
13901,Urine,Intermediate,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,1,,,50594,N,1,,CHEMBL627885,,BAO_0000218,1088.0
13902,Urine,Intermediate,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,1,,,50594,N,1,,CHEMBL627886,,BAO_0000218,1088.0
13903,Urine,Intermediate,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,1,,,50594,N,1,,CHEMBL627887,,BAO_0000218,1088.0
13904,Urine,Intermediate,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,1,,,50594,N,1,,CHEMBL627888,,BAO_0000218,1088.0
13905,Urine,Intermediate,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,1,,,50594,N,1,,CHEMBL628057,,BAO_0000218,1088.0
13906,Urine,Intermediate,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,1,,,50594,N,1,,CHEMBL627405,,BAO_0000218,1088.0
13907,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627406,,BAO_0000218,1088.0
13908,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627407,,BAO_0000218,1088.0
13909,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627408,,BAO_0000218,1088.0
13910,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627409,,BAO_0000218,1088.0
13911,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,,50588,N,1,,CHEMBL875486,,BAO_0000218,1088.0
13912,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627410,,BAO_0000218,1088.0
13913,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627411,,BAO_0000218,1088.0
13914,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627412,,BAO_0000218,1088.0
13915,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627413,,BAO_0000218,1088.0
13916,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627414,,BAO_0000218,1088.0
13917,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627415,,BAO_0000218,1088.0
13918,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627416,,BAO_0000218,1088.0
13919,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627417,,BAO_0000218,1088.0
13920,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627418,,BAO_0000218,1088.0
13921,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627419,,BAO_0000218,1088.0
13922,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627320,,BAO_0000218,1088.0
13923,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627321,,BAO_0000218,1088.0
13924,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627322,,BAO_0000218,2113.0
13925,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627323,,BAO_0000218,2113.0
13926,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL627491,,BAO_0000218,2113.0
13927,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627492,,BAO_0000218,2113.0
13928,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627493,,BAO_0000218,2113.0
13929,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627494,,BAO_0000218,2107.0
13930,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627495,,BAO_0000218,2107.0
13931,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL627496,,BAO_0000218,2107.0
13932,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627497,,BAO_0000218,2107.0
13933,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627498,,BAO_0000218,2107.0
13934,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627499,,BAO_0000218,2048.0
13935,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL627500,,BAO_0000218,2048.0
13936,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL627501,,BAO_0000218,2048.0
13937,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625616,,BAO_0000218,2048.0
13938,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625617,,BAO_0000218,2048.0
13939,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625618,,BAO_0000218,2385.0
13940,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625619,,BAO_0000218,2385.0
13941,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL625620,,BAO_0000218,2385.0
13942,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625621,,BAO_0000218,2385.0
13943,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625622,,BAO_0000218,2385.0
13944,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625788,,BAO_0000218,2106.0
13945,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625789,,BAO_0000218,2106.0
13946,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL625790,,BAO_0000218,2106.0
13947,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL625791,,BAO_0000218,2106.0
13948,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL622334,,BAO_0000218,2106.0
13949,Thyroid gland,Intermediate,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL622335,,BAO_0000218,2046.0
13950,Thyroid gland,Intermediate,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL622336,,BAO_0000218,2046.0
13951,Thyroid gland,Intermediate,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL622337,,BAO_0000218,2046.0
13952,Thyroid gland,Intermediate,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL622338,,BAO_0000218,2046.0
13953,Thyroid gland,Intermediate,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL622339,,BAO_0000218,2046.0
13954,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL624153,,BAO_0000218,
13955,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL628430,,BAO_0000218,
13956,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL628431,,BAO_0000218,
13957,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL628432,,BAO_0000218,
13958,,Intermediate,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL628433,,BAO_0000218,
13959,Spleen,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,,50597,N,1,,CHEMBL628434,,BAO_0000218,2106.0
13960,Spleen,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,,50597,N,1,,CHEMBL626789,,BAO_0000218,2106.0
13961,Spleen,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",1,,,50597,N,1,,CHEMBL626790,,BAO_0000218,2106.0
13962,Spleen,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,,50597,N,1,,CHEMBL626791,,BAO_0000218,2106.0
13963,Spleen,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,,50597,N,1,,CHEMBL626792,,BAO_0000218,2106.0
13964,Spleen,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,,50597,N,1,,CHEMBL626793,,BAO_0000218,2106.0
13965,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,,50597,N,1,,CHEMBL627436,,BAO_0000218,
13966,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,,50597,N,1,,CHEMBL627437,,BAO_0000218,
13967,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,,50597,N,1,,CHEMBL627438,,BAO_0000218,
13968,,Intermediate,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,,50597,N,1,,CHEMBL627439,,BAO_0000218,
13969,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,,50597,N,1,,CHEMBL627440,,BAO_0000218,
13970,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,,50597,N,1,,CHEMBL627602,,BAO_0000218,
13971,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,,50597,N,1,,CHEMBL627603,,BAO_0000218,
13972,,Intermediate,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,,50597,N,1,,CHEMBL627604,,BAO_0000218,
13973,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,,50597,N,1,,CHEMBL627605,,BAO_0000218,
13974,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,,50597,N,1,,CHEMBL627606,,BAO_0000218,
13975,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,,50597,N,1,,CHEMBL627607,,BAO_0000218,
13976,,Intermediate,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,,50597,N,1,,CHEMBL627608,,BAO_0000218,
13977,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,,50597,N,1,,CHEMBL627609,,BAO_0000218,
13978,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,,50597,N,1,,CHEMBL627610,,BAO_0000218,
13979,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,,50597,N,1,,CHEMBL627611,,BAO_0000218,
13980,,Intermediate,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,,50597,N,1,,CHEMBL627612,,BAO_0000218,
13981,,Autocuration,Octanol:water partition coefficient is evaluated,1,,,22229,U,0,,CHEMBL627613,,BAO_0000100,
13982,,Autocuration,Partition coefficient in 1-octanol/water system,1,,,22224,U,0,,CHEMBL627614,,BAO_0000100,
13983,,Autocuration,Partition coefficient in 1-octanol/water system measured using radio active compounds,1,,,22224,U,0,,CHEMBL627615,,BAO_0000100,
13984,,Autocuration,Partition coefficient in octanol/water system was determined,1,,,22224,U,0,,CHEMBL627616,,BAO_0000100,
13985,,Autocuration,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,1,,,22224,U,0,,CHEMBL627617,,BAO_0000100,
13986,,Autocuration,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,1,,,22224,U,0,,CHEMBL627618,,BAO_0000019,
13987,,Autocuration,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",1,,,22224,U,0,,CHEMBL627619,,BAO_0000019,
13988,,Autocuration,Pseudo-first-order rate constant of the compound,1,,,22224,U,0,,CHEMBL627620,,BAO_0000019,
13989,,Autocuration,Pseudo-first-order rate constant with 1-min time point,1,,,22224,U,0,,CHEMBL627621,,BAO_0000019,
13990,,Autocuration,Pseudo-first-order rate constant without 1-min time point,1,,,22224,U,0,,CHEMBL627622,,BAO_0000019,
13991,,Autocuration,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,1,,,22224,U,0,,CHEMBL627623,,BAO_0000019,
13992,,Autocuration,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,1,,,22224,U,0,,CHEMBL627624,,BAO_0000019,
13993,,Autocuration,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,1,,,22224,U,0,,CHEMBL627625,,BAO_0000019,
13994,,Autocuration,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,1,,,22224,U,0,,CHEMBL628523,,BAO_0000019,
13995,,Autocuration,The alkaline hydrolysis second order rate constant(K OH) of the compound,1,,,22224,U,0,,CHEMBL628524,,BAO_0000019,
13996,,Autocuration,The efflux rate constant of the compound,1,,,22224,U,0,,CHEMBL628525,,BAO_0000019,
13997,,Autocuration,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,,,22224,U,0,,CHEMBL625732,,BAO_0000019,
13998,,Autocuration,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,,,22224,U,0,,CHEMBL625733,,BAO_0000019,
13999,,Autocuration,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,,,22224,U,0,,CHEMBL625734,,BAO_0000019,
14000,,Autocuration,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,1,,,22224,U,0,,CHEMBL625913,,BAO_0000019,
14001,,Autocuration,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,1,,,22224,U,0,,CHEMBL625914,,BAO_0000019,
14002,,Autocuration,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,1,,,22224,U,0,,CHEMBL625915,,BAO_0000019,
14003,,Autocuration,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,1,,,22224,U,0,,CHEMBL625916,,BAO_0000019,
14004,,Autocuration,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),1,,,22224,U,0,,CHEMBL625917,,BAO_0000019,
14005,,Autocuration,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625918,,BAO_0000019,
14006,,Autocuration,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625919,,BAO_0000019,
14007,,Autocuration,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625920,,BAO_0000019,
14008,,Autocuration,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL874453,,BAO_0000019,
14009,,Autocuration,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625921,,BAO_0000019,
14010,,Autocuration,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,1,,,22224,U,0,,CHEMBL625922,,BAO_0000019,
14011,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625923,,BAO_0000019,
14012,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625924,,BAO_0000019,
14013,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625925,,BAO_0000019,
14014,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL625926,,BAO_0000019,
14015,Lung,Intermediate,Biodistribution in rat lung at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL627704,,BAO_0000218,2048.0
14016,,Intermediate,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL627705,,BAO_0000218,
14017,,Intermediate,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL627706,,BAO_0000218,
14018,,Intermediate,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL627707,,BAO_0000218,
14019,,Intermediate,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL627708,,BAO_0000218,
14020,,Intermediate,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628361,,BAO_0000218,
14021,,Intermediate,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628362,,BAO_0000218,
14022,Striatum,Intermediate,Biodistribution in rat striatum at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628363,,BAO_0000218,2435.0
14023,Striatum,Intermediate,Biodistribution in rat striatum at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628364,,BAO_0000218,2435.0
14024,Striatum,Intermediate,Biodistribution in rat striatum at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628365,,BAO_0000218,2435.0
14025,Striatum,Intermediate,Biodistribution in rat striatum at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL874454,,BAO_0000218,2435.0
14026,Striatum,Intermediate,Biodistribution in rat striatum at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628531,,BAO_0000218,2435.0
14027,Striatum,Intermediate,Biodistribution in rat striatum at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628532,,BAO_0000218,2435.0
14028,Striatum,Intermediate,Biodistribution in rat striatum at 3 hr after dose administration.,1,,,50597,N,1,,CHEMBL628533,,BAO_0000218,2435.0
14029,Striatum,Intermediate,Biodistribution in rat striatum at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628534,,BAO_0000218,2435.0
14030,Thyroid gland,Intermediate,Biodistribution in rat thyroid at 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628535,,BAO_0000218,2046.0
14031,Thyroid gland,Intermediate,Biodistribution in rat thyroid at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628536,,BAO_0000218,2046.0
14032,Thyroid gland,Intermediate,Biodistribution in rat thyroid at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628537,,BAO_0000218,2046.0
14033,Thyroid gland,Intermediate,Biodistribution in rat thyroid at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628538,,BAO_0000218,2046.0
14034,Thyroid gland,Intermediate,Biodistribution in rat thyroid at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628539,,BAO_0000218,2046.0
14035,Thyroid gland,Intermediate,Biodistribution in rat thyroid at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630297,,BAO_0000218,2046.0
14036,Thyroid gland,Intermediate,Biodistribution in rat thyroid at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630298,,BAO_0000218,2046.0
14037,Brain,Intermediate,Biodistribution in rest of brain of rat 120 minutes after dose administration.,1,,,50597,N,1,,CHEMBL630299,,BAO_0000218,955.0
14038,Brain,Intermediate,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628094,,BAO_0000218,955.0
14039,Brain,Intermediate,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628095,,BAO_0000218,955.0
14040,Brain,Intermediate,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,1,,,50597,N,1,,CHEMBL874648,,BAO_0000218,955.0
14041,Brain,Intermediate,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628096,,BAO_0000218,955.0
14042,Brain,Intermediate,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628097,,BAO_0000218,955.0
14043,Brain,Intermediate,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,1,,,50597,N,1,,CHEMBL628098,,BAO_0000218,955.0
14044,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",1,,,22224,U,0,,CHEMBL628099,,BAO_0000019,
14045,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",1,,,22224,U,0,,CHEMBL628100,,BAO_0000019,
14046,,Autocuration,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),1,,,22224,U,0,,CHEMBL628101,,BAO_0000019,
14047,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",1,,,22224,U,0,,CHEMBL628102,,BAO_0000019,
14048,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",1,,,22224,U,0,,CHEMBL628103,,BAO_0000019,
14049,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",1,,,22224,U,0,,CHEMBL628104,,BAO_0000019,
14050,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",1,,,22224,U,0,,CHEMBL628105,,BAO_0000019,
14051,,Autocuration,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",1,,,22224,U,0,,CHEMBL628106,,BAO_0000019,
14052,Urine,Intermediate,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,1,,,50597,N,1,,CHEMBL628107,,BAO_0000218,1088.0
14053,Urine,Autocuration,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,1,,,22224,U,0,,CHEMBL628108,,BAO_0000218,1088.0
14054,Urine,Intermediate,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,1,,,50597,N,1,,CHEMBL628109,,BAO_0000218,1088.0
14055,Urine,Autocuration,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,1,,,22224,U,0,,CHEMBL625299,,BAO_0000218,1088.0
14056,Urine,Intermediate,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,1,,,50597,N,1,,CHEMBL625300,,BAO_0000218,1088.0
14057,Urine,Intermediate,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,1,,,50597,N,1,,CHEMBL625301,,BAO_0000218,1088.0
14058,Urine,Intermediate,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,1,,,50597,N,1,,CHEMBL625302,,BAO_0000218,1088.0
14059,Urine,Intermediate,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,1,,,50597,N,1,,CHEMBL874649,,BAO_0000218,1088.0
14060,,Intermediate,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,1,,,50597,N,1,,CHEMBL625303,,BAO_0000218,
14061,,Intermediate,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,1,,,50597,N,1,,CHEMBL625463,,BAO_0000218,
14062,Liver,Intermediate,In vitro metabolism in human liver microsomes,1,,,50587,N,1,,CHEMBL625464,,BAO_0000218,2107.0
14063,,Intermediate,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,1,,,50587,N,1,,CHEMBL625465,,BAO_0000218,
14064,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625466,,BAO_0000218,1088.0
14065,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625467,,BAO_0000218,1088.0
14066,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625468,,BAO_0000218,1088.0
14067,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625469,,BAO_0000218,1088.0
14068,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625470,,BAO_0000218,1088.0
14069,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,,50597,N,1,,CHEMBL632418,,BAO_0000218,1088.0
14070,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627250,,BAO_0000218,1088.0
14071,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627251,,BAO_0000218,1088.0
14072,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627252,,BAO_0000218,1088.0
14073,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627253,,BAO_0000218,1088.0
14074,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627254,,BAO_0000218,1088.0
14075,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL875471,,BAO_0000218,1088.0
14076,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627255,,BAO_0000218,1088.0
14077,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627256,,BAO_0000218,1088.0
14078,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627257,,BAO_0000218,1088.0
14079,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627258,,BAO_0000218,1088.0
14080,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627259,,BAO_0000218,1088.0
14081,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627260,,BAO_0000218,1088.0
14082,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623256,,BAO_0000218,1088.0
14083,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL874413,,BAO_0000218,1088.0
14084,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623257,,BAO_0000218,1088.0
14085,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623258,,BAO_0000218,1088.0
14086,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623259,,BAO_0000218,1088.0
14087,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623260,,BAO_0000218,1088.0
14088,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623261,,BAO_0000218,1088.0
14089,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623262,,BAO_0000218,1088.0
14090,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623263,,BAO_0000218,1088.0
14091,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623264,,BAO_0000218,1088.0
14092,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623265,,BAO_0000218,1088.0
14093,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623266,,BAO_0000218,1088.0
14094,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623267,,BAO_0000218,1088.0
14095,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623268,,BAO_0000218,1088.0
14096,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623269,,BAO_0000218,1088.0
14097,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623270,,BAO_0000218,1088.0
14098,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623271,,BAO_0000218,1088.0
14099,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623272,,BAO_0000218,1088.0
14100,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623273,,BAO_0000218,1088.0
14101,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623274,,BAO_0000218,1088.0
14102,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL874414,,BAO_0000218,1088.0
14103,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623275,,BAO_0000218,1088.0
14104,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,,50597,N,1,,CHEMBL629150,,BAO_0000218,1088.0
14105,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623276,,BAO_0000218,1088.0
14106,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623277,,BAO_0000218,1088.0
14107,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623112,,BAO_0000218,1088.0
14108,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623113,,BAO_0000218,1088.0
14109,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623800,,BAO_0000218,1088.0
14110,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623801,,BAO_0000218,1088.0
14111,Spleen,Intermediate,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,,50597,N,1,,CHEMBL623802,,BAO_0000218,2106.0
14112,Uterus,Intermediate,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623803,,BAO_0000218,995.0
14113,Uterus,Intermediate,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623970,,BAO_0000218,995.0
14114,Uterus,Intermediate,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL623971,,BAO_0000218,995.0
14115,Blood,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623972,,BAO_0000218,178.0
14116,Blood,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623973,,BAO_0000218,178.0
14117,Blood,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623974,,BAO_0000218,178.0
14118,Blood,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623975,,BAO_0000218,178.0
14119,Brain,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623976,,BAO_0000218,955.0
14120,Brain,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623977,,BAO_0000218,955.0
14121,Brain,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623978,,BAO_0000218,955.0
14122,Brain,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623979,,BAO_0000218,955.0
14123,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623980,,BAO_0000218,
14124,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL623981,,BAO_0000218,
14125,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL626278,,BAO_0000218,
14126,,Intermediate,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),1,,,50597,N,1,,CHEMBL626279,,BAO_0000218,
14127,,Intermediate,Biodistribution in mice bladder plus excreted urine was determined,1,,,50594,N,1,,CHEMBL626280,,BAO_0000218,
14128,,Intermediate,"Percentage biodistribution in mouse blood, 10 minutes post injection",1,,,50594,N,1,,CHEMBL626281,,BAO_0000218,
14129,,Intermediate,"Percentage biodistribution in mouse blood, 30 minutes post injection",1,,,50594,N,1,,CHEMBL626282,,BAO_0000218,
14130,,Intermediate,"Percentage biodistribution in mouse blood, 5 minutes post injection",1,,,50594,N,1,,CHEMBL626283,,BAO_0000218,
14131,,Intermediate,"Percentage biodistribution in mouse blood, 60 minutes post injection",1,,,50594,N,1,,CHEMBL626284,,BAO_0000218,
14132,Brain,Intermediate,"Percentage biodistribution in mouse brain, 10 minutes post injection",1,,,50594,N,1,,CHEMBL626285,,BAO_0000218,955.0
14133,Brain,Intermediate,"Percentage biodistribution in mouse brain, 30 minutes post injection",1,,,50594,N,1,,CHEMBL626286,,BAO_0000218,955.0
14134,Brain,Intermediate,"Percentage biodistribution in mouse brain, 5 minutes post injection",1,,,50594,N,1,,CHEMBL626287,,BAO_0000218,955.0
14135,Brain,Intermediate,"Percentage biodistribution in mouse brain, 60 minutes post injection",1,,,50594,N,1,,CHEMBL626288,,BAO_0000218,955.0
14136,,Intermediate,"Percentage biodistribution in mouse heart, 10 minutes post injection",1,,,50594,N,1,,CHEMBL626289,,BAO_0000218,
14137,,Intermediate,"Percentage biodistribution in mouse heart, 30 minutes post injection",1,,,50594,N,1,,CHEMBL626290,,BAO_0000218,
14138,,Intermediate,"Percentage biodistribution in mouse heart, 5 minutes post injection",1,,,50594,N,1,,CHEMBL626291,,BAO_0000218,
14139,,Intermediate,"Percentage biodistribution in mouse heart, 60 minutes post injection",1,,,50594,N,1,,CHEMBL839888,,BAO_0000218,
14140,Intestine,Intermediate,"Percentage biodistribution in mouse intestine, 10 minutes post injection",1,,,50594,N,1,,CHEMBL626292,,BAO_0000218,160.0
14141,Intestine,Intermediate,"Percentage biodistribution in mouse intestine, 30 minutes post injection",1,,,50594,N,1,,CHEMBL626293,,BAO_0000218,160.0
14142,Intestine,Intermediate,"Percentage biodistribution in mouse intestine, 5 minutes post injection",1,,,50594,N,1,,CHEMBL626294,,BAO_0000218,160.0
14143,Intestine,Intermediate,"Percentage biodistribution in mouse intestine, 60 minutes post injection",1,,,50594,N,1,,CHEMBL626295,,BAO_0000218,160.0
14144,Liver,Intermediate,"Percentage biodistribution in mouse liver, 10 minutes post injection",1,,,50594,N,1,,CHEMBL627659,,BAO_0000218,2107.0
14145,Liver,Intermediate,"Percentage biodistribution in mouse liver, 30 minutes of post injection",1,,,50594,N,1,,CHEMBL627660,,BAO_0000218,2107.0
14146,Liver,Intermediate,"Percentage biodistribution in mouse liver, 5 minutes post injection",1,,,50594,N,1,,CHEMBL627661,,BAO_0000218,2107.0
14147,Liver,Intermediate,Biodistribution in mice liver at 60 minutes of post injection,1,,,50594,N,1,,CHEMBL627662,,BAO_0000218,2107.0
14148,Lung,Intermediate,Biodistribution in mice lungs at 10 min of post injection,1,,,50594,N,1,,CHEMBL627663,,BAO_0000218,2048.0
14149,,Intermediate,"Percentage biodistribution in mouse lung, 30 minutes post injection",1,,,50594,N,1,,CHEMBL627664,,BAO_0000218,
14150,,Intermediate,"Percentage biodistribution in mousee lung, 5 minutes post injection",1,,,50594,N,1,,CHEMBL627665,,BAO_0000218,
14151,Lung,Intermediate,Biodistribution in mice lungs at 60 min of post injection,1,,,50594,N,1,,CHEMBL627666,,BAO_0000218,2048.0
14152,Spleen,Intermediate,Percentage biodistribution in mouse spleen,1,,,50594,N,1,,CHEMBL627667,,BAO_0000218,2106.0
14153,Stomach,Intermediate,Percentage biodistribution in mouse stomach,1,,,50594,N,1,,CHEMBL627668,,BAO_0000218,945.0
14154,Urine,Intermediate,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,1,,,50594,N,1,,CHEMBL627669,,BAO_0000218,1088.0
14155,Urinary bladder,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,1,,,22224,U,0,,CHEMBL627670,,BAO_0000218,1255.0
14156,Blood,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,1,,,22224,U,0,,CHEMBL627671,,BAO_0000218,178.0
14157,Bone element,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,1,,,22224,U,0,,CHEMBL627672,,BAO_0000218,1474.0
14158,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,1,,,22224,U,0,,CHEMBL627673,,BAO_0000218,
14159,Kidney,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,1,,,22224,U,0,,CHEMBL627674,,BAO_0000218,2113.0
14160,Liver,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,1,,,22224,U,0,,CHEMBL627675,,BAO_0000218,2107.0
14161,Lung,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,1,,,22224,U,0,,CHEMBL627676,,BAO_0000218,2048.0
14162,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,1,,,22224,U,0,,CHEMBL627677,,BAO_0000218,2385.0
14163,,Autocuration,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL627678,,BAO_0000019,
14164,Serum,Intermediate,Affinity for protein binding expressed as association constant in fresh rat serum,1,,,50597,N,1,,CHEMBL627679,,BAO_0000218,1977.0
14165,,Autocuration,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,1,,,22224,U,0,,CHEMBL627680,,BAO_0000019,
14166,,Autocuration,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,1,,,22224,U,0,,CHEMBL627681,,BAO_0000019,
14167,,Autocuration,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,1,,,22224,U,0,,CHEMBL627682,,BAO_0000019,
14168,,Autocuration,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,1,,,22224,U,0,,CHEMBL627683,,BAO_0000019,
14169,,Autocuration,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,1,,,22224,U,0,,CHEMBL627684,,BAO_0000019,
14170,,Autocuration,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",1,,,22224,U,0,,CHEMBL874441,,BAO_0000019,
14171,,Autocuration,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,1,,,22224,U,0,,CHEMBL627685,,BAO_0000019,
14172,,Autocuration,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",1,,,22224,U,0,,CHEMBL627686,,BAO_0000019,
14173,,Autocuration,Apparent rate constant Koff for inactivation of dTMP synthase.,1,,,22224,U,0,,CHEMBL627687,,BAO_0000019,
14174,,Autocuration,The irreversible inhibitor activity by second order rate equation.,1,,,22224,U,0,,CHEMBL627688,,BAO_0000019,
14175,,Intermediate,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,1,,,50597,N,1,,CHEMBL628038,,BAO_0000218,
14176,,Intermediate,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,1,,,50597,N,1,,CHEMBL628039,,BAO_0000218,
14177,,Intermediate,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,1,,,50597,N,1,,CHEMBL628040,,BAO_0000218,
14178,,Autocuration,Dissociation rate calculated from the first-order equation using t1/2 value,1,,,22224,U,0,,CHEMBL628041,,BAO_0000019,
14179,,Autocuration,The compound was tested for Binding constant against DNA,1,,,22224,U,0,,CHEMBL630226,,BAO_0000019,
14180,,Autocuration,First order rate constant for cyclization of the compound,1,,,22224,U,0,,CHEMBL628042,,BAO_0000019,
14181,,Autocuration,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,1,,,22224,U,0,,CHEMBL625232,,BAO_0000019,
14182,,Autocuration,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,1,,,22224,U,0,,CHEMBL625233,,BAO_0000019,
14183,,Autocuration,Hydrolysis rate constant was determined,1,,,22224,U,0,,CHEMBL625979,,BAO_0000019,
14184,,Autocuration,Observed first order rate constant,1,,,22224,U,0,,CHEMBL625980,,BAO_0000019,
14185,,Autocuration,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,,,22224,U,0,,CHEMBL625981,,BAO_0000019,
14186,,Autocuration,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,,,22224,U,0,,CHEMBL625982,,BAO_0000019,
14187,,Autocuration,Second-order rate constant for attack on PNPA at 25 degree Centigrade,1,,,22224,U,0,,CHEMBL625983,,BAO_0000019,
14188,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625984,,BAO_0000019,
14189,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625985,,BAO_0000019,
14190,,Autocuration,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625986,,BAO_0000019,
14191,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625987,,BAO_0000019,
14192,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625988,,BAO_0000019,
14193,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625989,,BAO_0000019,
14194,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625990,,BAO_0000019,
14195,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625991,,BAO_0000019,
14196,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625992,,BAO_0000019,
14197,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL625993,,BAO_0000019,
14198,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL631973,,BAO_0000019,
14199,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632143,,BAO_0000019,
14200,,Autocuration,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632144,,BAO_0000019,
14201,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632145,,BAO_0000019,
14202,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632146,,BAO_0000019,
14203,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632147,,BAO_0000019,
14204,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632148,,BAO_0000019,
14205,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632149,,BAO_0000019,
14206,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632150,,BAO_0000019,
14207,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL632151,,BAO_0000019,
14208,,Intermediate,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,1,,,50587,N,1,,CHEMBL632152,,BAO_0000218,
14209,,Intermediate,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,,,50587,N,1,,CHEMBL632153,,BAO_0000218,
14210,,Intermediate,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,,,50587,N,1,,CHEMBL632154,,BAO_0000218,
14211,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL632155,,BAO_0000218,
14212,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,1,,,50602,N,1,,CHEMBL632156,,BAO_0000218,
14213,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL632157,,BAO_0000218,
14214,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL632158,,BAO_0000218,
14215,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,1,,,50602,N,1,,CHEMBL632159,,BAO_0000218,
14216,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL626305,,BAO_0000218,
14217,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,1,,,50602,N,1,,CHEMBL626306,,BAO_0000218,
14218,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL626307,,BAO_0000218,
14219,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL626308,,BAO_0000218,
14220,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL626479,,BAO_0000218,
14221,,Intermediate,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,1,,,50602,N,1,,CHEMBL626480,,BAO_0000218,
14222,,Autocuration,Calculated partition coefficient (clogP) (MlogP),1,,,22229,U,0,,CHEMBL626481,,BAO_0000100,
14223,,Autocuration,Equipotent potent ratio relative to carbachol (nicotinic activity),1,,,22224,U,0,,CHEMBL626482,,BAO_0000019,
14224,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",1,,,50588,N,1,,CHEMBL626483,,BAO_0000218,
14225,,Intermediate,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",1,,,50588,N,1,,CHEMBL626484,,BAO_0000218,
14226,,Autocuration,Solubility at pH 7.4 in micro g/mL;NA denotes available,1,,,22229,U,0,,CHEMBL626485,,BAO_0000100,
14227,,Autocuration,Solubility at pH 7.4 in micro g/mL;NA denotes not available,1,,,22229,U,0,,CHEMBL626486,,BAO_0000100,
14228,,Autocuration,Solubility at pH 7.4 in ug/mL;NA denotes not available,1,,,22229,U,0,,CHEMBL626487,,BAO_0000100,
14229,Plasma,Intermediate,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,,50588,N,1,,CHEMBL626488,,BAO_0000218,1969.0
14230,Serum,Intermediate,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,1,,,50597,N,1,,CHEMBL626489,,BAO_0000218,1977.0
14231,,Autocuration,Area under the MAP curve measured over 5 min; ND means Not determined,1,,,22224,U,0,,CHEMBL626490,,BAO_0000019,
14232,,Autocuration,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,1,,,22224,U,0,,CHEMBL626491,,BAO_0000100,
14233,,Autocuration,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,1,,,22229,U,0,,CHEMBL626492,,BAO_0000100,
14234,,Autocuration,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,1,,,22224,U,0,,CHEMBL626493,,BAO_0000019,
14235,,Intermediate,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,1,,,50597,N,1,,CHEMBL626494,,BAO_0000218,
14236,,Autocuration,Half life after oral tested,1,,,22224,U,0,,CHEMBL626495,,BAO_0000218,
14237,Plasma,Intermediate,Half life was determined in plasma of rat; NT indicates not tested,1,,,50597,N,1,,CHEMBL626496,,BAO_0000218,1969.0
14238,,Intermediate,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,1,,,50597,N,1,,CHEMBL626497,,BAO_0000218,
14239,,Autocuration,Oral bioavailability after oral tested,1,,,22224,U,0,,CHEMBL626498,,BAO_0000218,
14240,,Intermediate,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),1,,,50597,N,1,,CHEMBL626499,,BAO_0000218,
14241,,Intermediate,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),1,,,50597,N,1,,CHEMBL626500,,BAO_0000218,
14242,Plasma,Intermediate,half life was determined in plasma of rat; NT indicates not tested,1,,,50597,N,1,,CHEMBL626501,,BAO_0000218,1969.0
14243,Plasma,Intermediate,half life was determined in plasma of rat; NT means not tested,1,,,50597,N,1,,CHEMBL626502,,BAO_0000218,1969.0
14244,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,1,,,50597,N,1,,CHEMBL626503,,BAO_0000218,
14245,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); inactive,1,,,50597,N,1,,CHEMBL626504,,BAO_0000218,
14246,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,1,,,50597,N,1,,CHEMBL626505,,BAO_0000218,
14247,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,1,,,50597,N,1,,CHEMBL626506,,BAO_0000218,
14248,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,1,,,50597,N,1,,CHEMBL626507,,BAO_0000218,
14249,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,1,,,50597,N,1,,CHEMBL626508,,BAO_0000218,
14250,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,1,,,50597,N,1,,CHEMBL626509,,BAO_0000218,
14251,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,1,,,50597,N,1,,CHEMBL875480,,BAO_0000218,
14252,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,1,,,50597,N,1,,CHEMBL626510,,BAO_0000218,
14253,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,1,,,50597,N,1,,CHEMBL626511,,BAO_0000218,
14254,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,1,,,50597,N,1,,CHEMBL626512,,BAO_0000218,
14255,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,1,,,50597,N,1,,CHEMBL628208,,BAO_0000218,
14256,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,1,,,50597,N,1,,CHEMBL628209,,BAO_0000218,
14257,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,1,,,50597,N,1,,CHEMBL628210,,BAO_0000218,
14258,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,1,,,50597,N,1,,CHEMBL628211,,BAO_0000218,
14259,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,1,,,50597,N,1,,CHEMBL628212,,BAO_0000218,
14260,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,1,,,50597,N,1,,CHEMBL628213,,BAO_0000218,
14261,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628214,,BAO_0000218,1088.0
14262,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628215,,BAO_0000218,1088.0
14263,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628216,,BAO_0000218,1088.0
14264,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626595,,BAO_0000218,1088.0
14265,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626596,,BAO_0000218,1088.0
14266,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626597,,BAO_0000218,1088.0
14267,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626598,,BAO_0000218,1088.0
14268,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622242,,BAO_0000218,1088.0
14269,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622243,,BAO_0000218,1088.0
14270,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622244,,BAO_0000218,1088.0
14271,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622245,,BAO_0000218,1088.0
14272,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622246,,BAO_0000218,1088.0
14273,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622247,,BAO_0000218,1088.0
14274,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622248,,BAO_0000218,1088.0
14275,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL877483,,BAO_0000218,1088.0
14276,Urine,Intermediate,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL622249,,BAO_0000218,1088.0
14277,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622250,,BAO_0000218,1088.0
14278,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622251,,BAO_0000218,1088.0
14279,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622252,,BAO_0000218,1088.0
14280,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622253,,BAO_0000218,1088.0
14281,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622254,,BAO_0000218,1088.0
14282,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622255,,BAO_0000218,1088.0
14283,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622256,,BAO_0000218,1088.0
14284,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622257,,BAO_0000218,1088.0
14285,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622258,,BAO_0000218,1088.0
14286,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622259,,BAO_0000218,1088.0
14287,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622927,,BAO_0000218,1088.0
14288,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622928,,BAO_0000218,1088.0
14289,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,,50588,N,1,,CHEMBL622929,,BAO_0000218,1088.0
14290,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,,,50588,N,1,,CHEMBL623182,,BAO_0000218,1088.0
14291,Urine,Intermediate,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,,50588,N,1,,CHEMBL623183,,BAO_0000218,1088.0
14292,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623184,,BAO_0000218,1088.0
14293,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623185,,BAO_0000218,1088.0
14294,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,,50597,N,1,,CHEMBL877484,,BAO_0000218,1088.0
14295,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL627274,,BAO_0000218,1088.0
14296,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623186,,BAO_0000218,1088.0
14297,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623187,,BAO_0000218,1088.0
14298,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,,50597,N,1,,CHEMBL623188,,BAO_0000218,1088.0
14299,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628055,,BAO_0000218,1088.0
14300,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628056,,BAO_0000218,1088.0
14301,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628200,,BAO_0000218,1088.0
14302,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628201,,BAO_0000218,1088.0
14303,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628202,,BAO_0000218,1088.0
14304,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628203,,BAO_0000218,1088.0
14305,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628204,,BAO_0000218,1088.0
14306,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628205,,BAO_0000218,1088.0
14307,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628206,,BAO_0000218,1088.0
14308,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),1,,,22224,U,0,,CHEMBL628207,,BAO_0000218,2367.0
14309,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,1,,,22224,U,0,,CHEMBL627220,,BAO_0000218,2367.0
14310,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,1,,,22224,U,0,,CHEMBL627221,,BAO_0000218,2385.0
14311,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),1,,,22224,U,0,,CHEMBL627222,,BAO_0000218,2367.0
14312,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,1,,,22224,U,0,,CHEMBL627223,,BAO_0000218,
14313,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,1,,,22224,U,0,,CHEMBL632062,,BAO_0000218,2385.0
14314,Spleen,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,1,,,22224,U,0,,CHEMBL632063,,BAO_0000218,2106.0
14315,Urinary bladder,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,1,,,22224,U,0,,CHEMBL632064,,BAO_0000218,1255.0
14316,Blood,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,1,,,22224,U,0,,CHEMBL632065,,BAO_0000218,178.0
14317,Bone element,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,1,,,22224,U,0,,CHEMBL632066,,BAO_0000218,1474.0
14318,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,1,,,22224,U,0,,CHEMBL632067,,BAO_0000218,
14319,Kidney,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,1,,,22224,U,0,,CHEMBL629188,,BAO_0000218,2113.0
14320,Liver,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,1,,,22224,U,0,,CHEMBL629189,,BAO_0000218,2107.0
14321,Lung,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,1,,,22224,U,0,,CHEMBL629190,,BAO_0000218,2048.0
14322,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,1,,,22224,U,0,,CHEMBL629191,,BAO_0000218,2385.0
14323,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),1,,,22224,U,0,,CHEMBL629192,,BAO_0000218,2367.0
14324,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,1,,,22224,U,0,,CHEMBL629193,,BAO_0000218,2385.0
14325,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),1,,,22224,U,0,,CHEMBL629194,,BAO_0000218,2367.0
14326,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,1,,,22224,U,0,,CHEMBL629195,,BAO_0000218,
14327,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,1,,,22224,U,0,,CHEMBL629373,,BAO_0000218,2385.0
14328,Spleen,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,1,,,22224,U,0,,CHEMBL629374,,BAO_0000218,2106.0
14329,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,1,,,22224,U,0,,CHEMBL629375,,BAO_0000218,2367.0
14330,Urinary bladder,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,1,,,22224,U,0,,CHEMBL629376,,BAO_0000218,1255.0
14331,Blood,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,1,,,22224,U,0,,CHEMBL629377,,BAO_0000218,178.0
14332,Bone element,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,1,,,22224,U,0,,CHEMBL629378,,BAO_0000218,1474.0
14333,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,1,,,22224,U,0,,CHEMBL629379,,BAO_0000218,
14334,Kidney,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,1,,,22224,U,0,,CHEMBL629151,,BAO_0000218,2113.0
14335,Liver,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,1,,,22224,U,0,,CHEMBL629152,,BAO_0000218,2107.0
14336,Lung,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,1,,,22224,U,0,,CHEMBL629153,,BAO_0000218,2048.0
14337,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,1,,,22224,U,0,,CHEMBL629154,,BAO_0000218,2385.0
14338,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),1,,,22224,U,0,,CHEMBL629155,,BAO_0000218,2367.0
14339,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,1,,,22224,U,0,,CHEMBL629156,,BAO_0000218,2367.0
14340,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,1,,,22224,U,0,,CHEMBL629157,,BAO_0000218,2385.0
14341,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),1,,,22224,U,0,,CHEMBL629158,,BAO_0000218,2367.0
14342,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,1,,,22224,U,0,,CHEMBL629159,,BAO_0000218,
14343,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,1,,,22224,U,0,,CHEMBL629160,,BAO_0000218,2385.0
14344,Spleen,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,1,,,22224,U,0,,CHEMBL629161,,BAO_0000218,2106.0
14345,Urinary bladder,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,1,,,22224,U,0,,CHEMBL629162,,BAO_0000218,1255.0
14346,Blood,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,1,,,22224,U,0,,CHEMBL629163,,BAO_0000218,178.0
14347,Bone element,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,1,,,22224,U,0,,CHEMBL629164,,BAO_0000218,1474.0
14348,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,1,,,22224,U,0,,CHEMBL629165,,BAO_0000218,
14349,Liver,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,1,,,22224,U,0,,CHEMBL629166,,BAO_0000218,2107.0
14350,Lung,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,1,,,22224,U,0,,CHEMBL629167,,BAO_0000218,2048.0
14351,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,1,,,22224,U,0,,CHEMBL629168,,BAO_0000218,2385.0
14352,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,1,,,22224,U,0,,CHEMBL629169,,BAO_0000019,
14353,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,1,,,22224,U,0,,CHEMBL629170,,BAO_0000019,
14354,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,1,,,22224,U,0,,CHEMBL631153,,BAO_0000019,
14355,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,1,,,22224,U,0,,CHEMBL875121,,BAO_0000019,
14356,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,1,,,22224,U,0,,CHEMBL631154,,BAO_0000019,
14357,,Autocuration,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,1,,,22224,U,0,,CHEMBL631155,,BAO_0000019,
14358,,Autocuration,Hydrolysis rate constant was determined,1,,,22224,U,0,,CHEMBL631156,,BAO_0000019,
14359,,Autocuration,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",1,,,22224,U,0,,CHEMBL631157,,BAO_0000019,
14360,,Autocuration,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",1,,,22224,U,0,,CHEMBL631158,,BAO_0000019,
14361,,Autocuration,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",1,,,22224,U,0,,CHEMBL631159,,BAO_0000019,
14362,,Autocuration,Observed second order rate constant,1,,,22224,U,0,,CHEMBL631160,,BAO_0000019,
14363,,Autocuration,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,,,22224,U,0,,CHEMBL631161,,BAO_0000019,
14364,,Autocuration,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,1,,,22224,U,0,,CHEMBL631162,,BAO_0000019,
14365,,Autocuration,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,1,,,22224,U,0,,CHEMBL630313,,BAO_0000019,
14366,,Autocuration,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",1,,,22224,U,0,,CHEMBL630314,,BAO_0000019,
14367,,Autocuration,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",1,,,22224,U,0,,CHEMBL630315,,BAO_0000019,
14368,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630316,,BAO_0000019,
14369,,Autocuration,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630986,,BAO_0000019,
14370,,Autocuration,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630987,,BAO_0000019,
14371,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630988,,BAO_0000019,
14372,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630989,,BAO_0000019,
14373,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630990,,BAO_0000019,
14374,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630991,,BAO_0000019,
14375,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630992,,BAO_0000019,
14376,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630993,,BAO_0000019,
14377,,Autocuration,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,22224,U,0,,CHEMBL630994,,BAO_0000019,
14378,,Intermediate,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,1,,,50597,N,1,,CHEMBL630995,,BAO_0000218,
14379,,Autocuration,Association constant for compound at 31 degree C was determined,1,,,22224,U,0,,CHEMBL629252,,BAO_0000019,
14380,,Autocuration,Calculated antagonist equilibrium dissociation constant of the compound,1,,,22224,U,0,,CHEMBL629253,,BAO_0000019,
14381,,Autocuration,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,1,,,22224,U,0,,CHEMBL629944,,BAO_0000019,
14382,Trachea,Intermediate,Dissociation constants vs LTE4 on guinea pig trachea,1,,,50512,N,1,,CHEMBL629945,,BAO_0000218,3126.0
14383,,Autocuration,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",1,,,22224,U,0,,CHEMBL629946,,BAO_0000019,
14384,,Autocuration,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",1,,,22224,U,0,,CHEMBL629947,,BAO_0000019,
14385,,Autocuration,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",1,,,22224,U,0,,CHEMBL629948,,BAO_0000019,
14386,,Autocuration,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",1,,,22224,U,0,,CHEMBL856024,,BAO_0000019,
14387,,Autocuration,Affinity constant KD value was derived from TMP,1,,,22224,U,0,,CHEMBL629949,,BAO_0000019,
14388,,Autocuration,Apparent dissociation (binding) rate constant was evaluated,1,,,22224,U,0,,CHEMBL629950,,BAO_0000019,
14389,,Autocuration,Dissociation constant (KD) of the compound,1,,,22224,U,0,,CHEMBL630127,,BAO_0000100,
14390,,Autocuration,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,1,,,22224,U,0,,CHEMBL630128,,BAO_0000100,
14391,,Autocuration,Dissociation constant from ESR titration experiments,1,,,22224,U,0,,CHEMBL630129,,BAO_0000100,
14392,,Autocuration,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),1,,,22224,U,0,,CHEMBL630130,,BAO_0000019,
14393,,Autocuration,Dissociation constant was evaluated.,1,,,22224,U,0,,CHEMBL875234,,BAO_0000100,
14394,,Autocuration,Dissociation constant was reported,1,,,22224,U,0,,CHEMBL630131,,BAO_0000100,
14395,,Intermediate,Dissociation constant was determined in rat pituitary cells.,1,,,50597,N,1,,CHEMBL630132,,BAO_0000218,
14396,,Autocuration,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,1,,,22224,U,0,,CHEMBL630133,,BAO_0000019,
14397,,Autocuration,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,1,,,22224,U,0,,CHEMBL630134,,BAO_0000019,
14398,,Autocuration,Equilibrium dissociation constant of the compound,1,,,22224,U,0,,CHEMBL630135,,BAO_0000019,
14399,,Autocuration,Equilibrium dissociation constant was determined,1,,,22224,U,0,,CHEMBL630136,,BAO_0000019,
14400,,Autocuration,Kinetic constant KD was evaluated,1,,,22224,U,0,,CHEMBL630137,,BAO_0000019,
14401,,Autocuration,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,1,,,22224,U,0,,CHEMBL630138,,BAO_0000019,
14402,,Autocuration,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,1,,,22224,U,0,,CHEMBL630139,,BAO_0000019,
14403,,Autocuration,Rate constant for hydrolysis in aqueous acetone.,1,,,22224,U,0,,CHEMBL630140,,BAO_0000019,
14404,,Autocuration,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,1,,,22224,U,0,,CHEMBL875235,,BAO_0000019,
14405,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,1,,,50597,N,1,,CHEMBL876439,,BAO_0000218,
14406,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,1,,,50597,N,1,,CHEMBL630605,,BAO_0000218,
14407,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,1,,,50597,N,1,,CHEMBL630606,,BAO_0000218,
14408,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,1,,,50597,N,1,,CHEMBL630607,,BAO_0000218,
14409,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,1,,,50597,N,1,,CHEMBL630608,,BAO_0000218,
14410,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,1,,,50597,N,1,,CHEMBL630609,,BAO_0000218,
14411,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,1,,,50597,N,1,,CHEMBL630610,,BAO_0000218,
14412,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,1,,,50597,N,1,,CHEMBL630611,,BAO_0000218,
14413,,Intermediate,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,1,,,50597,N,1,,CHEMBL629552,,BAO_0000218,
14414,,Intermediate,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,,50597,N,1,,CHEMBL629733,,BAO_0000218,
14415,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,,50597,N,1,,CHEMBL629734,,BAO_0000218,
14416,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,,50597,N,1,,CHEMBL629735,,BAO_0000218,
14417,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,,50597,N,1,,CHEMBL629736,,BAO_0000218,
14418,,Intermediate,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,,50597,N,1,,CHEMBL629737,,BAO_0000218,
14419,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,,50597,N,1,,CHEMBL629738,,BAO_0000218,
14420,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,,50597,N,1,,CHEMBL629739,,BAO_0000218,
14421,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,,50597,N,1,,CHEMBL629740,,BAO_0000218,
14422,,Intermediate,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,,50597,N,1,,CHEMBL629741,,BAO_0000218,
14423,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,,50597,N,1,,CHEMBL629742,,BAO_0000218,
14424,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,,50597,N,1,,CHEMBL629743,,BAO_0000218,
14425,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,,50597,N,1,,CHEMBL629744,,BAO_0000218,
14426,,Intermediate,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,,50597,N,1,,CHEMBL629745,,BAO_0000218,
14427,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,,50597,N,1,,CHEMBL629746,,BAO_0000218,
14428,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,,50597,N,1,,CHEMBL629747,,BAO_0000218,
14429,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,,50597,N,1,,CHEMBL629748,,BAO_0000218,
14430,,Intermediate,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,,50597,N,1,,CHEMBL629749,,BAO_0000218,
14431,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,,50597,N,1,,CHEMBL629750,,BAO_0000218,
14432,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,,50597,N,1,,CHEMBL629751,,BAO_0000218,
14433,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,,50597,N,1,,CHEMBL629752,,BAO_0000218,
14434,,Intermediate,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,,50597,N,1,,CHEMBL629753,,BAO_0000218,
14435,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,,50597,N,1,,CHEMBL629754,,BAO_0000218,
14436,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,,50597,N,1,,CHEMBL629755,,BAO_0000218,
14437,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,,50597,N,1,,CHEMBL629756,,BAO_0000218,
14438,,Intermediate,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,,50597,N,1,,CHEMBL629757,,BAO_0000218,
14439,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,,50597,N,1,,CHEMBL629758,,BAO_0000218,
14440,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,,50597,N,1,,CHEMBL629759,,BAO_0000218,
14441,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,,50597,N,1,,CHEMBL629760,,BAO_0000218,
14442,,Intermediate,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,,50597,N,1,,CHEMBL876443,,BAO_0000218,
14443,,Intermediate,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,1,,,50588,N,1,,CHEMBL629761,,BAO_0000218,
14444,,Intermediate,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,1,,,50588,N,1,,CHEMBL629762,,BAO_0000218,
14445,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,50594,N,1,,CHEMBL629763,,BAO_0000218,
14446,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,,50594,N,1,,CHEMBL629764,,BAO_0000218,
14447,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,,50594,N,1,,CHEMBL629765,,BAO_0000218,
14448,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,1,,,50594,N,1,,CHEMBL629766,,BAO_0000218,
14449,,Intermediate,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,50594,N,1,,CHEMBL629767,,BAO_0000218,
14450,,Intermediate,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,1,,,50588,N,1,,CHEMBL629768,,BAO_0000218,
14451,,Intermediate,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,1,,,50594,N,1,,CHEMBL629769,,BAO_0000218,
14452,,Intermediate,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,1,,,50588,N,1,,CHEMBL629770,,BAO_0000218,
14453,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,1,,,50588,N,1,,CHEMBL629771,,BAO_0000218,
14454,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,50594,N,1,,CHEMBL629772,,BAO_0000218,
14455,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,50594,N,1,,CHEMBL629773,,BAO_0000218,
14456,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,,50594,N,1,,CHEMBL625455,,BAO_0000218,
14457,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,1,,,50594,N,1,,CHEMBL625456,,BAO_0000218,
14458,,Intermediate,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,1,,,50594,N,1,,CHEMBL625457,,BAO_0000218,
14459,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625458,,BAO_0000218,1088.0
14460,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625459,,BAO_0000218,1088.0
14461,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL875483,,BAO_0000218,1088.0
14462,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,1,,,50597,N,1,,CHEMBL634779,,BAO_0000218,1088.0
14463,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625460,,BAO_0000218,1088.0
14464,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626117,,BAO_0000218,1088.0
14465,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626118,,BAO_0000218,1088.0
14466,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628342,,BAO_0000218,1088.0
14467,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628343,,BAO_0000218,1088.0
14468,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628344,,BAO_0000218,1088.0
14469,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628345,,BAO_0000218,1088.0
14470,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628346,,BAO_0000218,1088.0
14471,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628347,,BAO_0000218,1088.0
14472,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628348,,BAO_0000218,1088.0
14473,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628349,,BAO_0000218,1088.0
14474,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL875611,,BAO_0000218,1088.0
14475,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628350,,BAO_0000218,1088.0
14476,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628351,,BAO_0000218,1088.0
14477,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628352,,BAO_0000218,1088.0
14478,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628353,,BAO_0000218,1088.0
14479,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628354,,BAO_0000218,1088.0
14480,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626667,,BAO_0000218,1088.0
14481,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626668,,BAO_0000218,1088.0
14482,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626669,,BAO_0000218,1088.0
14483,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626670,,BAO_0000218,1088.0
14484,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626671,,BAO_0000218,1088.0
14485,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626672,,BAO_0000218,1088.0
14486,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626673,,BAO_0000218,1088.0
14487,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626674,,BAO_0000218,1088.0
14488,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626675,,BAO_0000218,1088.0
14489,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626676,,BAO_0000218,1088.0
14490,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626677,,BAO_0000218,1088.0
14491,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626678,,BAO_0000218,1088.0
14492,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626679,,BAO_0000218,1088.0
14493,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL875612,,BAO_0000218,1088.0
14494,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626680,,BAO_0000218,1088.0
14495,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626681,,BAO_0000218,1088.0
14496,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626682,,BAO_0000218,1088.0
14497,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626683,,BAO_0000218,1088.0
14498,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626684,,BAO_0000218,1088.0
14499,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626685,,BAO_0000218,1088.0
14500,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626686,,BAO_0000218,1088.0
14501,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626687,,BAO_0000218,1088.0
14502,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,,50597,N,1,,CHEMBL624978,,BAO_0000218,1088.0
14503,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL624979,,BAO_0000218,1088.0
14504,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL624980,,BAO_0000218,1088.0
14505,Urine,Intermediate,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL624981,,BAO_0000218,1088.0
14506,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,,50588,N,1,,CHEMBL624982,,BAO_0000218,1088.0
14507,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),1,,,22224,U,0,,CHEMBL627564,,BAO_0000218,2367.0
14508,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),1,,,22224,U,0,,CHEMBL627565,,BAO_0000218,2367.0
14509,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,1,,,22224,U,0,,CHEMBL627566,,BAO_0000218,
14510,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,1,,,22224,U,0,,CHEMBL627567,,BAO_0000218,2385.0
14511,Spleen,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,1,,,22224,U,0,,CHEMBL627568,,BAO_0000218,2106.0
14512,Kidney,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,1,,,22224,U,0,,CHEMBL627569,,BAO_0000218,2113.0
14513,Urinary bladder,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,1,,,22224,U,0,,CHEMBL627570,,BAO_0000218,1255.0
14514,Blood,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,1,,,22224,U,0,,CHEMBL627571,,BAO_0000218,178.0
14515,Bone element,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,1,,,22224,U,0,,CHEMBL627572,,BAO_0000218,1474.0
14516,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,1,,,22224,U,0,,CHEMBL627573,,BAO_0000218,
14517,Kidney,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,1,,,22224,U,0,,CHEMBL627574,,BAO_0000218,2113.0
14518,Liver,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,1,,,22224,U,0,,CHEMBL627575,,BAO_0000218,2107.0
14519,Lung,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,1,,,22224,U,0,,CHEMBL627576,,BAO_0000218,2048.0
14520,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,1,,,22224,U,0,,CHEMBL627577,,BAO_0000218,2385.0
14521,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),1,,,22224,U,0,,CHEMBL627578,,BAO_0000218,2367.0
14522,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,1,,,22224,U,0,,CHEMBL627579,,BAO_0000218,2367.0
14523,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,1,,,22224,U,0,,CHEMBL627580,,BAO_0000218,2385.0
14524,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),1,,,22224,U,0,,CHEMBL627581,,BAO_0000218,2367.0
14525,,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,1,,,22224,U,0,,CHEMBL627582,,BAO_0000218,
14526,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,1,,,22224,U,0,,CHEMBL627583,,BAO_0000218,2385.0
14527,Spleen,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,1,,,22224,U,0,,CHEMBL627584,,BAO_0000218,2106.0
14528,Prostate gland,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,1,,,22224,U,0,,CHEMBL627585,,BAO_0000218,2367.0
14529,Muscle tissue,Autocuration,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,1,,,22224,U,0,,CHEMBL627586,,BAO_0000218,2385.0
14530,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL627587,,BAO_0000218,
14531,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL627588,,BAO_0000218,
14532,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628250,,BAO_0000218,
14533,,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628251,,BAO_0000218,
14534,Hippocampus,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628252,,BAO_0000218,10000000.0
14535,Hippocampus,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628253,,BAO_0000218,10000000.0
14536,Hypothalamus,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628254,,BAO_0000218,1898.0
14537,Hypothalamus,Intermediate,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL877493,,BAO_0000218,1898.0
14538,,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628255,,BAO_0000218,
14539,,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628256,,BAO_0000218,
14540,Hippocampus,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628257,,BAO_0000218,10000000.0
14541,Hypothalamus,Intermediate,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628258,,BAO_0000218,1898.0
14542,,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628259,,BAO_0000218,
14543,,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL628429,,BAO_0000218,
14544,Hippocampus,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,,50597,N,1,,CHEMBL626862,,BAO_0000218,10000000.0
14545,Hypothalamus,Intermediate,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,1,,,50597,N,1,,CHEMBL626863,,BAO_0000218,1898.0
14546,Cerebellum,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,1,,,50597,N,1,,CHEMBL625886,,BAO_0000218,2037.0
14547,Cerebellum,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,1,,,50597,N,1,,CHEMBL625887,,BAO_0000218,2037.0
14548,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cortex,1,,,50597,N,1,,CHEMBL625888,,BAO_0000218,
14549,,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,1,,,50597,N,1,,CHEMBL625889,,BAO_0000218,
14550,Hippocampus,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,1,,,50597,N,1,,CHEMBL625890,,BAO_0000218,10000000.0
14551,Hippocampus,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,1,,,50597,N,1,,CHEMBL625891,,BAO_0000218,10000000.0
14552,Hypothalamus,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,1,,,50597,N,1,,CHEMBL625892,,BAO_0000218,1898.0
14553,Hypothalamus,Intermediate,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,1,,,50597,N,1,,CHEMBL625893,,BAO_0000218,1898.0
14554,Cerebellum,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,1,,,50597,N,1,,CHEMBL625894,,BAO_0000218,2037.0
14555,,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat cortex,1,,,50597,N,1,,CHEMBL625895,,BAO_0000218,
14556,,Autocuration,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,,,22224,U,0,,CHEMBL625896,,BAO_0000019,
14557,,Autocuration,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",1,,,22224,U,0,,CHEMBL625897,,BAO_0000019,
14558,,Autocuration,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",1,,,22224,U,0,,CHEMBL625898,,BAO_0000019,
14559,,Autocuration,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",1,,,22224,U,0,,CHEMBL625899,,BAO_0000019,
14560,,Autocuration,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,,,22224,U,0,,CHEMBL626124,,BAO_0000019,
14561,,Intermediate,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,1,,,50212,N,1,,CHEMBL628500,,BAO_0000218,
14562,,Intermediate,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",1,,,50597,N,1,,CHEMBL857856,,BAO_0000218,
14563,,Intermediate,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",1,,,50597,N,1,,CHEMBL628501,,BAO_0000218,
14564,,Autocuration,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",1,,,22224,U,0,,CHEMBL628502,,BAO_0000019,
14565,,Autocuration,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,1,,,22224,U,0,,CHEMBL628503,,BAO_0000019,
14566,,Autocuration,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,1,,,22224,U,0,,CHEMBL628504,,BAO_0000019,
14567,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",1,,,22224,U,0,,CHEMBL628505,,BAO_0000019,
14568,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",1,,,22224,U,0,,CHEMBL874452,,BAO_0000019,
14569,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",1,,,22224,U,0,,CHEMBL628506,,BAO_0000019,
14570,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",1,,,22224,U,0,,CHEMBL628507,,BAO_0000019,
14571,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",1,,,22224,U,0,,CHEMBL628508,,BAO_0000019,
14572,,Autocuration,Michaelis constant (KM) was evaluated,1,,,22224,U,0,,CHEMBL628509,,BAO_0000019,
14573,,Autocuration,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,,,22224,U,0,,CHEMBL628510,,BAO_0000019,
14574,,Autocuration,Substrate concentration for half maximal velocity was reported for rat hexokinase I,1,,,22224,U,0,,CHEMBL628511,,BAO_0000019,
14575,,Autocuration,Substrate concentration for half maximal velocity was reported for rat hexokinase II,1,,,22224,U,0,,CHEMBL628512,,BAO_0000019,
14576,,Autocuration,Substrate concentration for half maximal velocity was reported for rat hexokinase III,1,,,22224,U,0,,CHEMBL628513,,BAO_0000019,
14577,,Autocuration,Substrate concentration for half maximal velocity was reported for yeast hexokinase,1,,,22224,U,0,,CHEMBL628514,,BAO_0000019,
14578,,Autocuration,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,1,,,22224,U,0,,CHEMBL628515,,BAO_0000019,
14579,,Autocuration,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,1,,,22224,U,0,,CHEMBL628516,,BAO_0000019,
14580,,Autocuration,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),1,,,22224,U,0,,CHEMBL628517,,BAO_0000019,
14581,,Autocuration,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),1,,,22224,U,0,,CHEMBL628518,,BAO_0000019,
14582,,Autocuration,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,1,,,22224,U,0,,CHEMBL628519,,BAO_0000019,
14583,,Autocuration,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,1,,,22224,U,0,,CHEMBL628520,,BAO_0000019,
14584,,Autocuration,Binding constant was determined,1,,,22224,U,0,,CHEMBL628521,,BAO_0000019,
14585,,Autocuration,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,1,,,22224,U,0,,CHEMBL630443,,BAO_0000019,
14586,,Autocuration,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,1,,,22224,U,0,,CHEMBL630444,,BAO_0000019,
14587,,Autocuration,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,1,,,22224,U,0,,CHEMBL857732,,BAO_0000019,
14588,,Autocuration,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,1,,,22224,U,0,,CHEMBL630445,,BAO_0000100,
14589,,Autocuration,Catalytic rate constant of the compound,1,,,22224,U,0,,CHEMBL630446,,BAO_0000019,
14590,,Autocuration,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,1,,,22224,U,0,,CHEMBL630447,,BAO_0000019,
14591,,Autocuration,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),1,,,22224,U,0,,CHEMBL630448,,BAO_0000019,
14592,,Autocuration,Catalytic rate constant against phospholipase A2 was determined,1,,,22224,U,0,,CHEMBL630449,,BAO_0000019,
14593,,Autocuration,"Compound was evaluated for catalytic constant, Kcat",1,,,22224,U,0,,CHEMBL630450,,BAO_0000019,
14594,,Autocuration,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,1,,,22224,U,0,,CHEMBL630451,,BAO_0000019,
14595,,Autocuration,Kcat calculated from 0.693/T1/2,1,,,22224,U,0,,CHEMBL630452,,BAO_0000019,
14596,,Autocuration,Kcat was determined,1,,,22224,U,0,,CHEMBL630453,,BAO_0000019,
14597,,Autocuration,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,1,,,22224,U,0,,CHEMBL630454,,BAO_0000019,
14598,,Autocuration,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,1,,,22224,U,0,,CHEMBL630455,,BAO_0000019,
14599,,Autocuration,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,1,,,22224,U,0,,CHEMBL631487,,BAO_0000019,
14600,,Autocuration,Kcat value was determined,1,,,22224,U,0,,CHEMBL631488,,BAO_0000019,
14601,,Autocuration,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,1,,,22224,U,0,,CHEMBL876440,,BAO_0000019,
14602,,Autocuration,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,1,,,22224,U,0,,CHEMBL631489,,BAO_0000019,
14603,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",1,,,22224,U,0,,CHEMBL857742,,BAO_0000019,
14604,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",1,,,22224,U,0,,CHEMBL631490,,BAO_0000019,
14605,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",1,,,22224,U,0,,CHEMBL631491,,BAO_0000019,
14606,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",1,,,22224,U,0,,CHEMBL631492,,BAO_0000019,
14607,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",1,,,22224,U,0,,CHEMBL631493,,BAO_0000019,
14608,,Autocuration,Kinetic parameter for rate of conversion to PABA was determined,1,,,22224,U,0,,CHEMBL631494,,BAO_0000019,
14609,,Autocuration,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,1,,,22224,U,0,,CHEMBL631495,,BAO_0000019,
14610,Feces,Intermediate,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,,,50597,N,1,,CHEMBL631496,,BAO_0000218,1988.0
14611,Urine,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,,,50597,N,1,,CHEMBL631497,,BAO_0000218,1088.0
14612,Urine,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,,,50597,N,1,,CHEMBL631498,,BAO_0000218,1088.0
14613,Urine,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,,,50597,N,1,,CHEMBL629776,,BAO_0000218,1088.0
14614,Urine,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,,,50597,N,1,,CHEMBL629777,,BAO_0000218,1088.0
14615,Urine,Intermediate,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,,,50597,N,1,,CHEMBL629778,,BAO_0000218,1088.0
14616,,Intermediate,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,1,,,50597,N,1,,CHEMBL630456,,BAO_0000218,
14617,,Intermediate,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,1,,,50597,N,1,,CHEMBL630457,,BAO_0000218,
14618,,Intermediate,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,1,,,50597,N,1,,CHEMBL630458,,BAO_0000218,
14619,,Intermediate,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,1,,,50597,N,1,,CHEMBL630459,,BAO_0000218,
14620,,Intermediate,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,1,,,50597,N,1,,CHEMBL630460,,BAO_0000218,
14621,,Intermediate,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,1,,,50597,N,1,,CHEMBL876550,,BAO_0000218,
14622,,Intermediate,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,1,,,50597,N,1,,CHEMBL630461,,BAO_0000218,
14623,,Intermediate,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,1,,,50597,N,1,,CHEMBL630462,,BAO_0000218,
14624,,Intermediate,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,1,,,50597,N,1,,CHEMBL630463,,BAO_0000218,
14625,,Intermediate,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,1,,,50597,N,1,,CHEMBL630464,,BAO_0000218,
14626,,Intermediate,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,1,,,50597,N,1,,CHEMBL630465,,BAO_0000218,
14627,,Intermediate,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,1,,,50597,N,1,,CHEMBL630466,,BAO_0000218,
14628,,Intermediate,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,1,,,50597,N,1,,CHEMBL630467,,BAO_0000218,
14629,,Intermediate,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,1,,,50597,N,1,,CHEMBL630633,,BAO_0000218,
14630,,Intermediate,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,1,,,50597,N,1,,CHEMBL630634,,BAO_0000218,
14631,,Intermediate,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,1,,,50597,N,1,,CHEMBL630635,,BAO_0000218,
14632,,Intermediate,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,1,,,50597,N,1,,CHEMBL630636,,BAO_0000218,
14633,,Intermediate,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,1,,,50597,N,1,,CHEMBL630637,,BAO_0000218,
14634,Feces,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,,,50592,N,1,,CHEMBL630638,,BAO_0000218,1988.0
14635,Feces,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,,,50592,N,1,,CHEMBL630639,,BAO_0000218,1988.0
14636,Feces,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,,,50592,N,1,,CHEMBL630640,,BAO_0000218,1988.0
14637,Feces,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,,,50592,N,1,,CHEMBL876551,,BAO_0000218,1988.0
14638,Urine,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",1,,,50592,N,1,,CHEMBL630641,,BAO_0000218,1088.0
14639,Urine,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,,,50592,N,1,,CHEMBL630642,,BAO_0000218,1088.0
14640,Urine,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,,,50592,N,1,,CHEMBL630643,,BAO_0000218,1088.0
14641,Urine,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,,,50592,N,1,,CHEMBL630644,,BAO_0000218,1088.0
14642,Urine,Intermediate,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,,,50592,N,1,,CHEMBL630645,,BAO_0000218,1088.0
14643,Feces,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,,,50592,N,1,,CHEMBL625599,,BAO_0000218,1988.0
14644,Feces,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,,,50592,N,1,,CHEMBL625600,,BAO_0000218,1988.0
14645,Feces,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,,,50592,N,1,,CHEMBL625601,,BAO_0000218,1988.0
14646,Feces,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,,,50592,N,1,,CHEMBL625602,,BAO_0000218,1988.0
14647,Urine,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",1,,,50592,N,1,,CHEMBL627470,,BAO_0000218,1088.0
14648,Urine,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,,,50592,N,1,,CHEMBL627471,,BAO_0000218,1088.0
14649,Urine,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,,,50592,N,1,,CHEMBL627472,,BAO_0000218,1088.0
14650,Urine,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,,,50592,N,1,,CHEMBL627473,,BAO_0000218,1088.0
14651,Urine,Intermediate,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,,,50592,N,1,,CHEMBL627474,,BAO_0000218,1088.0
14652,Blood,Intermediate,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL627475,,BAO_0000218,178.0
14653,Blood,Intermediate,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL627476,,BAO_0000218,178.0
14654,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627477,,BAO_0000218,1088.0
14655,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627478,,BAO_0000218,1088.0
14656,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627479,,BAO_0000218,1088.0
14657,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627480,,BAO_0000218,1088.0
14658,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627481,,BAO_0000218,1088.0
14659,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627482,,BAO_0000218,1088.0
14660,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,,50588,N,1,,CHEMBL627483,,BAO_0000218,1088.0
14661,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,,50588,N,1,,CHEMBL875636,,BAO_0000218,1088.0
14662,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625764,,BAO_0000218,1088.0
14663,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625765,,BAO_0000218,1088.0
14664,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625766,,BAO_0000218,1088.0
14665,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625767,,BAO_0000218,1088.0
14666,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625768,,BAO_0000218,1088.0
14667,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625769,,BAO_0000218,1088.0
14668,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625770,,BAO_0000218,1088.0
14669,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625771,,BAO_0000218,1088.0
14670,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625772,,BAO_0000218,1088.0
14671,Urine,Intermediate,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,,50588,N,1,,CHEMBL625773,,BAO_0000218,1088.0
14672,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625774,,BAO_0000218,1088.0
14673,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625775,,BAO_0000218,1088.0
14674,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625776,,BAO_0000218,1088.0
14675,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625777,,BAO_0000218,1088.0
14676,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625778,,BAO_0000218,1088.0
14677,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625779,,BAO_0000218,1088.0
14678,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625780,,BAO_0000218,1088.0
14679,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,,50597,N,1,,CHEMBL625781,,BAO_0000218,1088.0
14680,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,1,,,50597,N,1,,CHEMBL875637,,BAO_0000218,1088.0
14681,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626473,,BAO_0000218,1088.0
14682,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626474,,BAO_0000218,1088.0
14683,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626475,,BAO_0000218,1088.0
14684,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626476,,BAO_0000218,1088.0
14685,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL634397,,BAO_0000218,1088.0
14686,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,1,,,50597,N,1,,CHEMBL626477,,BAO_0000218,1088.0
14687,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631069,,BAO_0000218,1088.0
14688,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631070,,BAO_0000218,1088.0
14689,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631071,,BAO_0000218,1088.0
14690,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631072,,BAO_0000218,1088.0
14691,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631073,,BAO_0000218,1088.0
14692,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631074,,BAO_0000218,1088.0
14693,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631075,,BAO_0000218,1088.0
14694,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631725,,BAO_0000218,1088.0
14695,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631726,,BAO_0000218,1088.0
14696,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631727,,BAO_0000218,1088.0
14697,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631728,,BAO_0000218,1088.0
14698,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631729,,BAO_0000218,1088.0
14699,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631730,,BAO_0000218,1088.0
14700,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631731,,BAO_0000218,1088.0
14701,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631910,,BAO_0000218,1088.0
14702,Hippocampus,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,1,,,50597,N,1,,CHEMBL631911,,BAO_0000218,10000000.0
14703,Hypothalamus,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,1,,,50597,N,1,,CHEMBL631912,,BAO_0000218,1898.0
14704,Hypothalamus,Intermediate,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,1,,,50597,N,1,,CHEMBL631913,,BAO_0000218,1898.0
14705,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631914,,BAO_0000218,178.0
14706,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631915,,BAO_0000218,178.0
14707,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL875778,,BAO_0000218,178.0
14708,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631916,,BAO_0000218,178.0
14709,Blood,Intermediate,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631917,,BAO_0000218,178.0
14710,Blood,Intermediate,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631918,,BAO_0000218,178.0
14711,Blood,Intermediate,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631919,,BAO_0000218,178.0
14712,Blood,Intermediate,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL631920,,BAO_0000218,178.0
14713,Blood,Intermediate,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631921,,BAO_0000218,178.0
14714,Blood,Intermediate,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631922,,BAO_0000218,178.0
14715,Blood,Intermediate,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL631923,,BAO_0000218,178.0
14716,,Intermediate,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631924,,BAO_0000218,
14717,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630234,,BAO_0000218,
14718,,Intermediate,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630235,,BAO_0000218,
14719,,Intermediate,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630236,,BAO_0000218,
14720,,Intermediate,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630237,,BAO_0000218,
14721,,Intermediate,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630238,,BAO_0000218,
14722,,Intermediate,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630239,,BAO_0000218,
14723,,Intermediate,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630303,,BAO_0000218,
14724,,Intermediate,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630304,,BAO_0000218,
14725,,Intermediate,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630305,,BAO_0000218,
14726,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630306,,BAO_0000218,2113.0
14727,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630307,,BAO_0000218,2113.0
14728,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630308,,BAO_0000218,2113.0
14729,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630309,,BAO_0000218,2113.0
14730,Kidney,Intermediate,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL629309,,BAO_0000218,2113.0
14731,Kidney,Intermediate,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL629993,,BAO_0000218,2113.0
14732,Kidney,Intermediate,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL629994,,BAO_0000218,2113.0
14733,Kidney,Intermediate,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL629995,,BAO_0000218,2113.0
14734,Kidney,Intermediate,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631993,,BAO_0000218,2113.0
14735,Kidney,Intermediate,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631994,,BAO_0000218,2113.0
14736,Kidney,Intermediate,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631995,,BAO_0000218,2113.0
14737,Liver,Intermediate,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL631996,,BAO_0000218,2107.0
14738,Liver,Intermediate,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631997,,BAO_0000218,2107.0
14739,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631998,,BAO_0000218,2107.0
14740,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631999,,BAO_0000218,2107.0
14741,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL632000,,BAO_0000218,2107.0
14742,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL632001,,BAO_0000218,2107.0
14743,Liver,Intermediate,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL874424,,BAO_0000218,2107.0
14744,Liver,Intermediate,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL632002,,BAO_0000218,2107.0
14745,Liver,Intermediate,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL632003,,BAO_0000218,2107.0
14746,,Autocuration,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,1,,,22224,U,0,,CHEMBL632004,,BAO_0000019,
14747,,Autocuration,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,1,,,22224,U,0,,CHEMBL632005,,BAO_0000019,
14748,,Autocuration,Compound was tested for amidase rate in the presence of N62C screen enzyme,1,,,22224,U,0,,CHEMBL632006,,BAO_0000019,
14749,,Autocuration,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,1,,,22224,U,0,,CHEMBL632007,,BAO_0000019,
14750,,Autocuration,Compound was tested for amidase rate in the presence of S166C screen enzyme,1,,,22224,U,0,,CHEMBL632008,,BAO_0000019,
14751,,Autocuration,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,1,,,22224,U,0,,CHEMBL632009,,BAO_0000019,
14752,,Autocuration,Compound was tested for esterase rate in the presence of N62C screen enzyme,1,,,22224,U,0,,CHEMBL632010,,BAO_0000019,
14753,,Autocuration,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,1,,,22224,U,0,,CHEMBL857750,,BAO_0000019,
14754,,Autocuration,Compound was tested for esterase rate in the presence of S166C screen enzyme,1,,,22224,U,0,,CHEMBL632011,,BAO_0000019,
14755,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,22224,U,0,,CHEMBL632012,,BAO_0000019,
14756,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,22224,U,0,,CHEMBL632013,,BAO_0000019,
14757,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",1,,,22224,U,0,,CHEMBL632014,,BAO_0000019,
14758,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,22224,U,0,,CHEMBL629622,,BAO_0000019,
14759,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,22224,U,0,,CHEMBL629623,,BAO_0000019,
14760,,Autocuration,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",1,,,22224,U,0,,CHEMBL629624,,BAO_0000019,
14761,,Autocuration,Ratio of Kcat to that of Km was determined,1,,,22224,U,0,,CHEMBL629625,,BAO_0000019,
14762,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",1,,,22224,U,0,,CHEMBL629626,,BAO_0000019,
14763,,Autocuration,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",1,,,22224,U,0,,CHEMBL629627,,BAO_0000019,
14764,,Autocuration,"Compound was evaluated for constant, Kd",1,,,22224,U,0,,CHEMBL629628,,BAO_0000019,
14765,,Autocuration,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,1,,,22224,U,0,,CHEMBL629629,,BAO_0000019,
14766,,Autocuration,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,1,,,22224,U,0,,CHEMBL629630,,BAO_0000019,
14767,,Autocuration,Dissociation Constant of compound determined,1,,,22224,U,0,,CHEMBL856030,,BAO_0000019,
14768,,Autocuration,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,1,,,22224,U,0,,CHEMBL629631,,BAO_0000019,
14769,,Autocuration,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,1,,,22224,U,0,,CHEMBL629632,,BAO_0000019,
14770,,Autocuration,Dissociation constant of compound with Fructose was determined,1,,,22224,U,0,,CHEMBL629633,,BAO_0000100,
14771,,Autocuration,Dissociation constant of compound with Fructose was determined; Not determined,1,,,22224,U,0,,CHEMBL629634,,BAO_0000100,
14772,,Autocuration,Dissociation constant of compound with Lactulose was determined,1,,,22224,U,0,,CHEMBL629635,,BAO_0000100,
14773,,Autocuration,Dissociation constant of compound with Lactulose was determined; Not determined,1,,,22224,U,0,,CHEMBL629636,,BAO_0000100,
14774,,Autocuration,Dissociation constant of the Compound,1,,,22224,U,0,,CHEMBL629637,,BAO_0000100,
14775,,Autocuration,Dissociation constant by non-linear regression analysis,1,,,22224,U,0,,CHEMBL629638,,BAO_0000100,
14776,,Autocuration,Dissociation constant was determined,1,,,22224,U,0,,CHEMBL629639,,BAO_0000100,
14777,,Autocuration,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,1,,,22224,U,0,,CHEMBL629640,,BAO_0000100,
14778,,Autocuration,Dissociation constant was determined,1,,,22224,U,0,,CHEMBL629641,,BAO_0000100,
14779,,Autocuration,Dissociation constant was determined,1,,,22224,U,0,,CHEMBL631344,,BAO_0000100,
14780,Muscle tissue,Intermediate,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,1,,,50597,N,1,,CHEMBL631345,,BAO_0000218,2385.0
14781,,Autocuration,The dissociation constant determined by fluorescence displacement assay,1,,,22224,U,0,,CHEMBL631346,,BAO_0000019,
14782,,Autocuration,kd value surface plasmon resonance (SPR) method,1,,,22224,U,0,,CHEMBL631524,,BAO_0000019,
14783,Muscle tissue,Intermediate,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,1,,,50597,N,1,,CHEMBL631525,,BAO_0000218,2385.0
14784,,Autocuration,First dissociation constant of the binding of compound to V30M TTR,1,,,22224,U,0,,CHEMBL631526,,BAO_0000019,
14785,,Autocuration,Second dissociation constant of the binding of compound to V30M TTR,1,,,22224,U,0,,CHEMBL631527,,BAO_0000019,
14786,,Autocuration,"Compound was evaluated for equilibrium constant, Ke",1,,,22224,U,0,,CHEMBL631528,,BAO_0000019,
14787,Hypothalamus,Autocuration,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,1,,,22224,U,0,,CHEMBL631529,,BAO_0000019,1898.0
14788,Hypothalamus,Autocuration,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,1,,,22224,U,0,,CHEMBL631530,,BAO_0000019,1898.0
14789,,Autocuration,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,1,,,22224,U,0,,CHEMBL631531,,BAO_0000019,
14790,,Autocuration,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,1,,,22224,U,0,,CHEMBL631532,,BAO_0000019,
14791,,Autocuration,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,1,,,22224,U,0,,CHEMBL631533,,BAO_0000019,
14792,,Intermediate,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,50594,N,1,,CHEMBL876552,,BAO_0000218,
14793,,Intermediate,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,,,50594,N,1,,CHEMBL631534,,BAO_0000218,
14794,,Intermediate,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,50594,N,1,,CHEMBL631535,,BAO_0000218,
14795,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,50594,N,1,,CHEMBL631536,,BAO_0000218,
14796,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,1,,,50594,N,1,,CHEMBL631537,,BAO_0000218,
14797,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,,,50594,N,1,,CHEMBL631538,,BAO_0000218,
14798,,Intermediate,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,1,,,50594,N,1,,CHEMBL631539,,BAO_0000218,
14799,,Intermediate,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,50594,N,1,,CHEMBL631540,,BAO_0000218,
14800,,Intermediate,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,50597,N,1,,CHEMBL625637,,BAO_0000218,
14801,,Intermediate,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,50597,N,1,,CHEMBL625638,,BAO_0000218,
14802,,Intermediate,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,,,50597,N,1,,CHEMBL625639,,BAO_0000218,
14803,Brain,Intermediate,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625640,,BAO_0000218,955.0
14804,Brain,Intermediate,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625641,,BAO_0000218,955.0
14805,Heart,Intermediate,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625642,,BAO_0000218,948.0
14806,Heart,Intermediate,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625643,,BAO_0000218,948.0
14807,Kidney,Intermediate,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625644,,BAO_0000218,2113.0
14808,Kidney,Intermediate,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625645,,BAO_0000218,2113.0
14809,Liver,Intermediate,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625646,,BAO_0000218,2107.0
14810,Liver,Intermediate,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625647,,BAO_0000218,2107.0
14811,Lung,Intermediate,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625648,,BAO_0000218,2048.0
14812,Lung,Intermediate,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625649,,BAO_0000218,2048.0
14813,Muscle tissue,Intermediate,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625650,,BAO_0000218,2385.0
14814,Muscle tissue,Intermediate,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625651,,BAO_0000218,2385.0
14815,Zone of skin,Intermediate,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625652,,BAO_0000218,14.0
14816,Zone of skin,Intermediate,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625653,,BAO_0000218,14.0
14817,Spleen,Intermediate,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625654,,BAO_0000218,2106.0
14818,Spleen,Intermediate,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,,50597,N,1,,CHEMBL625655,,BAO_0000218,2106.0
14819,Blood,Intermediate,Biodistribution of Compound in rat blood after 15 minutes of administration,1,,,50597,N,1,,CHEMBL625656,,BAO_0000218,178.0
14820,Blood,Intermediate,Biodistribution of Compound in rat blood after 2 minutes of administration,1,,,50597,N,1,,CHEMBL625657,,BAO_0000218,178.0
14821,Brain,Intermediate,Biodistribution of Compound in rat brain after 15 minutes of administration,1,,,50597,N,1,,CHEMBL625658,,BAO_0000218,955.0
14822,Brain,Intermediate,Biodistribution of Compound in rat brain after 2 minutes of administration,1,,,50597,N,1,,CHEMBL625659,,BAO_0000218,955.0
14823,Heart,Intermediate,Biodistribution of Compound in rat heart after 15 minutes of administration,1,,,50597,N,1,,CHEMBL625660,,BAO_0000218,948.0
14824,Heart,Intermediate,Biodistribution of Compound in rat heart after 2 minutes of administration,1,,,50597,N,1,,CHEMBL625661,,BAO_0000218,948.0
14825,Liver,Intermediate,Biodistribution of Compound in rat liver after 15 minutes of administration,1,,,50597,N,1,,CHEMBL625662,,BAO_0000218,2107.0
14826,Liver,Intermediate,Biodistribution of Compound in rat liver after 2 minutes of administration,1,,,50597,N,1,,CHEMBL625663,,BAO_0000218,2107.0
14827,Lung,Intermediate,Biodistribution of Compound in rat lung after 15 minutes of administration,1,,,50597,N,1,,CHEMBL875621,,BAO_0000218,2048.0
14828,Lung,Intermediate,Biodistribution of Compound in rat lung after 2 minutes of administration,1,,,50597,N,1,,CHEMBL628382,,BAO_0000218,2048.0
14829,Muscle tissue,Intermediate,Biodistribution of Compound in rat muscle after 15 minutes of administration,1,,,50597,N,1,,CHEMBL628383,,BAO_0000218,2385.0
14830,Muscle tissue,Intermediate,Biodistribution of Compound in rat muscle after 2 minutes of administration,1,,,50597,N,1,,CHEMBL628384,,BAO_0000218,2385.0
14831,,Intermediate,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,1,,,50597,N,1,,CHEMBL628385,,BAO_0000218,
14832,,Intermediate,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,1,,,50597,N,1,,CHEMBL875753,,BAO_0000218,
14833,,Intermediate,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,1,,,50597,N,1,,CHEMBL628386,,BAO_0000218,
14834,,Intermediate,Organ distribution in rat blood 2 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL628387,,BAO_0000218,
14835,,Intermediate,Organ distribution in rat blood 2 hr after intravenous injection,1,,,50597,N,1,,CHEMBL628388,,BAO_0000218,
14836,,Intermediate,Organ distribution in rat blood 30 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL628389,,BAO_0000218,
14837,,Intermediate,Organ distribution in rat blood 30 min after intravenous injection,1,,,50597,N,1,,CHEMBL632756,,BAO_0000218,
14838,,Intermediate,Organ distribution in rat brain 2 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL628390,,BAO_0000218,
14839,,Intermediate,Organ distribution in rat brain 2 hr after intravenous injection,1,,,50597,N,1,,CHEMBL631811,,BAO_0000218,
14840,,Intermediate,Organ distribution in rat brain 30 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631812,,BAO_0000218,
14841,,Intermediate,Organ distribution in rat heart 2 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631813,,BAO_0000218,
14842,,Intermediate,Organ distribution in rat heart 2 hr after intravenous injection,1,,,50597,N,1,,CHEMBL631814,,BAO_0000218,
14843,,Intermediate,Organ distribution in rat heart 30 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631815,,BAO_0000218,
14844,,Intermediate,Organ distribution in rat kidney 2 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631816,,BAO_0000218,
14845,,Intermediate,Organ distribution in rat kidney 2 hr after intravenous injection,1,,,50597,N,1,,CHEMBL875758,,BAO_0000218,
14846,,Intermediate,Organ distribution in rat kidney 30 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631817,,BAO_0000218,
14847,Liver,Intermediate,Organ distribution in rat liver 2 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631818,,BAO_0000218,2107.0
14848,Liver,Intermediate,Organ distribution in rat liver 2 hr after intravenous injection,1,,,50597,N,1,,CHEMBL631819,,BAO_0000218,2107.0
14849,Liver,Intermediate,Organ distribution in rat liver 30 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631820,,BAO_0000218,2107.0
14850,,Intermediate,Organ distribution in rat lung 2 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631821,,BAO_0000218,
14851,,Intermediate,Organ distribution in rat lung 2 hr after intravenous injection,1,,,50597,N,1,,CHEMBL631822,,BAO_0000218,
14852,,Intermediate,Organ distribution in rat lung 30 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631823,,BAO_0000218,
14853,Muscle tissue,Intermediate,Organ distribution in rat muscle 2 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631824,,BAO_0000218,2385.0
14854,Muscle tissue,Intermediate,Organ distribution in rat muscle 2 hr after intravenous injection,1,,,50597,N,1,,CHEMBL631825,,BAO_0000218,2385.0
14855,Muscle tissue,Intermediate,Organ distribution in rat muscle 30 minutes after intravenous injection,1,,,50597,N,1,,CHEMBL631826,,BAO_0000218,2385.0
14856,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),1,,,50594,N,1,,CHEMBL631827,,BAO_0000218,
14857,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),1,,,50594,N,1,,CHEMBL631828,,BAO_0000218,
14858,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),1,,,50594,N,1,,CHEMBL631829,,BAO_0000218,
14859,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,,50597,N,1,,CHEMBL875759,,BAO_0000218,1088.0
14860,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631830,,BAO_0000218,1088.0
14861,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631831,,BAO_0000218,1088.0
14862,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631832,,BAO_0000218,1088.0
14863,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631833,,BAO_0000218,1088.0
14864,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631834,,BAO_0000218,1088.0
14865,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631835,,BAO_0000218,1088.0
14866,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631836,,BAO_0000218,1088.0
14867,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631837,,BAO_0000218,1088.0
14868,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631838,,BAO_0000218,1088.0
14869,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631839,,BAO_0000218,1088.0
14870,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631840,,BAO_0000218,1088.0
14871,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631841,,BAO_0000218,1088.0
14872,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631842,,BAO_0000218,1088.0
14873,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631843,,BAO_0000218,1088.0
14874,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631844,,BAO_0000218,1088.0
14875,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631845,,BAO_0000218,1088.0
14876,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631846,,BAO_0000218,1088.0
14877,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL875760,,BAO_0000218,1088.0
14878,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,,50597,N,1,,CHEMBL632199,,BAO_0000218,1088.0
14879,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631847,,BAO_0000218,1088.0
14880,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,,50597,N,1,,CHEMBL631848,,BAO_0000218,1088.0
14881,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628707,,BAO_0000218,1088.0
14882,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628708,,BAO_0000218,1088.0
14883,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628709,,BAO_0000218,1088.0
14884,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628710,,BAO_0000218,1088.0
14885,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628711,,BAO_0000218,1088.0
14886,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628712,,BAO_0000218,1088.0
14887,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628713,,BAO_0000218,1088.0
14888,Urine,Intermediate,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,,50597,N,1,,CHEMBL628714,,BAO_0000218,1088.0
14889,,Intermediate,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",1,,,50597,N,1,,CHEMBL628715,,BAO_0000218,
14890,,Autocuration,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,1,,,22224,U,0,,CHEMBL629179,,BAO_0000019,
14891,,Autocuration,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,1,,,22224,U,0,,CHEMBL629180,,BAO_0000019,
14892,,Autocuration,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,1,,,22224,U,0,,CHEMBL875108,,BAO_0000019,
14893,Adrenal cortex,Autocuration,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629181,,BAO_0000019,1235.0
14894,Adrenal cortex,Autocuration,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629182,,BAO_0000019,1235.0
14895,,Autocuration,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629183,,BAO_0000019,
14896,,Autocuration,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629184,,BAO_0000019,
14897,Adrenal cortex,Autocuration,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629185,,BAO_0000019,1235.0
14898,Adrenal cortex,Autocuration,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629186,,BAO_0000019,1235.0
14899,,Autocuration,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629187,,BAO_0000019,
14900,,Autocuration,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629887,,BAO_0000019,
14901,,Autocuration,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629888,,BAO_0000019,
14902,,Autocuration,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629889,,BAO_0000019,
14903,Adrenal cortex,Autocuration,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629890,,BAO_0000019,1235.0
14904,,Autocuration,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629891,,BAO_0000019,
14905,,Autocuration,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629892,,BAO_0000019,
14906,Adrenal cortex,Autocuration,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629893,,BAO_0000019,1235.0
14907,,Autocuration,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629894,,BAO_0000019,
14908,,Autocuration,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,1,,,22224,U,0,,CHEMBL629895,,BAO_0000019,
14909,,Autocuration,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",1,,,22224,U,0,,CHEMBL875109,,BAO_0000218,
14910,,Autocuration,Absolute bioavailability in male cynomolgus monkeys,1,,,22224,U,0,,CHEMBL629896,,BAO_0000218,
14911,,Autocuration,Absolute bioavailability in maleSprague-Dawley rats,1,,,22224,U,0,,CHEMBL629897,,BAO_0000218,
14912,Liver,Intermediate,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL629898,,BAO_0000218,2107.0
14913,Liver,Intermediate,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630057,,BAO_0000218,2107.0
14914,Liver,Intermediate,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630058,,BAO_0000218,2107.0
14915,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630059,,BAO_0000218,2048.0
14916,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630060,,BAO_0000218,2048.0
14917,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630061,,BAO_0000218,2048.0
14918,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630062,,BAO_0000218,2048.0
14919,Lung,Intermediate,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630063,,BAO_0000218,2048.0
14920,Lung,Intermediate,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630064,,BAO_0000218,2048.0
14921,Lung,Intermediate,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630065,,BAO_0000218,2048.0
14922,Lung,Intermediate,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630066,,BAO_0000218,2048.0
14923,Lung,Intermediate,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630067,,BAO_0000218,2048.0
14924,Lung,Intermediate,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630068,,BAO_0000218,2048.0
14925,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631113,,BAO_0000218,2385.0
14926,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631114,,BAO_0000218,2385.0
14927,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL631115,,BAO_0000218,2385.0
14928,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL631116,,BAO_0000218,2385.0
14929,Muscle tissue,Intermediate,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630528,,BAO_0000218,2385.0
14930,Muscle tissue,Intermediate,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630529,,BAO_0000218,2385.0
14931,Muscle tissue,Intermediate,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630530,,BAO_0000218,2385.0
14932,Muscle tissue,Intermediate,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630531,,BAO_0000218,2385.0
14933,Muscle tissue,Intermediate,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630532,,BAO_0000218,2385.0
14934,Muscle tissue,Intermediate,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630533,,BAO_0000218,2385.0
14935,Blood,Intermediate,Biodistribution in normal mice blood after 120 hr,1,,,50594,N,1,,CHEMBL630534,,BAO_0000218,178.0
14936,Blood,Intermediate,Biodistribution in normal mice blood after 24 hr,1,,,50594,N,1,,CHEMBL630535,,BAO_0000218,178.0
14937,Blood,Intermediate,Biodistribution in normal mice blood after 4 hr,1,,,50594,N,1,,CHEMBL630536,,BAO_0000218,178.0
14938,Bone,Intermediate,Biodistribution in normal mice bone after 120 hr,1,,,50594,N,1,,CHEMBL630537,,BAO_0000218,10000001.0
14939,Bone,Intermediate,Biodistribution in normal mice bone after 24 hr,1,,,50594,N,1,,CHEMBL630538,,BAO_0000218,10000001.0
14940,Bone,Intermediate,Biodistribution in normal mice bone after 4 hr,1,,,50594,N,1,,CHEMBL630539,,BAO_0000218,10000001.0
14941,Heart,Intermediate,Biodistribution in normal mice heart after 120 hr,1,,,50594,N,1,,CHEMBL630540,,BAO_0000218,948.0
14942,Heart,Intermediate,Biodistribution in normal mice heart after 24 hr,1,,,50594,N,1,,CHEMBL630541,,BAO_0000218,948.0
14943,Heart,Intermediate,Biodistribution in normal mice heart after 4 hr,1,,,50594,N,1,,CHEMBL630542,,BAO_0000218,948.0
14944,Kidney,Intermediate,Biodistribution in normal mice kidney after 120 hr,1,,,50594,N,1,,CHEMBL630543,,BAO_0000218,2113.0
14945,Kidney,Intermediate,Biodistribution in normal mice kidney after 24 hr,1,,,50594,N,1,,CHEMBL630544,,BAO_0000218,2113.0
14946,Kidney,Intermediate,Biodistribution in normal mice kidney after 4 hr,1,,,50594,N,1,,CHEMBL630545,,BAO_0000218,2113.0
14947,Liver,Intermediate,Biodistribution in normal mice liver after 120 hr,1,,,50594,N,1,,CHEMBL630546,,BAO_0000218,2107.0
14948,Liver,Intermediate,Biodistribution in normal mice liver after 24 hr,1,,,50594,N,1,,CHEMBL630547,,BAO_0000218,2107.0
14949,Liver,Intermediate,Biodistribution in normal mice liver after 4 hr,1,,,50594,N,1,,CHEMBL630548,,BAO_0000218,2107.0
14950,Spleen,Intermediate,Biodistribution in normal mice spleen after 120 hr,1,,,50594,N,1,,CHEMBL630549,,BAO_0000218,2106.0
14951,Spleen,Intermediate,Biodistribution in normal mice spleen after 24 hr,1,,,50594,N,1,,CHEMBL630550,,BAO_0000218,2106.0
14952,Spleen,Intermediate,Biodistribution in normal mice spleen after 4 hr,1,,,50594,N,1,,CHEMBL876426,,BAO_0000218,2106.0
14953,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630551,,BAO_0000218,2106.0
14954,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630552,,BAO_0000218,2106.0
14955,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630553,,BAO_0000218,2106.0
14956,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630554,,BAO_0000218,2106.0
14957,Spleen,Intermediate,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630555,,BAO_0000218,2106.0
14958,Spleen,Intermediate,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630556,,BAO_0000218,2106.0
14959,Spleen,Intermediate,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630557,,BAO_0000218,2106.0
14960,Spleen,Intermediate,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,50597,N,1,,CHEMBL630558,,BAO_0000218,2106.0
14961,Spleen,Intermediate,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630559,,BAO_0000218,2106.0
14962,Spleen,Intermediate,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL630560,,BAO_0000218,2106.0
14963,Thyroid gland,Intermediate,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,50597,N,1,,CHEMBL876427,,BAO_0000218,2046.0
14964,,Intermediate,The Kel values in female wistar rats.,1,,,50597,N,1,,CHEMBL630561,,BAO_0000218,
14965,,Autocuration,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,1,,,22224,U,0,,CHEMBL630562,,BAO_0000019,
14966,,Autocuration,Hydrolysis rate constant of the compound,1,,,22224,U,0,,CHEMBL630563,,BAO_0000019,
14967,,Autocuration,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,1,,,22229,U,0,,CHEMBL629673,,BAO_0000100,
14968,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",1,,,22224,U,0,,CHEMBL629674,,BAO_0000019,
14969,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",1,,,22224,U,0,,CHEMBL629675,,BAO_0000019,
14970,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",1,,,22224,U,0,,CHEMBL629676,,BAO_0000019,
14971,,Autocuration,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",1,,,22224,U,0,,CHEMBL629677,,BAO_0000019,
14972,,Autocuration,Apparent inactivation rate constant was evaluated,1,,,22224,U,0,,CHEMBL629678,,BAO_0000019,
14973,,Autocuration,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,1,,,22224,U,0,,CHEMBL629679,,BAO_0000019,
14974,,Autocuration,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,1,,,22224,U,0,,CHEMBL629680,,BAO_0000019,
14975,,Autocuration,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,1,,,22224,U,0,,CHEMBL629681,,BAO_0000019,
14976,,Autocuration,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,1,,,22224,U,0,,CHEMBL629682,,BAO_0000019,
14977,,Autocuration,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,1,,,22224,U,0,,CHEMBL629683,,BAO_0000019,
14978,,Autocuration,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,1,,,22224,U,0,,CHEMBL629684,,BAO_0000019,
14979,,Autocuration,Dissociation constant was determined,1,,,22224,U,0,,CHEMBL629685,,BAO_0000100,
14980,,Autocuration,Dissociation constant was determined,1,,,22224,U,0,,CHEMBL629686,,BAO_0000100,
14981,,Autocuration,Dissociation constant at pH 7.4,1,,,22224,U,0,,CHEMBL872932,,BAO_0000100,
14982,,Autocuration,Dissociation constant in presence of 1 mM dithiothreitol,1,,,22224,U,0,,CHEMBL629687,,BAO_0000100,
14983,,Autocuration,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,1,,,22224,U,0,,CHEMBL872931,,BAO_0000019,
14984,,Autocuration,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,1,,,22224,U,0,,CHEMBL628151,,BAO_0000019,
14985,,Autocuration,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,1,,,22224,U,0,,CHEMBL628152,,BAO_0000019,
14986,,Autocuration,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,1,,,22224,U,0,,CHEMBL628153,,BAO_0000019,
14987,,Autocuration,Kinetic constant for aromatization of androstenedione,1,,,22224,U,0,,CHEMBL628154,,BAO_0000019,
14988,,Autocuration,Kinetic constant for aromatization of testosterone,1,,,22224,U,0,,CHEMBL628155,,BAO_0000019,
14989,,Autocuration,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,1,,,22224,U,0,,CHEMBL628156,,BAO_0000019,
14990,,Autocuration,Local inhibition constant was determined,1,,,22224,U,0,,CHEMBL628157,,BAO_0000019,
14991,,Intermediate,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,1,,,50347,N,1,,CHEMBL857533,,BAO_0000218,
14992,,Autocuration,Dissociation constant value of the compound,1,,,22224,U,0,,CHEMBL628158,,BAO_0000100,
14993,Cornea,Autocuration,In vitro permeability through cornea without epithelium,1,,,22224,U,0,,CHEMBL628159,,BAO_0000019,964.0
14994,Cornea,Autocuration,In vitro permeability through intact cornea,1,,,22224,U,0,,CHEMBL875616,,BAO_0000019,964.0
14995,Cornea,Intermediate,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,1,,,50592,N,1,,CHEMBL628160,,BAO_0000218,964.0
14996,,Autocuration,Rate of enzyme inactivation for the compound was determined,1,,,22224,U,0,,CHEMBL628161,,BAO_0000019,
14997,Cornea,Autocuration,In vitro permeability through cornea without epithelium,1,,,22224,U,0,,CHEMBL628162,,BAO_0000019,964.0
14998,Cornea,Autocuration,In vitro permeability through intact cornea,1,,,22224,U,0,,CHEMBL628163,,BAO_0000019,964.0
14999,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628164,,BAO_0000019,
15000,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628165,,BAO_0000019,
15001,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628166,,BAO_0000019,
15002,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628167,,BAO_0000019,
15003,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628168,,BAO_0000019,
15004,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628169,,BAO_0000019,
15005,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628170,,BAO_0000019,
15006,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628171,,BAO_0000019,
15007,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL627434,,BAO_0000019,
15008,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL627435,,BAO_0000019,
15009,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628110,,BAO_0000019,
15010,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628111,,BAO_0000019,
15011,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628112,,BAO_0000019,
15012,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628260,,BAO_0000019,
15013,,Autocuration,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,22224,U,0,,CHEMBL628261,,BAO_0000019,
15014,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),1,,,50594,N,1,,CHEMBL628262,,BAO_0000218,
15015,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,1,,,50587,N,1,,CHEMBL628263,,BAO_0000218,
15016,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),1,,,50594,N,1,,CHEMBL628264,,BAO_0000218,
15017,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),1,,,50594,N,1,,CHEMBL628265,,BAO_0000218,
15018,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),1,,,50594,N,1,,CHEMBL628266,,BAO_0000218,
15019,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),1,,,50594,N,1,,CHEMBL628267,,BAO_0000218,
15020,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,1,,,50594,N,1,,CHEMBL628268,,BAO_0000218,
15021,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),1,,,50594,N,1,,CHEMBL628269,,BAO_0000218,
15022,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),1,,,50594,N,1,,CHEMBL628270,,BAO_0000218,
15023,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),1,,,50594,N,1,,CHEMBL628271,,BAO_0000218,
15024,,Intermediate,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),1,,,50594,N,1,,CHEMBL628272,,BAO_0000218,
